Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:bridged compound
go back to main search page
Accession:CHEBI:35990 term browser browse the term
Definition:A polycyclic compound that contains more than one ring with at least two common atoms (also known as bridgehead carbons) that are not adjacent to each other.
Synonyms:related_synonym: bridged compounds


show annotations for term's descendants           Sort by:
8,5'-cyclo-2'-deoxyadenosine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Neil1 nei-like DNA glycosylase 1 affects metabolic processing ISO NEIL1 protein affects the metabolism of 8,5'-cyclo-2'-deoxyadenosine CTD PMID:20067321 NCBI chr 8:66,446,106...66,452,844
Ensembl chr 8:57,550,147...57,556,258 		JBrowse link
albiflorin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein] CTD PMID:37523837 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Drd2 dopamine receptor D2 affects expression EXP albiflorin affects the expression of DRD2 CTD PMID:26475043 NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein] CTD PMID:37523837 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Htr1a 5-hydroxytryptamine receptor 1A affects expression EXP albiflorin affects the expression of HTR1A CTD PMID:26475043 NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442 		JBrowse link
G Htr2a 5-hydroxytryptamine receptor 2A affects expression EXP albiflorin affects the expression of HTR2A CTD PMID:26475043 NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928 		JBrowse link
G Map3k7 mitogen activated protein kinase kinase kinase 7 multiple interactions ISO Albiflorin inhibits the reaction [oxidized LDL increases phosphorylation of MAP3K7 protein in umbilical vein endothelial cells] RGD PMID:35601145 RGD:155804296 NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597 		JBrowse link
G Slc6a3 solute carrier family 6 member 3 affects expression EXP albiflorin affects the expression of SLC6A3 CTD PMID:26475043 NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413 		JBrowse link
G Th tyrosine hydroxylase affects expression EXP albiflorin affects the expression of TH CTD PMID:26475043 NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767 		JBrowse link
benzoylaconine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases transport
multiple interactions		 ISO ABCB1 protein results in increased transport of benzoylaconine
[Cyclosporine results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylaconine		 CTD PMID:23200901 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions ISO [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylaconine CTD PMID:23200901 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
benzoylhypaconine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases transport		 ISO [Cyclosporine results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylhypaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylhypaconine
ABCB1 protein results in increased transport of benzoylhypaconine		 CTD PMID:23200901 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions ISO [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylhypaconine CTD PMID:23200901 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions ISO [3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased transport of benzoylhypaconine CTD PMID:23200901 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409 		JBrowse link
benzoylmesaconine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases transport
multiple interactions		 ISO ABCB1 protein results in increased transport of benzoylmesaconine
[Cyclosporine results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylmesaconine; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased transport of benzoylmesaconine		 CTD PMID:23200901 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions ISO [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylmesaconine CTD PMID:23200901 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
C60 fullerene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 1700009N14Rikl RIKEN cDNA 1700009N14 gene like increases expression EXP fullerene C60 results in increased expression of 1700009N14RIKL mRNA CTD PMID:19167457 NCBI chr 5:54,456,005...54,457,381
Ensembl chr 5:54,455,893...54,457,677 		JBrowse link
G Aaas aladin WD repeat nucleoporin increases expression EXP fullerene C60 results in increased expression of AAAS mRNA CTD PMID:19167457 NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:133,464,315...133,483,961 		JBrowse link
G Abce1 ATP binding cassette subfamily E member 1 decreases expression EXP fullerene C60 results in decreased expression of ABCE1 mRNA CTD PMID:19167457 NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489 		JBrowse link
G Abcf3 ATP binding cassette subfamily F member 3 decreases expression EXP fullerene C60 results in decreased expression of ABCF3 mRNA CTD PMID:19167457 NCBI chr11:80,340,476...80,352,211
Ensembl chr11:80,339,977...80,352,211 		JBrowse link
G Abhd8 abhydrolase domain containing 8 increases expression EXP fullerene C60 results in increased expression of ABHD8 mRNA CTD PMID:19167457 NCBI chr16:18,178,441...18,185,178
Ensembl chr16:18,144,464...18,157,667 		JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase increases expression EXP fullerene C60 results in increased expression of ABL1 mRNA CTD PMID:19167457 NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:14,979,853...15,083,065 		JBrowse link
G Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase decreases expression EXP fullerene C60 results in decreased expression of ABL2 mRNA CTD PMID:19167457 NCBI chr13:71,223,902...71,319,770
Ensembl chr13:68,673,722...68,839,742 		JBrowse link
G Ablim2 actin binding LIM protein family, member 2 increases expression EXP fullerene C60 results in increased expression of ABLIM2 mRNA CTD PMID:19167457 NCBI chr14:79,090,046...79,214,986
Ensembl chr14:74,866,281...74,990,334 		JBrowse link
G Abra actin-binding Rho activating protein decreases expression EXP fullerene C60 results in decreased expression of ABRA mRNA CTD PMID:19167457 NCBI chr 7:74,855,008...74,859,076
Ensembl chr 7:72,970,186...72,974,255 		JBrowse link
G Acaa1a acetyl-CoA acyltransferase 1A decreases expression EXP fullerene C60 results in decreased expression of ACAA1 mRNA CTD PMID:19167457 NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:119,079,775...119,088,624 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha decreases expression EXP fullerene C60 results in decreased expression of ACACA mRNA CTD PMID:19167457 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457 		JBrowse link
G Acbd4 acyl-CoA binding domain containing 4 increases expression EXP fullerene C60 results in increased expression of ACBD4 mRNA CTD PMID:19167457 NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500 		JBrowse link
G Acer2 alkaline ceramidase 2 decreases expression EXP fullerene C60 results in decreased expression of ACER2 mRNA CTD PMID:19167457 NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614 		JBrowse link
G Ache acetylcholinesterase decreases expression EXP fullerene C60 results in decreased expression of ACHE mRNA CTD PMID:19167457 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 increases expression EXP fullerene C60 results in increased expression of ACOT1 mRNA CTD PMID:19167457 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:103,636,041...103,644,163 		JBrowse link
G Acp4 acid phosphatase 4 decreases expression EXP fullerene C60 results in decreased expression of ACP4 mRNA CTD PMID:19167457 NCBI chr 1:103,872,922...103,888,418
Ensembl chr 1:94,735,514...94,744,623 		JBrowse link
G Acp6 acid phosphatase 6, lysophosphatidic decreases expression EXP fullerene C60 results in decreased expression of ACP6 mRNA CTD PMID:19167457 NCBI chr 2:187,400,786...187,421,877
Ensembl chr 2:184,711,619...184,733,017 		JBrowse link
G Actl7a actin-like 7a decreases expression EXP fullerene C60 results in decreased expression of ACTL7A mRNA CTD PMID:19167457 NCBI chr 5:71,447,447...71,450,440
Ensembl chr 5:71,447,071...71,450,908 		JBrowse link
G Actl7b actin-like 7b decreases expression EXP fullerene C60 results in decreased expression of ACTL7B mRNA CTD PMID:19167457 NCBI chr 5:71,445,532...71,446,920
Ensembl chr 5:71,445,534...71,446,920 		JBrowse link
G Actn4 actinin alpha 4 decreases expression EXP fullerene C60 results in decreased expression of ACTN4 mRNA CTD PMID:19167457 NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:84,182,788...84,251,847 		JBrowse link
G Actrt2 actin-related protein T2 decreases expression EXP fullerene C60 results in decreased expression of ACTRT2 mRNA CTD PMID:19167457 NCBI chr 5:170,518,470...170,519,870
Ensembl chr 5:165,236,086...165,237,629 		JBrowse link
G Acy1 aminoacylase 1 increases expression EXP fullerene C60 results in increased expression of ACY1 mRNA CTD PMID:19167457 NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:107,072,358...107,077,682 		JBrowse link
G Adam19 ADAM metallopeptidase domain 19 decreases expression EXP fullerene C60 results in decreased expression of ADAM19 mRNA CTD PMID:19167457 NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,491,405...30,583,105 		JBrowse link
G Adam7 ADAM metallopeptidase domain 7 decreases expression EXP fullerene C60 results in decreased expression of ADAM7 mRNA CTD PMID:19167457 NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201 		JBrowse link
G Adam8 ADAM metallopeptidase domain 8 increases expression EXP fullerene C60 results in increased expression of ADAM8 mRNA CTD PMID:19167457 NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:194,770,060...194,788,801 		JBrowse link
G Adamtsl2 ADAMTS-like 2 increases expression EXP fullerene C60 results in increased expression of ADAMTSL2 mRNA CTD PMID:19167457 NCBI chr 3:10,397,774...10,434,557
Ensembl chr 3:10,404,626...10,434,554 		JBrowse link
G Adamtsl4 ADAMTS-like 4 increases expression EXP fullerene C60 results in increased expression of ADAMTSL4 mRNA CTD PMID:19167457 NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848 		JBrowse link
G Adarb1 adenosine deaminase, RNA-specific, B1 decreases expression EXP fullerene C60 results in decreased expression of ADARB1 mRNA CTD PMID:19167457 NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,583...11,350,852 		JBrowse link
G Adcy7 adenylate cyclase 7 decreases expression EXP fullerene C60 results in decreased expression of ADCY7 mRNA CTD PMID:19167457 NCBI chr19:34,913,154...34,972,366
Ensembl chr19:18,740,875...18,776,311 		JBrowse link
G Add1 adducin 1 decreases expression EXP fullerene C60 results in decreased expression of ADD1 mRNA CTD PMID:19167457 NCBI chr14:80,333,242...80,401,641
Ensembl chr14:76,108,654...76,167,182 		JBrowse link
G Adgre5 adhesion G protein-coupled receptor E5 increases expression EXP fullerene C60 results in increased expression of ADGRE5 mRNA CTD PMID:19167457 NCBI chr19:41,302,687...41,332,183
Ensembl chr19:24,398,689...24,418,638 		JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 increases expression EXP fullerene C60 results in increased expression of ADHFE1 mRNA CTD PMID:19167457 NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:9,705,970...9,732,517 		JBrowse link
G Adora1 adenosine A1 receptor decreases expression EXP fullerene C60 results in decreased expression of ADORA1 mRNA CTD PMID:19167457 NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801 		JBrowse link
G Adra1b adrenoceptor alpha 1B decreases expression EXP fullerene C60 results in decreased expression of ADRA1B mRNA CTD PMID:19167457 NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,255,025...28,312,919 		JBrowse link
G Adra1d adrenoceptor alpha 1D decreases expression EXP fullerene C60 results in decreased expression of ADRA1D mRNA CTD PMID:19167457 NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:118,793,346...118,809,354 		JBrowse link
G Adra2a adrenoceptor alpha 2A decreases expression EXP fullerene C60 results in decreased expression of ADRA2A mRNA CTD PMID:19167457 NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:253,060,218...253,064,365 		JBrowse link
G Adra2b adrenoceptor alpha 2B decreases expression EXP fullerene C60 results in decreased expression of ADRA2B mRNA CTD PMID:19167457 NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:114,585,169...114,589,355 		JBrowse link
G Adra2c adrenoceptor alpha 2C decreases expression EXP fullerene C60 results in decreased expression of ADRA2C mRNA CTD PMID:19167457 NCBI chr14:79,695,514...79,697,476
Ensembl chr14:75,471,143...75,472,846 		JBrowse link
G Adrb1 adrenoceptor beta 1 increases expression EXP fullerene C60 results in increased expression of ADRB1 mRNA CTD PMID:19167457 NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259 		JBrowse link
G Aebp1 AE binding protein 1 increases expression EXP fullerene C60 results in increased expression of AEBP1 mRNA CTD PMID:19167457 NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877 		JBrowse link
G Aff4 ALF transcription elongation factor 4 decreases expression EXP fullerene C60 results in decreased expression of AFF4 mRNA CTD PMID:19167457 NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751 		JBrowse link
G Agap1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 increases expression EXP fullerene C60 results in increased expression of AGAP1 mRNA CTD PMID:19167457 NCBI chr 9:90,039,720...90,475,196
Ensembl chr 9:90,039,605...90,470,958 		JBrowse link
G Agap3 ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 increases expression EXP fullerene C60 results in increased expression of AGAP3 mRNA CTD PMID:19167457 NCBI chr 4:11,567,191...11,617,610
Ensembl chr 4:10,674,064...10,725,244 		JBrowse link
G Ager advanced glycosylation end product-specific receptor multiple interactions ISO [[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein] which results in increased expression of RAC1 protein; [fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein CTD PMID:31504961 NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078 		JBrowse link
G Ahctf1 AT hook containing transcription factor 1 decreases expression EXP fullerene C60 results in decreased expression of AHCTF1 mRNA CTD PMID:19167457 NCBI chr13:94,013,894...94,068,348
Ensembl chr13:91,481,936...91,536,391 		JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 increases expression EXP fullerene C60 results in increased expression of AHCYL1 mRNA CTD PMID:19167457 NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:195,294,153...195,345,815 		JBrowse link
G Ahr aryl hydrocarbon receptor decreases expression EXP fullerene C60 results in decreased expression of AHR mRNA CTD PMID:19167457 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568 		JBrowse link
G Aifm2 AIF family member 2 increases expression EXP fullerene C60 results in increased expression of AIFM2 mRNA CTD PMID:19167457 NCBI chr20:30,195,781...30,222,014
Ensembl chr20:29,652,927...29,679,236 		JBrowse link
G Akap3 A-kinase anchoring protein 3 decreases expression EXP fullerene C60 results in decreased expression of AKAP3 mRNA CTD PMID:19167457 NCBI chr 4:161,374,198...161,400,062
Ensembl chr 4:159,699,289...159,713,903 		JBrowse link
G Akna AT-hook transcription factor decreases expression EXP fullerene C60 results in decreased expression of AKNA mRNA CTD PMID:19167457 NCBI chr 5:81,792,928...81,839,936
Ensembl chr 5:76,777,415...76,816,017 		JBrowse link
G Aknad1 AKNA domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of AKNAD1 mRNA CTD PMID:19167457 NCBI chr 2:196,385,149...196,432,319
Ensembl chr 2:196,393,535...196,432,309 		JBrowse link
G Akr1b1-ps1 aldo-keto reductase family 1, member B1 (aldose reductase), pseudogene 1 increases expression EXP fullerene C60 results in increased expression of AKR1B1-PS1 mRNA CTD PMID:19167457 NCBI chr 6:45,089,717...45,090,928
Ensembl chr 6:45,089,864...45,090,767 		JBrowse link
G Akr1c12l1 aldo-keto reductase family 1, member C12-like 1 decreases expression EXP fullerene C60 results in decreased expression of AKR1C12L1 mRNA CTD PMID:19167457 NCBI chr17:65,937,834...65,948,344
Ensembl chr17:65,937,814...65,997,595
Ensembl chr17:65,937,814...65,997,595 		JBrowse link
G Akt1s1 AKT1 substrate 1 increases expression EXP fullerene C60 results in increased expression of AKT1S1 mRNA CTD PMID:19167457 NCBI chr 1:104,469,823...104,476,168
Ensembl chr 1:95,332,898...95,339,677 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 increases expression EXP fullerene C60 results in increased expression of AKT2 mRNA CTD PMID:19167457 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817 		JBrowse link
G Alb albumin multiple interactions ISO fullerene C60 inhibits the reaction [ALB protein modified form results in increased expression of IL6 protein]; fullerene C60 promotes the reaction [ALB protein modified form results in increased expression of TNF protein] CTD PMID:19376187 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Aldh16a1 aldehyde dehydrogenase 16 family, member A1 increases expression EXP fullerene C60 results in increased expression of ALDH16A1 mRNA CTD PMID:19167457 NCBI chr 1:95,626,727...95,639,808
Ensembl chr 1:95,613,558...95,640,131 		JBrowse link
G Aldh4a1 aldehyde dehydrogenase 4 family, member A1 increases expression EXP fullerene C60 results in increased expression of ALDH4A1 mRNA CTD PMID:19167457 NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:151,830,701...151,925,345 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase increases expression EXP fullerene C60 results in increased expression of ALOX15 mRNA CTD PMID:19167457 NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,060,412...55,068,874 		JBrowse link
G Als2cl ALS2 C-terminal like increases expression EXP fullerene C60 results in increased expression of ALS2CL mRNA CTD PMID:19167457 NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419 		JBrowse link
G Alx3 ALX homeobox 3 decreases expression EXP fullerene C60 results in decreased expression of ALX3 mRNA CTD PMID:19167457 NCBI chr 2:195,231,197...195,241,609
Ensembl chr 2:195,231,197...195,241,609 		JBrowse link
G Ambn ameloblastin decreases expression EXP fullerene C60 results in decreased expression of AMBN mRNA CTD PMID:19167457 NCBI chr14:19,885,802...19,898,422
Ensembl chr14:19,601,702...19,614,393 		JBrowse link
G Amigo1 adhesion molecule with Ig like domain 1 decreases expression EXP fullerene C60 results in decreased expression of AMIGO1 mRNA CTD PMID:19167457 NCBI chr 2:195,823,138...195,828,593
Ensembl chr 2:195,823,042...195,829,585 		JBrowse link
G Amn amnion associated transmembrane protein decreases expression EXP fullerene C60 results in decreased expression of AMN mRNA CTD PMID:19167457 NCBI chr 6:136,132,567...136,140,008
Ensembl chr 6:130,311,372...130,318,815 		JBrowse link
G Ampd2 adenosine monophosphate deaminase 2 decreases expression EXP fullerene C60 results in decreased expression of AMPD2 mRNA CTD PMID:19167457 NCBI chr 2:195,707,609...195,720,454
Ensembl chr 2:195,707,610...195,720,271 		JBrowse link
G Angptl4 angiopoietin-like 4 decreases expression EXP fullerene C60 results in decreased expression of ANGPTL4 mRNA CTD PMID:19167457 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:14,550,311...14,556,519 		JBrowse link
G Ankrd13a ankyrin repeat domain 13a increases expression EXP fullerene C60 results in increased expression of ANKRD13A mRNA CTD PMID:19167457 NCBI chr12:47,458,828...47,488,959
Ensembl chr12:41,798,199...41,829,327 		JBrowse link
G Ankrd33b ankyrin repeat domain 33B increases expression EXP fullerene C60 results in increased expression of ANKRD33B mRNA CTD PMID:19167457 NCBI chr 2:82,277,604...82,359,420
Ensembl chr 2:82,283,108...82,358,872 		JBrowse link
G Anks1a ankyrin repeat and sterile alpha motif domain containing 1A increases expression EXP fullerene C60 results in increased expression of ANKS1A mRNA CTD PMID:19167457 NCBI chr20:5,965,421...6,118,875
Ensembl chr20:5,963,678...6,117,148 		JBrowse link
G Anpep alanyl aminopeptidase, membrane increases expression EXP fullerene C60 results in increased expression of ANPEP mRNA CTD PMID:19167457 NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789 		JBrowse link
G Anxa6 annexin A6 increases expression EXP fullerene C60 results in increased expression of ANXA6 mRNA CTD PMID:19167457 NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,097,109...39,156,433 		JBrowse link
G Ap1b1 adaptor related protein complex 1 subunit beta 1 increases expression EXP fullerene C60 results in increased expression of AP1B1 mRNA CTD PMID:19167457 NCBI chr14:84,093,529...84,144,835
Ensembl chr14:79,879,533...79,930,778 		JBrowse link
G Ap1m1 adaptor related protein complex 1 subunit mu 1 increases expression EXP fullerene C60 results in increased expression of AP1M1 mRNA CTD PMID:19167457 NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,584,730...17,602,403 		JBrowse link
G Ap1s1 adaptor related protein complex 1 subunit sigma 1 decreases expression EXP fullerene C60 results in decreased expression of AP1S1 mRNA CTD PMID:19167457 NCBI chr12:25,261,958...25,272,483
Ensembl chr12:19,625,332...19,756,713 		JBrowse link
G Ap2a1 adaptor related protein complex 2 subunit alpha 1 decreases expression EXP fullerene C60 results in decreased expression of AP2A1 mRNA CTD PMID:19167457 NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:95,384,309...95,414,147 		JBrowse link
G Apba2 amyloid beta precursor protein binding family A member 2 increases expression EXP fullerene C60 results in increased expression of APBA2 mRNA CTD PMID:19167457 NCBI chr 1:118,053,270...118,286,858
Ensembl chr 1:118,103,219...118,285,699 		JBrowse link
G Apc2 APC regulator of WNT signaling pathway 2 decreases expression EXP fullerene C60 results in decreased expression of APC2 mRNA CTD PMID:19167457 NCBI chr 7:9,392,336...9,414,364
Ensembl chr 7:9,392,336...9,414,310 		JBrowse link
G Apoa1 apolipoprotein A1 decreases expression
increases expression		 EXP fullerene C60 results in decreased expression of APOA1 mRNA
fullerene C60 results in increased expression of APOA1 mRNA		 CTD PMID:19167457 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035 		JBrowse link
G Apoa5 apolipoprotein A5 decreases expression EXP fullerene C60 results in decreased expression of APOA5 mRNA CTD PMID:19167457 NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:46,561,229...46,563,816 		JBrowse link
G Apol9a apolipoprotein L9a decreases expression EXP fullerene C60 results in decreased expression of APOL9A mRNA CTD PMID:19167457 NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649 		JBrowse link
G Apold1 apolipoprotein L domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of APOLD1 mRNA CTD PMID:19167457 NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706 		JBrowse link
G Aqp11 aquaporin 11 decreases expression EXP fullerene C60 results in decreased expression of AQP11 mRNA CTD PMID:19167457 NCBI chr 1:161,457,752...161,467,918
Ensembl chr 1:152,046,517...152,056,725 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) increases expression EXP fullerene C60 results in increased expression of AQP3 mRNA CTD PMID:19167457 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:56,239,201...56,244,720 		JBrowse link
G Arfip2 ARF interacting protein 2 increases expression EXP fullerene C60 results in increased expression of ARFIP2 mRNA CTD PMID:19167457 NCBI chr 1:169,387,484...169,392,290
Ensembl chr 1:159,974,201...159,980,336 		JBrowse link
G Arg2 arginase 2 decreases expression EXP fullerene C60 results in decreased expression of ARG2 mRNA CTD PMID:19167457 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:97,936,002...97,961,378 		JBrowse link
G Arhgap10 Rho GTPase activating protein 10 affects expression EXP fullerene C60 affects the expression of ARHGAP10 mRNA CTD PMID:19167457 NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313 		JBrowse link
G Arhgap25 Rho GTPase activating protein 25 decreases expression EXP fullerene C60 results in decreased expression of ARHGAP25 mRNA CTD PMID:19167457 NCBI chr 4:121,454,151...121,532,293
Ensembl chr 4:119,896,844...119,974,982 		JBrowse link
G Arhgap27 Rho GTPase activating protein 27 increases expression EXP fullerene C60 results in increased expression of ARHGAP27 mRNA CTD PMID:19167457 NCBI chr10:88,280,470...88,313,225
Ensembl chr10:88,280,455...88,313,185 		JBrowse link
G Arhgap31 Rho GTPase activating protein 31 increases expression EXP fullerene C60 results in increased expression of ARHGAP31 mRNA CTD PMID:19167457 NCBI chr11:62,038,635...62,151,564
Ensembl chr11:62,038,635...62,151,564 		JBrowse link
G Arhgap33 Rho GTPase activating protein 33 decreases expression EXP fullerene C60 results in decreased expression of ARHGAP33 mRNA CTD PMID:19167457 NCBI chr 1:85,776,112...85,789,767
Ensembl chr 1:85,776,108...85,789,678 		JBrowse link
G Arhgef11 Rho guanine nucleotide exchange factor 11 increases expression EXP fullerene C60 results in increased expression of ARHGEF11 mRNA CTD PMID:19167457 NCBI chr 2:175,372,269...175,493,852
Ensembl chr 2:173,074,368...173,196,010 		JBrowse link
G Arhgef12 Rho guanine nucleotide exchange factor 12 increases expression EXP fullerene C60 results in increased expression of ARHGEF12 mRNA CTD PMID:19167457 NCBI chr 8:52,247,047...52,373,158
Ensembl chr 8:43,353,799...43,476,366 		JBrowse link
G Arhgef18 Rho/Rac guanine nucleotide exchange factor 18 increases expression EXP fullerene C60 results in increased expression of ARHGEF18 mRNA CTD PMID:19167457 NCBI chr12:1,395,035...1,503,082
Ensembl chr12:1,395,088...1,503,081 		JBrowse link
G Arhgef28 Rho guanine nucleotide exchange factor 28 increases expression EXP fullerene C60 results in increased expression of ARHGEF28 mRNA CTD PMID:19167457 NCBI chr 2:29,263,888...29,560,595
Ensembl chr 2:29,263,886...29,560,672 		JBrowse link
G Arhgef37 Rho guanine nucleotide exchange factor 37 decreases expression EXP fullerene C60 results in decreased expression of ARHGEF37 mRNA CTD PMID:19167457 NCBI chr18:54,935,256...55,001,017
Ensembl chr18:54,949,110...55,000,669 		JBrowse link
G Arhgef4 Rho guanine nucleotide exchange factor 4 decreases expression EXP fullerene C60 results in decreased expression of ARHGEF4 mRNA CTD PMID:19167457 NCBI chr 9:44,357,716...44,500,959
Ensembl chr 9:36,861,835...37,005,075 		JBrowse link
G Arhgef7 Rho guanine nucleotide exchange factor 7 increases expression EXP fullerene C60 results in increased expression of ARHGEF7 mRNA CTD PMID:19167457 NCBI chr16:84,373,123...84,484,759
Ensembl chr16:77,671,023...77,782,697 		JBrowse link
G Arid3b AT-rich interaction domain 3B decreases expression EXP fullerene C60 results in decreased expression of ARID3B mRNA CTD PMID:19167457 NCBI chr 8:58,193,268...58,240,901
Ensembl chr 8:58,193,418...58,238,318 		JBrowse link
G Arl4d ARF like GTPase 4D affects expression EXP fullerene C60 affects the expression of ARL4D mRNA CTD PMID:19167457 NCBI chr10:87,092,276...87,103,079
Ensembl chr10:86,595,661...86,602,836 		JBrowse link
G Armc6 armadillo repeat containing 6 increases expression EXP fullerene C60 results in increased expression of ARMC6 mRNA CTD PMID:19167457 NCBI chr16:19,225,058...19,235,479
Ensembl chr16:19,191,093...19,206,047 		JBrowse link
G Armcx1 armadillo repeat containing, X-linked 1 increases expression EXP fullerene C60 results in increased expression of ARMCX1 mRNA CTD PMID:19167457 NCBI chr  X:102,192,225...102,196,130
Ensembl chr  X:97,898,883...97,903,299 		JBrowse link
G Armcx6 armadillo repeat containing, X-linked 6 decreases expression EXP fullerene C60 results in decreased expression of ARMCX6 mRNA CTD PMID:19167457 NCBI chr  X:97,929,032...97,932,031
Ensembl chr  X:97,929,041...97,931,977 		JBrowse link
G Arpc2 actin related protein 2/3 complex, subunit 2 decreases expression EXP fullerene C60 results in decreased expression of ARPC2 mRNA CTD PMID:19167457 NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:75,820,770...75,851,471 		JBrowse link
G Arrdc2 arrestin domain containing 2 increases expression EXP fullerene C60 results in increased expression of ARRDC2 mRNA CTD PMID:19167457 NCBI chr16:18,601,897...18,606,029
Ensembl chr16:18,601,897...18,606,029 		JBrowse link
G Arsb arylsulfatase B increases expression EXP fullerene C60 results in increased expression of ARSB mRNA CTD PMID:19167457 NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:25,002,346...25,162,671 		JBrowse link
G Arsl arylsulfatase L increases expression EXP fullerene C60 results in increased expression of ARSL mRNA CTD PMID:19167457 NCBI chr 2:119,038,803...119,047,579
Ensembl chr 2:119,038,921...119,046,846 		JBrowse link
G Asb1 ankyrin repeat and SOCS box-containing 1 decreases expression EXP fullerene C60 results in decreased expression of ASB1 mRNA CTD PMID:19167457 NCBI chr 9:99,566,852...99,588,321
Ensembl chr 9:92,120,306...92,136,376 		JBrowse link
G Asb6 ankyrin repeat and SOCS box-containing 6 increases expression EXP fullerene C60 results in increased expression of ASB6 mRNA CTD PMID:19167457 NCBI chr 3:14,110,628...14,115,274
Ensembl chr 3:14,110,628...14,115,242 		JBrowse link
G Asgr1 asialoglycoprotein receptor 1 decreases expression EXP fullerene C60 results in decreased expression of ASGR1 mRNA CTD PMID:19167457 NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631 		JBrowse link
G Ash1l ASH1 like histone lysine methyltransferase decreases expression EXP fullerene C60 results in decreased expression of ASH1L mRNA CTD PMID:19167457 NCBI chr 2:176,644,393...176,780,848
Ensembl chr 2:174,346,150...174,483,055 		JBrowse link
G Asic1 acid sensing ion channel subunit 1 increases expression EXP fullerene C60 results in increased expression of ASIC1 mRNA CTD PMID:19167457 NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:130,799,917...130,828,541 		JBrowse link
G Asic4 acid sensing ion channel subunit family member 4 decreases expression EXP fullerene C60 results in decreased expression of ASIC4 mRNA CTD PMID:19167457 NCBI chr 9:84,389,610...84,411,545
Ensembl chr 9:76,941,532...76,962,900 		JBrowse link
G Ate1 arginyltransferase 1 decreases expression EXP fullerene C60 results in decreased expression of ATE1 mRNA CTD PMID:19167457 NCBI chr 1:184,961,548...185,081,112
Ensembl chr 1:184,963,562...185,080,908 		JBrowse link
G Atf6 activating transcription factor 6 affects expression EXP fullerene C60 affects the expression of ATF6 mRNA CTD PMID:19167457 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:82,930,034...83,107,177 		JBrowse link
G Atg16l1 autophagy related 16-like 1 increases expression EXP fullerene C60 results in increased expression of ATG16L1 mRNA CTD PMID:19167457 NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529 		JBrowse link
G Atp13a2 ATPase cation transporting 13A2 increases expression EXP fullerene C60 results in increased expression of ATP13A2 mRNA CTD PMID:19167457 NCBI chr 5:158,575,727...158,595,157
Ensembl chr 5:153,292,751...153,312,139 		JBrowse link
G Atp1b3 ATPase Na+/K+ transporting subunit beta 3 decreases expression EXP fullerene C60 results in decreased expression of ATP1B3 mRNA CTD PMID:19167457 NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:96,910,309...96,941,598
Ensembl chr 8:96,910,309...96,941,598 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 decreases expression EXP fullerene C60 results in decreased expression of ATP2A1 mRNA CTD PMID:19167457 NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:181,026,608...181,044,838 		JBrowse link
G Atp2a3 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 increases expression EXP fullerene C60 results in increased expression of ATP2A3 mRNA CTD PMID:19167457 NCBI chr10:58,079,710...58,111,279
Ensembl chr10:57,582,128...57,612,748 		JBrowse link
G Atp5mc2 ATP synthase membrane subunit c locus 2 decreases expression EXP fullerene C60 results in decreased expression of ATP5MC2 mRNA CTD PMID:19167457 NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:133,791,342...133,799,733 		JBrowse link
G Atp5mc3 ATP synthase membrane subunit c locus 3 decreases expression EXP fullerene C60 results in decreased expression of ATP5MC3 mRNA CTD PMID:19167457 NCBI chr 3:79,218,014...79,220,664
Ensembl chr 3:58,810,535...58,814,279 		JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 affects expression EXP fullerene C60 affects the expression of ATP6AP2 mRNA CTD PMID:19167457 NCBI chr  X:12,856,708...12,883,670
Ensembl chr  X:10,183,068...10,210,918 		JBrowse link
G Atp6v0a1 ATPase H+ transporting V0 subunit a1 decreases expression EXP fullerene C60 results in decreased expression of ATP6V0A1 mRNA CTD PMID:19167457 NCBI chr10:85,935,802...85,989,901
Ensembl chr10:85,935,854...85,989,895 		JBrowse link
G Atp6v0d1 ATPase H+ transporting V0 subunit D1 decreases expression EXP fullerene C60 results in decreased expression of ATP6V0D1 mRNA CTD PMID:19167457 NCBI chr19:50,313,268...50,357,248
Ensembl chr19:33,403,355...33,447,450 		JBrowse link
G Atp6v0e2 ATPase, H+ transporting V0 subunit e2 decreases expression EXP fullerene C60 results in decreased expression of ATP6V0E2 mRNA CTD PMID:19167457 NCBI chr 4:77,484,868...77,488,016
Ensembl chr 4:77,482,226...77,488,777 		JBrowse link
G Atxn2l ataxin 2-like increases expression EXP fullerene C60 results in increased expression of ATXN2L mRNA CTD PMID:19167457 NCBI chr 1:181,078,293...181,090,079
Ensembl chr 1:181,078,288...181,089,686 		JBrowse link
G Avp arginine vasopressin decreases expression EXP fullerene C60 results in decreased expression of AVP mRNA CTD PMID:19167457 NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425 		JBrowse link
G Avpr2 arginine vasopressin receptor 2 decreases expression EXP fullerene C60 results in decreased expression of AVPR2 mRNA CTD PMID:19167457 NCBI chr  X:156,785,009...156,787,477
Ensembl chr  X:151,633,522...151,635,989 		JBrowse link
G Axin2 axin 2 increases expression EXP fullerene C60 results in increased expression of AXIN2 mRNA CTD PMID:19167457 NCBI chr10:94,393,379...94,426,579
Ensembl chr10:93,899,245...93,926,231 		JBrowse link
G B3gat1 beta-1,3-glucuronyltransferase 1 decreases expression EXP fullerene C60 results in decreased expression of B3GAT1 mRNA CTD PMID:19167457 NCBI chr 8:25,087,123...25,114,692
Ensembl chr 8:25,087,547...25,113,395 		JBrowse link
G B4galnt4 beta-1,4-N-acetyl-galactosaminyl transferase 4 decreases expression EXP fullerene C60 results in decreased expression of B4GALNT4 mRNA CTD PMID:19167457 NCBI chr 1:205,600,989...205,611,889
Ensembl chr 1:196,171,394...196,182,294 		JBrowse link
G B4galt2 beta-1,4-galactosyltransferase 2 increases expression EXP fullerene C60 results in increased expression of B4GALT2 mRNA CTD PMID:19167457 NCBI chr 5:131,412,541...131,422,573
Ensembl chr 5:131,412,541...131,421,013 		JBrowse link
G Baiap2 BAR/IMD domain containing adaptor protein 2 increases expression EXP fullerene C60 results in increased expression of BAIAP2 mRNA CTD PMID:19167457 NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134 		JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 decreases expression EXP fullerene C60 results in decreased expression of BASP1 mRNA CTD PMID:19167457 NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:75,816,122...75,864,043 		JBrowse link
G Baz2a bromodomain adjacent to zinc finger domain, 2A increases expression EXP fullerene C60 results in increased expression of BAZ2A mRNA CTD PMID:19167457 NCBI chr 7:523,204...560,911
Ensembl chr 7:523,265...560,659 		JBrowse link
G Bbs1 Bardet-Biedl syndrome 1 increases expression EXP fullerene C60 results in increased expression of BBS1 mRNA CTD PMID:19167457 NCBI chr 1:211,614,195...211,633,504
Ensembl chr 1:202,186,125...202,204,086 		JBrowse link
G Bbs4 Bardet-Biedl syndrome 4 decreases expression EXP fullerene C60 results in decreased expression of BBS4 mRNA CTD PMID:19167457 NCBI chr 8:68,627,739...68,661,232
Ensembl chr 8:59,731,912...59,765,607 		JBrowse link
G Bbx BBX high mobility group box domain containing affects expression EXP fullerene C60 affects the expression of BBX mRNA CTD PMID:19167457 NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251 		JBrowse link
G Bcam basal cell adhesion molecule (Lutheran blood group) increases expression EXP fullerene C60 results in increased expression of BCAM mRNA CTD PMID:19167457 NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403 		JBrowse link
G Bcar1 BCAR1 scaffold protein, Cas family member increases expression EXP fullerene C60 results in increased expression of BCAR1 mRNA CTD PMID:19167457 NCBI chr19:56,588,500...56,623,190
Ensembl chr19:39,679,204...39,713,907 		JBrowse link
G Bcas3 BCAS3, microtubule associated cell migration factor increases expression EXP fullerene C60 results in increased expression of BCAS3 mRNA CTD PMID:19167457 NCBI chr10:70,711,084...71,170,492
Ensembl chr10:70,214,098...70,673,080 		JBrowse link
G Bckdhb branched chain keto acid dehydrogenase E1 subunit beta decreases expression EXP fullerene C60 results in decreased expression of BCKDHB mRNA CTD PMID:19167457 NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:84,845,264...85,027,812 		JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression EXP fullerene C60 results in decreased expression of BCL2L1 mRNA CTD PMID:19167457 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479 		JBrowse link
G Bcl2l10 Bcl2-like 10 decreases expression EXP fullerene C60 results in decreased expression of BCL2L10 mRNA CTD PMID:19167457 NCBI chr 8:84,987,833...84,993,878
Ensembl chr 8:76,107,326...76,113,367 		JBrowse link
G Bco1 beta-carotene oxygenase 1 decreases expression EXP fullerene C60 results in decreased expression of BCO1 mRNA CTD PMID:19167457 NCBI chr19:62,058,061...62,094,923
Ensembl chr19:45,149,265...45,186,101 		JBrowse link
G Bdh1 3-hydroxybutyrate dehydrogenase 1 increases expression EXP fullerene C60 results in increased expression of BDH1 mRNA CTD PMID:19167457 NCBI chr11:82,806,125...82,848,133
Ensembl chr11:69,302,534...69,337,671 		JBrowse link
G Bdnf brain-derived neurotrophic factor decreases expression EXP fullerene C60 results in decreased expression of BDNF mRNA; fullerene C60 results in decreased expression of BDNF protein CTD PMID:29191454 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615 		JBrowse link
G Bean1 brain expressed, associated with NEDD4, 1 increases expression EXP fullerene C60 results in increased expression of BEAN1 mRNA CTD PMID:19167457 NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537 		JBrowse link
G Best2 bestrophin 2 decreases expression EXP fullerene C60 results in decreased expression of BEST2 mRNA CTD PMID:19167457 NCBI chr19:40,047,191...40,053,216
Ensembl chr19:23,141,602...23,148,339 		JBrowse link
G Bex3 brain expressed X-linked 3 decreases expression EXP fullerene C60 results in decreased expression of BEX3 mRNA CTD PMID:19167457 NCBI chr  X:104,064,896...104,066,425
Ensembl chr  X:99,273,161...99,274,800 		JBrowse link
G Bicd1 BICD cargo adaptor 1 decreases expression EXP fullerene C60 results in decreased expression of BICD1 mRNA CTD PMID:19167457 NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:182,479,071...182,627,434 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 decreases expression EXP fullerene C60 results in decreased expression of BMAL1 mRNA CTD PMID:19167457 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231 		JBrowse link
G Bmp2 bone morphogenetic protein 2 decreases expression EXP fullerene C60 results in decreased expression of BMP2 mRNA CTD PMID:19167457 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:120,812,882...120,821,397 		JBrowse link
G Borcs8 BLOC-1 related complex subunit 8 increases expression EXP fullerene C60 results in increased expression of BORCS8 mRNA CTD PMID:19167457 NCBI chr16:19,274,305...19,280,969
Ensembl chr16:19,274,023...19,280,339 		JBrowse link
G Bpgm bisphosphoglycerate mutase decreases expression EXP fullerene C60 results in decreased expression of BPGM mRNA CTD PMID:19167457 NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:63,140,018...63,168,581 		JBrowse link
G Brcc3 BRCA1/BRCA2-containing complex subunit 3 decreases expression EXP fullerene C60 results in decreased expression of BRCC3 mRNA CTD PMID:19167457 NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:1,986,575...1,991,080 		JBrowse link
G Bsn bassoon (presynaptic cytomatrix protein) decreases expression EXP fullerene C60 results in decreased expression of BSN mRNA CTD PMID:19167457 NCBI chr 8:117,663,447...117,754,412
Ensembl chr 8:108,788,542...108,875,819 		JBrowse link
G Btbd10 BTB domain containing 10 decreases expression EXP fullerene C60 results in decreased expression of BTBD10 mRNA CTD PMID:19167457 NCBI chr 1:167,431,311...167,489,320
Ensembl chr 1:167,431,329...167,489,916 		JBrowse link
G Btbd2 BTB domain containing 2 increases expression EXP fullerene C60 results in increased expression of BTBD2 mRNA CTD PMID:19167457 NCBI chr 7:9,058,609...9,075,341
Ensembl chr 7:9,060,788...9,075,344 		JBrowse link
G Bud13 BUD13 homolog decreases expression EXP fullerene C60 results in decreased expression of BUD13 mRNA CTD PMID:19167457 NCBI chr 8:46,575,124...46,590,964
Ensembl chr 8:46,575,115...46,590,958 		JBrowse link
G C1galt1c1 C1GALT1-specific chaperone 1 decreases expression EXP fullerene C60 results in decreased expression of C1GALT1C1 mRNA CTD PMID:19167457 NCBI chr  X:122,243,736...122,248,217
Ensembl chr  X:117,375,525...117,382,787 		JBrowse link
G C1qc complement C1q C chain decreases expression EXP fullerene C60 results in decreased expression of C1QC mRNA CTD PMID:19167457 NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:149,127,415...149,131,017 		JBrowse link
G C1qtnf1 C1q and TNF related 1 decreases expression EXP fullerene C60 results in decreased expression of C1QTNF1 mRNA CTD PMID:19167457 NCBI chr10:104,159,021...104,180,253
Ensembl chr10:103,660,327...103,681,660 		JBrowse link
G C2 complement C2 increases expression EXP fullerene C60 results in increased expression of C2 mRNA CTD PMID:19167457 NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,951,474...3,976,505 		JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 decreases expression EXP fullerene C60 results in decreased expression of C2CD2 mRNA CTD PMID:19167457 NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739 		JBrowse link
G C2cd2l C2CD2-like increases expression EXP fullerene C60 results in increased expression of C2CD2L mRNA CTD PMID:19167457 NCBI chr 8:44,648,074...44,658,856
Ensembl chr 8:44,648,079...44,658,340 		JBrowse link
G C2cd4d C2 calcium-dependent domain containing 4D increases expression EXP fullerene C60 results in increased expression of C2CD4D mRNA CTD PMID:19167457 NCBI chr 2:181,999,778...182,001,941
Ensembl chr 2:181,997,078...182,002,087 		JBrowse link
G C6 complement C6 increases expression EXP fullerene C60 results in increased expression of C6 mRNA CTD PMID:19167457 NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:53,851,985...53,921,275 		JBrowse link
G Cables1 Cdk5 and Abl enzyme substrate 1 decreases expression EXP fullerene C60 results in decreased expression of CABLES1 mRNA CTD PMID:19167457 NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,075,524...3,181,181 		JBrowse link
G Cachd1 cache domain containing 1 affects expression EXP fullerene C60 affects the expression of CACHD1 mRNA CTD PMID:19167457 NCBI chr 5:120,527,224...120,752,685
Ensembl chr 5:115,411,071...115,657,505 		JBrowse link
G Cacna1d calcium voltage-gated channel subunit alpha1 D decreases expression EXP fullerene C60 results in decreased expression of CACNA1D mRNA CTD PMID:19167457 NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,228,306...5,668,215 		JBrowse link
G Cacna1e calcium voltage-gated channel subunit alpha1 E decreases expression EXP fullerene C60 results in decreased expression of CACNA1E mRNA CTD PMID:19167457 NCBI chr13:69,125,048...69,613,795
Ensembl chr13:66,581,920...66,894,450 		JBrowse link
G Cacna1g calcium voltage-gated channel subunit alpha1 G decreases expression EXP fullerene C60 results in decreased expression of CACNA1G mRNA CTD PMID:19167457 NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752 		JBrowse link
G Cacna1i calcium voltage-gated channel subunit alpha1 I decreases expression EXP fullerene C60 results in decreased expression of CACNA1I mRNA CTD PMID:19167457 NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:111,836,012...111,944,688 		JBrowse link
G Cacna2d3 calcium voltage-gated channel auxiliary subunit alpha2delta 3 decreases expression EXP fullerene C60 results in decreased expression of CACNA2D3 mRNA CTD PMID:19167457 NCBI chr16:4,105,048...4,919,037
Ensembl chr16:4,098,445...4,912,351 		JBrowse link
G Calb2 calbindin 2 decreases expression EXP fullerene C60 results in decreased expression of CALB2 mRNA CTD PMID:19167457 NCBI chr19:55,023,849...55,050,858
Ensembl chr19:38,114,424...38,141,438 		JBrowse link
G Calm3 calmodulin 3 decreases expression EXP fullerene C60 results in decreased expression of CALM3 mRNA CTD PMID:19167457 NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:77,589,230...77,592,207 		JBrowse link
G Calml3 calmodulin-like 3 decreases expression EXP fullerene C60 results in decreased expression of CALML3 mRNA CTD PMID:19167457 NCBI chr17:71,329,438...71,333,068
Ensembl chr17:66,419,882...66,423,175 		JBrowse link
G Caly calcyon neuron-specific vesicular protein decreases expression EXP fullerene C60 results in decreased expression of CALY mRNA CTD PMID:19167457 NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:194,862,672...194,873,551 		JBrowse link
G Camk1g calcium/calmodulin-dependent protein kinase IG increases expression EXP fullerene C60 results in increased expression of CAMK1G mRNA CTD PMID:19167457 NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556 		JBrowse link
G Camk4 calcium/calmodulin-dependent protein kinase IV decreases expression EXP fullerene C60 results in decreased expression of CAMK4 mRNA CTD PMID:19167457 NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487 		JBrowse link
G Canx calnexin decreases expression EXP fullerene C60 results in decreased expression of CANX mRNA CTD PMID:19167457 NCBI chr10:35,124,941...35,157,954
Ensembl chr10:34,625,191...34,656,821 		JBrowse link
G Capn1 calpain 1 increases expression EXP fullerene C60 results in increased expression of CAPN1 mRNA CTD PMID:19167457 NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:203,277,344...203,300,177 		JBrowse link
G Car1 carbonic anhydrase 1 decreases expression EXP fullerene C60 results in decreased expression of CAR1 mRNA CTD PMID:19167457 NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:86,861,897...86,872,208 		JBrowse link
G Car5a carbonic anhydrase 5A increases expression EXP fullerene C60 results in increased expression of CA5A mRNA CTD PMID:19167457 NCBI chr19:66,881,678...66,911,486
Ensembl chr19:49,973,107...50,002,906 		JBrowse link
G Card10 caspase recruitment domain family, member 10 increases expression EXP fullerene C60 results in increased expression of CARD10 mRNA CTD PMID:19167457 NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:110,330,408...110,359,224 		JBrowse link
G Carm1 coactivator-associated arginine methyltransferase 1 decreases expression EXP fullerene C60 results in decreased expression of CARM1 mRNA CTD PMID:19167457 NCBI chr 8:28,373,370...28,418,056
Ensembl chr 8:20,097,254...20,147,689 		JBrowse link
G Cartpt CART prepropeptide decreases expression EXP fullerene C60 results in decreased expression of CARTPT mRNA CTD PMID:19167457 NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713 		JBrowse link
G Caskin2 cask-interacting protein 2 increases expression EXP fullerene C60 results in increased expression of CASKIN2 mRNA CTD PMID:19167457 NCBI chr10:101,027,196...101,041,429
Ensembl chr10:101,027,260...101,041,414 		JBrowse link
G Casp3 caspase 3 increases cleavage
increases activity		 ISO fullerene C60 analog results in increased cleavage of CASP3 protein
fullerene C60 metabolite results in increased activity of CASP3 protein		 CTD PMID:18926839 PMID:22108244 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp8ap2 caspase 8 associated protein 2 increases expression EXP fullerene C60 results in increased expression of CASP8AP2 mRNA CTD PMID:19167457 NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:47,014,667...47,052,275 		JBrowse link
G Cat catalase decreases activity ISO fullerene C60 metabolite results in decreased activity of CAT protein CTD PMID:22108244 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Cav3 caveolin 3 decreases expression EXP fullerene C60 results in decreased expression of CAV3 mRNA CTD PMID:19167457 NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:145,582,060...145,598,137 		JBrowse link
G Cbfa2t2 CBFA2/RUNX1 partner transcriptional co-repressor 2 decreases expression EXP fullerene C60 results in decreased expression of CBFA2T2 mRNA CTD PMID:19167457 NCBI chr 3:163,397,160...163,503,409
Ensembl chr 3:142,936,985...143,043,197 		JBrowse link
G Cbfb core-binding factor subunit beta decreases expression EXP fullerene C60 results in decreased expression of CBFB mRNA CTD PMID:19167457 NCBI chr19:49,955,133...50,002,661
Ensembl chr19:33,049,172...33,092,751 		JBrowse link
G Cby2 chibby family member 2 decreases expression EXP fullerene C60 results in decreased expression of CBY2 mRNA CTD PMID:19167457 NCBI chr15:50,909,435...51,004,449
Ensembl chr15:50,909,436...50,934,633 		JBrowse link
G Ccdc124 coiled-coil domain containing 124 decreases expression EXP fullerene C60 results in decreased expression of CCDC124 mRNA CTD PMID:19167457 NCBI chr16:18,600,737...18,606,556
Ensembl chr16:18,566,745...18,572,564 		JBrowse link
G Ccdc136 coiled-coil domain containing 136 increases expression EXP fullerene C60 results in increased expression of CCDC136 mRNA CTD PMID:19167457 NCBI chr 4:57,997,825...58,027,598
Ensembl chr 4:57,997,853...58,027,646 		JBrowse link
G Ccdc187 coiled-coil domain containing 187 decreases expression EXP fullerene C60 results in decreased expression of CCDC187 mRNA CTD PMID:19167457 NCBI chr 3:9,070,192...9,127,001
Ensembl chr 3:9,070,185...9,126,946 		JBrowse link
G Ccdc22 coiled-coil domain containing 22 increases expression EXP fullerene C60 results in increased expression of CCDC22 mRNA CTD PMID:19167457 NCBI chr  X:14,898,296...14,910,244
Ensembl chr  X:14,898,296...14,910,244 		JBrowse link
G Ccdc33 coiled-coil domain containing 33 increases expression EXP fullerene C60 results in increased expression of CCDC33 mRNA CTD PMID:19167457 NCBI chr 8:58,434,798...58,534,338
Ensembl chr 8:58,435,661...58,534,370 		JBrowse link
G Ccdc60 coiled-coil domain containing 60 increases expression EXP fullerene C60 results in increased expression of CCDC60 mRNA CTD PMID:19167457 NCBI chr12:40,314,687...40,480,338
Ensembl chr12:40,314,713...40,480,225 		JBrowse link
G Ccdc77 coiled-coil domain containing 77 increases expression EXP fullerene C60 results in increased expression of CCDC77 mRNA CTD PMID:19167457 NCBI chr 4:155,206,402...155,238,235
Ensembl chr 4:153,534,187...153,566,545 		JBrowse link
G Ccdc91 coiled-coil domain containing 91 decreases expression EXP fullerene C60 results in decreased expression of CCDC91 mRNA CTD PMID:19167457 NCBI chr 4:180,402,327...180,574,364
Ensembl chr 4:180,402,376...180,574,364 		JBrowse link
G Ccdc9b coiled-coil domain containing 9B decreases expression EXP fullerene C60 results in decreased expression of CCDC9B mRNA CTD PMID:19167457 NCBI chr 3:105,736,120...105,745,039
Ensembl chr 3:105,739,174...105,744,697 		JBrowse link
G Cchcr1 coiled-coil alpha-helical rod protein 1 increases expression EXP fullerene C60 results in increased expression of CCHCR1 mRNA CTD PMID:19167457 NCBI chr20:3,210,383...3,223,187
Ensembl chr20:3,205,676...3,218,308 		JBrowse link
G Ccl12 C-C motif chemokine ligand 12 increases expression EXP fullerene C60 results in increased expression of CCL12 mRNA CTD PMID:19167457 NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,070,230...67,071,780 		JBrowse link
G Ccl17 C-C motif chemokine ligand 17 increases expression EXP fullerene C60 results in increased expression of CCL17 mRNA CTD PMID:20471445 NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,202,128...10,203,819 		JBrowse link
G Ccl19 C-C motif chemokine ligand 19 decreases expression EXP fullerene C60 results in decreased expression of CCL19 mRNA CTD PMID:19167457 NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:56,963,364...56,965,308 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression EXP fullerene C60 results in increased expression of CCL2 mRNA CTD PMID:20471445 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Ccl22 C-C motif chemokine ligand 22 increases expression EXP fullerene C60 results in increased expression of CCL22 mRNA CTD PMID:20471445 NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,257,601...10,264,400 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression EXP fullerene C60 results in increased expression of CCL3 mRNA CTD PMID:20471445 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression EXP fullerene C60 results in increased expression of CCL7 mRNA CTD PMID:19167457 PMID:20471445 NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,016,446...67,018,303 		JBrowse link
G Ccl9 C-C motif chemokine ligand 9 increases expression EXP fullerene C60 results in increased expression of CCL6 mRNA CTD PMID:20471445 NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,366,487...68,371,369 		JBrowse link
G Ccm2 CCM2 scaffold protein increases expression EXP fullerene C60 results in increased expression of CCM2 mRNA CTD PMID:19167457 NCBI chr14:81,418,418...81,464,114
Ensembl chr14:81,418,236...81,464,116 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression EXP fullerene C60 results in increased expression of CCN1 mRNA CTD PMID:19167457 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484 		JBrowse link
G Ccnf cyclin F increases expression EXP fullerene C60 results in increased expression of CCNF mRNA CTD PMID:19167457 NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,253,380...13,279,101 		JBrowse link
G Ccnl1 cyclin L1 decreases expression EXP fullerene C60 results in decreased expression of CCNL1 mRNA CTD PMID:19167457 NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368 		JBrowse link
G Ccr9 C-C motif chemokine receptor 9 decreases expression EXP fullerene C60 results in decreased expression of CCR9 mRNA CTD PMID:19167457 NCBI chr 8:132,273,581...132,287,651
Ensembl chr 8:123,395,813...123,413,969 		JBrowse link
G Cct6a chaperonin containing TCP1 subunit 6A increases expression EXP fullerene C60 results in increased expression of CCT6A mRNA CTD PMID:19167457 NCBI chr12:32,508,842...32,519,072
Ensembl chr12:26,872,574...26,883,337 		JBrowse link
G Cct7 chaperonin containing TCP1 subunit 7 decreases expression EXP fullerene C60 results in decreased expression of CCT7 mRNA CTD PMID:19167457 NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:117,989,232...118,006,580 		JBrowse link
G Cd19 CD19 molecule increases expression EXP fullerene C60 results in increased expression of CD19 mRNA CTD PMID:19167457 NCBI chr 1:190,417,853...190,424,494
Ensembl chr 1:180,987,286...180,993,975 		JBrowse link
G Cd6 Cd6 molecule increases expression EXP fullerene C60 results in increased expression of CD6 mRNA CTD PMID:19167457 NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:207,442,877...207,481,634 		JBrowse link
G Cd7 Cd7 molecule decreases expression EXP fullerene C60 results in decreased expression of CD7 mRNA CTD PMID:19167457 NCBI chr10:106,304,046...106,306,963
Ensembl chr10:106,304,056...106,306,967 		JBrowse link
G Cd79b CD79b molecule increases expression EXP fullerene C60 results in increased expression of CD79B mRNA CTD PMID:19167457 NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,239,356...91,242,625 		JBrowse link
G Cdc25b cell division cycle 25B increases expression EXP fullerene C60 results in increased expression of CDC25B mRNA CTD PMID:19167457 NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:118,407,128...118,417,272 		JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta increases expression EXP fullerene C60 results in increased expression of CDC42BPB mRNA CTD PMID:19167457 NCBI chr 6:130,333,712...130,416,631
Ensembl chr 6:130,333,712...130,416,377 		JBrowse link
G Cdc42bpg CDC42 binding protein kinase gamma increases expression EXP fullerene C60 results in increased expression of CDC42BPG mRNA CTD PMID:19167457 NCBI chr 1:203,608,339...203,628,502
Ensembl chr 1:203,608,574...203,628,502 		JBrowse link
G Cdc42se1 CDC42 small effector 1 increases expression EXP fullerene C60 results in increased expression of CDC42SE1 mRNA CTD PMID:19167457 NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028 		JBrowse link
G Cdh16 cadherin 16 decreases expression EXP fullerene C60 results in decreased expression of CDH16 mRNA CTD PMID:19167457 NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007 		JBrowse link
G Cdk11b cyclin-dependent kinase 11B increases expression EXP fullerene C60 results in increased expression of CDK11B mRNA CTD PMID:19167457 NCBI chr 5:171,495,042...171,521,143
Ensembl chr 5:166,212,829...166,238,876 		JBrowse link
G Cdk14 cyclin-dependent kinase 14 decreases expression EXP fullerene C60 results in decreased expression of CDK14 mRNA CTD PMID:19167457 NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861 		JBrowse link
G Cdk18 cyclin-dependent kinase 18 decreases expression EXP fullerene C60 results in decreased expression of CDK18 mRNA CTD PMID:19167457 NCBI chr13:43,555,597...43,582,210
Ensembl chr13:43,556,748...43,588,525 		JBrowse link
G Cdk2ap1 cyclin-dependent kinase 2 associated protein 1 decreases expression EXP fullerene C60 results in decreased expression of CDK2AP1 mRNA CTD PMID:19167457 NCBI chr12:37,910,718...37,919,446
Ensembl chr12:32,249,747...32,258,479 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A decreases expression
increases expression		 EXP
ISO		 fullerene C60 results in decreased expression of CDKN1A mRNA
fullerene C60 analog results in increased expression of CDKN1A protein		 CTD PMID:19167457 PMID:20045429 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases expression ISO fullerene C60 analog results in increased expression of CDKN2A protein CTD PMID:20045429 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149 		JBrowse link
G Cdon cell adhesion associated, oncogene regulated decreases expression EXP fullerene C60 results in decreased expression of CDON mRNA CTD PMID:19167457 NCBI chr 8:42,032,921...42,119,451
Ensembl chr 8:33,806,183...33,859,033 		JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 increases expression EXP fullerene C60 results in increased expression of CDT1 mRNA CTD PMID:19167457 NCBI chr19:67,529,249...67,534,195
Ensembl chr19:50,620,713...50,625,659 		JBrowse link
G Ceacam20 CEA cell adhesion molecule 20 decreases expression EXP fullerene C60 results in decreased expression of CEACAM20 mRNA CTD PMID:19167457 NCBI chr 1:79,622,077...79,643,782
Ensembl chr 1:79,622,077...79,643,782 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha increases expression EXP fullerene C60 results in increased expression of CEBPA mRNA CTD PMID:19167457 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta decreases expression EXP fullerene C60 results in decreased expression of CEBPB mRNA CTD PMID:19167457 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta decreases expression EXP fullerene C60 results in decreased expression of CEBPD mRNA CTD PMID:19167457 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:84,764,565...84,765,829 		JBrowse link
G Celf5 CUGBP, Elav-like family member 5 decreases expression EXP fullerene C60 results in decreased expression of CELF5 mRNA CTD PMID:19167457 NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322 		JBrowse link
G Cemip2 cell migration inducing hyaluronidase 2 affects expression EXP fullerene C60 affects the expression of CEMIP2 mRNA CTD PMID:19167457 NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760 		JBrowse link
G Cep164 centrosomal protein 164 decreases expression EXP fullerene C60 results in decreased expression of CEP164 mRNA CTD PMID:19167457 NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336 		JBrowse link
G Cep89 centrosomal protein 89 increases expression EXP fullerene C60 results in increased expression of CEP89 mRNA CTD PMID:19167457 NCBI chr 1:97,195,116...97,237,015
Ensembl chr 1:88,058,227...88,100,112 		JBrowse link
G Cfap126 cilia and flagella associated protein 126 decreases expression EXP fullerene C60 results in decreased expression of CFAP126 mRNA CTD PMID:19167457 NCBI chr13:86,059,142...86,075,034
Ensembl chr13:83,526,657...83,542,552 		JBrowse link
G Cfap210 cilia and flagella associated protein 210 increases expression EXP fullerene C60 results in increased expression of CFAP210 mRNA CTD PMID:19167457 NCBI chr 3:54,520,455...54,554,677
Ensembl chr 3:54,520,458...54,554,607 		JBrowse link
G Chad chondroadherin decreases expression EXP fullerene C60 results in decreased expression of CHAD mRNA CTD PMID:19167457 NCBI chr10:79,512,170...79,515,941
Ensembl chr10:79,511,931...79,515,940 		JBrowse link
G Chrac1 chromatin accessibility complex subunit 1 decreases expression EXP fullerene C60 results in decreased expression of CHRAC1 mRNA CTD PMID:19167457 NCBI chr 7:106,901,841...106,905,441
Ensembl chr 7:105,013,015...105,017,136 		JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1 decreases expression EXP fullerene C60 results in decreased expression of CHRM1 mRNA CTD PMID:19167457 NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:205,567,220...205,582,356 		JBrowse link
G Chrm4 cholinergic receptor, muscarinic 4 decreases expression EXP fullerene C60 results in decreased expression of CHRM4 mRNA CTD PMID:19167457 NCBI chr 3:98,349,080...98,356,821
Ensembl chr 3:77,893,425...77,901,159 		JBrowse link
G Chrng cholinergic receptor nicotinic gamma subunit decreases expression EXP fullerene C60 results in decreased expression of CHRNG mRNA CTD PMID:19167457 NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:87,878,085...87,914,482 		JBrowse link
G Chst1 carbohydrate sulfotransferase 1 increases expression EXP fullerene C60 results in increased expression of CHST1 mRNA CTD PMID:19167457 NCBI chr 3:99,003,987...99,030,214
Ensembl chr 3:78,548,525...78,574,883 		JBrowse link
G Chst15 carbohydrate sulfotransferase 15 increases expression EXP fullerene C60 results in increased expression of CHST15 mRNA CTD PMID:19167457 NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:187,028,970...187,107,707 		JBrowse link
G Chst2 carbohydrate sulfotransferase 2 increases expression EXP fullerene C60 results in increased expression of CHST2 mRNA CTD PMID:19167457 NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955 		JBrowse link
G Cit citron rho-interacting serine/threonine kinase decreases expression EXP fullerene C60 results in decreased expression of CIT mRNA CTD PMID:19167457 NCBI chr12:46,263,881...46,425,642
Ensembl chr12:40,605,563...40,763,860 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 increases expression EXP fullerene C60 results in increased expression of CITED2 mRNA CTD PMID:19167457 NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:12,312,160...12,314,897 		JBrowse link
G Cklf chemokine-like factor increases expression EXP fullerene C60 results in increased expression of CKLF mRNA CTD PMID:19167457 NCBI chr19:704,528...712,998
Ensembl chr19:698,033...706,570 		JBrowse link
G Ckm creatine kinase, M-type affects expression EXP fullerene C60 affects the expression of CKM mRNA CTD PMID:19167457 NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720 		JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 increases expression EXP fullerene C60 results in increased expression of CLCF1 mRNA CTD PMID:19167457 NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:201,507,859...201,517,605 		JBrowse link
G Cldn12 claudin 12 decreases expression EXP fullerene C60 results in decreased expression of CLDN12 mRNA CTD PMID:19167457 NCBI chr 4:29,477,468...29,488,465
Ensembl chr 4:28,522,678...28,533,801 		JBrowse link
G Cldn15 claudin 15 decreases expression EXP fullerene C60 results in decreased expression of CLDN15 mRNA CTD PMID:19167457 NCBI chr12:25,334,849...25,345,104
Ensembl chr12:19,698,337...19,706,819 		JBrowse link
G Cldn23 claudin 23 decreases expression EXP fullerene C60 results in decreased expression of CLDN23 mRNA CTD PMID:19167457 NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523 		JBrowse link
G Cldn8 claudin 8 decreases expression EXP fullerene C60 results in decreased expression of CLDN8 mRNA CTD PMID:19167457 NCBI chr11:41,362,081...41,364,330
Ensembl chr11:27,875,692...27,878,513 		JBrowse link
G Cldn9 claudin 9 increases expression EXP fullerene C60 results in increased expression of CLDN9 mRNA CTD PMID:19167457 NCBI chr10:13,218,728...13,220,159 JBrowse link
G Clec4a1 C-type lectin domain family 4, member A1 increases expression EXP fullerene C60 results in increased expression of CLEC4A1 mRNA CTD PMID:19167457 NCBI chr 4:157,845,811...157,857,926
Ensembl chr 4:156,173,894...156,186,008 		JBrowse link
G Clip3 CAP-GLY domain containing linker protein 3 increases expression EXP fullerene C60 results in increased expression of CLIP3 mRNA CTD PMID:19167457 NCBI chr 1:94,674,492...94,690,643
Ensembl chr 1:85,547,206...85,563,184 		JBrowse link
G Clptm1 CLPTM1 regulator of GABA type A receptor forward trafficking increases expression EXP fullerene C60 results in increased expression of CLPTM1 mRNA CTD PMID:19167457 NCBI chr 1:88,417,447...88,449,047
Ensembl chr 1:79,289,477...79,321,092 		JBrowse link
G Clvs1 clavesin 1 decreases expression EXP fullerene C60 results in decreased expression of CLVS1 mRNA CTD PMID:19167457 NCBI chr 5:22,408,384...22,604,281
Ensembl chr 5:22,408,384...22,604,270 		JBrowse link
G Cngb1 cyclic nucleotide gated channel subunit beta 1 decreases expression EXP fullerene C60 results in decreased expression of CNGB1 mRNA CTD PMID:19167457 NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,726,595...9,791,173 		JBrowse link
G Cnih1 cornichon family member 1 decreases expression EXP fullerene C60 results in decreased expression of CNIH1 mRNA CTD PMID:19167457 NCBI chr15:22,517,755...22,529,651
Ensembl chr15:20,037,885...20,049,761 		JBrowse link
G Cnn1 calponin 1 increases expression EXP fullerene C60 results in increased expression of CNN1 mRNA CTD PMID:19167457 NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098 		JBrowse link
G Cnot4 CCR4-NOT transcription complex, subunit 4 increases expression EXP fullerene C60 results in increased expression of CNOT4 mRNA CTD PMID:19167457 NCBI chr 4:63,712,770...63,814,355
Ensembl chr 4:63,712,770...63,814,360 		JBrowse link
G Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase decreases expression EXP fullerene C60 results in decreased expression of CNP mRNA CTD PMID:19167457 NCBI chr10:86,011,504...86,018,063
Ensembl chr10:85,511,160...85,517,720 		JBrowse link
G Cnppd1 cyclin Pas1/PHO80 domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of CNPPD1 mRNA CTD PMID:19167457 NCBI chr 9:84,082,148...84,088,888
Ensembl chr 9:76,633,477...76,640,188 		JBrowse link
G Cnpy3 canopy FGF signaling regulator 3 increases expression EXP fullerene C60 results in increased expression of CNPY3 mRNA CTD PMID:19167457 NCBI chr 9:21,731,088...21,745,448
Ensembl chr 9:14,233,428...14,247,831 		JBrowse link
G Coa3 cytochrome C oxidase assembly factor 3 decreases expression EXP fullerene C60 results in decreased expression of COA3 mRNA CTD PMID:19167457 NCBI chr10:86,720,454...86,721,435
Ensembl chr10:86,220,194...86,221,178 		JBrowse link
G Coch cochlin increases expression EXP fullerene C60 results in increased expression of COCH mRNA CTD PMID:19167457 NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:69,031,167...69,045,109 		JBrowse link
G Col10a1 collagen type X alpha 1 chain decreases expression EXP fullerene C60 results in decreased expression of COL10A1 mRNA CTD PMID:19167457 NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494 		JBrowse link
G Col20a1 collagen type XX alpha 1 chain decreases expression EXP fullerene C60 results in decreased expression of COL20A1 mRNA CTD PMID:19167457 NCBI chr 3:168,102,475...168,134,759
Ensembl chr 3:168,084,560...168,135,309 		JBrowse link
G Col23a1 collagen type XXIII alpha 1 chain increases expression EXP fullerene C60 results in increased expression of COL23A1 mRNA CTD PMID:19167457 NCBI chr10:36,050,327...36,337,279
Ensembl chr10:35,549,113...35,836,314 		JBrowse link
G Col2a1 collagen type II alpha 1 chain decreases expression EXP fullerene C60 results in decreased expression of COL2A1 mRNA CTD PMID:19167457 NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:129,098,786...129,127,546 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain increases expression EXP fullerene C60 results in increased expression of COL4A2 mRNA CTD PMID:19167457 NCBI chr16:84,749,672...84,885,520
Ensembl chr16:78,047,602...78,183,839 		JBrowse link
G Col5a1 collagen type V alpha 1 chain increases expression EXP fullerene C60 results in increased expression of COL5A1 mRNA CTD PMID:19167457 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:11,208,512...11,354,588 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain increases expression EXP fullerene C60 results in increased expression of COL7A1 mRNA CTD PMID:19167457 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:109,604,861...109,637,252 		JBrowse link
G Col8a1 collagen type VIII alpha 1 chain decreases expression EXP fullerene C60 results in decreased expression of COL8A1 mRNA CTD PMID:19167457 NCBI chr11:56,245,998...56,378,586
Ensembl chr11:42,777,628...42,906,424 		JBrowse link
G Comtd1 catechol-O-methyltransferase domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of COMTD1 mRNA CTD PMID:19167457 NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895 		JBrowse link
G Cops5 COP9 signalosome subunit 5 decreases expression EXP fullerene C60 results in decreased expression of COPS5 mRNA CTD PMID:19167457 NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:9,192,100...9,210,731 		JBrowse link
G Copz1 COPI coat complex subunit zeta 1 decreases expression EXP fullerene C60 results in decreased expression of COPZ1 mRNA CTD PMID:19167457 NCBI chr 7:136,287,696...136,314,131
Ensembl chr 7:134,409,799...134,435,662 		JBrowse link
G Coq8a coenzyme Q8A decreases expression EXP fullerene C60 results in decreased expression of COQ8A mRNA CTD PMID:19167457 NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431 		JBrowse link
G Coro1a coronin 1A decreases expression EXP fullerene C60 results in decreased expression of CORO1A mRNA CTD PMID:19167457 NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:181,295,562...181,300,534 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 decreases expression EXP fullerene C60 results in decreased expression of COX6A2 mRNA CTD PMID:19167457 NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:182,788,528...182,789,274 		JBrowse link
G Cpa2 carboxypeptidase A2 decreases expression EXP fullerene C60 results in decreased expression of CPA2 mRNA CTD PMID:19167457 NCBI chr 4:59,160,357...59,183,677
Ensembl chr 4:59,160,357...59,183,674 		JBrowse link
G Cpeb1 cytoplasmic polyadenylation element binding protein 1 decreases expression EXP fullerene C60 results in decreased expression of CPEB1 mRNA CTD PMID:19167457 NCBI chr 1:144,709,278...144,817,388
Ensembl chr 1:135,300,461...135,409,760 		JBrowse link
G Cplx2 complexin 2 decreases expression EXP fullerene C60 results in decreased expression of CPLX2 mRNA CTD PMID:19167457 NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,222,347...10,293,855 		JBrowse link
G Crat carnitine O-acetyltransferase increases expression EXP fullerene C60 results in increased expression of CRAT mRNA CTD PMID:19167457 NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:13,675,684...13,689,255 		JBrowse link
G Crebbp CREB binding protein decreases expression EXP fullerene C60 results in decreased expression of CREBBP mRNA CTD PMID:19167457 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888 		JBrowse link
G Crlf1 cytokine receptor-like factor 1 increases expression EXP fullerene C60 results in increased expression of CRLF1 mRNA CTD PMID:19167457 NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,924,722...18,935,997 		JBrowse link
G Crtc2 CREB regulated transcription coactivator 2 decreases expression EXP fullerene C60 results in decreased expression of CRTC2 mRNA CTD PMID:19167457 NCBI chr 2:178,007,233...178,017,397
Ensembl chr 2:175,709,644...175,719,763 		JBrowse link
G Cry2 cryptochrome circadian regulator 2 increases expression EXP fullerene C60 results in increased expression of CRY2 mRNA CTD PMID:19167457 NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:78,374,995...78,404,965 		JBrowse link
G Crybb1 crystallin, beta B1 decreases expression EXP fullerene C60 results in decreased expression of CRYBB1 mRNA CTD PMID:19167457 NCBI chr12:44,369,734...44,383,344
Ensembl chr12:44,369,735...44,383,344 		JBrowse link
G Crym crystallin, mu decreases expression EXP fullerene C60 results in decreased expression of CRYM mRNA CTD PMID:19167457 NCBI chr 1:183,991,752...184,006,923
Ensembl chr 1:174,560,416...174,575,633 		JBrowse link
G Csde1 cold shock domain containing E1 decreases expression EXP fullerene C60 results in decreased expression of UNR mRNA CTD PMID:19167457 NCBI chr 2:193,234,546...193,271,301
Ensembl chr 2:190,554,980...190,582,784 		JBrowse link
G Csf1r colony stimulating factor 1 receptor decreases expression EXP fullerene C60 results in decreased expression of CSF1R mRNA CTD PMID:19167457 NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415 		JBrowse link
G Csf2rb colony stimulating factor 2 receptor subunit beta decreases expression EXP fullerene C60 results in decreased expression of CSF2RB mRNA CTD PMID:19167457 NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:109,886,425...109,904,157 		JBrowse link
G Csnk1g2 casein kinase 1, gamma 2 increases expression EXP fullerene C60 results in increased expression of CSNK1G2 mRNA CTD PMID:19167457 NCBI chr 7:9,076,739...9,095,082
Ensembl chr 7:9,076,740...9,095,052 		JBrowse link
G Csnk2a2 casein kinase 2 alpha 2 decreases expression EXP fullerene C60 results in decreased expression of CSNK2A2 mRNA CTD PMID:19167457 NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,556,260...9,596,080 		JBrowse link
G Cstf1 cleavage stimulation factor subunit 1 decreases expression EXP fullerene C60 results in decreased expression of CSTF1 mRNA CTD PMID:19167457 NCBI chr 3:161,144,522...161,156,294
Ensembl chr 3:161,144,548...161,156,300 		JBrowse link
G Cstf2t cleavage stimulation factor subunit 2, tau variant decreases expression EXP fullerene C60 results in decreased expression of CSTF2T mRNA CTD PMID:19167457 NCBI chr 1:228,952,617...228,956,183
Ensembl chr 1:228,952,504...228,955,873 		JBrowse link
G Ctdnep1 CTD nuclear envelope phosphatase 1 increases expression EXP fullerene C60 results in increased expression of CTDNEP1 mRNA CTD PMID:19167457 NCBI chr10:55,203,047...55,212,469
Ensembl chr10:54,704,148...54,713,781 		JBrowse link
G Ctnnb1 catenin beta 1 increases expression EXP fullerene C60 results in increased expression of CTNNB1 mRNA CTD PMID:19167457 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111 		JBrowse link
G Ctrb1 chymotrypsinogen B1 decreases expression EXP fullerene C60 results in decreased expression of CTRB mRNA CTD PMID:19167457 NCBI chr19:39,652,931...39,657,689
Ensembl chr19:39,652,933...39,657,688 		JBrowse link
G Cts7l2 cathepsin 7 like 2 increases expression EXP fullerene C60 results in increased expression of CTS7L2 mRNA CTD PMID:19167457 NCBI chr17:3,903,602...3,907,088
Ensembl chr17:3,903,602...3,906,568 		JBrowse link
G Ctsk cathepsin K increases expression EXP fullerene C60 results in increased expression of CTSK mRNA CTD PMID:20471445 NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:183,058,569...183,069,550 		JBrowse link
G Ctxn1 cortexin 1 decreases expression EXP fullerene C60 results in decreased expression of CTXN1 mRNA CTD PMID:19167457 NCBI chr12:2,610,465...2,612,076 JBrowse link
G Cuedc1 CUE domain containing 1 increases expression EXP fullerene C60 results in increased expression of CUEDC1 mRNA CTD PMID:19167457 NCBI chr10:72,892,637...72,986,546
Ensembl chr10:72,892,637...72,986,542 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 increases expression EXP fullerene C60 results in increased expression of CXCL1 mRNA CTD PMID:20471445 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression EXP fullerene C60 results in increased expression of CXCL2 mRNA CTD PMID:20471445 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression EXP fullerene C60 results in increased expression of CXCL3 mRNA CTD PMID:20471445 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511 		JBrowse link
G Cyb5d1 cytochrome b5 domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of CYB5D1 mRNA CTD PMID:19167457 NCBI chr10:54,612,230...54,616,375
Ensembl chr10:54,113,438...54,117,911 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 increases expression EXP fullerene C60 results in increased expression of CYB5R3 mRNA CTD PMID:19167457 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:114,306,685...114,324,298 		JBrowse link
G Cyba cytochrome b-245 alpha chain decreases expression EXP fullerene C60 results in decreased expression of CYBA mRNA CTD PMID:19167457 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 decreases expression EXP fullerene C60 results in decreased expression of CYP11B3 mRNA CTD PMID:19167457 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:106,808,559...106,814,048 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression EXP fullerene C60 results in decreased expression of CYP17A1 mRNA CTD PMID:19167457 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases expression EXP fullerene C60 results in decreased expression of CYP1A2 mRNA CTD PMID:19167457 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases expression EXP fullerene C60 results in decreased expression of CYP1B1 mRNA CTD PMID:19167457 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 decreases expression EXP fullerene C60 results in decreased expression of CYP26B1 mRNA CTD PMID:19167457 NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:117,041,808...117,058,628 		JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 decreases expression EXP fullerene C60 results in decreased expression of CYP27A1 mRNA CTD PMID:19167457 NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:76,264,860...76,294,551 		JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 increases expression EXP fullerene C60 results in increased expression of CYP2A3 mRNA CTD PMID:19167457 NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:82,169,949...82,179,979 		JBrowse link
G Cyp2b15 cytochrome P450, family 2, subfamily b, polypeptide 15 increases expression EXP fullerene C60 results in increased expression of CYP2B15 mRNA CTD PMID:19167457 NCBI chr 1:91,221,865...91,234,169
Ensembl chr 1:82,094,180...82,106,492 		JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression EXP fullerene C60 results in increased expression of CYP2B13 mRNA CTD PMID:19167457 NCBI chr 1:90,722,243...90,736,272
Ensembl chr 1:81,594,555...81,608,566 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression EXP fullerene C60 results in increased expression of CYP2B3 mRNA CTD PMID:19167457 NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression EXP fullerene C60 results in increased expression of CYP2E1 mRNA CTD PMID:19167457 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Cyp2u1 cytochrome P450, family 2, subfamily u, polypeptide 1 increases expression EXP fullerene C60 results in increased expression of CYP2U1 mRNA CTD PMID:19167457 NCBI chr 2:219,849,403...219,866,959
Ensembl chr 2:219,849,407...219,866,882 		JBrowse link
G Cyrib CYFIP related Rac1 interactor B decreases expression EXP fullerene C60 results in decreased expression of CYRIB mRNA CTD PMID:19167457 NCBI chr 7:97,524,941...97,649,846
Ensembl chr 7:95,633,876...95,697,686 		JBrowse link
G Cytl1 cytokine like 1 affects expression EXP fullerene C60 affects the expression of CYTL1 mRNA CTD PMID:19167457 NCBI chr14:73,053,876...73,058,886
Ensembl chr14:73,053,877...73,058,886 		JBrowse link
G Cyyr1 cysteine and tyrosine rich 1 decreases expression EXP fullerene C60 results in decreased expression of CYYR1 mRNA CTD PMID:19167457 NCBI chr11:24,557,620...24,664,007
Ensembl chr11:24,515,316...24,663,961 		JBrowse link
G D2hgdh D-2-hydroxyglutarate dehydrogenase decreases expression EXP fullerene C60 results in decreased expression of D2HGDH mRNA CTD PMID:19167457 NCBI chr 9:94,350,555...94,368,384
Ensembl chr 9:94,350,576...94,368,382 		JBrowse link
G Dact2 dishevelled-binding antagonist of beta-catenin 2 increases expression EXP fullerene C60 results in increased expression of DACT2 mRNA CTD PMID:19167457 NCBI chr 1:63,854,182...63,864,153
Ensembl chr 1:55,181,024...55,191,096 		JBrowse link
G Dagla diacylglycerol lipase, alpha decreases expression EXP fullerene C60 results in decreased expression of DAGLA mRNA CTD PMID:19167457 NCBI chr 1:216,315,515...216,372,219
Ensembl chr 1:206,890,638...206,947,232 		JBrowse link
G Dbh dopamine beta-hydroxylase decreases expression EXP fullerene C60 results in decreased expression of DBH mRNA CTD PMID:19167457 NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:10,488,260...10,505,248 		JBrowse link
G Dbndd2 dysbindin domain containing 2 affects expression EXP fullerene C60 affects the expression of DBNDD2 mRNA CTD PMID:19167457 NCBI chr 3:173,634,551...173,639,999
Ensembl chr 3:153,191,090...153,220,651 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor increases expression EXP fullerene C60 results in increased expression of DBP mRNA CTD PMID:19167457 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:96,175,440...96,180,745 		JBrowse link
G Dcaf1 DDB1 and CUL4 associated factor 1 decreases expression EXP fullerene C60 results in decreased expression of DCAF1 mRNA CTD PMID:19167457 NCBI chr 8:116,344,927...116,419,329
Ensembl chr 8:107,474,312...107,540,627 		JBrowse link
G Dcaf15 DDB1 and CUL4 associated factor 15 decreases expression EXP fullerene C60 results in decreased expression of DCAF15 mRNA CTD PMID:19167457 NCBI chr19:24,053,925...24,061,277
Ensembl chr19:24,053,925...24,061,277 		JBrowse link
G Dcaf6 DDB1 and CUL4 associated factor 6 decreases expression EXP fullerene C60 results in decreased expression of DCAF6 mRNA CTD PMID:19167457 NCBI chr13:80,159,282...80,260,510
Ensembl chr13:77,626,307...77,727,512 		JBrowse link
G Dclk1 doublecortin-like kinase 1 decreases expression EXP fullerene C60 results in decreased expression of DCLK1 mRNA CTD PMID:19167457 NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:139,417,163...139,710,956 		JBrowse link
G Dcst1 DC-STAMP domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of DCST1 mRNA CTD PMID:19167457 NCBI chr 2:177,063,083...177,079,914
Ensembl chr 2:174,765,350...174,781,806 		JBrowse link
G Dctn1 dynactin subunit 1 increases expression EXP fullerene C60 results in increased expression of DCTN1 mRNA CTD PMID:19167457 NCBI chr 4:117,228,722...117,261,528
Ensembl chr 4:115,661,638...115,703,815 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 decreases expression EXP fullerene C60 results in decreased expression of DDIT4 mRNA CTD PMID:19167457 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105 		JBrowse link
G Ddx1 DEAD-box helicase 1 decreases expression EXP fullerene C60 results in decreased expression of DDX1 mRNA CTD PMID:19167457 NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:35,996,469...36,027,365 		JBrowse link
G Ddx11 DEAD/H-box helicase 11 increases expression EXP fullerene C60 results in increased expression of DDX11 mRNA CTD PMID:19167457 NCBI chr 9:113,204,886...113,309,692
Ensembl chr 9:105,833,504...105,862,550 		JBrowse link
G Ddx23 DEAD-box helicase 23 increases expression EXP fullerene C60 results in increased expression of DDX23 mRNA CTD PMID:19167457 NCBI chr 7:131,676,636...131,693,917
Ensembl chr 7:129,797,614...129,814,949 		JBrowse link
G Ddx24 DEAD-box helicase 24 decreases expression EXP fullerene C60 results in decreased expression of DDX24 mRNA CTD PMID:19167457 NCBI chr 6:128,329,554...128,346,818
Ensembl chr 6:122,564,767...122,581,927 		JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked decreases expression EXP fullerene C60 results in decreased expression of DDX3X mRNA CTD PMID:19167457 NCBI chr  X:12,152,346...12,165,983
Ensembl chr  X:9,479,532...9,493,168 		JBrowse link
G Def8 differentially expressed in FDCP 8 homolog decreases expression EXP fullerene C60 results in decreased expression of DEF8 mRNA CTD PMID:19167457 NCBI chr19:51,474,783...51,495,638
Ensembl chr19:51,474,878...51,495,638 		JBrowse link
G Defb22 defensin beta 22 decreases expression EXP fullerene C60 results in decreased expression of DEFB22 mRNA CTD PMID:19167457 NCBI chr 3:140,957,093...140,961,373
Ensembl chr 3:140,957,090...140,961,373 		JBrowse link
G Dek DEK proto-oncogene decreases expression EXP fullerene C60 results in decreased expression of DEK mRNA CTD PMID:19167457 NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,580,843...17,602,808 		JBrowse link
G Dennd3 DENN domain containing 3 increases expression EXP fullerene C60 results in increased expression of DENND3 mRNA CTD PMID:19167457 NCBI chr 7:105,415,870...105,473,583
Ensembl chr 7:105,415,677...105,473,592 		JBrowse link
G Dgkb diacylglycerol kinase, beta decreases expression EXP fullerene C60 results in decreased expression of DGKB mRNA CTD PMID:19167457 NCBI chr 6:60,368,101...61,124,420
Ensembl chr 6:54,641,614...55,397,043 		JBrowse link
G Dhdds dehydrodolichyl diphosphate synthase subunit decreases expression EXP fullerene C60 results in decreased expression of DHDDS mRNA CTD PMID:19167457 NCBI chr 5:146,198,359...146,224,479
Ensembl chr 5:146,197,457...146,224,454 		JBrowse link
G Dhx16 DEAH-box helicase 16 affects expression EXP fullerene C60 affects the expression of DHX16 mRNA CTD PMID:19167457 NCBI chr20:2,866,804...2,879,790
Ensembl chr20:2,862,000...2,874,948 		JBrowse link
G Dhx36 DEAH-box helicase 36 increases expression EXP fullerene C60 results in increased expression of DHX36 mRNA CTD PMID:19167457 NCBI chr 2:149,006,089...149,044,192
Ensembl chr 2:146,856,469...146,894,572 		JBrowse link
G Dio3 iodothyronine deiodinase 3 decreases expression EXP fullerene C60 results in decreased expression of DIO3 mRNA CTD PMID:19167457 NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:129,285,749...129,286,660 		JBrowse link
G Dkc1 dyskerin pseudouridine synthase 1 decreases expression EXP fullerene C60 results in decreased expression of DKC1 mRNA CTD PMID:19167457 NCBI chr  X:157,751,651...157,757,796 JBrowse link
G Dlk2 delta like non-canonical Notch ligand 2 increases expression EXP fullerene C60 results in increased expression of DLK2 mRNA CTD PMID:19167457 NCBI chr 9:22,174,667...22,179,149
Ensembl chr 9:14,676,562...14,681,594 		JBrowse link
G Dll1 delta like canonical Notch ligand 1 decreases expression EXP fullerene C60 results in decreased expression of DLL1 mRNA CTD PMID:19167457 NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:56,312,066...56,320,179 		JBrowse link
G Dlx2 distal-less homeobox 2 decreases expression EXP fullerene C60 results in decreased expression of DLX2 mRNA CTD PMID:19167457 NCBI chr 3:56,370,238...56,373,581
Ensembl chr 3:56,370,483...56,373,597 		JBrowse link
G Dlx5 distal-less homeobox 5 increases expression EXP fullerene C60 results in increased expression of DLX5 mRNA CTD PMID:19167457 NCBI chr 4:35,965,579...35,969,973
Ensembl chr 4:34,999,139...35,003,407 		JBrowse link
G Dmrta2 DMRT-like family A2 increases expression EXP fullerene C60 results in increased expression of DMRTA2 mRNA CTD PMID:19167457 NCBI chr 5:124,805,883...124,811,694
Ensembl chr 5:124,805,883...124,811,630 		JBrowse link
G Dmtn dematin actin binding protein increases expression EXP fullerene C60 results in increased expression of DMTN mRNA CTD PMID:19167457 NCBI chr15:52,087,667...52,111,956
Ensembl chr15:45,677,977...45,705,601 		JBrowse link
G Dnaaf1 dynein, axonemal, assembly factor 1 decreases expression EXP fullerene C60 results in decreased expression of DNAAF1 mRNA CTD PMID:19167457 NCBI chr19:64,532,859...64,560,942
Ensembl chr19:47,624,181...47,652,313 		JBrowse link
G Dnah1 dynein, axonemal, heavy chain 1 decreases expression EXP fullerene C60 results in decreased expression of DNAH1 mRNA CTD PMID:19167457 NCBI chr16:6,462,419...6,523,545
Ensembl chr16:6,456,002...6,518,350 		JBrowse link
G Dnah17 dynein, axonemal, heavy chain 17 decreases expression EXP fullerene C60 results in decreased expression of DNAH17 mRNA CTD PMID:19167457 NCBI chr10:103,244,144...103,364,953
Ensembl chr10:103,249,363...103,364,901 		JBrowse link
G Dnajb13 DnaJ heat shock protein family (Hsp40) member B13 decreases expression EXP fullerene C60 results in decreased expression of DNAJB13 mRNA CTD PMID:19167457 NCBI chr 1:164,260,716...164,275,172
Ensembl chr 1:154,848,594...154,862,963 		JBrowse link
G Dnajb5 DnaJ heat shock protein family (Hsp40) member B5 affects expression EXP fullerene C60 affects the expression of DNAJB5 mRNA CTD PMID:19167457 NCBI chr 5:61,972,637...61,981,887
Ensembl chr 5:57,176,845...57,185,490 		JBrowse link
G Dnase2b deoxyribonuclease 2 beta decreases expression EXP fullerene C60 results in decreased expression of DNASE2B mRNA CTD PMID:19167457 NCBI chr 2:235,470,915...235,515,211
Ensembl chr 2:235,470,919...235,486,295 		JBrowse link
G Dnm1l dynamin 1-like decreases expression EXP fullerene C60 results in decreased expression of DNM1L mRNA CTD PMID:19167457 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:84,581,216...84,631,482 		JBrowse link
G Doc2b double C2 domain beta decreases expression EXP fullerene C60 results in decreased expression of DOC2B mRNA CTD PMID:19167457 NCBI chr10:61,126,295...61,151,533
Ensembl chr10:60,628,029...60,653,267 		JBrowse link
G Dpp9 dipeptidyl peptidase 9 increases expression EXP fullerene C60 results in increased expression of DPP9 mRNA CTD PMID:19167457 NCBI chr 9:1,098,505...1,133,500
Ensembl chr 9:1,011,351...1,046,541 		JBrowse link
G Drd2 dopamine receptor D2 decreases expression EXP fullerene C60 results in decreased expression of DRD2 mRNA CTD PMID:19167457 NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875 		JBrowse link
G Drd3 dopamine receptor D3 decreases expression EXP fullerene C60 results in decreased expression of DRD3 mRNA CTD PMID:19167457 NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596 		JBrowse link
G Drd5 dopamine receptor D5 decreases expression EXP fullerene C60 results in decreased expression of DRD5 mRNA CTD PMID:19167457 NCBI chr14:76,700,244...76,703,344
Ensembl chr14:72,489,347...72,490,774 		JBrowse link
G Dsn1 DSN1 component of MIS12 kinetochore complex increases expression EXP fullerene C60 results in increased expression of DSN1 mRNA CTD PMID:19167457 NCBI chr 3:166,072,775...166,089,029
Ensembl chr 3:145,652,737...145,665,856 		JBrowse link
G Dtnb dystrobrevin, beta increases expression EXP fullerene C60 results in increased expression of DTNB mRNA CTD PMID:19167457 NCBI chr 6:26,566,418...26,763,467
Ensembl chr 6:26,566,925...26,766,335 		JBrowse link
G Dusp15 dual specificity phosphatase 15 decreases expression EXP fullerene C60 results in decreased expression of DUSP15 mRNA CTD PMID:19167457 NCBI chr 3:141,408,495...141,419,137
Ensembl chr 3:141,408,498...141,418,999 		JBrowse link
G Dusp3 dual specificity phosphatase 3 increases expression EXP fullerene C60 results in increased expression of DUSP3 mRNA CTD PMID:19167457 NCBI chr10:87,420,213...87,434,202
Ensembl chr10:86,920,014...86,933,962 		JBrowse link
G Dusp7 dual specificity phosphatase 7 decreases expression EXP fullerene C60 results in decreased expression of DUSP7 mRNA CTD PMID:19167457 NCBI chr 8:115,888,091...115,895,126
Ensembl chr 8:107,008,528...107,016,404 		JBrowse link
G Dusp9 dual specificity phosphatase 9 decreases expression EXP fullerene C60 results in decreased expression of DUSP9 mRNA CTD PMID:19167457 NCBI chr  X:151,351,897...151,355,822
Ensembl chr  X:151,351,897...151,355,821 		JBrowse link
G Dyrk2 dual specificity tyrosine phosphorylation regulated kinase 2 increases expression EXP fullerene C60 results in increased expression of DYRK2 mRNA CTD PMID:19167457 NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:54,349,610...54,380,106 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase decreases expression EXP fullerene C60 results in decreased expression of EBP mRNA CTD PMID:19167457 NCBI chr  X:16,971,372...16,977,782
Ensembl chr  X:14,299,448...14,305,826 		JBrowse link
G Edc4 enhancer of mRNA decapping 4 decreases expression EXP fullerene C60 results in decreased expression of EDC4 mRNA CTD PMID:19167457 NCBI chr19:33,774,062...33,786,054
Ensembl chr19:33,774,055...33,787,758 		JBrowse link
G Edn3 endothelin 3 affects expression EXP fullerene C60 affects the expression of EDN3 mRNA CTD PMID:19167457 NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:163,562,520...163,585,093 		JBrowse link
G Eef1a2 eukaryotic translation elongation factor 1 alpha 2 affects expression EXP fullerene C60 affects the expression of EEF1A2 mRNA CTD PMID:19167457 NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:168,195,357...168,275,071 		JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma decreases expression EXP fullerene C60 results in decreased expression of EEF1G mRNA CTD PMID:19167457 NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:205,860,698...205,872,382 		JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase increases expression EXP fullerene C60 results in increased expression of EEF2K mRNA CTD PMID:19167457 NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:175,393,154...175,455,164 		JBrowse link
G Eeig2 EEIG family member 2 decreases expression EXP fullerene C60 results in decreased expression of EEIG2 mRNA CTD PMID:19167457 NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371 		JBrowse link
G Eepd1 endonuclease/exonuclease/phosphatase family domain containing 1 increases expression EXP fullerene C60 results in increased expression of EEPD1 mRNA CTD PMID:19167457 NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340 		JBrowse link
G Efcab11 EF-hand calcium binding domain 11 decreases expression EXP fullerene C60 results in decreased expression of EFCAB11 mRNA CTD PMID:19167457 NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046 		JBrowse link
G Efhd2 EF-hand domain family, member D2 decreases expression EXP fullerene C60 results in decreased expression of EFHD2 mRNA CTD PMID:19167457 NCBI chr 5:159,443,959...159,459,993
Ensembl chr 5:154,160,946...154,176,980 		JBrowse link
G Efna3 ephrin A3 decreases expression EXP fullerene C60 results in decreased expression of EFNA3 mRNA CTD PMID:19167457 NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:174,729,764...174,738,736 		JBrowse link
G Efnb3 ephrin B3 decreases expression EXP fullerene C60 results in decreased expression of EFNB3 mRNA CTD PMID:19167457 NCBI chr10:54,773,282...54,780,727
Ensembl chr10:54,274,506...54,280,471 		JBrowse link
G Egln2 egl-9 family hypoxia-inducible factor 2 increases expression EXP fullerene C60 results in increased expression of EGLN2 mRNA CTD PMID:19167457 NCBI chr 1:91,579,205...91,586,985
Ensembl chr 1:82,451,555...82,459,751 		JBrowse link
G Ehbp1l1 EH domain binding protein 1-like 1 increases expression EXP fullerene C60 results in increased expression of EHBP1L1 mRNA CTD PMID:19167457 NCBI chr 1:212,423,444...212,444,357
Ensembl chr 1:202,994,118...203,014,270 		JBrowse link
G Ehd1 EH-domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of EHD1 mRNA CTD PMID:19167457 NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:203,579,869...203,602,212 		JBrowse link
G Ehd3 EH-domain containing 3 increases expression EXP fullerene C60 results in increased expression of EHD3 mRNA CTD PMID:19167457 NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:21,639,290...21,665,236 		JBrowse link
G Ehmt2 euchromatic histone lysine methyltransferase 2 increases expression EXP fullerene C60 results in increased expression of EHMT2 mRNA CTD PMID:19167457 NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,919,624...3,941,547 		JBrowse link
G Eif3b eukaryotic translation initiation factor 3, subunit B increases expression EXP fullerene C60 results in increased expression of EIF3B mRNA CTD PMID:19167457 NCBI chr12:19,310,308...19,334,768
Ensembl chr12:14,196,403...14,220,886 		JBrowse link
G Eif6 eukaryotic translation initiation factor 6 decreases expression EXP fullerene C60 results in decreased expression of EIF6 mRNA CTD PMID:19167457 NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401 		JBrowse link
G Elf1 E74 like ETS transcription factor 1 decreases expression EXP fullerene C60 results in decreased expression of ELF1 mRNA CTD PMID:19167457 NCBI chr15:61,354,026...61,395,762
Ensembl chr15:54,865,616...54,986,699 		JBrowse link
G Eln elastin decreases expression EXP fullerene C60 results in decreased expression of ELN mRNA CTD PMID:19167457 NCBI chr12:27,604,983...27,648,413
Ensembl chr12:21,968,544...22,011,928 		JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 decreases expression EXP fullerene C60 results in decreased expression of ELOVL5 mRNA CTD PMID:19167457 NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:78,790,846...78,857,284 		JBrowse link
G Eml1 EMAP like 1 decreases expression EXP fullerene C60 results in decreased expression of EML1 mRNA CTD PMID:19167457 NCBI chr 6:133,048,271...133,221,642
Ensembl chr 6:127,284,029...127,457,246 		JBrowse link
G Eng endoglin increases expression EXP fullerene C60 results in increased expression of ENG mRNA CTD PMID:19167457 NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:15,934,518...15,973,230 		JBrowse link
G Engase endo-beta-N-acetylglucosaminidase decreases expression EXP fullerene C60 results in decreased expression of ENGASE mRNA CTD PMID:19167457 NCBI chr10:103,707,169...103,719,833
Ensembl chr10:103,707,169...103,719,819 		JBrowse link
G Entr1 endosome associated trafficking regulator 1 decreases expression EXP fullerene C60 results in decreased expression of ENTR1 mRNA CTD PMID:19167457 NCBI chr 3:29,599,059...29,605,780
Ensembl chr 3:9,200,967...9,207,688 		JBrowse link
G Entrep1 endosomal transmembrane epsin interactor 1 increases expression EXP fullerene C60 results in increased expression of ENTREP1 mRNA CTD PMID:19167457 NCBI chr 1:231,018,987...231,073,474
Ensembl chr 1:221,592,503...221,646,758 		JBrowse link
G Epha4 Eph receptor A4 decreases expression EXP fullerene C60 results in decreased expression of EPHA4 mRNA CTD PMID:19167457 NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:78,815,460...78,958,139 		JBrowse link
G Epha8 Eph receptor A8 decreases expression EXP fullerene C60 results in decreased expression of EPHA8 mRNA CTD PMID:19167457 NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:149,166,697...149,193,399 		JBrowse link
G Ephb2 Eph receptor B2 decreases expression EXP fullerene C60 results in decreased expression of EPHB2 mRNA CTD PMID:19167457 NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:148,897,246...149,077,059 		JBrowse link
G Ephb3 Eph receptor B3 increases expression EXP fullerene C60 results in increased expression of EPHB3 mRNA CTD PMID:19167457 NCBI chr11:79,840,668...79,859,345
Ensembl chr11:79,840,668...79,859,370 		JBrowse link
G Ephx3 epoxide hydrolase 3 decreases expression EXP fullerene C60 results in decreased expression of EPHX3 mRNA CTD PMID:19167457 NCBI chr 7:11,206,812...11,212,122
Ensembl chr 7:11,206,812...11,212,122 		JBrowse link
G Epn2 epsin 2 increases expression EXP fullerene C60 results in increased expression of EPN2 mRNA CTD PMID:19167457 NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,197,785...46,259,642 		JBrowse link
G Epor erythropoietin receptor decreases expression EXP fullerene C60 results in decreased expression of EPOR mRNA CTD PMID:19167457 NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit increases expression EXP fullerene C60 results in increased expression of ERCC4 mRNA CTD PMID:19167457 NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,419,038...2,448,369
Ensembl chr10:2,419,038...2,448,369 		JBrowse link
G Ercc5 ERCC excision repair 5, endonuclease decreases expression EXP fullerene C60 results in decreased expression of ERCC5 mRNA CTD PMID:19167457 NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472 		JBrowse link
G Ergic2 ERGIC and golgi 2 affects expression EXP fullerene C60 affects the expression of ERGIC2 mRNA CTD PMID:19167457 NCBI chr 4:182,822,225...182,858,392
Ensembl chr 4:181,090,808...181,123,060 		JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 decreases expression EXP fullerene C60 results in decreased expression of ERRFI1 mRNA CTD PMID:19167457 NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:161,323,998...161,337,282 		JBrowse link
G Espn espin decreases expression EXP fullerene C60 results in decreased expression of ESPN mRNA CTD PMID:19167457 NCBI chr 5:162,626,560...162,660,439
Ensembl chr 5:162,626,560...162,660,256 		JBrowse link
G Ess2 ess-2 splicing factor homolog increases expression EXP fullerene C60 results in increased expression of ESS2 mRNA CTD PMID:19167457 NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846 		JBrowse link
G Etnk1 ethanolamine kinase 1 decreases expression EXP fullerene C60 results in decreased expression of ETNK1 mRNA CTD PMID:19167457 NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:176,126,180...176,193,770 		JBrowse link
G Etv3 ETS variant transcription factor 3 decreases expression EXP fullerene C60 results in decreased expression of ETV3 mRNA CTD PMID:19167457 NCBI chr 2:175,263,389...175,278,217
Ensembl chr 2:172,965,588...172,980,314 		JBrowse link
G Etv4 ETS variant transcription factor 4 increases expression EXP fullerene C60 results in increased expression of ETV4 mRNA CTD PMID:19167457 NCBI chr10:87,206,977...87,222,202
Ensembl chr10:86,706,749...86,721,974 		JBrowse link
G Etv5 ETS variant transcription factor 5 increases expression EXP fullerene C60 results in increased expression of ETV5 mRNA CTD PMID:19167457 NCBI chr11:92,113,171...92,170,758
Ensembl chr11:78,608,710...78,666,215 		JBrowse link
G Eva1b eva-1 homolog B decreases expression EXP fullerene C60 results in decreased expression of EVA1B mRNA CTD PMID:19167457 NCBI chr 5:143,711,627...143,716,963
Ensembl chr 5:138,427,151...138,432,433 		JBrowse link
G Exoc3l1 exocyst complex component 3-like 1 increases expression EXP fullerene C60 results in increased expression of EXOC3L1 mRNA CTD PMID:19167457 NCBI chr19:33,166,836...33,174,371
Ensembl chr19:33,166,837...33,172,486 		JBrowse link
G Exosc8 exosome component 8 decreases expression EXP fullerene C60 results in decreased expression of EXOSC8 mRNA CTD PMID:19167457 NCBI chr 2:141,080,568...141,087,112
Ensembl chr 2:138,930,405...138,936,928 		JBrowse link
G Exph5 exophilin 5 decreases expression EXP fullerene C60 results in decreased expression of EXPH5 mRNA CTD PMID:19167457 NCBI chr 8:62,595,116...62,671,575
Ensembl chr 8:53,698,852...53,773,169 		JBrowse link
G Eya4 EYA transcriptional coactivator and phosphatase 4 decreases expression EXP fullerene C60 results in decreased expression of EYA4 mRNA CTD PMID:19167457 NCBI chr 1:23,991,431...24,235,132
Ensembl chr 1:22,172,275...22,415,976 		JBrowse link
G F10 coagulation factor X decreases expression EXP fullerene C60 results in decreased expression of F10 mRNA CTD PMID:19167457 NCBI chr16:83,170,973...83,190,280
Ensembl chr16:76,468,838...76,488,141 		JBrowse link
G F12 coagulation factor XII decreases expression EXP fullerene C60 results in decreased expression of F12 mRNA CTD PMID:19167457 NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530 		JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression EXP fullerene C60 results in decreased expression of F2R mRNA CTD PMID:19167457 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870 		JBrowse link
G F2rl1 F2R like trypsin receptor 1 decreases expression EXP fullerene C60 results in decreased expression of F2RL1 mRNA CTD PMID:19167457 NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:26,772,278...26,785,226 		JBrowse link
G F2rl2 coagulation factor II (thrombin) receptor-like 2 decreases expression EXP fullerene C60 results in decreased expression of F2RL2 mRNA CTD PMID:19167457 NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:26,972,054...26,977,098 		JBrowse link
G F2rl3 F2R like thrombin or trypsin receptor 3 decreases expression EXP fullerene C60 results in decreased expression of F2RL3 mRNA CTD PMID:19167457 NCBI chr16:17,151,516...17,153,509
Ensembl chr16:17,117,441...17,119,472 		JBrowse link
G Faim2 Fas apoptotic inhibitory molecule 2 decreases expression EXP fullerene C60 results in decreased expression of FAIM2 mRNA CTD PMID:19167457 NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168 		JBrowse link
G Fam120b family with sequence similarity 120 member B decreases expression EXP fullerene C60 results in decreased expression of FAM120B mRNA CTD PMID:19167457 NCBI chr 1:56,320,015...56,385,064
Ensembl chr 1:56,339,129...56,385,061 		JBrowse link
G Fam13b family with sequence similarity 13, member B increases expression EXP fullerene C60 results in increased expression of FAM13B mRNA CTD PMID:19167457 NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587 		JBrowse link
G Fam151a family with sequence similarity 151, member A decreases expression EXP fullerene C60 results in decreased expression of FAM151A mRNA CTD PMID:19167457 NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:121,514,804...121,527,555 		JBrowse link
G Fam168a family with sequence similarity 168, member A decreases expression EXP fullerene C60 results in decreased expression of FAM168A mRNA CTD PMID:19167457 NCBI chr 1:164,469,447...164,615,542
Ensembl chr 1:155,057,352...155,201,220 		JBrowse link
G Fam20b FAM20B, glycosaminoglycan xylosylkinase decreases expression EXP fullerene C60 results in decreased expression of FAM20B mRNA CTD PMID:19167457 NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915 		JBrowse link
G Fam234a family with sequence similarity 234, member A increases expression EXP fullerene C60 results in increased expression of FAM234A mRNA CTD PMID:19167457 NCBI chr10:15,736,741...15,768,043
Ensembl chr10:15,232,278...15,263,488 		JBrowse link
G Fam98c family with sequence similarity 98, member C decreases expression EXP fullerene C60 results in decreased expression of FAM98C mRNA CTD PMID:19167457 NCBI chr 1:84,452,806...84,456,414
Ensembl chr 1:84,452,814...84,456,385 		JBrowse link
G Farp1 FERM, ARH/RhoGEF and pleckstrin domain protein 1 increases expression EXP fullerene C60 results in increased expression of FARP1 mRNA CTD PMID:19167457 NCBI chr15:104,531,196...104,770,148
Ensembl chr15:98,182,329...98,363,299 		JBrowse link
G Fbll1 fibrillarin-like 1 decreases expression EXP fullerene C60 results in decreased expression of FBLL1 mRNA CTD PMID:19167457 NCBI chr10:20,258,656...20,260,299
Ensembl chr10:20,258,656...20,260,299 		JBrowse link
G Fbn2 fibrillin 2 decreases expression EXP fullerene C60 results in decreased expression of FBN2 mRNA CTD PMID:19167457 NCBI chr18:53,696,197...53,901,992
Ensembl chr18:51,499,737...51,703,976 		JBrowse link
G Fbxl13 F-box and leucine-rich repeat protein 13 decreases expression EXP fullerene C60 results in decreased expression of FBXL13 mRNA CTD PMID:19167457 NCBI chr 4:13,414,880...13,607,079
Ensembl chr 4:13,414,926...13,641,494 		JBrowse link
G Fbxl2 F-box and leucine-rich repeat protein 2 decreases expression EXP fullerene C60 results in decreased expression of FBXL2 mRNA CTD PMID:19167457 NCBI chr 8:122,794,870...122,843,265
Ensembl chr 8:113,913,373...113,965,066 		JBrowse link
G Fbxo2 F-box protein 2 decreases expression EXP fullerene C60 results in decreased expression of FBXO2 mRNA CTD PMID:19167457 NCBI chr 5:163,876,079...163,881,508
Ensembl chr 5:158,592,925...158,598,355 		JBrowse link
G Fbxo39 F-box protein 39 increases expression EXP fullerene C60 results in increased expression of FBXO39 mRNA CTD PMID:19167457 NCBI chr10:56,929,699...56,934,911
Ensembl chr10:56,932,297...56,934,906 		JBrowse link
G Fbxw5 F-box and WD repeat domain containing 5 increases expression EXP fullerene C60 results in increased expression of FBXW5 mRNA CTD PMID:19167457 NCBI chr 3:28,720,670...28,725,237
Ensembl chr 3:8,322,543...8,327,092 		JBrowse link
G Fcf1 Fcf1 rRNA-processing protein increases expression EXP fullerene C60 results in increased expression of NOMO1 mRNA CTD PMID:19167457 NCBI chr 6:104,617,780...104,629,643
Ensembl chr 6:104,617,770...104,629,643 		JBrowse link
G Fcnb ficolin B increases expression EXP fullerene C60 results in increased expression of FCNB mRNA CTD PMID:19167457 NCBI chr 3:31,791,750...31,800,188
Ensembl chr 3:11,393,739...11,402,151 		JBrowse link
G Fes FES proto-oncogene, tyrosine kinase increases expression EXP fullerene C60 results in increased expression of FES mRNA CTD PMID:19167457 NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:134,337,698...134,346,934 		JBrowse link
G Fgd2 FYVE, RhoGEF and PH domain containing 2 increases expression EXP fullerene C60 results in increased expression of FGD2 mRNA CTD PMID:19167457 NCBI chr20:7,426,407...7,443,207
Ensembl chr20:7,424,790...7,441,603 		JBrowse link
G Fgf2 fibroblast growth factor 2 decreases expression EXP fullerene C60 results in decreased expression of FGF2 mRNA CTD PMID:19167457 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221 		JBrowse link
G Fgfr4 fibroblast growth factor receptor 4 increases expression EXP fullerene C60 results in increased expression of FGFR4 mRNA CTD PMID:19167457 NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,461,547...9,476,242 		JBrowse link
G Fgl2 fibrinogen-like 2 decreases expression EXP fullerene C60 results in decreased expression of FGL2 mRNA CTD PMID:19167457 NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:13,710,575...13,716,207 		JBrowse link
G Fh fumarate hydratase decreases expression EXP fullerene C60 results in decreased expression of FH mRNA CTD PMID:19167457 NCBI chr13:90,056,565...90,082,450
Ensembl chr13:87,524,337...87,550,266 		JBrowse link
G Fhip2b FHF complex subunit HOOK interacting protein 2B increases expression EXP fullerene C60 results in increased expression of FHIP2B mRNA CTD PMID:19167457 NCBI chr15:45,656,641...45,674,603
Ensembl chr15:45,656,647...45,674,105 		JBrowse link
G Fhod1 formin homology 2 domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of FHOD1 mRNA CTD PMID:19167457 NCBI chr19:33,206,492...33,225,448
Ensembl chr19:33,206,492...33,225,356 		JBrowse link
G Fibin fin bud initiation factor homolog decreases expression EXP fullerene C60 results in decreased expression of FIBIN mRNA CTD PMID:19167457 NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:96,942,406...96,944,676 		JBrowse link
G Fkbp4 FKBP prolyl isomerase 4 increases expression EXP fullerene C60 results in increased expression of FKBP4 mRNA CTD PMID:19167457 NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:161,703,379...161,711,833 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 affects expression EXP fullerene C60 affects the expression of FKBP5 mRNA CTD PMID:19167457 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674 		JBrowse link
G Flg filaggrin decreases expression EXP fullerene C60 results in decreased expression of FLG mRNA CTD PMID:19167457 NCBI chr 2:178,884,793...178,912,986 JBrowse link
G Flnb filamin B increases expression EXP fullerene C60 results in increased expression of FLNB mRNA CTD PMID:19167457 NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 decreases expression EXP fullerene C60 results in decreased expression of FLT1 mRNA CTD PMID:19167457 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626 		JBrowse link
G Fmnl1 formin-like 1 increases expression EXP fullerene C60 results in increased expression of FMNL1 mRNA CTD PMID:19167457 NCBI chr10:88,115,876...88,143,342
Ensembl chr10:88,116,009...88,143,357 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 increases expression EXP fullerene C60 results in increased expression of FMO3 mRNA CTD PMID:19167457 NCBI chr13:77,838,899...77,868,869
Ensembl chr13:75,309,374...75,328,028 		JBrowse link
G Fndc7 fibronectin type III domain containing 7 increases expression EXP fullerene C60 results in increased expression of FNDC7 mRNA CTD PMID:19167457 NCBI chr 2:196,501,313...196,537,816
Ensembl chr 2:196,502,460...196,537,694 		JBrowse link
G Fndc8 fibronectin type III domain containing 8 decreases expression EXP fullerene C60 results in decreased expression of FNDC8 mRNA CTD PMID:19167457 NCBI chr10:67,825,952...67,834,090
Ensembl chr10:67,825,952...67,834,090 		JBrowse link
G Fntb farnesyltransferase, CAAX box, subunit beta increases expression EXP fullerene C60 results in increased expression of FNTB mRNA CTD PMID:19167457 NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586 		JBrowse link
G Folr1 folate receptor alpha decreases expression EXP fullerene C60 results in decreased expression of FOLR1 mRNA CTD PMID:19167457 NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression EXP fullerene C60 results in increased expression of FOS mRNA CTD PMID:19167457 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit decreases expression EXP fullerene C60 results in decreased expression of FOSL1 mRNA CTD PMID:19167457 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:202,754,529...202,764,930 		JBrowse link
G Fosl2 FOS like 2, AP-1 transcription factor subunit decreases expression EXP fullerene C60 results in decreased expression of FOSL2 mRNA CTD PMID:19167457 NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:24,300,956...24,320,034 		JBrowse link
G Foxb1 forkhead box B1 decreases expression EXP fullerene C60 results in decreased expression of FOXB1 mRNA CTD PMID:19167457 NCBI chr 8:70,407,221...70,409,841
Ensembl chr 8:70,408,186...70,409,781 		JBrowse link
G Foxc2 forkhead box C2 decreases expression EXP fullerene C60 results in decreased expression of FOXC2 mRNA CTD PMID:19167457 NCBI chr19:66,094,718...66,097,420
Ensembl chr19:49,185,662...49,188,737 		JBrowse link
G Foxn1 forkhead box N1 decreases expression EXP fullerene C60 results in decreased expression of FOXN1 mRNA CTD PMID:19167457 NCBI chr10:63,749,461...63,778,468
Ensembl chr10:63,251,400...63,273,710 		JBrowse link
G Foxn4 forkhead box N4 decreases expression EXP fullerene C60 results in decreased expression of FOXN4 mRNA CTD PMID:19167457 NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921 		JBrowse link
G Foxo3 forkhead box O3 decreases expression EXP fullerene C60 results in decreased expression of FOXO3 mRNA CTD PMID:19167457 NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561 		JBrowse link
G Foxred2 FAD-dependent oxidoreductase domain containing 2 decreases expression EXP fullerene C60 results in decreased expression of FOXRED2 mRNA CTD PMID:19167457 NCBI chr 7:111,402,322...111,419,056
Ensembl chr 7:109,521,761...109,540,874 		JBrowse link
G Frem2 FRAS1 related extracellular matrix 2 decreases expression EXP fullerene C60 results in decreased expression of FREM2 mRNA CTD PMID:19167457 NCBI chr 2:137,602,784...137,740,785
Ensembl chr 2:137,602,784...137,740,785 		JBrowse link
G Frmd4a FERM domain containing 4A decreases expression EXP fullerene C60 results in decreased expression of FRMD4A mRNA CTD PMID:19167457 NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687 		JBrowse link
G Frmd4b FERM domain containing 4B decreases expression EXP fullerene C60 results in decreased expression of FRMD4B mRNA CTD PMID:19167457 NCBI chr 4:131,452,361...131,778,734
Ensembl chr 4:129,895,708...130,084,197 		JBrowse link
G Fstl3 follistatin like 3 increases expression EXP fullerene C60 results in increased expression of FSTL3 mRNA CTD PMID:19167457 NCBI chr 7:10,574,195...10,579,844
Ensembl chr 7:9,923,576...9,939,639 		JBrowse link
G Fxr2 FMR1 autosomal homolog 2 increases expression EXP fullerene C60 results in increased expression of FXR2 mRNA CTD PMID:19167457 NCBI chr10:54,350,577...54,370,964
Ensembl chr10:54,350,131...54,370,964 		JBrowse link
G Fzd2 frizzled class receptor 2 increases expression EXP fullerene C60 results in increased expression of FZD2 mRNA CTD PMID:19167457 NCBI chr10:88,061,988...88,063,898
Ensembl chr10:87,561,326...87,565,334 		JBrowse link
G Gab2 GRB2-associated binding protein 2 decreases expression EXP fullerene C60 results in decreased expression of GAB2 mRNA CTD PMID:19167457 NCBI chr 1:160,841,066...161,036,940
Ensembl chr 1:151,429,695...151,625,031 		JBrowse link
G Gabrq gamma-aminobutyric acid type A receptor subunit theta decreases expression EXP fullerene C60 results in decreased expression of GABRQ mRNA CTD PMID:19167457 NCBI chr  X:155,737,838...155,755,225
Ensembl chr  X:150,696,427...150,709,919 		JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 decreases expression EXP fullerene C60 results in decreased expression of GALNT16 mRNA CTD PMID:19167457 NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:100,170,306...100,250,705 		JBrowse link
G Gapdhs glyceraldehyde-3-phosphate dehydrogenase, spermatogenic decreases expression EXP fullerene C60 results in decreased expression of GAPDHS mRNA CTD PMID:19167457 NCBI chr 1:95,106,516...95,125,918
Ensembl chr 1:85,979,098...85,993,640 		JBrowse link
G Garin1b golgi associated RAB2 interactor 1B decreases expression EXP fullerene C60 results in decreased expression of GARIN1B mRNA CTD PMID:19167457 NCBI chr 4:57,915,184...57,938,593
Ensembl chr 4:57,920,790...57,938,591 		JBrowse link
G Gas2 growth arrest-specific 2 decreases expression EXP fullerene C60 results in decreased expression of GAS2 mRNA CTD PMID:19167457 NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619 		JBrowse link
G Gas7 growth arrest specific 7 increases expression EXP fullerene C60 results in increased expression of GAS7 mRNA CTD PMID:19167457 NCBI chr10:52,152,718...52,383,283
Ensembl chr10:52,152,493...52,383,276 		JBrowse link
G Gast gastrin decreases expression EXP fullerene C60 results in decreased expression of GAST mRNA CTD PMID:19167457 NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,264,832...85,267,496 		JBrowse link
G Gatad2a GATA zinc finger domain containing 2A increases expression EXP fullerene C60 results in increased expression of GATAD2A mRNA CTD PMID:19167457 NCBI chr16:19,429,578...19,520,320
Ensembl chr16:19,429,578...19,519,587 		JBrowse link
G Gbx2 gastrulation brain homeobox 2 decreases expression EXP fullerene C60 results in decreased expression of GBX2 mRNA CTD PMID:19167457 NCBI chr 9:97,957,304...97,959,883
Ensembl chr 9:90,509,633...90,512,212 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit decreases expression EXP fullerene C60 results in decreased expression of GCLM mRNA CTD PMID:19167457 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535 		JBrowse link
G Gda guanine deaminase increases expression EXP fullerene C60 results in increased expression of GDA mRNA CTD PMID:19167457 NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:218,906,815...218,982,416 		JBrowse link
G Gdap1 ganglioside-induced differentiation-associated-protein 1 decreases expression EXP fullerene C60 results in decreased expression of GDAP1 mRNA CTD PMID:19167457 NCBI chr 5:6,715,935...6,735,013
Ensembl chr 5:1,932,613...2,030,061 		JBrowse link
G Gdf15 growth differentiation factor 15 decreases expression EXP fullerene C60 results in decreased expression of GDF15 mRNA CTD PMID:19167457 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055 		JBrowse link
G Gdf5 growth differentiation factor 5 decreases expression EXP fullerene C60 results in decreased expression of GDF5 mRNA CTD PMID:19167457 NCBI chr 3:164,914,401...164,918,593
Ensembl chr 3:144,454,338...144,458,612 		JBrowse link
G Gdf7 growth differentiation factor 7 decreases expression EXP fullerene C60 results in decreased expression of GDF7 mRNA CTD PMID:19167457 NCBI chr 6:36,890,799...36,901,783
Ensembl chr 6:31,178,119...31,182,447 		JBrowse link
G Ghdc GH3 domain containing decreases expression EXP fullerene C60 results in decreased expression of GHDC mRNA CTD PMID:19167457 NCBI chr10:85,693,612...85,697,833
Ensembl chr10:85,693,616...85,697,865 		JBrowse link
G Ghrh growth hormone releasing hormone decreases expression EXP fullerene C60 results in decreased expression of GHRH mRNA CTD PMID:19167457 NCBI chr 3:166,412,763...166,432,519
Ensembl chr 3:145,992,763...146,011,889 		JBrowse link
G Giot1 gonadotropin inducible ovarian transcription factor 1 increases expression EXP fullerene C60 results in increased expression of GIOT1 mRNA CTD PMID:19167457 NCBI chr 7:10,215,602...10,236,423
Ensembl chr 7:10,202,982...10,237,099 		JBrowse link
G Gipc1 GIPC PDZ domain containing family, member 1 increases expression EXP fullerene C60 results in increased expression of GIPC1 mRNA CTD PMID:19167457 NCBI chr19:41,380,125...41,392,078
Ensembl chr19:24,453,123...24,486,997 		JBrowse link
G Gipc2 GIPC PDZ domain containing family, member 2 increases expression EXP fullerene C60 results in increased expression of GIPC2 mRNA CTD PMID:19167457 NCBI chr 2:243,690,742...243,770,199
Ensembl chr 2:241,030,770...241,110,236 		JBrowse link
G Gja4 gap junction protein, alpha 4 decreases expression EXP fullerene C60 results in decreased expression of GJA4 mRNA CTD PMID:19167457 NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:139,633,287...139,635,925 		JBrowse link
G Gjb1 gap junction protein, beta 1 decreases expression EXP fullerene C60 results in decreased expression of GJB1 mRNA CTD PMID:19167457 NCBI chr  X:70,541,845...70,549,776
Ensembl chr  X:66,501,820...66,509,925 		JBrowse link
G Gjb4 gap junction protein, beta 4 decreases expression EXP fullerene C60 results in decreased expression of GJB4 mRNA CTD PMID:19167457 NCBI chr 5:144,948,231...144,964,014
Ensembl chr 5:139,675,780...139,679,667 		JBrowse link
G Gjb5 gap junction protein, beta 5 decreases expression EXP fullerene C60 results in decreased expression of GJB5 mRNA CTD PMID:19167457 NCBI chr 5:144,965,133...144,968,051
Ensembl chr 5:139,680,671...139,683,583 		JBrowse link
G Gjd4 gap junction protein, delta 4 decreases expression EXP fullerene C60 results in decreased expression of GJD4 mRNA CTD PMID:19167457 NCBI chr17:62,043,770...62,047,527
Ensembl chr17:57,349,877...57,352,446 		JBrowse link
G Glis2 GLIS family zinc finger 2 increases expression EXP fullerene C60 results in increased expression of GLIS2 mRNA CTD PMID:19167457 NCBI chr10:10,951,157...10,978,524
Ensembl chr10:10,951,371...10,971,578 		JBrowse link
G Glmn glomulin, FKBP associated protein increases expression EXP fullerene C60 results in increased expression of GLMN mRNA CTD PMID:19167457 NCBI chr14:2,332,052...2,375,366
Ensembl chr14:2,187,642...2,230,420 		JBrowse link
G Glp1r glucagon-like peptide 1 receptor increases expression EXP fullerene C60 results in increased expression of GLP1R mRNA CTD PMID:19167457 NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,972,004...9,010,241 		JBrowse link
G Gmnn geminin, DNA replication inhibitor increases expression EXP fullerene C60 results in increased expression of GMNN mRNA CTD PMID:19167457 NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,301,808...40,310,054 		JBrowse link
G Gna12 G protein subunit alpha 12 increases expression EXP fullerene C60 results in increased expression of GNA12 mRNA CTD PMID:19167457 NCBI chr12:18,919,629...19,000,185
Ensembl chr12:13,805,698...13,886,255 		JBrowse link
G Gna15 G protein subunit alpha 15 increases expression EXP fullerene C60 results in increased expression of GNA15 mRNA CTD PMID:19167457 NCBI chr 7:8,835,396...8,856,269
Ensembl chr 7:8,184,861...8,205,508 		JBrowse link
G Gnal G protein subunit alpha L decreases expression EXP fullerene C60 results in decreased expression of GNAL mRNA CTD PMID:19167457 NCBI chr18:62,892,257...63,032,510
Ensembl chr18:60,622,311...60,762,599 		JBrowse link
G Gnb2 G protein subunit beta 2 increases expression EXP fullerene C60 results in increased expression of GNB2 mRNA CTD PMID:19167457 NCBI chr12:24,795,505...24,800,796
Ensembl chr12:19,158,973...19,164,019 		JBrowse link
G Gng2 G protein subunit gamma 2 decreases expression EXP fullerene C60 results in decreased expression of GNG2 mRNA CTD PMID:19167457 NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,316,059...4,417,183 		JBrowse link
G Golga3 golgin A3 increases expression EXP fullerene C60 results in increased expression of GOLGA3 mRNA CTD PMID:19167457 NCBI chr12:52,112,129...52,160,311
Ensembl chr12:46,454,870...46,500,509
Ensembl chr 4:46,454,870...46,500,509 		JBrowse link
G Gosr1 golgi SNAP receptor complex member 1 decreases expression EXP fullerene C60 results in decreased expression of GOSR1 mRNA CTD PMID:19167457 NCBI chr10:62,068,662...62,105,442
Ensembl chr10:61,450,494...61,607,177
Ensembl chr10:61,450,494...61,607,177 		JBrowse link
G Gosr2 golgi SNAP receptor complex member 2 decreases expression EXP fullerene C60 results in decreased expression of GOSR2 mRNA CTD PMID:19167457 NCBI chr10:89,085,323...89,105,665
Ensembl chr10:88,586,299...88,605,625 		JBrowse link
G Got2 glutamic-oxaloacetic transaminase 2 increases expression EXP fullerene C60 results in increased expression of GOT2 mRNA CTD PMID:19167457 NCBI chr19:9,180,428...9,206,113
Ensembl chr19:9,174,311...9,199,994 		JBrowse link
G Gp1bb glycoprotein Ib platelet subunit beta decreases expression EXP fullerene C60 results in decreased expression of GP1BB mRNA CTD PMID:19167457 NCBI chr11:95,882,561...95,883,738
Ensembl chr11:82,378,199...82,379,392 		JBrowse link
G Gpatch2 G patch domain containing 2 decreases expression EXP fullerene C60 results in decreased expression of GPATCH2 mRNA CTD PMID:19167457 NCBI chr13:98,784,993...98,925,696
Ensembl chr13:98,784,969...98,925,661 		JBrowse link
G Gpbp1 GC-rich promoter binding protein 1 increases expression EXP fullerene C60 results in increased expression of GPBP1 mRNA CTD PMID:19167457 NCBI chr 2:44,756,861...44,824,281
Ensembl chr 2:43,023,504...43,090,907 		JBrowse link
G Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 affects expression EXP fullerene C60 affects the expression of GPIHBP1 mRNA CTD PMID:19167457 NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:107,285,654...107,288,702 		JBrowse link
G Gpr146 G protein-coupled receptor 146 increases expression EXP fullerene C60 results in increased expression of GPR146 mRNA CTD PMID:19167457 NCBI chr12:20,365,790...20,381,122
Ensembl chr12:15,251,813...15,267,206 		JBrowse link
G Gpr15 G protein-coupled receptor 15 decreases expression EXP fullerene C60 results in decreased expression of GPR15 mRNA CTD PMID:19167457 NCBI chr11:55,367,496...55,368,842
Ensembl chr11:41,898,356...41,900,441 		JBrowse link
G Gpr153 G protein-coupled receptor 153 decreases expression EXP fullerene C60 results in decreased expression of GPR153 mRNA CTD PMID:19167457 NCBI chr 5:168,064,134...168,075,697
Ensembl chr 5:162,781,587...162,792,971 		JBrowse link
G Gpr156 G protein-coupled receptor 156 decreases expression EXP fullerene C60 results in decreased expression of GPR156 mRNA CTD PMID:19167457 NCBI chr11:76,228,104...76,320,890
Ensembl chr11:62,723,872...62,815,435 		JBrowse link
G Gpr157 G protein-coupled receptor 157 increases expression EXP fullerene C60 results in increased expression of GPR157 mRNA CTD PMID:19167457 NCBI chr 5:165,833,651...165,849,376
Ensembl chr 5:160,550,713...160,566,432 		JBrowse link
G Gpr162 G protein-coupled receptor 162 decreases expression EXP fullerene C60 results in decreased expression of GPR162 mRNA CTD PMID:19167457 NCBI chr 4:159,348,465...159,354,577
Ensembl chr 4:157,662,200...157,668,121 		JBrowse link
G Gpr22 G protein-coupled receptor 22 decreases expression EXP fullerene C60 results in decreased expression of GPR22 mRNA CTD PMID:19167457 NCBI chr 6:54,037,998...54,044,994
Ensembl chr 6:48,310,505...48,317,486 		JBrowse link
G Gpr3 G protein-coupled receptor 3 decreases expression EXP fullerene C60 results in decreased expression of GPR3 mRNA CTD PMID:19167457 NCBI chr 5:150,695,406...150,698,526
Ensembl chr 5:145,411,510...145,414,590 		JBrowse link
G Gprasp3 G protein-coupled receptor associated sorting protein family member 3 decreases expression EXP fullerene C60 results in decreased expression of GPRASP3 mRNA CTD PMID:19167457 NCBI chr  X:98,847,591...98,854,949
Ensembl chr  X:98,817,593...98,854,545 		JBrowse link
G Gprin1 G protein-regulated inducer of neurite outgrowth 1 decreases expression EXP fullerene C60 results in decreased expression of GPRIN1 mRNA CTD PMID:19167457 NCBI chr17:9,863,881...9,876,832
Ensembl chr17:9,863,571...9,876,915 		JBrowse link
G Gpsm1 G-protein signaling modulator 1 decreases expression EXP fullerene C60 results in decreased expression of GPSM1 mRNA CTD PMID:19167457 NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:9,128,636...9,167,827 		JBrowse link
G Gpsm3 G-protein signaling modulator 3 decreases expression EXP fullerene C60 results in decreased expression of GPSM3 mRNA CTD PMID:19167457 NCBI chr20:4,161,730...4,163,591
Ensembl chr20:4,157,123...4,159,035 		JBrowse link
G Gpx3 glutathione peroxidase 3 increases expression EXP fullerene C60 results in increased expression of GPX3 mRNA CTD PMID:19167457 NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035 		JBrowse link
G Gpx6 glutathione peroxidase 6 decreases expression EXP fullerene C60 results in decreased expression of GPX6 mRNA CTD PMID:19167457 NCBI chr17:48,104,197...48,111,816
Ensembl chr17:43,408,472...43,416,091 		JBrowse link
G Grb10 growth factor receptor bound protein 10 decreases expression EXP fullerene C60 results in decreased expression of GRB10 mRNA CTD PMID:19167457 NCBI chr14:90,708,653...90,816,399
Ensembl chr14:86,495,054...86,602,806 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist decreases expression EXP fullerene C60 results in decreased expression of GREM1 mRNA CTD PMID:19167457 NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:100,512,313...100,524,082 		JBrowse link
G Grem2 gremlin 2, DAN family BMP antagonist decreases expression EXP fullerene C60 results in decreased expression of GREM2 mRNA CTD PMID:19167457 NCBI chr13:89,310,897...89,403,856
Ensembl chr13:86,778,500...86,871,615 		JBrowse link
G Grik1 glutamate ionotropic receptor kainate type subunit 1 decreases expression EXP fullerene C60 results in decreased expression of GRIK1 mRNA CTD PMID:19167457 NCBI chr11:40,655,974...41,056,966
Ensembl chr11:27,169,740...27,570,645 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 decreases expression EXP fullerene C60 results in decreased expression of GRIN1 mRNA CTD PMID:19167457 NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603 		JBrowse link
G Grin2d glutamate ionotropic receptor NMDA type subunit 2D decreases expression EXP fullerene C60 results in decreased expression of GRIN2D mRNA CTD PMID:19167457 NCBI chr 1:105,443,317...105,483,400
Ensembl chr 1:96,308,365...96,344,793 		JBrowse link
G Grina glutamate ionotropic receptor NMDA type subunit associated protein 1 increases expression EXP fullerene C60 results in increased expression of GRINA mRNA CTD PMID:19167457 NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:107,962,207...107,965,366 		JBrowse link
G Grk1 G protein-coupled receptor kinase 1 decreases expression EXP fullerene C60 results in decreased expression of GRK1 mRNA CTD PMID:19167457 NCBI chr16:82,821,184...82,837,971
Ensembl chr16:76,123,842...76,135,792 		JBrowse link
G Grk6 G protein-coupled receptor kinase 6 decreases expression EXP fullerene C60 results in decreased expression of GRK6 mRNA CTD PMID:19167457 NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,177,019...9,192,644 		JBrowse link
G Gstm4 glutathione S-transferase mu 4 increases expression EXP fullerene C60 results in increased expression of GSTM4 mRNA CTD PMID:19167457 NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:195,680,004...195,685,323 		JBrowse link
G Gstm5l glutathione S-transferase, mu 5-like decreases expression EXP fullerene C60 results in decreased expression of GSTM5 mRNA CTD PMID:19167457 NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961 		JBrowse link
G Gsx1 GS homeobox 1 decreases expression EXP fullerene C60 results in decreased expression of GSX1 mRNA CTD PMID:19167457 NCBI chr12:7,880,663...7,882,947
Ensembl chr12:7,881,460...7,882,753 		JBrowse link
G Gtf2ird1 GTF2I repeat domain containing 1 increases expression EXP fullerene C60 results in increased expression of GTF2IRD1 mRNA CTD PMID:19167457 NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040 		JBrowse link
G Gtf3c1 general transcription factor IIIC subunit 1 increases expression EXP fullerene C60 results in increased expression of GTF3C1 mRNA CTD PMID:19167457 NCBI chr 1:180,203,995...180,270,201
Ensembl chr 1:180,203,995...180,270,201 		JBrowse link
G Gtpbp2 GTP binding protein 2 increases expression EXP fullerene C60 results in increased expression of GTPBP2 mRNA CTD PMID:19167457 NCBI chr 9:22,311,532...22,321,405
Ensembl chr 9:14,813,964...14,823,241 		JBrowse link
G Gtse1 G-2 and S-phase expressed 1 increases expression EXP fullerene C60 results in increased expression of GTSE1 mRNA CTD PMID:19167457 NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:116,950,053...116,966,806 		JBrowse link
G Gys1 glycogen synthase 1 decreases expression EXP fullerene C60 results in decreased expression of GYS1 mRNA CTD PMID:19167457 NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:95,915,443...95,935,292 		JBrowse link
G Gys2 glycogen synthase 2 decreases expression EXP fullerene C60 results in decreased expression of GYS2 mRNA CTD PMID:19167457 NCBI chr 4:177,096,063...177,137,236
Ensembl chr 4:175,365,054...175,406,228 		JBrowse link
G Gzmb granzyme B decreases expression EXP fullerene C60 results in decreased expression of GZMB mRNA CTD PMID:19167457 NCBI chr15:34,459,007...34,462,469
Ensembl chr15:30,173,603...30,346,814 		JBrowse link
G Hacl1 2-hydroxyacyl-CoA lyase 1 increases expression EXP fullerene C60 results in increased expression of HACL1 mRNA CTD PMID:19167457 NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,824,906...6,863,027 		JBrowse link
G Hamp hepcidin antimicrobial peptide increases expression EXP fullerene C60 results in increased expression of HAMP mRNA CTD PMID:19167457 NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891 		JBrowse link
G Hand1 heart and neural crest derivatives expressed 1 decreases expression EXP fullerene C60 results in decreased expression of HAND1 mRNA CTD PMID:19167457 NCBI chr10:42,507,117...42,509,684
Ensembl chr10:42,006,651...42,009,213 		JBrowse link
G Hapln4 hyaluronan and proteoglycan link protein 4 decreases expression EXP fullerene C60 results in decreased expression of HAPLN4 mRNA CTD PMID:19167457 NCBI chr16:19,333,106...19,341,243
Ensembl chr16:19,333,106...19,341,243 		JBrowse link
G Haus7 HAUS augmin-like complex, subunit 7 increases expression EXP fullerene C60 results in increased expression of HAUS7 mRNA CTD PMID:19167457 NCBI chr  X:151,154,979...151,174,441
Ensembl chr  X:151,154,979...151,180,577 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 decreases expression EXP fullerene C60 results in decreased expression of HAVCR1 mRNA CTD PMID:19167457 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698 		JBrowse link
G Havcr2 hepatitis A virus cellular receptor 2 decreases expression EXP fullerene C60 results in decreased expression of HAVCR2 mRNA CTD PMID:19167457 NCBI chr10:31,383,801...31,415,334
Ensembl chr10:30,882,606...30,909,137 		JBrowse link
G Hbe1 hemoglobin subunit epsilon 1 decreases expression EXP fullerene C60 results in decreased expression of HBE1 mRNA CTD PMID:19167457 NCBI chr 1:158,282,931...158,458,855
Ensembl chr 1:158,282,936...158,284,391 		JBrowse link
G Hcrt hypocretin neuropeptide precursor increases expression EXP fullerene C60 results in increased expression of HCRT mRNA CTD PMID:19167457 NCBI chr10:86,190,289...86,191,524
Ensembl chr10:85,689,465...85,691,210 		JBrowse link
G Hdac1 histone deacetylase 1 decreases expression EXP fullerene C60 results in decreased expression of HDAC1 mRNA CTD PMID:19167457 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111 		JBrowse link
G Hdac2 histone deacetylase 2 decreases expression EXP fullerene C60 results in decreased expression of HDAC2 mRNA CTD PMID:19167457 NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609 		JBrowse link
G Hdac5 histone deacetylase 5 decreases expression EXP fullerene C60 results in decreased expression of HDAC5 mRNA CTD PMID:19167457 NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,152,978...87,188,235 		JBrowse link
G Hdac7 histone deacetylase 7 increases expression EXP fullerene C60 results in increased expression of HDAC7 mRNA CTD PMID:19167457 NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:128,923,920...128,962,072 		JBrowse link
G Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 decreases expression EXP fullerene C60 results in decreased expression of HECW2 mRNA CTD PMID:19167457 NCBI chr 9:55,359,462...55,753,106
Ensembl chr 9:55,365,203...55,580,327 		JBrowse link
G Helz2 helicase with zinc finger 2 increases expression EXP fullerene C60 results in increased expression of HELZ2 mRNA CTD PMID:19167457 NCBI chr 3:188,716,370...188,730,776
Ensembl chr 3:168,338,813...168,353,159 		JBrowse link
G Hes3 hes family bHLH transcription factor 3 decreases expression EXP fullerene C60 results in decreased expression of HES3 mRNA CTD PMID:19167457 NCBI chr 5:168,076,337...168,082,270
Ensembl chr 5:162,794,367...162,796,261 		JBrowse link
G Hes5 hes family bHLH transcription factor 5 affects expression EXP fullerene C60 affects the expression of HES5 mRNA CTD PMID:19167457 NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:165,522,234...165,523,001 		JBrowse link
G Hif3a hypoxia inducible factor 3 subunit alpha decreases expression EXP fullerene C60 results in decreased expression of HIF3A mRNA CTD PMID:19167457 NCBI chr 1:86,846,196...86,878,527
Ensembl chr 1:77,722,471...77,749,758 		JBrowse link
G Hint3 histidine triad nucleotide binding protein 3 increases expression EXP fullerene C60 results in increased expression of HINT3 mRNA CTD PMID:19167457 NCBI chr 1:27,035,936...27,045,799
Ensembl chr 1:27,035,905...27,047,721 		JBrowse link
G Hip1r huntingtin interacting protein 1 related increases expression EXP fullerene C60 results in increased expression of HIP1R mRNA CTD PMID:19167457 NCBI chr12:38,251,085...38,279,756
Ensembl chr12:32,590,165...32,618,734 		JBrowse link
G Hist1h2bo histone cluster 1 H2B family member O increases expression EXP fullerene C60 results in increased expression of H2BC15 mRNA CTD PMID:19167457 NCBI chr17:42,716,433...42,718,046
Ensembl chr17:42,673,067...42,718,095
Ensembl chr17:42,673,067...42,718,095 		JBrowse link
G Hist2h2be histone cluster 2 H2B family member E increases expression EXP fullerene C60 results in increased expression of HIST2H2BE mRNA CTD PMID:19167457 NCBI chr 2:186,469,452...186,471,899 JBrowse link
G Hivep1 HIVEP zinc finger 1 increases expression EXP fullerene C60 results in increased expression of HIVEP1 mRNA CTD PMID:19167457 NCBI chr17:22,585,016...22,714,517
Ensembl chr17:22,585,016...22,711,956 		JBrowse link
G Hjurp Holliday junction recognition protein decreases expression EXP fullerene C60 results in decreased expression of HJURP mRNA CTD PMID:19167457 NCBI chr 9:88,853,379...88,867,730
Ensembl chr 9:88,853,386...88,867,728 		JBrowse link
G Hjv hemojuvelin BMP co-receptor increases expression EXP fullerene C60 results in increased expression of HJV mRNA CTD PMID:19167457 NCBI chr 2:186,754,801...186,758,708
Ensembl chr 2:184,065,970...184,069,850 		JBrowse link
G Hk1 hexokinase 1 increases expression EXP fullerene C60 results in increased expression of HK1 mRNA CTD PMID:19167457 NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,230,486...30,332,131 		JBrowse link
G Hlcs holocarboxylase synthetase decreases expression EXP fullerene C60 results in decreased expression of HLCS mRNA CTD PMID:19167457 NCBI chr11:46,925,491...47,123,111
Ensembl chr11:33,455,809...33,624,222 		JBrowse link
G Hmgb1 high mobility group box 1 increases secretion
multiple interactions		 ISO fullerene C60 results in increased secretion of HMGB1 protein
2',3'-dialdehyde ATP inhibits the reaction [fullerene C60 results in increased secretion of HMGB1 protein]; [[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein] which results in increased expression of RAC1 protein; [fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein; Adenosine Triphosphate promotes the reaction [fullerene C60 results in increased secretion of HMGB1 protein]; fullerene C60 results in increased localization of and results in increased secretion of HMGB1 protein; P2RX7 protein affects the reaction [fullerene C60 results in increased secretion of HMGB1 protein]		 CTD PMID:31504961 NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565
Ensembl chr16:5,901,586...5,978,565 		JBrowse link
G Hmgcl 3-hydroxy-3-methylglutaryl-CoA lyase decreases expression EXP fullerene C60 results in decreased expression of HMGCL mRNA CTD PMID:19167457 NCBI chr 5:153,461,738...153,475,552
Ensembl chr 5:148,178,252...148,192,068 		JBrowse link
G Hmgn1 high mobility group nucleosome binding domain 1 decreases expression EXP fullerene C60 results in decreased expression of HMGN1 mRNA CTD PMID:19167457 NCBI chr11:48,891,813...48,897,732
Ensembl chr11:35,422,328...35,428,254 		JBrowse link
G Hmx2 H6 family homeobox 2 decreases expression EXP fullerene C60 results in decreased expression of HMX2 mRNA CTD PMID:19167457 NCBI chr 1:195,749,284...195,758,347
Ensembl chr 1:186,319,110...186,326,771 		JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha decreases expression EXP fullerene C60 results in decreased expression of HNF4A mRNA CTD PMID:19167457 NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:152,186,787...152,248,320 		JBrowse link
G Hnrnpll heterogeneous nuclear ribonucleoprotein L-like increases expression EXP fullerene C60 results in increased expression of HNRNPLL mRNA CTD PMID:19167457 NCBI chr 6:20,720,013...20,752,803
Ensembl chr 6:14,970,057...14,999,745 		JBrowse link
G Hoga1 4-hydroxy-2-oxoglutarate aldolase 1 decreases expression EXP fullerene C60 results in decreased expression of HOGA1 mRNA CTD PMID:19167457 NCBI chr 1:250,806,430...250,833,544
Ensembl chr 1:240,857,126...240,884,568 		JBrowse link
G Hopx HOP homeobox decreases expression EXP fullerene C60 results in decreased expression of HOPX mRNA CTD PMID:19167457 NCBI chr14:31,410,235...31,437,189
Ensembl chr14:31,075,148...31,082,909 		JBrowse link
G Hoxc5 homeo box C5 decreases expression EXP fullerene C60 results in decreased expression of HOXC5 mRNA CTD PMID:19167457 NCBI chr 7:134,150,988...134,154,410
Ensembl chr 7:134,150,988...134,154,410 		JBrowse link
G Hpcal1 hippocalcin-like 1 increases expression EXP fullerene C60 results in increased expression of HPCAL1 mRNA CTD PMID:19167457 NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687 		JBrowse link
G Hpn hepsin increases expression EXP fullerene C60 results in increased expression of HPN mRNA CTD PMID:19167457 NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:86,337,087...86,352,811 		JBrowse link
G Hps1 HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 increases expression EXP fullerene C60 results in increased expression of HPS1 mRNA CTD PMID:19167457 NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268 		JBrowse link
G Hrh4 histamine receptor H4 decreases expression EXP fullerene C60 results in decreased expression of HRH4 mRNA CTD PMID:19167457 NCBI chr18:4,440,977...4,457,132
Ensembl chr18:4,166,270...4,246,345 		JBrowse link
G Hs6st1 heparan sulfate 6-O-sulfotransferase 1 increases expression EXP fullerene C60 results in increased expression of HS6ST1 mRNA CTD PMID:19167457 NCBI chr 9:38,283,502...38,322,684
Ensembl chr 9:38,282,395...38,322,683 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 decreases expression EXP fullerene C60 results in decreased expression of HSD11B2 mRNA CTD PMID:19167457 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:33,397,656...33,402,899 		JBrowse link
G Hspa12b heat shock protein family A (Hsp70) member 12B increases expression EXP fullerene C60 results in increased expression of HSPA12B mRNA CTD PMID:19167457 NCBI chr 3:138,799,396...138,817,396
Ensembl chr 3:118,346,354...118,364,737 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A affects expression EXP fullerene C60 affects the expression of HSPA1A mRNA CTD PMID:19167457 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227 		JBrowse link
G Hspa1l heat shock protein family A (Hsp70) member 1 like decreases expression EXP fullerene C60 results in decreased expression of HSPA1L mRNA CTD PMID:19167457 NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,848,843...3,855,571 		JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 increases expression EXP fullerene C60 results in increased expression of HSPA8 mRNA CTD PMID:19167457 NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259 		JBrowse link
G Hspb3 heat shock protein family B (small) member 3 decreases expression EXP fullerene C60 results in decreased expression of HSPB3 mRNA CTD PMID:19167457 NCBI chr 2:45,295,285...45,295,999
Ensembl chr 2:45,295,053...45,296,145 		JBrowse link
G Hspb7 heat shock protein family B (small) member 7 decreases expression EXP fullerene C60 results in decreased expression of HSPB7 mRNA CTD PMID:19167457 NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266 		JBrowse link
G Hspd1l2 heat shock protein family D (Hsp60) member 1 like 2 increases expression EXP fullerene C60 results in increased expression of HSPD1L2 mRNA CTD PMID:19167457 NCBI chr 5:107,131,587...107,131,895
Ensembl chr 5:107,131,587...107,131,895 		JBrowse link
G Htr5b 5-hydroxytryptamine (serotonin) receptor 5B decreases expression EXP fullerene C60 results in decreased expression of HTR5B mRNA CTD PMID:19167457 NCBI chr13:35,239,662...35,252,586
Ensembl chr13:32,687,042...32,699,835 		JBrowse link
G Htra3 HtrA serine peptidase 3 increases expression EXP fullerene C60 results in increased expression of HTRA3 mRNA CTD PMID:19167457 NCBI chr14:75,068,917...75,097,315
Ensembl chr14:75,068,917...75,097,315 		JBrowse link
G Hyal2 hyaluronidase 2 decreases expression EXP fullerene C60 results in decreased expression of HYAL2 mRNA CTD PMID:19167457 NCBI chr 8:117,121,802...117,125,494
Ensembl chr 8:108,243,133...108,246,850 		JBrowse link
G Hykk hydroxylysine kinase decreases expression EXP fullerene C60 results in decreased expression of HYKK mRNA CTD PMID:19167457 NCBI chr 8:64,212,043...64,235,809
Ensembl chr 8:55,315,969...55,337,339 		JBrowse link
G Idh3b isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta decreases expression EXP fullerene C60 results in decreased expression of IDH3B mRNA CTD PMID:19167457 NCBI chr 3:137,934,971...137,940,275
Ensembl chr 3:117,481,845...117,486,982 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 increases expression EXP fullerene C60 results in increased expression of IDI1 mRNA CTD PMID:19167457 NCBI chr17:66,539,761...66,547,524
Ensembl chr17:61,629,594...61,637,357 		JBrowse link
G Ier5l immediate early response 5-like increases expression EXP fullerene C60 results in increased expression of IER5L mRNA CTD PMID:19167457 NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647 		JBrowse link
G Iffo1 intermediate filament family orphan 1 increases expression EXP fullerene C60 results in increased expression of IFFO1 mRNA CTD PMID:19167457 NCBI chr 4:159,631,309...159,648,531
Ensembl chr 4:157,945,107...157,962,302 		JBrowse link
G Ifi30 IFI30, lysosomal thiol reductase decreases expression EXP fullerene C60 results in decreased expression of IFI30 mRNA CTD PMID:19167457 NCBI chr16:18,709,570...18,713,635
Ensembl chr16:18,675,613...18,681,175 		JBrowse link
G Ifng interferon gamma increases secretion ISO fullerene C60 results in increased secretion of IFNG protein CTD PMID:20064541 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Ift27 intraflagellar transport 27 decreases expression EXP fullerene C60 results in decreased expression of IFT27 mRNA CTD PMID:19167457 NCBI chr 7:111,619,145...111,635,129
Ensembl chr 7:109,738,622...109,754,416 		JBrowse link
G Ift43 intraflagellar transport 43 decreases expression EXP fullerene C60 results in decreased expression of IFT43 mRNA CTD PMID:19167457 NCBI chr 6:105,729,734...105,806,257
Ensembl chr 6:105,729,792...105,806,257 		JBrowse link
G Iftap intraflagellar transport associated protein decreases expression EXP fullerene C60 results in decreased expression of IFTAP mRNA CTD PMID:19167457 NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression EXP fullerene C60 results in decreased expression of IGF1 mRNA CTD PMID:19167457 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 decreases expression EXP fullerene C60 results in decreased expression of IGFBP1 mRNA CTD PMID:19167457 NCBI chr14:86,261,277...86,266,344
Ensembl chr14:82,047,415...82,052,482 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 decreases expression EXP fullerene C60 results in decreased expression of IGFBP3 mRNA CTD PMID:19167457 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression EXP fullerene C60 results in decreased expression of IGFBP5 mRNA CTD PMID:19167457 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:74,448,382...74,465,156 		JBrowse link
G Ighmbp2 immunoglobulin mu DNA binding protein 2 increases expression EXP fullerene C60 results in increased expression of IGHMBP2 mRNA CTD PMID:19167457 NCBI chr 1:209,935,922...209,958,570
Ensembl chr 1:200,506,338...200,529,514 		JBrowse link
G Igsf3 immunoglobulin superfamily, member 3 decreases expression EXP fullerene C60 results in decreased expression of IGSF3 mRNA CTD PMID:19167457 NCBI chr 2:191,499,972...191,588,249
Ensembl chr 2:188,811,380...188,899,645 		JBrowse link
G Il10 interleukin 10 increases secretion ISO fullerene C60 results in increased secretion of IL10 protein CTD PMID:20064541 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il17ra interleukin 17 receptor A increases expression EXP fullerene C60 results in increased expression of IL17RA mRNA CTD PMID:19167457 NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:153,667,534...153,690,174 		JBrowse link
G Il1b interleukin 1 beta decreases expression EXP fullerene C60 results in decreased expression of IL1B mRNA CTD PMID:19167457 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il2 interleukin 2 increases secretion ISO fullerene C60 results in increased secretion of IL2 protein CTD PMID:20064541 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566 		JBrowse link
G Il21r interleukin 21 receptor increases expression EXP fullerene C60 results in increased expression of IL21R mRNA CTD PMID:19167457 NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522 		JBrowse link
G Il22ra1 interleukin 22 receptor subunit alpha 1 decreases expression EXP fullerene C60 results in decreased expression of IL22RA1 mRNA CTD PMID:19167457 NCBI chr 5:153,245,067...153,269,865
Ensembl chr 5:147,961,349...147,986,296 		JBrowse link
G Il2rg interleukin 2 receptor subunit gamma decreases expression EXP fullerene C60 results in decreased expression of IL2RG mRNA CTD PMID:19167457 NCBI chr  X:70,435,340...70,439,052
Ensembl chr  X:66,392,542...66,399,823 		JBrowse link
G Il33 interleukin 33 decreases expression EXP fullerene C60 results in decreased expression of IL33 mRNA CTD PMID:19167457 NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:227,721,435...227,736,373 		JBrowse link
G Il4r interleukin 4 receptor increases expression EXP fullerene C60 results in increased expression of IL4RA mRNA CTD PMID:19167457 NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases secretion		 ISO fullerene C60 inhibits the reaction [ALB protein modified form results in increased expression of IL6 protein]
fullerene C60 results in increased secretion of IL6 protein		 CTD PMID:19376187 PMID:20064541 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Ilvbl ilvB acetolactate synthase like decreases expression EXP fullerene C60 results in decreased expression of ILVBL mRNA CTD PMID:19167457 NCBI chr 7:11,039,870...11,049,924
Ensembl chr 7:11,039,871...11,049,924 		JBrowse link
G Impa2 inositol monophosphatase 2 decreases expression EXP fullerene C60 results in decreased expression of IMPA2 mRNA CTD PMID:19167457 NCBI chr18:63,104,113...63,135,232
Ensembl chr18:60,834,246...60,865,641 		JBrowse link
G Inhba inhibin subunit beta A decreases expression EXP fullerene C60 results in decreased expression of INHBA mRNA CTD PMID:19167457 NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982 		JBrowse link
G Inpp4b inositol polyphosphate-4-phosphatase type II B decreases expression EXP fullerene C60 results in decreased expression of INPP4B mRNA CTD PMID:19167457 NCBI chr19:42,824,710...43,575,039
Ensembl chr19:25,925,358...26,280,634 		JBrowse link
G Inppl1 inositol polyphosphate phosphatase-like 1 increases expression EXP fullerene C60 results in increased expression of INPPL1 mRNA CTD PMID:19167457 NCBI chr 1:165,595,047...165,609,503
Ensembl chr 1:156,183,059...156,197,500 		JBrowse link
G Ints7 integrator complex subunit 7 decreases expression EXP fullerene C60 results in decreased expression of INTS7 mRNA CTD PMID:19167457 NCBI chr13:105,686,208...105,739,609
Ensembl chr13:103,155,090...103,208,592 		JBrowse link
G Ipo5 importin 5 decreases expression EXP fullerene C60 results in decreased expression of IPO5 mRNA CTD PMID:19167457 NCBI chr15:104,397,626...104,447,985
Ensembl chr15:98,005,299...98,041,126 		JBrowse link
G Iqgap3 IQ motif containing GTPase activating protein 3 decreases expression EXP fullerene C60 results in decreased expression of IQGAP3 mRNA CTD PMID:19167457 NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:173,542,110...173,583,956 		JBrowse link
G Irak1bp1 interleukin-1 receptor-associated kinase 1 binding protein 1 decreases expression EXP fullerene C60 results in decreased expression of IRAK1BP1 mRNA CTD PMID:19167457 NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289 		JBrowse link
G Irf2bpl interferon regulatory factor 2 binding protein-like decreases expression EXP fullerene C60 results in decreased expression of IRF2BPL mRNA CTD PMID:19167457 NCBI chr 6:112,258,149...112,262,264
Ensembl chr 6:106,528,053...106,530,401 		JBrowse link
G Irf7 interferon regulatory factor 7 decreases expression EXP fullerene C60 results in decreased expression of IRF7 mRNA CTD PMID:19167457 NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832 		JBrowse link
G Irx1 iroquois homeobox 1 increases expression EXP fullerene C60 results in increased expression of IRX1 mRNA CTD PMID:19167457 NCBI chr 1:33,123,122...33,128,951
Ensembl chr 1:31,294,615...31,300,444 		JBrowse link
G Irx3 iroquois homeobox 3 increases expression EXP fullerene C60 results in increased expression of IRX3 mRNA CTD PMID:19167457 NCBI chr19:15,211,882...15,215,317
Ensembl chr19:15,211,878...15,215,317 		JBrowse link
G Isca1 iron-sulfur cluster assembly 1 decreases expression EXP fullerene C60 results in decreased expression of ISCA1 mRNA CTD PMID:19167457 NCBI chr17:4,910,816...4,923,478
Ensembl chr17:4,905,287...4,917,955 		JBrowse link
G Itga7 integrin subunit alpha 7 decreases expression EXP fullerene C60 results in decreased expression of ITGA7 mRNA CTD PMID:19167457 NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,359,940...1,388,450 		JBrowse link
G Itgam integrin subunit alpha M increases expression EXP fullerene C60 results in increased expression of ITGAM mRNA CTD PMID:19167457 NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Itgb1bp2 integrin subunit beta 1 binding protein 2 decreases expression EXP fullerene C60 results in decreased expression of ITGB1BP2 mRNA CTD PMID:19167457 NCBI chr  X:70,612,118...70,617,158
Ensembl chr  X:66,572,537...66,577,174 		JBrowse link
G Itgb3 integrin subunit beta 3 decreases expression EXP fullerene C60 results in decreased expression of ITGB3 mRNA CTD PMID:19167457 NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679 		JBrowse link
G Itpr3 inositol 1,4,5-trisphosphate receptor, type 3 increases expression EXP fullerene C60 results in increased expression of ITPR3 mRNA CTD PMID:19167457 NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,136,441...5,202,337 		JBrowse link
G Itsn1 intersectin 1 increases expression EXP fullerene C60 results in increased expression of ITSN1 mRNA CTD PMID:19167457 NCBI chr11:44,464,515...44,646,598
Ensembl chr11:30,978,590...31,160,645 		JBrowse link
G Ivd isovaleryl-CoA dehydrogenase increases expression EXP fullerene C60 results in increased expression of IVD mRNA CTD PMID:19167457 NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:105,851,683...105,872,575 		JBrowse link
G Jade2 jade family PHD finger 2 decreases expression EXP fullerene C60 results in decreased expression of JADE2 mRNA CTD PMID:19167457 NCBI chr10:36,576,187...36,625,129
Ensembl chr10:36,078,917...36,116,984 		JBrowse link
G Jag2 jagged canonical Notch ligand 2 increases expression EXP fullerene C60 results in increased expression of JAG2 mRNA CTD PMID:19167457 NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:131,983,056...132,005,818 		JBrowse link
G Jchain joining chain of multimeric IgA and IgM decreases expression EXP fullerene C60 results in decreased expression of JCHAIN mRNA CTD PMID:19167457 NCBI chr14:19,822,976...19,831,072
Ensembl chr14:19,538,952...19,546,298 		JBrowse link
G Jph1 junctophilin 1 decreases expression EXP fullerene C60 results in decreased expression of JPH1 mRNA CTD PMID:19167457 NCBI chr 5:6,813,553...6,920,488
Ensembl chr 5:2,030,281...2,125,284 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit increases expression EXP fullerene C60 results in increased expression of JUNB mRNA CTD PMID:19167457 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035 		JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit increases expression EXP fullerene C60 results in increased expression of JUND mRNA CTD PMID:19167457 NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799 		JBrowse link
G Jup junction plakoglobin increases expression EXP fullerene C60 results in increased expression of JUP mRNA CTD PMID:19167457 NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,300,440...85,327,057 		JBrowse link
G Kalrn kalirin, RhoGEF kinase decreases expression EXP fullerene C60 results in decreased expression of KALRN mRNA CTD PMID:19167457 NCBI chr11:79,703,345...80,309,210
Ensembl chr11:66,198,173...66,797,610 		JBrowse link
G Kansl3 KAT8 regulatory NSL complex subunit 3 increases expression EXP fullerene C60 results in increased expression of KANSL3 mRNA CTD PMID:19167457 NCBI chr 9:46,058,070...46,101,643
Ensembl chr 9:38,562,177...38,605,692 		JBrowse link
G Kat14 lysine acetyltransferase 14 decreases expression EXP fullerene C60 results in decreased expression of KAT14 mRNA CTD PMID:19167457 NCBI chr 3:131,736,430...131,781,732
Ensembl chr 3:131,736,549...131,781,706 		JBrowse link
G Kcng2 potassium voltage-gated channel modifier subfamily G member 2 decreases expression EXP fullerene C60 results in decreased expression of KCNG2 mRNA CTD PMID:19167457 NCBI chr18:76,017,225...76,085,377
Ensembl chr18:73,743,074...73,808,723 		JBrowse link
G Kcnn3 potassium calcium-activated channel subfamily N member 3 increases expression EXP fullerene C60 results in increased expression of KCNN3 mRNA CTD PMID:19167457 NCBI chr 2:177,227,276...177,378,849
Ensembl chr 2:174,936,629...175,081,145 		JBrowse link
G Kcnq1 potassium voltage-gated channel subfamily Q member 1 increases expression EXP fullerene C60 results in increased expression of KCNQ1 mRNA CTD PMID:19167457 NCBI chr 1:207,721,134...208,054,073
Ensembl chr 1:198,291,766...198,624,669 		JBrowse link
G Kctd13 potassium channel tetramerization domain containing 13 decreases expression EXP fullerene C60 results in decreased expression of KCTD13 mRNA CTD PMID:19167457 NCBI chr 1:190,965,073...190,983,381
Ensembl chr 1:181,534,515...181,552,881 		JBrowse link
G Kdm4c lysine demethylase 4C affects expression EXP fullerene C60 affects the expression of KDM4C mRNA CTD PMID:19167457 NCBI chr 5:93,146,404...93,353,040
Ensembl chr 5:88,100,733...88,306,818 		JBrowse link
G Kdm6b lysine demethylase 6B increases expression EXP fullerene C60 results in increased expression of KDM6B mRNA CTD PMID:19167457 NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 increases expression EXP fullerene C60 results in increased expression of KEAP1 mRNA CTD PMID:19167457 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862 		JBrowse link
G Kel Kell metallo-endopeptidase (Kell blood group) decreases expression EXP fullerene C60 results in decreased expression of KEL mRNA CTD PMID:19167457 NCBI chr 4:70,568,241...70,585,666
Ensembl chr 4:70,568,243...70,585,631 		JBrowse link
G Kiaa1671 KIAA1671 homolog decreases expression EXP fullerene C60 results in decreased expression of KIAA1671 mRNA CTD PMID:19167457 NCBI chr12:43,409,479...43,552,152
Ensembl chr12:43,411,069...43,552,157 		JBrowse link
G Kif20b kinesin family member 20B increases expression EXP fullerene C60 results in increased expression of KIF20B mRNA CTD PMID:19167457 NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:232,428,371...232,483,787 		JBrowse link
G Kif26a kinesin family member 26A increases expression EXP fullerene C60 results in increased expression of KIF26A mRNA CTD PMID:19167457 NCBI chr 6:137,035,986...137,072,027
Ensembl chr 6:131,214,861...131,250,320 		JBrowse link
G Kifc3 kinesin family member C3 decreases expression
increases expression		 EXP fullerene C60 results in decreased expression of KIFC3 mRNA
fullerene C60 results in increased expression of KIFC3 mRNA		 CTD PMID:19167457 NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451 		JBrowse link
G Kirrel1 kirre like nephrin family adhesion molecule 1 decreases expression EXP fullerene C60 results in decreased expression of KIRREL1 mRNA CTD PMID:19167457 NCBI chr 2:172,521,644...172,615,057
Ensembl chr 2:172,525,245...172,615,299 		JBrowse link
G Klc3 kinesin light chain 3 increases expression EXP fullerene C60 results in increased expression of KLC3 mRNA CTD PMID:19167457 NCBI chr 1:88,173,842...88,183,806
Ensembl chr 1:79,045,844...79,055,416 		JBrowse link
G Klf11 KLF transcription factor 11 decreases expression EXP fullerene C60 results in decreased expression of KLF11 mRNA CTD PMID:19167457 NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550 		JBrowse link
G Klf15 KLF transcription factor 15 decreases expression EXP fullerene C60 results in decreased expression of KLF15 mRNA CTD PMID:19167457 NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:122,965,807...122,978,374 		JBrowse link
G Klf7 KLF transcription factor 7 decreases expression EXP fullerene C60 results in decreased expression of KLF7 mRNA CTD PMID:19167457 NCBI chr 9:72,927,485...73,020,167
Ensembl chr 9:65,437,167...65,526,261 		JBrowse link
G Klf9 KLF transcription factor 9 affects expression EXP fullerene C60 affects the expression of KLF9 mRNA CTD PMID:19167457 NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:220,700,108...220,725,037 		JBrowse link
G Klhdc3 kelch domain containing 3 increases expression EXP fullerene C60 results in increased expression of KLHDC3 mRNA CTD PMID:19167457 NCBI chr 9:21,799,870...21,806,337
Ensembl chr 9:14,302,354...14,308,736 		JBrowse link
G Klhdc8b kelch domain containing 8B increases expression EXP fullerene C60 results in increased expression of KLHDC8B mRNA CTD PMID:19167457 NCBI chr 8:118,020,136...118,025,102
Ensembl chr 8:109,141,594...109,146,918 		JBrowse link
G Klhl18 kelch-like family member 18 increases expression EXP fullerene C60 results in increased expression of KLHL18 mRNA CTD PMID:19167457 NCBI chr 8:119,279,081...119,337,850
Ensembl chr 8:110,400,681...110,459,323 		JBrowse link
G Klhl21 kelch-like family member 21 increases expression EXP fullerene C60 results in increased expression of KLHL21 mRNA CTD PMID:19167457 NCBI chr 5:167,797,621...167,806,276
Ensembl chr 5:162,514,765...162,523,545 		JBrowse link
G Klhl22 kelch-like family member 22 increases expression EXP fullerene C60 results in increased expression of KLHL22 mRNA CTD PMID:19167457 NCBI chr11:96,695,168...96,736,079
Ensembl chr11:83,190,891...83,231,770 		JBrowse link
G Klhl25 kelch-like family member 25 increases expression EXP fullerene C60 results in increased expression of KLHL25 mRNA CTD PMID:19167457 NCBI chr 1:139,134,655...139,159,898
Ensembl chr 1:129,722,026...129,750,227 		JBrowse link
G Klhl42 kelch-like family, member 42 increases expression EXP fullerene C60 results in increased expression of KLHL42 mRNA CTD PMID:19167457 NCBI chr 4:179,999,655...180,027,283
Ensembl chr 4:180,004,580...180,027,283 		JBrowse link
G Klhl7 kelch-like family member 7 decreases expression EXP fullerene C60 results in decreased expression of KLHL7 mRNA CTD PMID:19167457 NCBI chr 4:11,898,766...11,947,796
Ensembl chr 4:11,006,375...11,055,541 		JBrowse link
G Klk1 kallikrein 1 decreases expression EXP fullerene C60 results in decreased expression of KLK1 mRNA CTD PMID:19167457 NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:94,642,687...94,646,754 		JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 decreases expression EXP fullerene C60 results in decreased expression of KLK1C10 mRNA CTD PMID:19167457 NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:94,402,993...94,407,052 		JBrowse link
G Klk9 kallikrein related-peptidase 9 decreases expression EXP fullerene C60 results in decreased expression of KLK9 mRNA CTD PMID:19167457 NCBI chr 1:94,246,339...94,250,631
Ensembl chr 1:94,246,339...94,250,631 		JBrowse link
G Klrc2 killer cell lectin like receptor C2 increases expression EXP fullerene C60 results in increased expression of KLRC2 mRNA CTD PMID:19167457 NCBI chr 4:164,808,722...164,819,865
Ensembl chr 4:163,122,704...163,133,843 		JBrowse link
G Kmt5b lysine methyltransferase 5B decreases expression EXP fullerene C60 results in decreased expression of KMT5B mRNA CTD PMID:19167457 NCBI chr 1:210,429,672...210,479,042
Ensembl chr 1:201,000,444...201,049,819 		JBrowse link
G Kmt5c lysine methyltransferase 5C increases expression EXP fullerene C60 results in increased expression of KMT5C mRNA CTD PMID:19167457 NCBI chr 1:78,128,325...78,135,931
Ensembl chr 1:69,099,539...69,107,145 		JBrowse link
G Krt13 keratin 13 decreases expression EXP fullerene C60 results in decreased expression of KRT13 mRNA CTD PMID:19167457 NCBI chr10:85,051,887...85,056,099
Ensembl chr10:85,051,889...85,056,084 		JBrowse link
G Krt8 keratin 8 increases expression EXP fullerene C60 results in increased expression of KRT8 mRNA CTD PMID:19167457 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:133,124,203...133,131,728 		JBrowse link
G Krtap3-3 keratin associated protein 3-3 decreases expression EXP fullerene C60 results in decreased expression of KRTAP3-3 mRNA CTD PMID:19167457 NCBI chr10:84,511,459...84,511,758
Ensembl chr10:84,511,092...84,511,812
Ensembl chr10:84,511,092...84,511,812 		JBrowse link
G Ky kyphoscoliosis peptidase decreases expression EXP fullerene C60 results in decreased expression of KY mRNA CTD PMID:19167457 NCBI chr 8:103,086,959...103,126,305
Ensembl chr 8:103,086,630...103,126,024 		JBrowse link
G Lactb lactamase, beta decreases expression EXP fullerene C60 results in decreased expression of LACTB mRNA CTD PMID:19167457 NCBI chr 8:67,571,504...67,587,592
Ensembl chr 8:67,571,500...67,587,539 		JBrowse link
G Lamb3 laminin subunit beta 3 decreases expression EXP fullerene C60 results in decreased expression of LAMB3 mRNA CTD PMID:19167457 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:104,833,873...104,875,405 		JBrowse link
G Lamc2 laminin subunit gamma 2 increases expression EXP fullerene C60 results in increased expression of LAMC2 mRNA CTD PMID:19167457 NCBI chr13:67,835,199...67,894,694
Ensembl chr13:65,284,664...65,344,200 		JBrowse link
G Lancl1 LanC like glutathione S-transferase 1 decreases expression EXP fullerene C60 results in decreased expression of LANCL1 mRNA CTD PMID:19167457 NCBI chr 9:75,968,284...75,998,397
Ensembl chr 9:68,518,574...68,548,628 		JBrowse link
G Larp6 La ribonucleoprotein 6, translational regulator decreases expression EXP fullerene C60 results in decreased expression of LARP6 mRNA CTD PMID:19167457 NCBI chr 8:61,183,744...61,205,548
Ensembl chr 8:61,184,116...61,205,535 		JBrowse link
G Lats2 large tumor suppressor kinase 2 decreases expression EXP fullerene C60 results in decreased expression of LATS2 mRNA CTD PMID:19167457 NCBI chr15:35,940,632...35,992,225
Ensembl chr15:31,825,092...31,877,220 		JBrowse link
G Lcn2 lipocalin 2 increases expression EXP fullerene C60 results in increased expression of LCN2 mRNA CTD PMID:20471445 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095 		JBrowse link
G Ldb3 LIM domain binding 3 increases expression EXP fullerene C60 results in increased expression of LDB3 mRNA CTD PMID:19167457 NCBI chr16:9,855,768...9,920,108
Ensembl chr16:9,855,927...9,918,532 		JBrowse link
G Ldhb lactate dehydrogenase B increases expression EXP fullerene C60 results in increased expression of LDHB mRNA CTD PMID:19167457 NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:175,428,385...175,446,403 		JBrowse link
G Lemd2 LEM domain nuclear envelope protein 2 increases expression EXP fullerene C60 results in increased expression of LEMD2 mRNA CTD PMID:19167457 NCBI chr20:5,282,397...5,296,621
Ensembl chr20:5,282,397...5,296,626 		JBrowse link
G Lemd3 LEM domain containing 3 decreases expression EXP fullerene C60 results in decreased expression of LEMD3 mRNA CTD PMID:19167457 NCBI chr 7:58,300,556...58,389,485
Ensembl chr 7:56,305,448...56,502,474 		JBrowse link
G Lhfpl4 LHFPL tetraspan subfamily member 4 decreases expression EXP fullerene C60 results in decreased expression of LHFPL4 mRNA CTD PMID:19167457 NCBI chr 4:147,872,877...147,895,770
Ensembl chr 4:146,313,541...146,340,463 		JBrowse link
G Lhfpl6 LHFPL tetraspan subfamily member 6 decreases expression EXP fullerene C60 results in decreased expression of LHFPL6 mRNA CTD PMID:19167457 NCBI chr 2:137,126,485...137,324,442
Ensembl chr 2:137,126,509...137,324,443 		JBrowse link
G Lhx3 LIM homeobox 3 decreases expression EXP fullerene C60 results in decreased expression of LHX3 mRNA CTD PMID:19167457 NCBI chr 3:29,424,620...29,432,637
Ensembl chr 3:9,027,425...9,034,480 		JBrowse link
G Lig3 DNA ligase 3 decreases expression EXP fullerene C60 results in decreased expression of LIG3 mRNA CTD PMID:19167457 NCBI chr10:68,215,371...68,238,705
Ensembl chr10:67,717,812...67,798,414 		JBrowse link
G Lim2 lens intrinsic membrane protein 2 decreases expression EXP fullerene C60 results in decreased expression of LIM2 mRNA CTD PMID:19167457 NCBI chr 1:102,974,188...102,980,358
Ensembl chr 1:93,837,597...93,843,769 		JBrowse link
G Limd2 LIM domain containing 2 decreases expression EXP fullerene C60 results in decreased expression of LIMD2 mRNA CTD PMID:19167457 NCBI chr10:91,090,279...91,092,772
Ensembl chr10:91,090,280...91,092,775 		JBrowse link
G Limk1 LIM domain kinase 1 decreases expression EXP fullerene C60 results in decreased expression of LIMK1 mRNA CTD PMID:19167457 NCBI chr12:27,663,177...27,697,085
Ensembl chr12:22,026,672...22,060,606 		JBrowse link
G Lin28a lin-28 homolog A decreases expression EXP fullerene C60 results in decreased expression of LIN28A mRNA CTD PMID:19167457 NCBI chr 5:151,510,891...151,527,884
Ensembl chr 5:146,227,119...146,244,122 		JBrowse link
G Lipc lipase C, hepatic type decreases expression EXP fullerene C60 results in decreased expression of LIPC mRNA CTD PMID:19167457 NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464 		JBrowse link
G Lipogenin Lipogenin increases expression EXP fullerene C60 results in increased expression of LIPOGENIN mRNA CTD PMID:19167457 NCBI chr 4:57,356,298...57,357,553 JBrowse link
G Lix1l limb and CNS expressed 1 like increases expression EXP fullerene C60 results in increased expression of LIX1L mRNA CTD PMID:19167457 NCBI chr 2:184,136,018...184,161,918
Ensembl chr 2:184,136,038...184,161,916 		JBrowse link
G Llgl1 LLGL scribble cell polarity complex component 1 increases expression EXP fullerene C60 results in increased expression of LLGL1 mRNA CTD PMID:19167457 NCBI chr10:45,379,423...45,394,096
Ensembl chr10:45,379,515...45,394,094 		JBrowse link
G Llgl2 LLGL scribble cell polarity complex component 2 increases expression EXP fullerene C60 results in increased expression of LLGL2 mRNA CTD PMID:19167457 NCBI chr10:101,549,911...101,585,466
Ensembl chr10:101,051,408...101,086,525 		JBrowse link
G Lmo3 LIM domain only 3 decreases expression EXP fullerene C60 results in decreased expression of LMO3 mRNA CTD PMID:19167457 NCBI chr 4:172,965,944...173,028,980
Ensembl chr 4:171,234,696...171,292,222 		JBrowse link
G Lnpep leucyl and cystinyl aminopeptidase decreases expression EXP fullerene C60 results in decreased expression of LNPEP mRNA CTD PMID:19167457 NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544 		JBrowse link
G Lnx2 ligand of numb-protein X 2 decreases expression EXP fullerene C60 results in decreased expression of LNX2 mRNA CTD PMID:19167457 NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494 		JBrowse link
G Lpar1 lysophosphatidic acid receptor 1 decreases expression EXP fullerene C60 results in decreased expression of LPAR1 mRNA CTD PMID:19167457 NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:73,229,625...73,369,895 		JBrowse link
G Lpo lactoperoxidase decreases expression EXP fullerene C60 results in decreased expression of LPO mRNA CTD PMID:19167457 NCBI chr10:73,104,170...73,124,683
Ensembl chr10:72,606,944...72,626,535 		JBrowse link
G Lratd1 LRAT domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of LRATD1 mRNA CTD PMID:19167457 NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:36,913,469...36,922,319 		JBrowse link
G Lrfn1 leucine rich repeat and fibronectin type III domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of LRFN1 mRNA CTD PMID:19167457 NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449 		JBrowse link
G Lrp1 LDL receptor related protein 1 decreases expression EXP fullerene C60 results in decreased expression of LRP1 mRNA CTD PMID:19167457 NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910 		JBrowse link
G Lrp5 LDL receptor related protein 5 increases expression EXP fullerene C60 results in increased expression of LRP5 mRNA CTD PMID:19167457 NCBI chr 1:210,243,499...210,346,886
Ensembl chr 1:200,814,250...200,917,581 		JBrowse link
G Lrpprc leucine-rich pentatricopeptide repeat containing decreases expression EXP fullerene C60 results in decreased expression of LRPPRC mRNA CTD PMID:19167457 NCBI chr 6:15,612,638...15,695,113
Ensembl chr 6:9,859,867...9,942,293 		JBrowse link
G Lrrc10b leucine rich repeat containing 10B increases expression EXP fullerene C60 results in increased expression of LRRC10B mRNA CTD PMID:19167457 NCBI chr 1:207,096,471...207,097,699
Ensembl chr 1:207,022,919...207,098,045 		JBrowse link
G Lrrc15 leucine rich repeat containing 15 decreases expression EXP fullerene C60 results in decreased expression of LRRC15 mRNA CTD PMID:19167457 NCBI chr11:70,469,817...70,484,268
Ensembl chr11:70,469,804...70,484,267 		JBrowse link
G Lrrc24 leucine rich repeat containing 24 increases expression EXP fullerene C60 results in increased expression of LRRC24 mRNA CTD PMID:19167457 NCBI chr 7:108,437,296...108,444,561
Ensembl chr 7:108,437,296...108,444,438 		JBrowse link
G Lrrc27 leucine rich repeat containing 27 decreases expression EXP fullerene C60 results in decreased expression of LRRC27 mRNA CTD PMID:19167457 NCBI chr 1:203,433,463...203,464,683
Ensembl chr 1:194,005,182...194,035,084 		JBrowse link
G Lrrc3 leucine rich repeat containing 3 decreases expression EXP fullerene C60 results in decreased expression of LRRC3 mRNA CTD PMID:19167457 NCBI chr20:10,758,919...10,763,736
Ensembl chr20:10,758,955...10,762,067 		JBrowse link
G Lrrc42 leucine rich repeat containing 42 decreases expression EXP fullerene C60 results in decreased expression of LRRC42 mRNA CTD PMID:19167457 NCBI chr 5:122,014,678...122,035,792
Ensembl chr 5:122,014,678...122,035,829 		JBrowse link
G Lrrc47 leucine rich repeat containing 47 increases expression EXP fullerene C60 results in increased expression of LRRC47 mRNA CTD PMID:19167457 NCBI chr 5:169,852,926...169,862,598
Ensembl chr 5:164,570,435...164,580,174 		JBrowse link
G Lrrc63 leucine rich repeat containing 63 decreases expression EXP fullerene C60 results in decreased expression of LRRC63 mRNA CTD PMID:19167457 NCBI chr15:50,400,199...50,437,321
Ensembl chr15:50,400,200...50,437,321 		JBrowse link
G Lrrc8b leucine rich repeat containing 8 VRAC subunit B increases expression EXP fullerene C60 results in increased expression of LRRC8B mRNA CTD PMID:19167457 NCBI chr14:4,350,462...4,416,336
Ensembl chr14:4,354,508...4,416,311 		JBrowse link
G Lrrk1 leucine-rich repeat kinase 1 increases expression EXP fullerene C60 results in increased expression of LRRK1 mRNA CTD PMID:19167457 NCBI chr 1:129,254,815...129,390,217
Ensembl chr 1:119,845,146...119,979,734 		JBrowse link
G Ltbr lymphotoxin beta receptor increases expression EXP fullerene C60 results in increased expression of LTBR mRNA CTD PMID:19167457 NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:158,108,886...158,121,539 		JBrowse link
G Ly49s7 Ly49 stimulatory receptor 7 decreases expression EXP fullerene C60 results in decreased expression of LY49S7 mRNA CTD PMID:19167457 NCBI chr 4:164,761,847...164,779,735
Ensembl chr 4:164,761,855...164,779,735 		JBrowse link
G Ly6a lymphocyte antigen 6 family member A increases expression EXP fullerene C60 results in increased expression of LY6AL mRNA CTD PMID:19167457 NCBI chr 7:109,064,222...109,067,757
Ensembl chr 7:107,183,469...107,189,981 		JBrowse link
G Ly6g5c lymphocyte antigen 6 family member G5C decreases expression EXP fullerene C60 results in decreased expression of LY6G5C mRNA CTD PMID:19167457 NCBI chr20:3,709,426...3,713,940
Ensembl chr20:3,709,529...3,713,608 		JBrowse link
G Ly6g6d lymphocyte antigen 6 family member G6D decreases expression EXP fullerene C60 results in decreased expression of LY6G6D mRNA CTD PMID:19167457 NCBI chr20:3,741,973...3,752,378
Ensembl chr20:3,737,459...3,752,248 		JBrowse link
G Lyar Ly1 antibody reactive decreases expression EXP fullerene C60 results in decreased expression of LYAR mRNA CTD PMID:19167457 NCBI chr14:76,789,193...76,802,973
Ensembl chr14:72,576,879...72,590,612 		JBrowse link
G Lyl1 LYL1, basic helix-loop-helix family member decreases expression EXP fullerene C60 results in decreased expression of LYL1 mRNA CTD PMID:19167457 NCBI chr19:40,356,967...40,359,834
Ensembl chr19:23,452,140...23,455,007 		JBrowse link
G Lynx1 Ly6/neurotoxin 1 decreases expression EXP fullerene C60 results in decreased expression of LYNX1 mRNA CTD PMID:19167457 NCBI chr 7:108,521,783...108,527,012
Ensembl chr 7:106,632,797...106,638,023 		JBrowse link
G Lypd2 Ly6/Plaur domain containing 2 decreases expression EXP fullerene C60 results in decreased expression of LYPD2 mRNA CTD PMID:19167457 NCBI chr 7:106,617,561...106,619,598
Ensembl chr 7:106,617,561...106,619,598 		JBrowse link
G Lypla1 lysophospholipase 1 decreases expression EXP fullerene C60 results in decreased expression of LYPLA1 mRNA CTD PMID:19167457 NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746 		JBrowse link
G Lzts2 leucine zipper tumor suppressor 2 increases expression EXP fullerene C60 results in increased expression of LZTS2 mRNA CTD PMID:19167457 NCBI chr 1:253,824,073...253,837,614
Ensembl chr 1:243,880,022...243,888,423 		JBrowse link
G Maff MAF bZIP transcription factor F decreases expression EXP fullerene C60 results in decreased expression of MAFF mRNA CTD PMID:19167457 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851 		JBrowse link
G Man1b1 mannosidase, alpha, class 1B, member 1 increases expression EXP fullerene C60 results in increased expression of MAN1B1 mRNA CTD PMID:19167457 NCBI chr 3:28,539,778...28,563,155
Ensembl chr 3:8,143,381...8,165,006 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta increases expression EXP fullerene C60 results in increased expression of MAP1LC3B mRNA CTD PMID:19167457 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690
Ensembl chr16:49,665,791...49,677,690 		JBrowse link
G Map3k1 mitogen-activated protein kinase kinase kinase 1 increases expression EXP fullerene C60 results in increased expression of MAP3K1 mRNA CTD PMID:19167457 NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:43,350,098...43,414,463 		JBrowse link
G Map3k10 mitogen activated protein kinase kinase kinase 10 decreases expression EXP fullerene C60 results in decreased expression of MAP3K10 mRNA CTD PMID:19167457 NCBI chr 1:92,083,376...92,101,676
Ensembl chr 1:82,955,207...82,974,084 		JBrowse link
G Map3k3 mitogen activated protein kinase kinase kinase 3 increases expression EXP fullerene C60 results in increased expression of MAP3K3 mRNA CTD PMID:19167457 NCBI chr10:91,519,976...91,588,651
Ensembl chr10:91,020,174...91,088,848 		JBrowse link
G Map3k4 mitogen activated protein kinase kinase kinase 4 decreases expression EXP fullerene C60 results in decreased expression of MAP3K4 mRNA CTD PMID:19167457 NCBI chr 1:50,977,870...51,067,117
Ensembl chr 1:48,431,830...48,519,358 		JBrowse link
G Map3k6 mitogen-activated protein kinase kinase kinase 6 decreases expression EXP fullerene C60 results in decreased expression of MAP3K6 mRNA CTD PMID:19167457 NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:145,440,346...145,452,212 		JBrowse link
G Map4k2 mitogen activated protein kinase kinase kinase kinase 2 increases expression EXP fullerene C60 results in increased expression of MAP4K2 mRNA CTD PMID:19167457 NCBI chr 1:213,074,360...213,090,042
Ensembl chr 1:203,645,153...203,660,331 		JBrowse link
G Map6 microtubule-associated protein 6 increases expression EXP fullerene C60 results in increased expression of MAP6 mRNA CTD PMID:19167457 NCBI chr 1:162,980,339...163,046,548
Ensembl chr 1:153,568,368...153,634,414 		JBrowse link
G Mapk8ip1 mitogen-activated protein kinase 8 interacting protein 1 increases expression EXP fullerene C60 results in increased expression of MAPK8IP1 mRNA CTD PMID:19167457 NCBI chr 3:98,810,540...98,829,302
Ensembl chr 3:78,355,048...78,372,884 		JBrowse link
G Mapk8ip3 mitogen-activated protein kinase 8 interacting protein 3 increases expression EXP fullerene C60 results in increased expression of MAPK8IP3 mRNA CTD PMID:19167457 NCBI chr10:14,422,936...14,463,387
Ensembl chr10:13,918,400...13,958,273 		JBrowse link
G Mapkapk3 MAPK activated protein kinase 3 increases expression EXP fullerene C60 results in increased expression of MAPKAPK3 mRNA CTD PMID:19167457 NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:107,929,762...107,963,568 		JBrowse link
G Marchf11 membrane associated ring-CH-type finger 11 decreases expression EXP fullerene C60 results in decreased expression of MARCHF11 mRNA CTD PMID:19167457 NCBI chr 2:76,898,330...76,999,690
Ensembl chr 2:76,898,386...76,999,691 		JBrowse link
G Marchf3 membrane associated ring-CH-type finger 3 decreases expression EXP fullerene C60 results in decreased expression of MARCHF3 mRNA CTD PMID:19167457 NCBI chr18:50,237,218...50,389,343
Ensembl chr18:50,237,230...50,389,150 		JBrowse link
G Marcksl1 MARCKS-like 1 increases expression EXP fullerene C60 results in increased expression of MARCKSL1 mRNA CTD PMID:19167457 NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817 		JBrowse link
G Masp1 MBL associated serine protease 1 decreases expression EXP fullerene C60 results in decreased expression of MASP1 mRNA CTD PMID:19167457 NCBI chr11:90,839,081...90,909,922
Ensembl chr11:77,334,859...77,402,974 		JBrowse link
G Mast2 microtubule associated serine/threonine kinase 2 increases expression EXP fullerene C60 results in increased expression of MAST2 mRNA CTD PMID:19167457 NCBI chr 5:129,776,293...129,915,502
Ensembl chr 5:129,775,676...129,915,606 		JBrowse link
G Matn1 matrilin 1 decreases expression EXP fullerene C60 results in decreased expression of MATN1 mRNA CTD PMID:19167457 NCBI chr 5:143,117,198...143,127,140
Ensembl chr 5:143,117,504...143,127,059 		JBrowse link
G Mb myoglobin decreases expression EXP fullerene C60 results in decreased expression of MB mRNA CTD PMID:19167457 NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383 		JBrowse link
G Mbd6 methyl-CpG binding domain protein 6 increases expression EXP fullerene C60 results in increased expression of MBD6 mRNA CTD PMID:19167457 NCBI chr 7:63,107,562...63,115,841
Ensembl chr 7:63,107,562...63,113,274 		JBrowse link
G Mboat7 membrane bound O-acyltransferase domain containing 7 increases expression EXP fullerene C60 results in increased expression of MBOAT7 mRNA CTD PMID:19167457 NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538 		JBrowse link
G Mbp myelin basic protein decreases expression EXP fullerene C60 results in decreased expression of MBP mRNA CTD PMID:19167457 NCBI chr18:78,130,652...78,241,174
Ensembl chr18:75,855,878...75,966,404 		JBrowse link
G Mc3r melanocortin 3 receptor decreases expression EXP fullerene C60 results in decreased expression of MC3R mRNA CTD PMID:19167457 NCBI chr 3:181,434,776...181,435,873
Ensembl chr 3:161,016,347...161,017,444 		JBrowse link
G Mcam melanoma cell adhesion molecule increases expression EXP fullerene C60 results in increased expression of MCAM mRNA CTD PMID:19167457 NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571 		JBrowse link
G Mcat malonyl-CoA-acyl carrier protein transacylase increases expression EXP fullerene C60 results in increased expression of MCAT mRNA CTD PMID:19167457 NCBI chr 7:116,573,632...116,585,767
Ensembl chr 7:114,693,612...114,704,542 		JBrowse link
G Mcf2l MCF.2 cell line derived transforming sequence-like increases expression EXP fullerene C60 results in increased expression of MCF2L mRNA CTD PMID:19167457 NCBI chr16:83,209,277...83,355,683
Ensembl chr16:76,507,133...76,652,733 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 increases expression EXP fullerene C60 results in increased expression of MCM2 mRNA CTD PMID:19167457 NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:121,346,434...121,360,847 		JBrowse link
G Mcm5 minichromosome maintenance complex component 5 increases expression EXP fullerene C60 results in increased expression of MCM5 mRNA CTD PMID:19167457 NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,483,066...13,504,389 		JBrowse link
G Mcrs1 microspherule protein 1 increases expression EXP fullerene C60 results in increased expression of MCRS1 mRNA CTD PMID:19167457 NCBI chr 7:132,262,719...132,271,533
Ensembl chr 7:130,383,853...130,392,685 		JBrowse link
G Mdfic MyoD family inhibitor domain containing decreases expression EXP fullerene C60 results in decreased expression of MDFIC mRNA CTD PMID:19167457 NCBI chr 4:44,938,301...45,018,157
Ensembl chr 4:43,972,507...44,052,161 		JBrowse link
G Mecp2 methyl CpG binding protein 2 decreases expression EXP fullerene C60 results in decreased expression of MECP2 mRNA CTD PMID:19167457 NCBI chr  X:156,932,481...156,995,981
Ensembl chr  X:151,789,930...151,844,689 		JBrowse link
G Med13 mediator complex subunit 13 decreases expression EXP fullerene C60 results in decreased expression of MED13 mRNA CTD PMID:19167457 NCBI chr10:71,584,354...71,674,614
Ensembl chr10:71,090,516...71,177,242 		JBrowse link
G Med21 mediator complex subunit 21 decreases expression EXP fullerene C60 results in decreased expression of MED21 mRNA CTD PMID:19167457 NCBI chr 4:181,291,191...181,314,504
Ensembl chr 4:179,560,579...179,567,548 		JBrowse link
G Med24 mediator complex subunit 24 decreases expression EXP fullerene C60 results in decreased expression of MED24 mRNA CTD PMID:19167457 NCBI chr10:84,160,866...84,198,607
Ensembl chr10:83,664,609...83,690,123 		JBrowse link
G Med27 mediator complex subunit 27 decreases expression EXP fullerene C60 results in decreased expression of MED27 mRNA CTD PMID:19167457 NCBI chr 3:33,027,240...33,201,240
Ensembl chr 3:12,629,603...12,803,339 		JBrowse link
G Meig1 meiosis/spermiogenesis associated 1 increases expression EXP fullerene C60 results in increased expression of MEIG1 mRNA CTD PMID:19167457 NCBI chr17:74,810,791...74,828,433
Ensembl chr17:74,814,632...74,828,433 		JBrowse link
G Meis3 Meis homeobox 3 increases expression EXP fullerene C60 results in increased expression of MEIS3 mRNA CTD PMID:19167457 NCBI chr 1:76,861,267...76,872,691
Ensembl chr 1:76,861,924...76,872,691 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase decreases expression EXP fullerene C60 results in decreased expression of MET mRNA CTD PMID:19167457 NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876 		JBrowse link
G Mex3a mex-3 RNA binding family member A decreases expression EXP fullerene C60 results in decreased expression of MEX3A mRNA CTD PMID:19167457 NCBI chr 2:173,990,098...173,999,567
Ensembl chr 2:173,989,856...173,997,377 		JBrowse link
G Mfap2 microfibril associated protein 2 decreases expression EXP fullerene C60 results in decreased expression of MFAP2 mRNA CTD PMID:19167457 NCBI chr 5:153,312,068...153,320,266
Ensembl chr 5:153,314,711...153,320,259 		JBrowse link
G Mfap4 microfibril associated protein 4 increases expression EXP fullerene C60 results in increased expression of MFAP4 mRNA CTD PMID:19167457 NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,167,217...46,170,155 		JBrowse link
G Mfhas1 multifunctional ROCO family signaling regulator 1 decreases expression EXP fullerene C60 results in decreased expression of MFHAS1 mRNA CTD PMID:19167457 NCBI chr16:63,248,833...63,336,441
Ensembl chr16:56,546,207...56,633,743 		JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid affects expression EXP fullerene C60 affects the expression of MFSD2A mRNA CTD PMID:19167457 NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:135,225,816...135,240,690 		JBrowse link
G Mgat4b alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B increases expression EXP fullerene C60 results in increased expression of MGAT4B mRNA CTD PMID:19167457 NCBI chr10:35,049,421...35,060,307
Ensembl chr10:34,549,433...34,559,229 		JBrowse link
G Mgp matrix Gla protein decreases expression EXP fullerene C60 results in decreased expression of MGP mRNA CTD PMID:19167457 NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:169,766,279...169,769,667 		JBrowse link
G Mixl1 Mix paired-like homeobox 1 decreases expression EXP fullerene C60 results in decreased expression of MIXL1 mRNA CTD PMID:19167457 NCBI chr13:94,953,907...94,957,938
Ensembl chr13:92,422,031...92,426,065 		JBrowse link
G Mlc1 modulator of VRAC current 1 increases expression EXP fullerene C60 results in increased expression of MLC1 mRNA CTD PMID:19167457 NCBI chr 7:121,926,356...121,949,484
Ensembl chr 7:120,046,705...120,067,049 		JBrowse link
G Mlf2 myeloid leukemia factor 2 decreases expression EXP fullerene C60 results in decreased expression of MLF2 mRNA CTD PMID:19167457 NCBI chr 4:159,425,542...159,430,584
Ensembl chr 4:157,728,756...157,744,317 		JBrowse link
G Mmachc metabolism of cobalamin associated C decreases expression EXP fullerene C60 results in decreased expression of MMACHC mRNA CTD PMID:19167457 NCBI chr 5:130,166,056...130,172,735
Ensembl chr 5:130,166,451...130,172,601 		JBrowse link
G Mmd2 monocyte to macrophage differentiation-associated 2 decreases expression EXP fullerene C60 results in decreased expression of MMD2 mRNA CTD PMID:19167457 NCBI chr12:17,075,870...17,123,255
Ensembl chr12:11,962,757...12,009,773 		JBrowse link
G Mmp11 matrix metallopeptidase 11 increases expression ISO fullerene C60 results in increased expression of MMP11 mRNA CTD PMID:20064541 NCBI chr20:12,730,846...12,739,629
Ensembl chr20:12,730,836...12,739,628 		JBrowse link
G Mmp12 matrix metallopeptidase 12 increases expression EXP fullerene C60 results in increased expression of MMP12 mRNA CTD PMID:20471445 NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:4,581,785...4,599,611 		JBrowse link
G Mmp2 matrix metallopeptidase 2 increases expression ISO fullerene C60 results in increased expression of MMP2 mRNA CTD PMID:20064541 PMID:31504961 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870 		JBrowse link
G Mmp24 matrix metallopeptidase 24 decreases expression EXP fullerene C60 results in decreased expression of MMP24 mRNA CTD PMID:19167457 NCBI chr 3:144,279,096...144,323,572
Ensembl chr 3:144,279,096...144,323,572 		JBrowse link
G Mmp25 matrix metallopeptidase 25 decreases expression EXP fullerene C60 results in decreased expression of MMP25 mRNA CTD PMID:19167457 NCBI chr10:12,661,297...12,676,119
Ensembl chr10:12,661,208...12,675,871 		JBrowse link
G Mmp28 matrix metallopeptidase 28 decreases expression EXP fullerene C60 results in decreased expression of MMP28 mRNA CTD PMID:19167457 NCBI chr10:68,241,138...68,264,866
Ensembl chr10:68,241,138...68,264,866 		JBrowse link
G Mmp3 matrix metallopeptidase 3 increases expression ISO fullerene C60 results in increased expression of MMP3 mRNA CTD PMID:20064541 NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961 		JBrowse link
G Mmp7 matrix metallopeptidase 7 increases expression EXP fullerene C60 results in increased expression of MMP7 mRNA CTD PMID:20471445 NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902 		JBrowse link
G Mob4 MOB family member 4, phocein increases expression EXP fullerene C60 results in increased expression of MOB4 mRNA CTD PMID:19167457 NCBI chr 9:64,111,170...64,135,740
Ensembl chr 9:56,617,368...56,641,329 		JBrowse link
G Mocs1 molybdenum cofactor synthesis 1 increases expression EXP fullerene C60 results in increased expression of MOCS1 mRNA CTD PMID:19167457 NCBI chr 9:19,045,223...19,071,628
Ensembl chr 9:11,547,531...11,567,790 		JBrowse link
G Mospd2 motile sperm domain containing 2 affects expression EXP fullerene C60 affects the expression of MOSPD2 mRNA CTD PMID:19167457 NCBI chr  X:33,052,063...33,105,550
Ensembl chr  X:29,420,586...29,462,398 		JBrowse link
G Mpp3 MAGUK p55 scaffold protein 3 decreases expression EXP fullerene C60 results in decreased expression of MPP3 mRNA CTD PMID:19167457 NCBI chr10:87,445,905...87,475,461
Ensembl chr10:86,945,714...86,974,737 		JBrowse link
G Mpped1 metallophosphoesterase domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of MPPED1 mRNA CTD PMID:19167457 NCBI chr 7:114,932,221...115,011,797
Ensembl chr 7:114,944,764...115,011,787 		JBrowse link
G Mras muscle RAS oncogene homolog decreases expression EXP fullerene C60 results in decreased expression of MRAS mRNA CTD PMID:19167457 NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:99,944,036...99,996,408 		JBrowse link
G Mrpl1 mitochondrial ribosomal protein L1 decreases expression EXP fullerene C60 results in decreased expression of MRPL1 mRNA CTD PMID:19167457 NCBI chr14:13,604,498...13,663,633
Ensembl chr14:13,300,522...13,359,721 		JBrowse link
G Mrpl21 mitochondrial ribosomal protein L21 decreases expression EXP fullerene C60 results in decreased expression of MRPL21 mRNA CTD PMID:19167457 NCBI chr 1:209,958,693...209,987,393
Ensembl chr 1:200,529,416...200,537,896 		JBrowse link
G Msh5 mutS homolog 5 decreases expression EXP fullerene C60 results in decreased expression of MSH5 mRNA CTD PMID:19167457 NCBI chr20:3,779,180...3,797,996
Ensembl chr20:3,776,942...3,793,336 		JBrowse link
G Msl3 MSL complex subunit 3 increases expression EXP fullerene C60 results in increased expression of MSL3 mRNA CTD PMID:19167457 NCBI chr  X:25,638,029...25,655,698
Ensembl chr  X:25,637,804...25,655,697 		JBrowse link
G Msx3 msh homeobox 3 decreases expression EXP fullerene C60 results in decreased expression of MSX3 mRNA CTD PMID:19167457 NCBI chr 1:194,839,041...194,842,209
Ensembl chr 1:194,839,041...194,841,969 		JBrowse link
G Mterf3 mitochondrial transcription termination factor 3 decreases expression EXP fullerene C60 results in decreased expression of MTERF3 mRNA CTD PMID:19167457 NCBI chr 7:63,826,418...63,844,747
Ensembl chr 7:63,826,427...63,844,658 		JBrowse link
G Mtm1 myotubularin 1 decreases expression EXP fullerene C60 results in decreased expression of MTM1 mRNA CTD PMID:19167457 NCBI chr 6:488,923...506,882
Ensembl chr 6:488,969...506,860 		JBrowse link
G Mtmr14 myotubularin related protein 14 increases expression EXP fullerene C60 results in increased expression of MTMR14 mRNA CTD PMID:19167457 NCBI chr 4:147,942,604...147,985,649
Ensembl chr 4:146,386,956...146,429,990 		JBrowse link
G Mtrex Mtr4 exosome RNA helicase decreases expression EXP fullerene C60 results in decreased expression of MTREX mRNA CTD PMID:19167457 NCBI chr 2:46,233,528...46,293,827
Ensembl chr 2:44,461,444...44,560,627 		JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of MTSS1 mRNA CTD PMID:19167457 NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:90,488,754...90,627,968 		JBrowse link
G Muc4 mucin 4, cell surface associated affects expression EXP fullerene C60 affects the expression of MUC4 mRNA CTD PMID:19167457 NCBI chr11:81,513,321...81,575,200 JBrowse link
G Muc5b mucin 5B, oligomeric mucus/gel-forming increases expression EXP fullerene C60 results in increased expression of MUC5B mRNA CTD PMID:19167457 NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250 		JBrowse link
G Muc6 mucin 6, oligomeric mucus/gel-forming decreases expression EXP fullerene C60 results in decreased expression of MUC6 mRNA CTD PMID:19167457 NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842 		JBrowse link
G Mvb12b multivesicular body subunit 12B decreases expression EXP fullerene C60 results in decreased expression of MVB12B mRNA CTD PMID:19167457 NCBI chr 3:17,034,002...17,192,658
Ensembl chr 3:17,034,003...17,193,202 		JBrowse link
G Mxd1 max dimerization protein 1 decreases expression EXP fullerene C60 results in decreased expression of MXD1 mRNA CTD PMID:19167457 NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:119,097,353...119,117,751 		JBrowse link
G Myadml2 myeloid-associated differentiation marker-like 2 decreases expression EXP fullerene C60 results in decreased expression of MYADML2 mRNA CTD PMID:19167457 NCBI chr10:105,922,557...105,927,867
Ensembl chr10:105,925,947...105,927,575 		JBrowse link
G Mybpc3 myosin binding protein C3 increases expression EXP fullerene C60 results in increased expression of MYBPC3 mRNA CTD PMID:19167457 NCBI chr 3:97,550,974...97,569,216
Ensembl chr 3:77,095,252...77,113,405 		JBrowse link
G Myh3 myosin heavy chain 3 decreases expression EXP fullerene C60 results in decreased expression of MYH3 mRNA CTD PMID:19167457 NCBI chr10:51,770,177...51,793,994
Ensembl chr10:51,770,177...51,793,992 		JBrowse link
G Myl7 myosin light chain 7 decreases expression EXP fullerene C60 results in decreased expression of MYL7 mRNA CTD PMID:19167457 NCBI chr14:84,994,644...84,997,173
Ensembl chr14:80,779,776...80,783,244 		JBrowse link
G Mylk2 myosin light chain kinase 2 decreases expression EXP fullerene C60 results in decreased expression of MYLK2 mRNA CTD PMID:19167457 NCBI chr 3:161,836,705...161,848,609
Ensembl chr 3:141,376,691...141,387,728 		JBrowse link
G Mynn myoneurin increases expression EXP fullerene C60 results in increased expression of MYNN mRNA CTD PMID:19167457 NCBI chr 2:112,779,654...112,797,188
Ensembl chr 2:112,779,657...112,796,397 		JBrowse link
G Myo10 myosin X decreases expression EXP fullerene C60 results in decreased expression of MYO10 mRNA CTD PMID:19167457 NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030 		JBrowse link
G Myo1a myosin IA decreases expression EXP fullerene C60 results in decreased expression of MYO1A mRNA CTD PMID:19167457 NCBI chr 7:63,542,988...63,557,944
Ensembl chr 7:63,542,988...63,557,944 		JBrowse link
G Myo3b myosin IIIB decreases expression EXP fullerene C60 results in decreased expression of MYO3B mRNA CTD PMID:19167457 NCBI chr 3:75,228,017...75,636,272
Ensembl chr 3:54,820,251...55,227,373 		JBrowse link
G Myo7a myosin VIIA increases expression EXP fullerene C60 results in increased expression of MYO7A mRNA CTD PMID:19167457 NCBI chr 1:161,755,110...161,825,397
Ensembl chr 1:152,344,448...152,414,157 		JBrowse link
G Myo9b myosin IXb increases expression EXP fullerene C60 results in increased expression of MYO9B mRNA CTD PMID:19167457 NCBI chr16:17,979,374...18,064,100
Ensembl chr16:17,945,448...18,030,126 		JBrowse link
G Myof myoferlin increases expression EXP fullerene C60 results in increased expression of MYOF mRNA CTD PMID:19167457 NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:235,673,666...235,822,334 		JBrowse link
G Myom2 myomesin 2 affects expression EXP fullerene C60 affects the expression of MYOM2 mRNA CTD PMID:19167457 NCBI chr16:74,520,148...74,592,658
Ensembl chr16:74,520,157...74,592,772 		JBrowse link
G N4bp3 Nedd4 binding protein 3 decreases expression EXP fullerene C60 results in decreased expression of N4BP3 mRNA CTD PMID:19167457 NCBI chr10:36,400,053...36,407,609
Ensembl chr10:35,899,096...35,907,001 		JBrowse link
G Naa11 N(alpha)-acetyltransferase 11, NatA catalytic subunit increases expression EXP fullerene C60 results in increased expression of NAA11 mRNA CTD PMID:19167457 NCBI chr14:12,487,652...12,497,688
Ensembl chr14:12,183,651...12,193,686 		JBrowse link
G Naa35 N(alpha)-acetyltransferase 35, NatC auxiliary subunit decreases expression EXP fullerene C60 results in decreased expression of NAA35 mRNA CTD PMID:19167457 NCBI chr17:5,034,360...5,086,456
Ensembl chr17:5,034,356...5,086,386 		JBrowse link
G Nagpa N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase increases expression EXP fullerene C60 results in increased expression of NAGPA mRNA CTD PMID:19167457 NCBI chr10:10,380,262...10,388,609
Ensembl chr10:10,380,264...10,388,592 		JBrowse link
G Naxe NAD(P)HX epimerase decreases expression EXP fullerene C60 results in decreased expression of NAXE mRNA CTD PMID:19167457 NCBI chr 2:173,518,971...173,521,036
Ensembl chr 2:173,518,971...173,521,040 		JBrowse link
G Nbr1 NBR1, autophagy cargo receptor increases expression EXP fullerene C60 results in increased expression of NBR1 mRNA CTD PMID:19167457 NCBI chr10:86,978,024...87,006,664
Ensembl chr10:86,478,290...86,506,412 		JBrowse link
G Ncl-ps1 nucleolin, pseudogene 1 affects expression EXP fullerene C60 affects the expression of NCL-PS1 mRNA CTD PMID:19167457 NCBI chr15:3,698,175...3,699,885 JBrowse link
G Ncoa3 nuclear receptor coactivator 3 increases expression EXP fullerene C60 results in increased expression of NCOA3 mRNA CTD PMID:19167457 NCBI chr 3:175,157,824...175,237,831
Ensembl chr 3:154,738,581...154,818,594 		JBrowse link
G Ncoa6 nuclear receptor coactivator 6 increases expression EXP fullerene C60 results in increased expression of NCOA6 mRNA CTD PMID:19167457 NCBI chr 3:164,351,062...164,422,079
Ensembl chr 3:143,890,896...143,952,268 		JBrowse link
G Ncor1 nuclear receptor co-repressor 1 increases expression EXP fullerene C60 results in increased expression of NCOR1 mRNA CTD PMID:19167457 NCBI chr10:47,498,852...47,641,612
Ensembl chr10:46,999,536...47,141,032 		JBrowse link
G Ndufb3 NADH:ubiquinone oxidoreductase subunit B3 decreases expression EXP fullerene C60 results in decreased expression of NDUFB3 mRNA CTD PMID:19167457 NCBI chr 9:67,623,417...67,633,629
Ensembl chr 9:60,129,154...60,139,446 		JBrowse link
G Ndufc2 NADH:ubiquinone oxidoreductase subunit C2 increases expression EXP fullerene C60 results in increased expression of NDUFC2 mRNA CTD PMID:19167457 NCBI chr 1:161,122,370...161,129,413
Ensembl chr 1:151,711,901...151,718,189 		JBrowse link
G Nectin1 nectin cell adhesion molecule 1 decreases expression EXP fullerene C60 results in decreased expression of NECTIN1 mRNA CTD PMID:19167457 NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:44,101,776...44,189,787 		JBrowse link
G Nell2 neural EGFL like 2 increases expression EXP fullerene C60 results in increased expression of NELL2 mRNA CTD PMID:19167457 NCBI chr 7:126,343,089...126,662,903
Ensembl chr 7:126,198,851...126,733,503 		JBrowse link
G Nemp2 nuclear envelope integral membrane protein 2 decreases expression EXP fullerene C60 results in decreased expression of NEMP2 mRNA CTD PMID:19167457 NCBI chr 9:48,861,252...48,880,565
Ensembl chr 9:48,861,252...48,880,512 		JBrowse link
G Neurod2 neuronal differentiation 2 decreases expression EXP fullerene C60 results in decreased expression of NEUROD2 mRNA CTD PMID:19167457 NCBI chr10:83,820,092...83,824,277
Ensembl chr10:83,324,442...83,327,986 		JBrowse link
G Neurod6 neuronal differentiation 6 decreases expression EXP fullerene C60 results in decreased expression of NEUROD6 mRNA CTD PMID:19167457 NCBI chr 4:84,846,659...84,849,905
Ensembl chr 4:84,846,231...84,849,999 		JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated decreases expression EXP fullerene C60 results in decreased expression of NFIL3 mRNA CTD PMID:19167457 NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,280,484...12,295,858 		JBrowse link
G Nfix nuclear factor I X increases expression EXP fullerene C60 results in increased expression of NFIX mRNA CTD PMID:19167457 NCBI chr19:40,259,873...40,356,966
Ensembl chr19:23,355,498...23,448,265 		JBrowse link
G Nfkbia NFKB inhibitor alpha decreases expression EXP fullerene C60 results in decreased expression of NFKBIA mRNA CTD PMID:19167457 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Nfkbiz NFKB inhibitor zeta decreases expression EXP fullerene C60 results in decreased expression of NFKBIZ mRNA CTD PMID:19167457 NCBI chr11:58,251,720...58,279,767
Ensembl chr11:44,782,676...44,810,723 		JBrowse link
G Nfrkb nuclear factor related to kappa B binding protein increases expression EXP fullerene C60 results in increased expression of NFRKB mRNA CTD PMID:19167457 NCBI chr 8:38,089,574...38,121,506
Ensembl chr 8:29,831,812...29,863,359 		JBrowse link
G Ngf nerve growth factor affects expression EXP fullerene C60 affects the expression of NGF mRNA CTD PMID:19167457 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452 		JBrowse link
G Ngfr nerve growth factor receptor increases expression EXP fullerene C60 results in increased expression of NGFR mRNA CTD PMID:19167457 NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518 		JBrowse link
G Nherf1 NHERF family PDZ scaffold protein 1 decreases expression EXP fullerene C60 results in decreased expression of NHERF1 mRNA CTD PMID:19167457 NCBI chr10:100,902,165...100,919,265
Ensembl chr10:100,403,069...100,420,598 		JBrowse link
G Nherf2 NHERF family PDZ scaffold protein 2 increases expression
decreases expression		 EXP fullerene C60 results in increased expression of NHERF2 mRNA
fullerene C60 results in decreased expression of NHERF2 mRNA		 CTD PMID:19167457 NCBI chr10:14,167,005...14,177,519
Ensembl chr10:13,662,461...13,673,049 		JBrowse link
G Niban2 niban apoptosis regulator 2 increases expression EXP fullerene C60 results in increased expression of NIBAN2 mRNA CTD PMID:19167457 NCBI chr 3:36,572,356...36,621,968
Ensembl chr 3:16,174,659...16,224,293 		JBrowse link
G Ninj2 ninjurin 2 increases expression EXP fullerene C60 results in increased expression of NINJ2 mRNA CTD PMID:19167457 NCBI chr 4:154,978,660...155,080,860
Ensembl chr 4:153,306,553...153,408,617 		JBrowse link
G Nisch nischarin increases expression EXP fullerene C60 results in increased expression of NISCH mRNA CTD PMID:19167457 NCBI chr16:6,370,809...6,407,104
Ensembl chr16:6,364,374...6,400,668 		JBrowse link
G Nkrf NFKB repressing factor decreases expression EXP fullerene C60 results in decreased expression of NKRF mRNA CTD PMID:19167457 NCBI chr  X:116,126,341...116,144,554
Ensembl chr  X:116,128,798...116,144,628 		JBrowse link
G Nkx3-1 NK3 homeobox 1 decreases expression EXP fullerene C60 results in decreased expression of NKX3-1 mRNA CTD PMID:19167457 NCBI chr15:50,883,661...50,886,253
Ensembl chr15:44,473,851...44,476,441 		JBrowse link
G Nlgn3 neuroligin 3 decreases expression EXP fullerene C60 results in decreased expression of NLGN3 mRNA CTD PMID:19167457 NCBI chr  X:70,469,251...70,497,380
Ensembl chr  X:66,429,458...66,451,876 		JBrowse link
G Nlrx1 NLR family member X1 increases expression EXP fullerene C60 results in increased expression of NLRX1 mRNA CTD PMID:19167457 NCBI chr 8:53,486,866...53,503,498
Ensembl chr 8:44,590,048...44,606,484 		JBrowse link
G Nos3 nitric oxide synthase 3 increases expression EXP fullerene C60 results in increased expression of NOS3 mRNA CTD PMID:19167457 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166 		JBrowse link
G Notch2 notch receptor 2 decreases expression EXP fullerene C60 results in decreased expression of NOTCH2 mRNA CTD PMID:19167457 NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:185,610,589...185,744,088 		JBrowse link
G Npbwr1 neuropeptides B and W receptor 1 increases expression EXP fullerene C60 results in increased expression of NPBWR1 mRNA CTD PMID:19167457 NCBI chr 5:18,282,180...18,285,622
Ensembl chr 5:13,495,426...13,496,415 		JBrowse link
G Nphp4 nephrocystin 4 increases expression EXP fullerene C60 results in increased expression of NPHP4 mRNA CTD PMID:19167457 NCBI chr 5:168,270,522...168,356,393
Ensembl chr 5:162,988,370...163,073,706 		JBrowse link
G Nppa natriuretic peptide A decreases expression EXP fullerene C60 results in decreased expression of NPPA mRNA CTD PMID:19167457 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351 		JBrowse link
G Npr3 natriuretic peptide receptor 3 decreases expression EXP fullerene C60 results in decreased expression of NPR3 mRNA CTD PMID:19167457 NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:60,870,594...60,932,955 		JBrowse link
G Npvf neuropeptide VF precursor decreases expression EXP fullerene C60 results in decreased expression of NPVF mRNA CTD PMID:19167457 NCBI chr 4:81,043,128...81,047,045
Ensembl chr 4:79,712,520...79,716,236 		JBrowse link
G Npy neuropeptide Y increases expression EXP fullerene C60 results in increased expression of NPY mRNA CTD PMID:19167457 NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495 		JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 increases expression EXP fullerene C60 results in increased expression of NR1D1 mRNA CTD PMID:19167457 NCBI chr10:84,224,599...84,231,812
Ensembl chr10:83,728,318...83,735,705 		JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 increases expression EXP fullerene C60 results in increased expression of NR1D2 mRNA CTD PMID:19167457 NCBI chr15:9,955,034...9,981,329
Ensembl chr15:7,524,257...7,550,553 		JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 decreases expression EXP fullerene C60 results in decreased expression of NR4A3 mRNA CTD PMID:19167457 NCBI chr 5:67,157,141...67,198,287
Ensembl chr 5:62,361,822...62,402,733 		JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 decreases expression EXP fullerene C60 results in decreased expression of NR5A2 mRNA CTD PMID:19167457 NCBI chr13:50,865,253...50,985,107
Ensembl chr13:48,316,301...48,433,326 		JBrowse link
G Nrg2 neuregulin 2 decreases expression EXP fullerene C60 results in decreased expression of NRG2 mRNA CTD PMID:19167457 NCBI chr18:27,890,578...28,072,538
Ensembl chr18:27,619,661...27,798,505 		JBrowse link
G Nrgn neurogranin decreases expression EXP fullerene C60 results in decreased expression of NRGN mRNA CTD PMID:19167457 NCBI chr 8:37,255,462...37,263,659
Ensembl chr 8:37,256,930...37,257,516 		JBrowse link
G Nrsn1 neurensin 1 decreases expression EXP fullerene C60 results in decreased expression of NRSN1 mRNA CTD PMID:19167457 NCBI chr17:40,234,302...40,252,614
Ensembl chr17:39,806,238...39,823,813 		JBrowse link
G Nsg1 neuronal vesicle trafficking associated 1 decreases expression EXP fullerene C60 results in decreased expression of NSG1 mRNA CTD PMID:19167457 NCBI chr14:76,861,079...76,882,822
Ensembl chr14:72,648,741...72,670,514 		JBrowse link
G Nsmf NMDA receptor synaptonuclear signaling and neuronal migration factor increases expression EXP fullerene C60 results in increased expression of NSMF mRNA CTD PMID:19167457 NCBI chr 3:7,861,846...7,870,615
Ensembl chr 3:7,861,872...7,870,614 		JBrowse link
G Ntm neurotrimin decreases expression EXP fullerene C60 results in decreased expression of NTM mRNA CTD PMID:19167457 NCBI chr 8:35,634,929...36,625,081
Ensembl chr 8:27,377,773...28,366,595 		JBrowse link
G Ntn5 netrin 5 decreases expression EXP fullerene C60 results in decreased expression of NTN5 mRNA CTD PMID:19167457 NCBI chr 1:96,156,948...96,165,997
Ensembl chr 1:96,156,985...96,165,630 		JBrowse link
G Ntrk3 neurotrophic receptor tyrosine kinase 3 decreases expression EXP fullerene C60 results in decreased expression of NTRK3 mRNA CTD PMID:19167457 NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:132,132,849...132,503,286 		JBrowse link
G Ntsr2 neurotensin receptor 2 decreases expression EXP fullerene C60 results in decreased expression of NTSR2 mRNA CTD PMID:19167457 NCBI chr 6:45,153,095...45,159,783
Ensembl chr 6:39,424,324...39,431,014 		JBrowse link
G Nucb1 nucleobindin 1 increases expression EXP fullerene C60 results in increased expression of NUCB1 mRNA CTD PMID:19167457 NCBI chr 1:105,104,793...105,135,730
Ensembl chr 1:95,968,326...96,003,220 		JBrowse link
G Nudt4 nudix hydrolase 4 decreases expression EXP fullerene C60 results in decreased expression of NUDT4 mRNA CTD PMID:19167457 NCBI chr 7:30,188,100...30,204,615
Ensembl chr 7:30,188,100...30,204,615 		JBrowse link
G Nup62 nucleoporin 62 increases expression EXP fullerene C60 results in increased expression of NUP62 mRNA CTD PMID:19167457 NCBI chr 1:104,435,532...104,451,392
Ensembl chr 1:95,295,526...95,315,174 		JBrowse link
G Nup98 nucleoporin 98 and 96 precursor decreases expression EXP fullerene C60 results in decreased expression of NUP98 mRNA CTD PMID:19167457 NCBI chr 1:165,906,405...166,003,366
Ensembl chr 1:156,494,423...156,591,415 		JBrowse link
G Nxn nucleoredoxin decreases expression EXP fullerene C60 results in decreased expression of NXN mRNA CTD PMID:19167457 NCBI chr10:61,607,557...61,745,807
Ensembl chr10:61,110,020...61,248,251 		JBrowse link
G Nxt1 nuclear transport factor 2-like export factor 1 decreases expression EXP fullerene C60 results in decreased expression of NXT1 mRNA CTD PMID:19167457 NCBI chr 3:156,562,121...156,565,043
Ensembl chr 3:136,108,862...136,111,907 		JBrowse link
G Oaz2 ornithine decarboxylase antizyme 2 decreases expression EXP fullerene C60 results in decreased expression of OAZ2 mRNA CTD PMID:19167457 NCBI chr 8:75,094,817...75,108,634
Ensembl chr 8:66,199,706...66,231,453 		JBrowse link
G Oaz3 ornithine decarboxylase antizyme 3 decreases expression EXP fullerene C60 results in decreased expression of OAZ3 mRNA CTD PMID:19167457 NCBI chr 2:184,762,242...184,765,176
Ensembl chr 2:182,073,215...182,082,399 		JBrowse link
G Odc1 ornithine decarboxylase 1 decreases expression EXP fullerene C60 results in decreased expression of ODC1 mRNA CTD PMID:19167457 NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:40,329,964...40,336,440 		JBrowse link
G Ogdhl oxoglutarate dehydrogenase L decreases expression EXP fullerene C60 results in decreased expression of OGDHL mRNA CTD PMID:19167457 NCBI chr16:7,584,666...7,610,705
Ensembl chr16:7,578,367...7,604,386 		JBrowse link
G Ogg1 8-oxoguanine DNA glycosylase increases expression EXP fullerene C60 results in increased expression of OGG1 mRNA CTD PMID:19479010 NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766 		JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase affects expression EXP fullerene C60 affects the expression of OGT mRNA CTD PMID:19167457 NCBI chr  X:70,811,317...70,856,123
Ensembl chr  X:66,771,349...66,816,146 		JBrowse link
G Oit3 oncoprotein induced transcript 3 decreases expression EXP fullerene C60 results in decreased expression of OIT3 mRNA CTD PMID:19167457 NCBI chr20:27,390,113...27,410,692
Ensembl chr20:27,390,113...27,410,692 		JBrowse link
G Olfm2 olfactomedin 2 decreases expression EXP fullerene C60 results in decreased expression of OLFM2 mRNA CTD PMID:19167457 NCBI chr 8:19,204,472...19,282,154
Ensembl chr 8:19,204,475...19,282,117 		JBrowse link
G Olr1 oxidized low density lipoprotein receptor 1 increases expression EXP fullerene C60 results in increased expression of OLR1 mRNA CTD PMID:19167457 NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:162,926,439...162,948,523 		JBrowse link
G Olr1191 olfactory receptor 1191 decreases expression EXP fullerene C60 results in decreased expression of OLR1191 mRNA CTD PMID:19167457 NCBI chr 8:27,081,112...27,082,041
Ensembl chr 8:18,804,864...18,805,793 		JBrowse link
G Olr1198 olfactory receptor 1198 decreases expression EXP fullerene C60 results in decreased expression of OLR1198 mRNA CTD PMID:19167457 NCBI chr 8:45,764,097...45,765,026
Ensembl chr 8:37,574,531...37,576,995 		JBrowse link
G Olr551 olfactory receptor 551 decreases expression EXP fullerene C60 results in decreased expression of OLR551 mRNA CTD PMID:19167457 NCBI chr 3:92,982,993...92,983,931
Ensembl chr 3:72,526,005...72,526,943 		JBrowse link
G Olr59 olfactory receptor 59 decreases expression EXP fullerene C60 results in decreased expression of OLR59 mRNA CTD PMID:19167457 NCBI chr 1:166,604,972...166,639,634
Ensembl chr 1:157,193,080...157,211,179 		JBrowse link
G Omp olfactory marker protein increases expression EXP fullerene C60 results in increased expression of OMP mRNA CTD PMID:19167457 NCBI chr 1:152,440,278...152,440,828
Ensembl chr 1:152,433,652...152,441,922 		JBrowse link
G Opcml opioid binding protein/cell adhesion molecule-like decreases expression EXP fullerene C60 results in decreased expression of OPCML mRNA CTD PMID:19167457 NCBI chr 8:26,788,988...27,304,551
Ensembl chr 8:26,192,841...27,300,620 		JBrowse link
G Oprd1 opioid receptor, delta 1 decreases expression EXP fullerene C60 results in decreased expression of OPRD1 mRNA CTD PMID:19167457 NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960 		JBrowse link
G Or10a2 olfactory receptor family 10 subfamily A member 2 decreases expression EXP fullerene C60 results in decreased expression of OR10A2 mRNA CTD PMID:19167457 NCBI chr 1:170,359,819...170,360,772
Ensembl chr 1:160,945,152...160,951,529 		JBrowse link
G Or10ag59b olfactory receptor family 10 subfamily AG member 59B decreases expression EXP fullerene C60 results in decreased expression of OR10AG59B mRNA CTD PMID:19167457 NCBI chr 3:93,260,040...93,260,984
Ensembl chr 3:72,803,755...72,804,699 		JBrowse link
G Or10c1 olfactory receptor family 10 subfamily C member 1 increases expression EXP fullerene C60 results in increased expression of OR10C1 mRNA CTD PMID:19167457 NCBI chr20:1,375,847...1,376,785
Ensembl chr20:1,370,586...1,371,563 		JBrowse link
G Or11h23b olfactory receptor family 11 subfamily H member 23B decreases expression EXP fullerene C60 results in decreased expression of OR11H23B mRNA CTD PMID:19167457 NCBI chr15:26,280,168...26,281,106
Ensembl chr15:23,806,594...23,807,532 		JBrowse link
G Or13a27e olfactory receptor family 13 subfamily A member 27E decreases expression EXP fullerene C60 results in decreased expression of OR13A27E mRNA CTD PMID:19167457 NCBI chr 1:205,068,855...205,069,787
Ensembl chr 1:195,630,495...195,641,181 		JBrowse link
G Or14j5e olfactory receptor family 14 subfamily J member 5E decreases expression EXP fullerene C60 results in decreased expression of OR14J5E mRNA CTD PMID:19167457 NCBI chr20:598,816...599,820
Ensembl chr20:589,265...599,909 		JBrowse link
G Or1a1 olfactory receptor family 1 subfamily A member 1 decreases expression EXP fullerene C60 results in decreased expression of OR1A1 mRNA CTD PMID:19167457 NCBI chr10:59,557,386...59,558,324
Ensembl chr10:59,052,828...59,060,676 		JBrowse link
G Or1f20 olfactory receptor family 1 subfamily F member 20 decreases expression EXP fullerene C60 results in decreased expression of OR1F20 mRNA CTD PMID:19167457 NCBI chr10:12,585,633...12,643,095
Ensembl chr10:12,127,874...12,129,839 		JBrowse link
G Or1f26 olfactory receptor family 1 subfamily F member 26 increases expression EXP fullerene C60 results in increased expression of OR1F26 mRNA CTD PMID:19167457 NCBI chr10:12,808,716...12,809,657 JBrowse link
G Or1f30 olfactory receptor family 1 subfamily F member 30 decreases expression EXP fullerene C60 results in decreased expression of OR1F30 mRNA CTD PMID:19167457 NCBI chr10:12,987,662...12,988,603
Ensembl chr10:12,481,906...12,484,513 		JBrowse link
G Or1f45 olfactory receptor family 1 subfamily F member 45 decreases expression EXP fullerene C60 results in decreased expression of OR1F45 mRNA CTD PMID:19167457 NCBI chr10:12,497,516...12,498,457
Ensembl chr10:11,992,870...11,993,811
Ensembl chr10:11,992,870...11,993,811 		JBrowse link
G Or1j19 olfactory receptor family 1 subfamily J member 19 decreases expression EXP fullerene C60 results in decreased expression of OR1J19 mRNA CTD PMID:19167457 NCBI chr 3:40,727,817...40,732,751
Ensembl chr 3:20,338,376...20,341,870
Ensembl chr 3:20,338,376...20,341,870 		JBrowse link
G Or1j22 olfactory receptor family 1 subfamily J member 22 decreases expression EXP fullerene C60 results in decreased expression of OR1J22 mRNA CTD PMID:19167457 NCBI chr 3:40,236,165...40,237,094
Ensembl chr 3:19,836,418...19,839,913 		JBrowse link
G Or1p1e olfactory receptor family 1 subfamily P member 1E decreases expression EXP fullerene C60 results in decreased expression of OR1P1 mRNA; fullerene C60 results in decreased expression of OR1P1E mRNA CTD PMID:19167457 NCBI chr10:59,591,976...59,592,947 JBrowse link
G Or2d36b olfactory receptor family 2 subfamily D member 36B decreases expression EXP fullerene C60 results in decreased expression of OR2D36B mRNA CTD PMID:19167457 NCBI chr 1:170,342,043...170,342,987
Ensembl chr 1:160,927,587...160,935,889 		JBrowse link
G Or2h2c olfactory receptor family 2 subfamily H member 2C decreases expression EXP fullerene C60 results in decreased expression of OR2H2 mRNA CTD PMID:19167457 NCBI chr20:1,404,211...1,405,149
Ensembl chr20:1,395,108...1,400,441 		JBrowse link
G Or2n1i olfactory receptor family 2 subfamily N member 1I decreases expression EXP fullerene C60 results in decreased expression of OR2N1I mRNA CTD PMID:19167457 NCBI chr20:389,914...390,852
Ensembl chr20:297,043...354,706 		JBrowse link
G Or2w6 olfactory receptor family 2 subfamily W member 6 decreases expression EXP fullerene C60 results in decreased expression of OR2W6 mRNA CTD PMID:19167457 NCBI chr17:47,596,741...47,603,138
Ensembl chr17:42,904,951...42,919,599 		JBrowse link
G Or4a47 olfactory receptor family 4 subfamily A member 47 decreases expression EXP fullerene C60 results in decreased expression of OR4A47 mRNA CTD PMID:19167457 NCBI chr 3:96,330,089...96,331,018
Ensembl chr 3:75,871,362...75,879,648 		JBrowse link
G Or4c103b olfactory receptor family 4 subfamily C member 103B decreases expression EXP fullerene C60 results in decreased expression of OR4C103 mRNA CTD PMID:19167457 NCBI chr 3:94,856,835...94,857,761
Ensembl chr 3:74,397,673...74,405,942 		JBrowse link
G Or4c35 olfactory receptor family 4 subfamily C member 35 increases expression EXP fullerene C60 results in increased expression of OR4C35 mRNA CTD PMID:19167457 NCBI chr 3:96,449,536...96,450,468
Ensembl chr 3:75,990,392...75,994,675 		JBrowse link
G Or4f53b olfactory receptor family 4 subfamily F member 53B decreases expression EXP fullerene C60 results in decreased expression of OR4F53B mRNA CTD PMID:19167457 NCBI chr 3:118,322,435...118,323,373
Ensembl chr 3:97,865,457...97,868,940 		JBrowse link
G Or4f60b olfactory receptor family 4 subfamily F member 60B decreases expression EXP fullerene C60 results in decreased expression of OR4F60B mRNA CTD PMID:19167457 NCBI chr 3:119,096,342...119,097,277
Ensembl chr 3:98,641,837...98,642,772 		JBrowse link
G Or4n4 olfactory receptor family 4 subfamily N member 4 decreases expression EXP fullerene C60 results in decreased expression of OR4N4 mRNA CTD PMID:19167457 NCBI chr15:25,968,149...25,969,140
Ensembl chr15:23,492,445...23,498,563 		JBrowse link
G Or4x13 olfactory receptor family 4 subfamily X member 13 decreases expression EXP fullerene C60 results in decreased expression of OR4X11 mRNA CTD PMID:19167457 NCBI chr 3:96,819,903...96,820,832
Ensembl chr 3:76,338,893...76,342,434
Ensembl chr 3:76,338,893...76,342,434 		JBrowse link
G Or51f4 olfactory receptor family 51 subfamily F member 4 decreases expression EXP fullerene C60 results in decreased expression of OR51F4 mRNA CTD PMID:19167457 NCBI chr 1:166,666,225...166,670,094
Ensembl chr 1:157,257,231...157,258,175 		JBrowse link
G Or52e15c olfactory receptor family 52 subfamily E member 15C decreases expression EXP fullerene C60 results in decreased expression of OR52E15C mRNA CTD PMID:19167457 NCBI chr 1:168,813,740...168,814,681
Ensembl chr 1:159,401,808...159,408,026 		JBrowse link
G Or52p1 olfactory receptor family 52 subfamily P member 1 increases expression EXP fullerene C60 results in increased expression of OR52P1 mRNA CTD PMID:19167457 NCBI chr 1:168,301,668...168,302,657
Ensembl chr 1:158,885,881...158,893,038 		JBrowse link
G Or56a5 olfactory receptor family 56 subfamily A member 5 decreases expression EXP fullerene C60 results in decreased expression of OR56A5 mRNA CTD PMID:19167457 NCBI chr 1:168,912,530...168,913,468
Ensembl chr 1:159,500,672...159,501,610 		JBrowse link
G Or5aq1d olfactory receptor family 5 subfamily AQ member 1D decreases expression EXP fullerene C60 results in decreased expression of OR5AQ1D mRNA CTD PMID:19167457 NCBI chr 3:92,826,559...92,880,020
Ensembl chr 3:72,378,931...72,508,391 		JBrowse link
G Or5h17c olfactory receptor family 5 subfamily H member 17C decreases expression EXP fullerene C60 results in decreased expression of OR5H17C mRNA CTD PMID:19167457 NCBI chr11:54,987,072...54,988,001
Ensembl chr11:41,516,242...41,523,737 		JBrowse link
G Or5h18 olfactory receptor family 5 subfamily H member 18 decreases expression EXP fullerene C60 results in decreased expression of OR5H26 mRNA CTD PMID:19167457 NCBI chr11:54,874,390...54,893,013
Ensembl chr11:41,385,342...41,424,011 		JBrowse link
G Or5l14b olfactory receptor family 5 subfamily L member 14B decreases expression EXP fullerene C60 results in decreased expression of OR5L14B mRNA CTD PMID:19167457 NCBI chr 3:93,888,961...93,889,899
Ensembl chr 3:73,432,677...73,433,615
Ensembl chr 3:73,432,677...73,433,615 		JBrowse link
G Or5p5b olfactory receptor family 5 subfamily P member 5B decreases expression EXP fullerene C60 results in decreased expression of OR5P5B mRNA CTD PMID:19167457 NCBI chr 1:171,147,442...171,148,380
Ensembl chr 1:161,735,695...161,736,633 		JBrowse link
G Or6b1 olfactory receptor family 6 subfamily B member 1 decreases expression EXP fullerene C60 results in decreased expression of OR6B1 mRNA CTD PMID:19167457 NCBI chr 4:72,800,004...72,800,939
Ensembl chr 4:71,796,561...71,802,656 		JBrowse link
G Or6b3 olfactory receptor family 6 subfamily B member 3 decreases expression EXP fullerene C60 results in decreased expression of OR6B2 mRNA CTD PMID:19167457 NCBI chr 9:100,517,492...100,518,430
Ensembl chr 9:93,067,048...93,077,530 		JBrowse link
G Or6c214b olfactory receptor family 6 subfamily C member 214B decreases expression EXP fullerene C60 results in decreased expression of OR6C214B mRNA CTD PMID:19167457 NCBI chr 7:3,881,713...3,882,648
Ensembl chr 7:3,232,698...3,233,633 		JBrowse link
G Or6c35d olfactory receptor family 6 subfamily C member 35D decreases expression EXP fullerene C60 results in decreased expression of OR6C35D mRNA CTD PMID:19167457 NCBI chr 7:3,478,247...3,479,182
Ensembl chr 7:2,829,238...2,830,173 		JBrowse link
G Or6c6i olfactory receptor family 6 subfamily C member 6I decreases expression EXP fullerene C60 results in decreased expression of OR6C6I mRNA CTD PMID:19167457 NCBI chr 7:2,598,438...2,599,382
Ensembl chr 7:1,969,945...1,970,889
Ensembl chr 7:1,969,945...1,970,889 		JBrowse link
G Or6c76b olfactory receptor family 6 subfamily C member 76B decreases expression EXP fullerene C60 results in decreased expression of OR6C76B mRNA CTD PMID:19167457 NCBI chr 7:3,765,256...3,771,688
Ensembl chr 7:3,121,741...3,122,676 		JBrowse link
G Or6e1 olfactory receptor family 6 subfamily E member 1 decreases expression EXP fullerene C60 results in decreased expression of OR6E1 mRNA CTD PMID:19167457 NCBI chr15:31,703,919...31,704,863
Ensembl chr15:27,729,827...27,736,945 		JBrowse link
G Or6x1 olfactory receptor family 6 subfamily X member 1 decreases expression EXP fullerene C60 results in decreased expression of OR6X1 mRNA CTD PMID:19167457 NCBI chr 8:49,435,318...49,436,256
Ensembl chr 8:40,533,033...40,541,586 		JBrowse link
G Or6y1 olfactory receptor family 6 subfamily Y member 1 decreases expression EXP fullerene C60 results in decreased expression of OR6Y1 mRNA CTD PMID:19167457 NCBI chr13:88,925,706...88,926,683
Ensembl chr13:86,393,381...86,394,358 		JBrowse link
G Or7g34b olfactory receptor family 7 subfamily G member 34B decreases expression EXP fullerene C60 results in decreased expression of OR7G34B mRNA CTD PMID:19167457 NCBI chr 8:25,774,598...25,775,536
Ensembl chr 8:17,498,328...17,499,275 		JBrowse link
G Or7h7 olfactory receptor family 7 subfamily H member 7 decreases expression EXP fullerene C60 results in decreased expression of OR7H7 mRNA CTD PMID:19167457 NCBI chr 8:27,110,036...27,111,001
Ensembl chr 8:18,823,703...18,834,759 		JBrowse link
G Or8c10b olfactory receptor family 8 subfamily C member 10B decreases expression EXP fullerene C60 results in decreased expression of OR8C10B mRNA CTD PMID:19167457 NCBI chr 8:47,348,578...47,349,519
Ensembl chr 8:38,451,349...38,452,290 		JBrowse link
G Or8u3 olfactory receptor family 8 subfamily U member 3 decreases expression EXP fullerene C60 results in decreased expression of OR8U3 mRNA CTD PMID:19167457 NCBI chr 3:91,514,054...91,515,013
Ensembl chr 3:71,107,387...71,108,346 		JBrowse link
G Orai1 ORAI calcium release-activated calcium modulator 1 increases expression EXP fullerene C60 results in increased expression of ORAI1 mRNA CTD PMID:19167457 NCBI chr12:39,195,139...39,209,030
Ensembl chr12:33,534,344...33,548,405 		JBrowse link
G Orm1 orosomucoid 1 increases expression EXP fullerene C60 results in increased expression of ORM1 mRNA CTD PMID:20471445 NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:76,772,941...76,776,154 		JBrowse link
G Osbp2 oxysterol binding protein 2 decreases expression EXP fullerene C60 results in decreased expression of OSBP2 mRNA CTD PMID:19167457 NCBI chr14:82,808,693...82,970,386
Ensembl chr14:78,585,089...78,746,786 		JBrowse link
G Osbpl10 oxysterol binding protein-like 10 increases expression EXP fullerene C60 results in increased expression of OSBPL10 mRNA CTD PMID:19167457 NCBI chr 8:114,661,050...114,918,664
Ensembl chr 8:114,660,743...114,918,625 		JBrowse link
G Osbpl5 oxysterol binding protein-like 5 increases expression EXP fullerene C60 results in increased expression of OSBPL5 mRNA CTD PMID:19167457 NCBI chr 1:198,862,071...198,916,469
Ensembl chr 1:198,862,055...198,916,469 		JBrowse link
G Osr1 odd-skipped related transcription factor 1 decreases expression EXP fullerene C60 results in decreased expression of OSR1 mRNA CTD PMID:19167457 NCBI chr 6:32,369,561...32,380,822
Ensembl chr 6:32,373,816...32,380,817 		JBrowse link
G Ostc oligosaccharyltransferase complex non-catalytic subunit decreases expression EXP fullerene C60 results in decreased expression of OSTC mRNA CTD PMID:19167457 NCBI chr 2:219,250,549...219,266,076
Ensembl chr 2:219,236,952...219,266,107 		JBrowse link
G Otop1 otopetrin 1 decreases expression EXP fullerene C60 results in decreased expression of OTOP1 mRNA CTD PMID:19167457 NCBI chr14:76,717,330...76,744,785
Ensembl chr14:72,503,592...72,532,497 		JBrowse link
G Otop3 otopetrin 3 decreases expression EXP fullerene C60 results in decreased expression of OTOP3 mRNA CTD PMID:19167457 NCBI chr10:100,577,346...100,588,729
Ensembl chr10:100,577,392...100,588,726 		JBrowse link
G Oxnad1 oxidoreductase NAD-binding domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of OXNAD1 mRNA CTD PMID:19167457 NCBI chr16:7,293,470...7,322,540
Ensembl chr16:7,293,470...7,322,540 		JBrowse link
G P2rx2 purinergic receptor P2X 2 decreases expression EXP fullerene C60 results in decreased expression of P2RX2 mRNA CTD PMID:19167457 NCBI chr12:51,999,107...52,002,627
Ensembl chr12:46,339,549...46,342,891 		JBrowse link
G P2rx7 purinergic receptor P2X 7 multiple interactions ISO P2RX7 protein affects the reaction [fullerene C60 results in increased secretion of HMGB1 protein] CTD PMID:31504961 NCBI chr12:39,550,531...39,594,984
Ensembl chr12:33,879,745...33,934,619 		JBrowse link
G P3h3 prolyl 3-hydroxylase 3 increases expression EXP fullerene C60 results in increased expression of P3H3 mRNA CTD PMID:19167457 NCBI chr 4:159,332,514...159,348,428
Ensembl chr 4:157,646,243...157,662,035 		JBrowse link
G P3h4 prolyl 3-hydroxylase family member 4 increases expression EXP fullerene C60 results in increased expression of P3H4 mRNA CTD PMID:19167457 NCBI chr10:85,838,528...85,845,476
Ensembl chr10:85,338,161...85,345,093 		JBrowse link
G P4htm prolyl 4-hydroxylase, transmembrane decreases expression EXP fullerene C60 results in decreased expression of P4HTM mRNA CTD PMID:19167457 NCBI chr 8:118,153,158...118,172,199
Ensembl chr 8:109,274,626...109,292,473 		JBrowse link
G Pabpc4l poly(A) binding protein, cytoplasmic 4-like decreases expression EXP fullerene C60 results in decreased expression of PABPC4L mRNA CTD PMID:19167457 NCBI chr 2:129,807,755...129,809,745
Ensembl chr 2:129,807,755...129,809,745 		JBrowse link
G Pabpn1l PABPN1 like decreases expression EXP fullerene C60 results in decreased expression of PABPN1L mRNA CTD PMID:19167457 NCBI chr19:67,578,494...67,581,938
Ensembl chr19:50,669,967...50,673,366 		JBrowse link
G Pacs1 phosphofurin acidic cluster sorting protein 1 decreases expression EXP fullerene C60 results in decreased expression of PACS1 mRNA CTD PMID:19167457 NCBI chr 1:211,866,872...211,998,828
Ensembl chr 1:202,437,505...202,569,473 		JBrowse link
G Pacsin3 protein kinase C and casein kinase substrate in neurons 3 decreases expression EXP fullerene C60 results in decreased expression of PACSIN3 mRNA CTD PMID:19167457 NCBI chr 3:97,683,054...97,691,619
Ensembl chr 3:77,222,710...77,235,811 		JBrowse link
G Padi3 peptidyl arginine deiminase 3 decreases expression EXP fullerene C60 results in decreased expression of PADI3 mRNA CTD PMID:19167457 NCBI chr 5:153,089,717...153,117,146
Ensembl chr 5:153,089,717...153,117,146 		JBrowse link
G Paip1 poly(A) binding protein interacting protein 1 decreases expression EXP fullerene C60 results in decreased expression of PAIP1 mRNA CTD PMID:19167457 NCBI chr 2:51,523,190...51,550,241
Ensembl chr 2:51,522,921...51,550,241 		JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 decreases expression EXP fullerene C60 results in decreased expression of PAK3 mRNA CTD PMID:19167457 NCBI chr  X:111,912,967...112,171,037
Ensembl chr  X:107,260,898...107,368,314 		JBrowse link
G Pakap paralemmin A kinase anchor protein increases expression EXP fullerene C60 results in increased expression of PAKAP mRNA CTD PMID:19167457 NCBI chr 5:76,976,906...77,443,656
Ensembl chr 5:72,181,718...72,648,524 		JBrowse link
G Pan3 poly(A) specific ribonuclease subunit PAN3 increases expression EXP fullerene C60 results in increased expression of PAN3 mRNA CTD PMID:19167457 NCBI chr12:7,476,707...7,595,384
Ensembl chr12:7,476,697...7,599,204 		JBrowse link
G Papolg poly(A) polymerase gamma decreases expression EXP fullerene C60 results in decreased expression of PAPOLG mRNA CTD PMID:19167457 NCBI chr14:97,827,712...97,861,024
Ensembl chr14:97,827,712...97,861,024 		JBrowse link
G Pappa pappalysin decreases expression EXP fullerene C60 results in decreased expression of PAPPA mRNA CTD PMID:19167457 NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:78,498,300...78,730,666 		JBrowse link
G Patz1 POZ (BTB) and AT hook containing zinc finger 1 decreases expression EXP fullerene C60 results in decreased expression of PATZ1 mRNA CTD PMID:19167457 NCBI chr14:82,378,226...82,396,679
Ensembl chr14:78,152,516...78,173,032 		JBrowse link
G Pax2 paired box 2 increases expression EXP fullerene C60 results in increased expression of PAX2 mRNA CTD PMID:19167457 NCBI chr 1:253,555,447...253,646,623
Ensembl chr 1:243,616,606...243,695,321 		JBrowse link
G Pax6 paired box 6 decreases expression EXP fullerene C60 results in decreased expression of PAX6 mRNA CTD PMID:19167457 NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:92,135,637...92,157,014 		JBrowse link
G Pbp2 phosphatidylethanolamine binding protein 2 decreases expression EXP fullerene C60 results in decreased expression of PBP2 mRNA CTD PMID:19167457 NCBI chr 4:168,155,827...168,157,121
Ensembl chr 4:168,155,709...168,157,117 		JBrowse link
G Pcdh10 protocadherin 10 decreases expression EXP fullerene C60 results in decreased expression of PCDH10 mRNA CTD PMID:19167457 NCBI chr 2:128,617,212...128,683,354
Ensembl chr 2:128,617,174...128,677,190 		JBrowse link
G Pcdh17 protocadherin 17 increases expression EXP fullerene C60 results in increased expression of PCDH17 mRNA CTD PMID:19167457 NCBI chr15:66,631,549...66,725,007
Ensembl chr15:60,222,004...60,313,999 		JBrowse link
G Pcdhb3 protocadherin beta 3 decreases expression EXP fullerene C60 results in decreased expression of PCDHB3 mRNA CTD PMID:19167457 NCBI chr18:29,011,667...29,014,221
Ensembl chr18:29,011,816...29,015,188 		JBrowse link
G Pcdhga5 protocadherin gamma subfamily A, 5 decreases expression EXP fullerene C60 results in decreased expression of PCDHGA5 mRNA CTD PMID:19167457 NCBI chr18:29,519,705...29,667,865
Ensembl chr18:29,493,954...29,667,868 		JBrowse link
G Pcyt2 phosphate cytidylyltransferase 2, ethanolamine increases expression EXP fullerene C60 results in increased expression of PCYT2 mRNA CTD PMID:19167457 NCBI chr10:105,888,769...105,896,182
Ensembl chr10:105,888,775...105,896,172 		JBrowse link
G Pdcl3 phosducin-like 3 decreases expression EXP fullerene C60 results in decreased expression of PDCL3 mRNA CTD PMID:19167457 NCBI chr 9:48,730,083...48,738,554
Ensembl chr 9:41,234,234...41,243,735 		JBrowse link
G Pde10a phosphodiesterase 10A decreases expression EXP fullerene C60 results in decreased expression of PDE10A mRNA CTD PMID:19167457 NCBI chr 1:54,313,343...54,765,668
Ensembl chr 1:51,770,132...52,216,563 		JBrowse link
G Pde1b phosphodiesterase 1B decreases expression EXP fullerene C60 results in decreased expression of PDE1B mRNA CTD PMID:19167457 NCBI chr 7:136,505,834...136,533,034
Ensembl chr 7:134,627,322...134,654,580 		JBrowse link
G Pde4c phosphodiesterase 4C increases expression EXP fullerene C60 results in increased expression of PDE4C mRNA CTD PMID:19167457 NCBI chr16:18,724,703...18,745,528
Ensembl chr16:18,691,700...18,710,640 		JBrowse link
G Pde4d phosphodiesterase 4D decreases expression EXP fullerene C60 results in decreased expression of PDE4D mRNA CTD PMID:19167457 NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:40,019,933...41,525,884 		JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein affects expression EXP fullerene C60 affects the expression of PDE4DIP mRNA CTD PMID:19167457 NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:185,293,214...185,468,379 		JBrowse link
G Pde6h phosphodiesterase 6H increases expression EXP fullerene C60 results in increased expression of PDE6H mRNA CTD PMID:19167457 NCBI chr 4:171,588,896...171,604,142
Ensembl chr 4:169,857,812...169,872,969 		JBrowse link
G Pdgfb platelet derived growth factor subunit B increases expression EXP fullerene C60 results in increased expression of PDGFB mRNA CTD PMID:19167457 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984 		JBrowse link
G Pdgfrb platelet derived growth factor receptor beta decreases expression EXP fullerene C60 results in decreased expression of PDGFRB mRNA CTD PMID:19167457 NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843 		JBrowse link
G Pdha2 pyruvate dehydrogenase E1 subunit alpha 2 decreases expression EXP fullerene C60 results in decreased expression of PDHA2 mRNA CTD PMID:19167457 NCBI chr 2:232,545,550...232,547,098 JBrowse link
G Pdzd2 PDZ domain containing 2 increases expression EXP fullerene C60 results in increased expression of PDZD2 mRNA CTD PMID:19167457 NCBI chr 2:61,384,614...61,770,516
Ensembl chr 2:61,386,381...61,770,524 		JBrowse link
G Pdzd7 PDZ domain containing 7 decreases expression EXP fullerene C60 results in decreased expression of PDZD7 mRNA CTD PMID:19167457 NCBI chr 1:253,837,454...253,856,919
Ensembl chr 1:243,888,281...243,906,839 		JBrowse link
G Pdzk1 PDZ domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of PDZK1 mRNA CTD PMID:19167457 NCBI chr 2:187,064,995...187,096,348
Ensembl chr 2:184,376,161...184,407,514 		JBrowse link
G Pdzk1ip1 PDZK1 interacting protein 1 decreases expression EXP fullerene C60 results in decreased expression of PDZK1IP1 mRNA CTD PMID:19167457 NCBI chr 5:133,841,586...133,859,894
Ensembl chr 5:128,618,237...128,623,131 		JBrowse link
G Pdzrn4 PDZ domain containing RING finger 4 decreases expression EXP fullerene C60 results in decreased expression of PDZRN4 mRNA CTD PMID:19167457 NCBI chr 7:123,816,961...123,965,491
Ensembl chr 7:123,816,961...123,965,491 		JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 decreases expression EXP fullerene C60 results in decreased expression of PEBP1 mRNA CTD PMID:19167457 NCBI chr12:44,946,307...44,967,890
Ensembl chr12:39,302,840...39,307,862 		JBrowse link
G Per1 period circadian regulator 1 decreases expression EXP fullerene C60 results in decreased expression of PER1 mRNA CTD PMID:19167457 NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431 		JBrowse link
G Per2 period circadian regulator 2 increases expression EXP fullerene C60 results in increased expression of PER2 mRNA CTD PMID:19167457 NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459 		JBrowse link
G Per3 period circadian regulator 3 increases expression EXP fullerene C60 results in increased expression of PER3 mRNA CTD PMID:19167457 NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:161,459,533...161,495,607 		JBrowse link
G Pex6 peroxisomal biogenesis factor 6 increases expression EXP fullerene C60 results in increased expression of PEX6 mRNA CTD PMID:19167457 NCBI chr 9:21,755,747...21,767,939
Ensembl chr 9:14,258,145...14,270,303 		JBrowse link
G Pf4 platelet factor 4 decreases expression EXP fullerene C60 results in decreased expression of PF4 mRNA CTD PMID:19167457 NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365 		JBrowse link
G Pfas phosphoribosylformylglycinamidine synthase decreases expression EXP fullerene C60 results in decreased expression of PFAS mRNA CTD PMID:19167457 NCBI chr10:54,189,157...54,210,685
Ensembl chr10:53,691,626...53,708,420 		JBrowse link
G Pgam2 phosphoglycerate mutase 2 decreases expression EXP fullerene C60 results in decreased expression of PGAM2 mRNA CTD PMID:19167457 NCBI chr14:84,895,763...84,897,874
Ensembl chr14:80,681,776...80,683,940 		JBrowse link
G Pgbd5 piggyBac transposable element derived 5 decreases expression EXP fullerene C60 results in decreased expression of PGBD5 mRNA CTD PMID:19167457 NCBI chr19:52,336,751...52,401,906
Ensembl chr19:52,336,751...52,402,397 		JBrowse link
G Phc2 polyhomeotic homolog 2 increases expression EXP fullerene C60 results in increased expression of PHC2 mRNA CTD PMID:19167457 NCBI chr 5:141,000,604...141,099,268
Ensembl chr 5:141,050,842...141,099,268 		JBrowse link
G Phldb3 pleckstrin homology-like domain, family B, member 3 increases expression EXP fullerene C60 results in increased expression of PHLDB3 mRNA CTD PMID:19167457 NCBI chr 1:80,201,083...80,219,541
Ensembl chr 1:80,201,578...80,219,534 		JBrowse link
G Phox2a paired-like homeobox 2a decreases expression EXP fullerene C60 results in decreased expression of PHOX2A mRNA CTD PMID:19167457 NCBI chr 1:156,178,754...156,183,118
Ensembl chr 1:156,178,754...156,183,118 		JBrowse link
G Pi15 peptidase inhibitor 15 decreases expression EXP fullerene C60 results in decreased expression of PI15 mRNA CTD PMID:19167457 NCBI chr 5:1,395,094...1,423,213
Ensembl chr 5:1,395,094...1,423,213 		JBrowse link
G Piezo1 piezo-type mechanosensitive ion channel component 1 increases expression EXP fullerene C60 results in increased expression of PIEZO1 mRNA CTD PMID:19167457 NCBI chr19:67,453,120...67,515,347
Ensembl chr19:50,544,582...50,606,501 		JBrowse link
G Pik3cd phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta increases expression EXP fullerene C60 results in increased expression of PIK3CD mRNA CTD PMID:19167457 NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:160,094,952...160,120,930 		JBrowse link
G Pik3ip1 phosphoinositide-3-kinase interacting protein 1 increases expression EXP fullerene C60 results in increased expression of PIK3IP1 mRNA CTD PMID:19167457 NCBI chr14:82,428,315...82,440,261
Ensembl chr14:78,204,053...78,216,608 		JBrowse link
G Pik3r2 phosphoinositide-3-kinase regulatory subunit 2 increases expression EXP fullerene C60 results in increased expression of PIK3R2 mRNA CTD PMID:19167457 NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,665,457...18,674,065 		JBrowse link
G Pikfyve phosphoinositide kinase, FYVE-type zinc finger containing affects expression EXP fullerene C60 affects the expression of PIKFYVE mRNA CTD PMID:19167457 NCBI chr 9:74,057,488...74,151,610
Ensembl chr 9:66,563,727...66,657,868 		JBrowse link
G Pimreg PICALM interacting mitotic regulator increases expression EXP fullerene C60 results in increased expression of PIMREG mRNA CTD PMID:19167457 NCBI chr10:57,168,136...57,173,713
Ensembl chr10:56,669,675...56,674,791 		JBrowse link
G Pip5k1a phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha decreases expression EXP fullerene C60 results in decreased expression of PIP5K1A mRNA CTD PMID:19167457 NCBI chr 2:185,317,319...185,361,859
Ensembl chr 2:182,628,300...182,671,598 		JBrowse link
G Pipox pipecolic acid and sarcosine oxidase decreases expression EXP fullerene C60 results in decreased expression of PIPOX mRNA CTD PMID:19167457 NCBI chr10:63,267,946...63,281,556
Ensembl chr10:62,769,900...62,782,370 		JBrowse link
G Pirb paired Ig-like receptor B increases expression EXP fullerene C60 results in increased expression of LILRB3 mRNA CTD PMID:19167457 NCBI chr 1:74,414,556...74,433,015
Ensembl chr 1:65,499,195...65,506,666 		JBrowse link
G Pkdcc protein kinase domain containing, cytoplasmic increases expression EXP fullerene C60 results in increased expression of PKDCC mRNA CTD PMID:19167457 NCBI chr 6:17,208,171...17,217,488
Ensembl chr 6:11,455,686...11,465,556 		JBrowse link
G Pkia cAMP-dependent protein kinase inhibitor alpha decreases expression EXP fullerene C60 results in decreased expression of PKIA mRNA CTD PMID:19167457 NCBI chr 2:96,306,181...96,380,959
Ensembl chr 2:94,398,869...94,414,282 		JBrowse link
G Pkn3 protein kinase N3 increases expression EXP fullerene C60 results in increased expression of PKN3 mRNA CTD PMID:19167457 NCBI chr 3:13,350,082...13,363,572
Ensembl chr 3:13,335,041...13,363,567 		JBrowse link
G Pkp1 plakophilin 1 decreases expression EXP fullerene C60 results in decreased expression of PKP1 mRNA CTD PMID:19167457 NCBI chr13:49,861,340...49,909,162
Ensembl chr13:47,309,614...47,357,465 		JBrowse link
G Pla2g15 phospholipase A2, group XV increases expression EXP fullerene C60 results in increased expression of PLA2G15 mRNA CTD PMID:19167457 NCBI chr19:34,050,685...34,068,070
Ensembl chr19:34,050,694...34,068,063 		JBrowse link
G Pla2g1b phospholipase A2 group IB increases expression EXP fullerene C60 results in increased expression of PLA2G1B mRNA CTD PMID:19167457 NCBI chr12:46,802,932...46,814,511
Ensembl chr12:41,142,200...41,153,226 		JBrowse link
G Pla2g2a phospholipase A2 group IIA increases expression EXP fullerene C60 results in increased expression of PLA2G2A mRNA CTD PMID:19167457 NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:151,076,442...151,079,014 		JBrowse link
G Pla2g6 phospholipase A2 group VI increases expression EXP fullerene C60 results in increased expression of PLA2G6 mRNA CTD PMID:19167457 NCBI chr 7:112,731,803...112,771,978
Ensembl chr 7:110,851,378...110,891,114 		JBrowse link
G Plagl1 PLAG1 like zinc finger 1 decreases expression EXP fullerene C60 results in decreased expression of PLAGL1 mRNA CTD PMID:19167457 NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228 		JBrowse link
G Plagl2 PLAG1 like zinc finger 2 increases expression EXP fullerene C60 results in increased expression of PLAGL2 mRNA CTD PMID:19167457 NCBI chr 3:162,155,554...162,168,748
Ensembl chr 3:141,695,322...141,708,503 		JBrowse link
G Plcb1 phospholipase C beta 1 increases expression EXP fullerene C60 results in increased expression of PLCB1 mRNA CTD PMID:19167457 NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:122,060,031...122,772,869 		JBrowse link
G Plcg2 phospholipase C, gamma 2 increases expression EXP fullerene C60 results in increased expression of PLCG2 mRNA CTD PMID:19167457 NCBI chr19:62,456,196...62,592,684
Ensembl chr19:45,547,416...45,683,930 		JBrowse link
G Pld2 phospholipase D2 increases expression EXP fullerene C60 results in increased expression of PLD2 mRNA CTD PMID:19167457 NCBI chr10:55,754,957...55,772,819
Ensembl chr10:55,256,359...55,272,808 		JBrowse link
G Plekhg2 pleckstrin homology and RhoGEF domain containing G2 increases expression EXP fullerene C60 results in increased expression of PLEKHG2 mRNA CTD PMID:19167457 NCBI chr 1:83,651,902...83,665,063
Ensembl chr 1:83,647,748...83,665,063 		JBrowse link
G Plekhh1 pleckstrin homology, MyTH4 and FERM domain containing H1 increases expression EXP fullerene C60 results in increased expression of PLEKHH1 mRNA CTD PMID:19167457 NCBI chr 6:97,839,288...97,888,712
Ensembl chr 6:97,839,288...97,888,709 		JBrowse link
G Plekho2 pleckstrin homology domain containing O2 increases expression EXP fullerene C60 results in increased expression of PLEKHO2 mRNA CTD PMID:19167457 NCBI chr 8:74,973,578...75,000,532
Ensembl chr 8:66,078,448...66,105,266 		JBrowse link
G Plk3 polo-like kinase 3 increases expression EXP fullerene C60 results in increased expression of PLK3 mRNA CTD PMID:19167457 NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:130,607,142...130,612,317 		JBrowse link
G Plk5 polo-like kinase 5 increases expression EXP fullerene C60 results in increased expression of PLK5 mRNA CTD PMID:19167457 NCBI chr 7:9,346,777...9,367,923
Ensembl chr 7:9,346,777...9,355,196 		JBrowse link
G Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 increases expression EXP fullerene C60 results in increased expression of PLOD1 mRNA CTD PMID:19167457 NCBI chr 5:158,340,674...158,367,581
Ensembl chr 5:158,340,490...158,367,620 		JBrowse link
G Plp1 proteolipid protein 1 decreases expression EXP fullerene C60 results in decreased expression of PLP1 mRNA CTD PMID:19167457 NCBI chr  X:104,933,921...104,993,317
Ensembl chr  X:100,185,767...100,201,032 		JBrowse link
G Pls3 plastin 3 decreases expression EXP fullerene C60 results in decreased expression of PLS3 mRNA CTD PMID:19167457 NCBI chr  X:116,401,247...116,495,898
Ensembl chr  X:111,589,254...111,683,891 		JBrowse link
G Pltp phospholipid transfer protein increases expression EXP fullerene C60 results in increased expression of PLTP mRNA CTD PMID:19167457 NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:153,574,825...153,592,647 		JBrowse link
G Plvap plasmalemma vesicle associated protein increases expression EXP fullerene C60 results in increased expression of PLVAP mRNA CTD PMID:19167457 NCBI chr16:18,184,985...18,197,301
Ensembl chr16:18,184,975...18,197,301 		JBrowse link
G Plxdc1 plexin domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of PLXDC1 mRNA CTD PMID:19167457 NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130 		JBrowse link
G Plxna2 plexin A2 decreases expression EXP fullerene C60 results in decreased expression of PLXNA2 mRNA CTD PMID:19167457 NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979 		JBrowse link
G Plxnb2 plexin B2 increases expression EXP fullerene C60 results in increased expression of PLXNB2 mRNA CTD PMID:19167457 NCBI chr 7:120,232,276...120,258,385
Ensembl chr 7:120,232,331...120,258,330 		JBrowse link
G Pnma5 PNMA family member 5 decreases expression EXP fullerene C60 results in decreased expression of PNMA5 mRNA CTD PMID:19167457 NCBI chr  X:155,923,131...155,925,055
Ensembl chr  X:150,880,865...150,882,789 		JBrowse link
G Pnpo pyridoxamine 5'-phosphate oxidase increases expression EXP fullerene C60 results in increased expression of PNPO mRNA CTD PMID:19167457 NCBI chr10:81,924,584...81,930,844
Ensembl chr10:81,924,569...81,930,871 		JBrowse link
G Polm DNA polymerase mu increases expression EXP fullerene C60 results in increased expression of POLM mRNA CTD PMID:19167457 NCBI chr14:84,921,039...84,930,649
Ensembl chr14:80,706,345...80,717,086 		JBrowse link
G Polr1g RNA polymerase I subunit G decreases expression EXP fullerene C60 results in decreased expression of POLR1G mRNA CTD PMID:19167457 NCBI chr 1:88,135,493...88,138,769
Ensembl chr 1:79,007,490...79,010,766 		JBrowse link
G Polr2a RNA polymerase II subunit A decreases expression EXP fullerene C60 results in decreased expression of POLR2A mRNA CTD PMID:19167457 NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,452,441...54,478,455 		JBrowse link
G Popdc2 popeye domain cAMP effector 2 decreases expression EXP fullerene C60 results in decreased expression of POPDC2 mRNA CTD PMID:19167457 NCBI chr11:75,850,068...75,897,094
Ensembl chr11:62,374,759...62,390,756 		JBrowse link
G Por cytochrome p450 oxidoreductase increases expression EXP fullerene C60 results in increased expression of POR mRNA CTD PMID:19167457 NCBI chr12:26,587,674...26,655,612
Ensembl chr12:20,951,058...20,999,245 		JBrowse link
G Porcn porcupine O-acyltransferase decreases expression EXP fullerene C60 results in decreased expression of PORCN mRNA CTD PMID:19167457 NCBI chr  X:16,957,811...16,970,440
Ensembl chr  X:14,285,871...14,298,481 		JBrowse link
G Pou2f1 POU class 2 homeobox 1 decreases expression EXP fullerene C60 results in decreased expression of POU2F1 mRNA CTD PMID:19167457 NCBI chr13:80,653,602...80,796,279
Ensembl chr13:78,130,685...78,263,363 		JBrowse link
G Pou2f3 POU class 2 homeobox 3 decreases expression EXP fullerene C60 results in decreased expression of POU2F3 mRNA CTD PMID:19167457 NCBI chr 8:43,495,408...43,577,795
Ensembl chr 8:43,495,527...43,577,795 		JBrowse link
G Pp2d1 protein phosphatase 2C-like domain containing 1 increases expression EXP fullerene C60 results in increased expression of PP2D1 mRNA CTD PMID:19167457 NCBI chr 9:6,512,282...6,533,653
Ensembl chr 9:6,512,657...6,533,639 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha decreases expression EXP fullerene C60 results in decreased expression of PPARGC1A mRNA CTD PMID:19167457 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656 		JBrowse link
G Ppfia2 PTPRF interacting protein alpha 2 decreases expression EXP fullerene C60 results in decreased expression of PPFIA2 mRNA CTD PMID:19167457 NCBI chr 7:41,765,716...42,240,104
Ensembl chr 7:41,765,575...42,239,599 		JBrowse link
G Ppil3 peptidylprolyl isomerase like 3 decreases expression EXP fullerene C60 results in decreased expression of PPIL3 mRNA CTD PMID:19167457 NCBI chr 9:67,460,594...67,474,325
Ensembl chr 9:59,964,919...59,979,886 		JBrowse link
G Ppl periplakin decreases expression EXP fullerene C60 results in decreased expression of PPL mRNA CTD PMID:19167457 NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,450,919...10,496,575 		JBrowse link
G Ppm1f protein phosphatase, Mg2+/Mn2+ dependent, 1F decreases expression EXP fullerene C60 results in decreased expression of PPM1F mRNA CTD PMID:19167457 NCBI chr11:97,568,627...97,598,613
Ensembl chr11:84,064,420...84,094,340 		JBrowse link
G Ppp1r12c protein phosphatase 1, regulatory subunit 12C increases expression EXP fullerene C60 results in increased expression of PPP1R12C mRNA CTD PMID:19167457 NCBI chr 1:69,320,240...69,343,200
Ensembl chr 1:69,320,255...69,343,200 		JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A increases expression EXP fullerene C60 results in increased expression of PPP1R15A mRNA CTD PMID:19167457 NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:96,000,058...96,003,171 		JBrowse link
G Ppp1r1c protein phosphatase 1, regulatory (inhibitor) subunit 1C decreases expression EXP fullerene C60 results in decreased expression of PPP1R1C mRNA CTD PMID:19167457 NCBI chr 3:64,616,700...64,719,696
Ensembl chr 3:64,616,700...64,724,104 		JBrowse link
G Ppp1r37 protein phosphatase 1, regulatory subunit 37 increases expression EXP fullerene C60 results in increased expression of PPP1R37 mRNA CTD PMID:19167457 NCBI chr 1:79,180,794...79,212,612
Ensembl chr 1:79,180,793...79,212,612 		JBrowse link
G Ppp2r1a protein phosphatase 2 scaffold subunit A alpha decreases expression EXP fullerene C60 results in decreased expression of PPP2R1A mRNA CTD PMID:19167457 NCBI chr 1:69,213,198...69,232,441
Ensembl chr 1:60,540,194...60,560,129 		JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta decreases expression EXP fullerene C60 results in decreased expression of PPP2R1B mRNA CTD PMID:19167457 NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485 		JBrowse link
G Ppp2r5a protein phosphatase 2, regulatory subunit B', alpha increases expression EXP fullerene C60 results in increased expression of PPP2R5A mRNA CTD PMID:19167457 NCBI chr13:105,462,371...105,506,767
Ensembl chr13:102,931,264...102,975,661 		JBrowse link
G Ppp2r5b protein phosphatase 2, regulatory subunit B', beta increases expression EXP fullerene C60 results in increased expression of PPP2R5B mRNA CTD PMID:19167457 NCBI chr 1:212,956,533...212,964,706
Ensembl chr 1:203,527,270...203,535,416 		JBrowse link
G Ppp2r5d protein phosphatase 2, regulatory subunit B', delta increases expression EXP fullerene C60 results in increased expression of PPP2R5D mRNA CTD PMID:19167457 NCBI chr 9:21,767,963...21,797,997
Ensembl chr 9:14,268,745...14,300,400 		JBrowse link
G Ppp5c protein phosphatase 5, catalytic subunit increases expression EXP fullerene C60 results in increased expression of PPP5C mRNA CTD PMID:19167457 NCBI chr 1:86,818,297...86,842,505
Ensembl chr 1:77,690,208...77,714,456 		JBrowse link
G Pprc1 PPARG related coactivator 1 decreases expression EXP fullerene C60 results in decreased expression of PPRC1 mRNA CTD PMID:19167457 NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:244,902,179...244,918,587 		JBrowse link
G Prex1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 increases expression EXP fullerene C60 results in increased expression of PREX1 mRNA CTD PMID:19167457 NCBI chr 3:175,724,939...175,875,764
Ensembl chr 3:155,306,950...155,456,688 		JBrowse link
G Prickle3 prickle planar cell polarity protein 3 increases expression EXP fullerene C60 results in increased expression of PRICKLE3 mRNA CTD PMID:19167457 NCBI chr  X:14,837,647...14,849,305
Ensembl chr  X:14,837,650...14,848,218 		JBrowse link
G Prkacb protein kinase cAMP-activated catalytic subunit beta decreases expression EXP fullerene C60 results in decreased expression of PRKACB mRNA CTD PMID:19167457 NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:235,636,885...235,726,198 		JBrowse link
G Prkag3 protein kinase AMP-activated non-catalytic subunit gamma 3 decreases expression EXP fullerene C60 results in decreased expression of PRKAG3 mRNA CTD PMID:19167457 NCBI chr 9:83,744,385...83,753,629
Ensembl chr 9:76,295,715...76,304,959 		JBrowse link
G Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta decreases expression EXP fullerene C60 results in decreased expression of PRKAR1B mRNA CTD PMID:19167457 NCBI chr12:20,606,066...20,738,766
Ensembl chr12:15,511,801...15,624,942 		JBrowse link
G Prkar2a protein kinase cAMP-dependent type II regulatory subunit alpha decreases expression EXP fullerene C60 results in decreased expression of PRKAR2A mRNA CTD PMID:19167457 NCBI chr 8:118,271,608...118,337,332
Ensembl chr 8:109,395,833...109,455,628 		JBrowse link
G Prkce protein kinase C, epsilon decreases expression EXP fullerene C60 results in decreased expression of PRKCE mRNA CTD PMID:19167457 NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719 		JBrowse link
G Prkci protein kinase C, iota decreases expression EXP fullerene C60 results in decreased expression of PRKCI mRNA CTD PMID:19167457 NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:112,321,929...112,382,352 		JBrowse link
G Prkd2 protein kinase D2 increases expression EXP fullerene C60 results in increased expression of PRKD2 mRNA CTD PMID:19167457 NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:77,513,986...77,542,376 		JBrowse link
G Prkg1 protein kinase cGMP-dependent 1 decreases expression EXP fullerene C60 results in decreased expression of PRKG1 mRNA CTD PMID:19167457 NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:228,408,947...229,639,080 		JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase decreases expression EXP fullerene C60 results in decreased expression of PRKN mRNA CTD PMID:19167457 NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555 		JBrowse link
G Prl8a3 prolactin family 8, subfamily A, member 3 decreases expression EXP fullerene C60 results in decreased expression of PRL8A3 mRNA CTD PMID:19167457 NCBI chr17:37,716,716...37,723,215
Ensembl chr17:37,508,328...37,514,825 		JBrowse link
G Prmt2 protein arginine methyltransferase 2 increases expression EXP fullerene C60 results in increased expression of PRMT2 mRNA CTD PMID:19167457 NCBI chr20:12,391,388...12,420,096
Ensembl chr20:12,394,798...12,420,643 		JBrowse link
G Prmt7 protein arginine methyltransferase 7 decreases expression EXP fullerene C60 results in decreased expression of PRMT7 mRNA CTD PMID:19167457 NCBI chr19:51,020,596...51,071,401
Ensembl chr19:34,110,747...34,162,577 		JBrowse link
G Prox1 prospero homeobox 1 decreases expression EXP fullerene C60 results in decreased expression of PROX1 mRNA CTD PMID:19167457 NCBI chr13:104,196,615...104,251,007
Ensembl chr13:101,669,184...101,711,183 		JBrowse link
G Prp2 proline rich protein 2 decreases expression EXP fullerene C60 results in decreased expression of PRP2 mRNA CTD PMID:19167457 NCBI chr 4:165,600,085...165,603,662 JBrowse link
G Prph2 peripherin 2 decreases expression EXP fullerene C60 results in decreased expression of PRPH2 mRNA CTD PMID:19167457 NCBI chr 9:21,563,770...21,579,074
Ensembl chr 9:14,066,156...14,081,454 		JBrowse link
G Prrc2a proline-rich coiled-coil 2A increases expression EXP fullerene C60 results in increased expression of PRRC2A mRNA CTD PMID:19167457 NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130 		JBrowse link
G Prrc2b proline-rich coiled-coil 2B decreases expression EXP fullerene C60 results in decreased expression of PRRC2B mRNA CTD PMID:19167457 NCBI chr 3:15,433,357...15,519,105
Ensembl chr 3:15,465,294...15,519,104 		JBrowse link
G Prrt2 proline-rich transmembrane protein 2 decreases expression EXP fullerene C60 results in decreased expression of PRRT2 mRNA CTD PMID:19167457 NCBI chr 1:191,054,962...191,059,632
Ensembl chr 1:181,604,545...181,628,850 		JBrowse link
G Prss16 serine protease 16 decreases expression EXP fullerene C60 results in decreased expression of PRSS16 mRNA CTD PMID:19167457 NCBI chr17:42,514,306...42,521,885
Ensembl chr17:42,514,306...42,521,884 		JBrowse link
G Prx periaxin increases expression EXP fullerene C60 results in increased expression of PRX mRNA CTD PMID:19167457 NCBI chr 1:82,785,082...82,807,154
Ensembl chr 1:82,786,815...82,807,407 		JBrowse link
G Psma7 proteasome 20S subunit alpha 7 decreases expression EXP fullerene C60 results in decreased expression of PSMA7 mRNA CTD PMID:19167457 NCBI chr 3:167,137,279...167,143,626
Ensembl chr 3:167,137,263...167,143,672 		JBrowse link
G Psmb8 proteasome 20S subunit beta 8 decreases expression EXP fullerene C60 results in decreased expression of PSMB8 mRNA CTD PMID:19167457 NCBI chr20:4,654,068...4,657,049
Ensembl chr20:4,652,159...4,655,283 		JBrowse link
G Psmb9 proteasome 20S subunit beta 9 decreases expression EXP fullerene C60 results in decreased expression of PSMB9 mRNA CTD PMID:19167457 NCBI chr20:4,668,952...4,674,421
Ensembl chr20:4,666,046...4,672,512 		JBrowse link
G Psmd6 proteasome 26S subunit, non-ATPase 6 increases expression EXP fullerene C60 results in increased expression of PSMD6 mRNA CTD PMID:19167457 NCBI chr15:13,532,675...13,542,682
Ensembl chr15:11,102,180...11,205,620 		JBrowse link
G Pspn persephin decreases expression EXP fullerene C60 results in decreased expression of PSPN mRNA CTD PMID:19167457 NCBI chr 9:1,927,911...1,930,785
Ensembl chr 9:1,840,896...1,854,327 		JBrowse link
G Psx1 placenta specific homeobox 1 decreases expression EXP fullerene C60 results in decreased expression of PSX1 mRNA CTD PMID:19167457 NCBI chr 3:6,251,362...6,252,207
Ensembl chr 3:6,251,495...6,252,166 		JBrowse link
G Ptch2 patched 2 increases expression EXP fullerene C60 results in increased expression of PTCH2 mRNA CTD PMID:19167457 NCBI chr 5:135,808,856...135,829,087
Ensembl chr 5:130,572,312...130,592,405 		JBrowse link
G Ptgdr2 prostaglandin D2 receptor 2 decreases expression EXP fullerene C60 results in decreased expression of PTGDR2 mRNA CTD PMID:19167457 NCBI chr 1:217,010,183...217,015,044
Ensembl chr 1:207,587,917...207,589,213 		JBrowse link
G Ptger1 prostaglandin E receptor 1 decreases expression EXP fullerene C60 results in decreased expression of PTGER1 mRNA CTD PMID:19167457 NCBI chr19:41,374,983...41,379,593
Ensembl chr19:24,467,532...24,473,559 		JBrowse link
G Ptgr1 prostaglandin reductase 1 decreases expression EXP fullerene C60 results in decreased expression of PTGR1 mRNA CTD PMID:19167457 NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:73,784,009...73,802,666 		JBrowse link
G Ptms parathymosin affects expression EXP fullerene C60 affects the expression of PTMS mRNA CTD PMID:19167457 NCBI chr 4:159,408,647...159,412,837
Ensembl chr 4:157,722,386...157,727,009 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 decreases expression EXP fullerene C60 results in decreased expression of PTP4A1 mRNA CTD PMID:19167457 NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:33,214,208...33,221,964 		JBrowse link
G Ptp4a3 protein tyrosine phosphatase 4A3 affects expression EXP fullerene C60 affects the expression of PTP4A3 mRNA CTD PMID:19167457 NCBI chr 7:107,518,220...107,549,949
Ensembl chr 7:105,628,029...105,660,919 		JBrowse link
G Ptpn12 protein tyrosine phosphatase, non-receptor type 12 increases expression EXP fullerene C60 results in increased expression of PTPN12 mRNA CTD PMID:19167457 NCBI chr 4:14,913,071...14,985,084
Ensembl chr 4:14,021,052...14,092,927 		JBrowse link
G Ptprq protein tyrosine phosphatase, receptor type, Q decreases expression EXP fullerene C60 results in decreased expression of PTPRQ mRNA CTD PMID:19167457 NCBI chr 7:44,720,916...44,903,291
Ensembl chr 7:42,837,109...43,016,917 		JBrowse link
G Purg purine-rich element binding protein G decreases expression EXP fullerene C60 results in decreased expression of PURG mRNA CTD PMID:19167457 NCBI chr16:58,732,327...58,763,356
Ensembl chr16:58,720,335...58,763,359 		JBrowse link
G Pwwp2a PWWP domain containing 2A increases expression EXP fullerene C60 results in increased expression of PWWP2A mRNA CTD PMID:19167457 NCBI chr10:28,155,509...28,195,255
Ensembl chr10:28,155,605...28,194,308 		JBrowse link
G Pwwp3a PWWP domain containing 3A, DNA repair factor decreases expression EXP fullerene C60 results in decreased expression of PWWP3A mRNA CTD PMID:19167457 NCBI chr 7:9,465,180...9,482,053
Ensembl chr 7:9,465,195...9,481,966 		JBrowse link
G Pycr2 pyrroline-5-carboxylate reductase 2 decreases expression EXP fullerene C60 results in decreased expression of PYCR2 mRNA CTD PMID:19167457 NCBI chr13:92,626,462...92,630,256
Ensembl chr13:92,626,471...92,634,184 		JBrowse link
G Qki QKI, KH domain containing RNA binding increases expression EXP fullerene C60 results in increased expression of QKI mRNA CTD PMID:19167457 NCBI chr 1:52,935,357...53,047,338
Ensembl chr 1:50,387,698...50,498,831 		JBrowse link
G Qsox1 quiescin sulfhydryl oxidase 1 increases expression EXP fullerene C60 results in increased expression of QSOX1 mRNA CTD PMID:19167457 NCBI chr13:67,949,780...67,987,434
Ensembl chr13:67,949,780...67,987,459 		JBrowse link
G Rab1-ps1 RAB1, member RAS oncogene family, pseudogene 1 decreases expression EXP fullerene C60 results in decreased expression of RAB1-PS1 mRNA CTD PMID:19167457 NCBI chr 1:38,799,300...38,800,803 JBrowse link
G Rab11fip1 RAB11 family interacting protein 1 increases expression EXP fullerene C60 results in increased expression of RAB11FIP1 mRNA CTD PMID:19167457 NCBI chr16:64,886,902...64,917,491
Ensembl chr16:64,884,676...64,917,491 		JBrowse link
G Rab15 RAB15, member RAS oncogene family increases expression EXP fullerene C60 results in increased expression of RAB15 mRNA CTD PMID:19167457 NCBI chr 6:95,499,584...95,524,073
Ensembl chr 6:95,499,587...95,523,942 		JBrowse link
G Rab19 RAB19, member RAS oncogene family decreases expression EXP fullerene C60 results in decreased expression of RAB19 mRNA CTD PMID:19167457 NCBI chr 4:69,123,962...69,133,691
Ensembl chr 4:68,156,881...68,166,886 		JBrowse link
G Rab31 RAB31, member RAS oncogene family decreases expression EXP fullerene C60 results in decreased expression of RAB31 mRNA CTD PMID:19167457 NCBI chr 9:112,693,596...112,828,104
Ensembl chr 9:105,246,709...105,381,253 		JBrowse link
G Rab3a RAB3A, member RAS oncogene family increases expression EXP fullerene C60 results in increased expression of RAB3A mRNA CTD PMID:19167457 NCBI chr16:18,718,164...18,722,273
Ensembl chr16:18,684,188...18,688,336 		JBrowse link
G Rab3b RAB3B, member RAS oncogene family decreases expression EXP fullerene C60 results in decreased expression of RAB3B mRNA CTD PMID:19167457 NCBI chr 5:128,859,034...128,926,087
Ensembl chr 5:123,644,423...123,697,401 		JBrowse link
G Rab3gap2 RAB3 GTPase activating non-catalytic protein subunit 2 increases expression EXP fullerene C60 results in increased expression of RAB3GAP2 mRNA CTD PMID:19167457 NCBI chr13:96,757,430...96,828,930
Ensembl chr13:96,757,460...96,829,478 		JBrowse link
G Rab3il1 RAB3A interacting protein-like 1 increases expression EXP fullerene C60 results in increased expression of RAB3IL1 mRNA CTD PMID:19167457 NCBI chr 1:216,071,043...216,107,609
Ensembl chr 1:206,646,155...206,679,972 		JBrowse link
G Rabif RAB interacting factor decreases expression EXP fullerene C60 results in decreased expression of RABIF mRNA CTD PMID:19167457 NCBI chr13:45,936,371...45,948,929
Ensembl chr13:45,936,369...45,949,775 		JBrowse link
G Rac1 Rac family small GTPase 1 multiple interactions ISO [[fullerene C60 results in increased secretion of HMGB1 protein] which results in increased expression of and results in increased activity of AGER protein] which results in increased expression of RAC1 protein CTD PMID:31504961 NCBI chr12:16,150,411...16,170,864
Ensembl chr12:11,036,698...11,057,251 		JBrowse link
G Ralgdsl2 ral guanine nucleotide dissociation stimulator like 2 increases expression EXP fullerene C60 results in increased expression of RGL2 mRNA CTD PMID:19167457 NCBI chr20:4,948,495...4,956,774
Ensembl chr20:4,948,497...4,969,911 		JBrowse link
G Ran RAN, member RAS oncogene family decreases expression EXP fullerene C60 results in decreased expression of RAN mRNA CTD PMID:19167457 NCBI chr12:33,311,155...33,314,339
Ensembl chr12:27,674,050...27,678,276 		JBrowse link
G Ranbp10 RAN binding protein 10 decreases expression EXP fullerene C60 results in decreased expression of RANBP10 mRNA CTD PMID:19167457 NCBI chr19:33,656,046...33,716,864
Ensembl chr19:33,656,046...33,717,033 		JBrowse link
G Ranbp17 RAN binding protein 17 decreases expression EXP fullerene C60 results in decreased expression of RANBP17 mRNA CTD PMID:19167457 NCBI chr10:18,304,634...18,607,162
Ensembl chr10:17,800,999...18,102,831 		JBrowse link
G Rap1b RAP1B, member of RAS oncogene family decreases expression EXP fullerene C60 results in decreased expression of RAP1B mRNA CTD PMID:19167457 NCBI chr 7:55,308,922...55,342,217
Ensembl chr 7:53,423,130...53,456,370 		JBrowse link
G Rapgef3 Rap guanine nucleotide exchange factor 3 increases expression EXP fullerene C60 results in increased expression of RAPGEF3 mRNA CTD PMID:19167457 NCBI chr 7:130,754,883...130,777,303
Ensembl chr 7:128,875,773...128,898,521 		JBrowse link
G Rasa3 RAS p21 protein activator 3 decreases expression EXP fullerene C60 results in decreased expression of RASA3 mRNA CTD PMID:19167457 NCBI chr16:75,855,360...75,969,349
Ensembl chr16:75,855,265...75,970,804 		JBrowse link
G Rasgrf1 RAS protein-specific guanine nucleotide-releasing factor 1 decreases expression EXP fullerene C60 results in decreased expression of RASGRF1 mRNA CTD PMID:19167457 NCBI chr 8:99,324,986...99,454,099
Ensembl chr 8:90,445,154...90,574,269 		JBrowse link
G Rasgrp2 RAS guanyl releasing protein 2 increases expression EXP fullerene C60 results in increased expression of RASGRP2 mRNA CTD PMID:19167457 NCBI chr 1:203,705,777...203,722,993
Ensembl chr 1:203,707,481...203,722,993 		JBrowse link
G Raver1 ribonucleoprotein, PTB-binding 1 decreases expression EXP fullerene C60 results in decreased expression of RAVER1 mRNA CTD PMID:19167457 NCBI chr 8:19,610,464...19,629,188
Ensembl chr 8:19,610,466...19,629,152 		JBrowse link
G Rbm14 RNA binding motif protein 14 increases expression EXP fullerene C60 results in increased expression of RBM14 mRNA CTD PMID:19167457 NCBI chr 1:211,476,298...211,535,077
Ensembl chr 1:202,078,287...202,105,665
Ensembl chr 1:202,078,287...202,105,665 		JBrowse link
G Rbm42 RNA binding motif protein 42 decreases expression EXP fullerene C60 results in decreased expression of RBM42 mRNA CTD PMID:19167457 NCBI chr 1:95,026,050...95,036,020
Ensembl chr 1:85,898,625...85,908,573 		JBrowse link
G Rbpms RNA binding protein, mRNA processing factor increases expression EXP fullerene C60 results in increased expression of RBPMS mRNA CTD PMID:19167457 NCBI chr16:64,942,159...65,098,504
Ensembl chr16:58,239,474...58,395,426 		JBrowse link
G Rcc2 regulator of chromosome condensation 2 decreases expression EXP fullerene C60 results in decreased expression of RCC2 mRNA CTD PMID:19167457 NCBI chr 5:158,277,476...158,300,294
Ensembl chr 5:152,993,665...153,017,205 		JBrowse link
G Rcn1 reticulocalbin 1 decreases expression EXP fullerene C60 results in decreased expression of RCN1 mRNA CTD PMID:19167457 NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295 		JBrowse link
G Reg3g regenerating family member 3 gamma decreases expression EXP fullerene C60 results in decreased expression of REG3G mRNA CTD PMID:19167457 NCBI chr 4:112,482,183...112,484,738
Ensembl chr 4:110,924,168...110,926,723 		JBrowse link
G Rell2 RELT-like 2 decreases expression EXP fullerene C60 results in decreased expression of RELL2 mRNA CTD PMID:19167457 NCBI chr18:29,789,996...29,793,986
Ensembl chr18:29,790,415...29,793,986 		JBrowse link
G Rem2 RRAD and GEM like GTPase 2 decreases expression EXP fullerene C60 results in decreased expression of REM2 mRNA CTD PMID:19167457 NCBI chr15:31,903,972...31,908,451
Ensembl chr15:27,933,950...27,938,429 		JBrowse link
G Rest RE1-silencing transcription factor decreases expression EXP fullerene C60 results in decreased expression of REST mRNA CTD PMID:19167457 NCBI chr14:31,213,415...31,233,451
Ensembl chr14:30,862,553...30,894,354 		JBrowse link
G Retreg2 reticulophagy regulator family member 2 increases expression EXP fullerene C60 results in increased expression of RETREG2 mRNA CTD PMID:19167457 NCBI chr 9:76,640,282...76,646,400
Ensembl chr 9:76,640,319...76,646,395 		JBrowse link
G Rexo1 RNA exonuclease 1 homolog increases expression EXP fullerene C60 results in increased expression of REXO1 mRNA CTD PMID:19167457 NCBI chr 7:9,154,050...9,174,035
Ensembl chr 7:9,154,061...9,173,454 		JBrowse link
G Rfc5 replication factor C subunit 5 decreases expression EXP fullerene C60 results in decreased expression of RFC5 mRNA CTD PMID:19167457 NCBI chr12:44,868,322...44,877,879
Ensembl chr12:39,207,484...39,217,312 		JBrowse link
G Rftn1 raftlin lipid raft linker 1 decreases expression EXP fullerene C60 results in decreased expression of RFTN1 mRNA CTD PMID:19167457 NCBI chr 9:18,302,143...18,499,819
Ensembl chr 9:10,804,611...11,002,084 		JBrowse link
G Rfx3 regulatory factor X3 decreases expression EXP fullerene C60 results in decreased expression of RFX3 mRNA CTD PMID:19167457 NCBI chr 1:234,863,462...235,122,989
Ensembl chr 1:225,456,187...225,709,402 		JBrowse link
G Rgs11 regulator of G-protein signaling 11 decreases expression EXP fullerene C60 results in decreased expression of RGS11 mRNA CTD PMID:19167457 NCBI chr10:15,727,279...15,735,536
Ensembl chr10:15,222,803...15,231,060 		JBrowse link
G Rgs12 regulator of G-protein signaling 12 increases expression EXP fullerene C60 results in increased expression of RGS12 mRNA CTD PMID:19167457 NCBI chr14:79,940,561...80,048,637
Ensembl chr14:75,715,934...75,794,596 		JBrowse link
G Rgs17 regulator of G-protein signaling 17 affects expression EXP fullerene C60 affects the expression of RGS17 mRNA CTD PMID:19167457 NCBI chr 1:44,627,583...44,729,957
Ensembl chr 1:42,227,070...42,324,609 		JBrowse link
G Rgs3 regulator of G-protein signaling 3 increases expression EXP fullerene C60 results in increased expression of RGS3 mRNA CTD PMID:19167457 NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894 		JBrowse link
G Rhbdf2 rhomboid 5 homolog 2 increases expression EXP fullerene C60 results in increased expression of RHBDF2 mRNA CTD PMID:19167457 NCBI chr10:101,833,157...101,860,283
Ensembl chr10:101,833,157...101,860,283 		JBrowse link
G Rhobtb1 Rho-related BTB domain containing 1 decreases expression EXP fullerene C60 results in decreased expression of RHOBTB1 mRNA CTD PMID:19167457 NCBI chr20:19,326,197...19,455,182
Ensembl chr20:19,327,155...19,403,012 		JBrowse link
G Rhobtb2 Rho-related BTB domain containing 2 affects expression EXP fullerene C60 affects the expression of RHOBTB2 mRNA CTD PMID:19167457 NCBI chr15:51,278,024...51,298,209
Ensembl chr15:44,870,376...44,888,651 		JBrowse link
G Rhpn2 rhophilin, Rho GTPase binding protein 2 decreases expression EXP fullerene C60 results in decreased expression of RHPN2 mRNA CTD PMID:19167457 NCBI chr 1:97,128,054...97,188,803
Ensembl chr 1:87,991,144...88,051,902 		JBrowse link
G Ripor1 RHO family interacting cell polarization regulator 1 increases expression EXP fullerene C60 results in increased expression of RIPOR1 mRNA CTD PMID:19167457 NCBI chr19:50,387,447...50,416,323
Ensembl chr19:33,477,793...33,506,420 		JBrowse link
G Rnase11 ribonuclease A family member 11 decreases expression EXP fullerene C60 results in decreased expression of RNASE11 mRNA CTD PMID:19167457 NCBI chr15:24,268,206...24,270,192
Ensembl chr15:24,268,207...24,270,192 		JBrowse link
G Rnf13 ring finger protein 13 decreases expression EXP fullerene C60 results in decreased expression of RNF13 mRNA CTD PMID:19167457 NCBI chr 2:141,927,887...142,061,801
Ensembl chr 2:141,927,909...142,061,801 		JBrowse link
G Rnf187 ring finger protein 187 increases expression EXP fullerene C60 results in increased expression of RNF187 mRNA CTD PMID:19167457 NCBI chr10:43,709,493...43,715,392
Ensembl chr10:43,702,357...43,716,157 		JBrowse link
G Rnf19a ring finger protein 19A, RBR E3 ubiquitin protein ligase decreases expression EXP fullerene C60 results in decreased expression of RNF19A mRNA CTD PMID:19167457 NCBI chr 7:67,425,833...67,465,214
Ensembl chr 7:67,425,837...67,465,222 		JBrowse link
G Rnf213 ring finger protein 213 increases expression EXP fullerene C60 results in increased expression of KRTAP6-2 mRNA CTD PMID:19167457 NCBI chr10:105,154,873...105,254,148
Ensembl chr10:104,656,883...104,757,918 		JBrowse link
G Rnf215 ring finger protein 215 increases expression EXP fullerene C60 results in increased expression of RNF215 mRNA CTD PMID:19167457 NCBI chr14:79,006,659...79,013,091
Ensembl chr14:79,006,688...79,013,091 		JBrowse link
G Rnf4 ring finger protein 4 decreases expression EXP fullerene C60 results in decreased expression of RNF4 mRNA CTD PMID:19167457 NCBI chr14:80,625,864...80,647,138
Ensembl chr14:76,401,299...76,422,566 		JBrowse link
G Rnf43 ring finger protein 43 decreases expression EXP fullerene C60 results in decreased expression of RNF43 mRNA CTD PMID:19167457 NCBI chr10:72,958,744...73,034,540
Ensembl chr10:72,464,348...72,536,977 		JBrowse link
G Romo1 reactive oxygen species modulator 1 decreases expression EXP fullerene C60 results in decreased expression of ROMO1 mRNA CTD PMID:19167457 NCBI chr 3:165,119,794...165,121,394
Ensembl chr 3:144,659,826...144,661,310 		JBrowse link
G Rorc RAR-related orphan receptor C decreases expression EXP fullerene C60 results in decreased expression of RORC mRNA CTD PMID:19167457 NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:182,009,286...182,034,907 		JBrowse link
G Rpl14 ribosomal protein L14 decreases expression EXP fullerene C60 results in decreased expression of RPL14 mRNA CTD PMID:19167457 NCBI chr 8:129,163,620...129,166,745
Ensembl chr 8:120,284,645...120,289,064 		JBrowse link
G Rpl19 ribosomal protein L19 affects expression EXP fullerene C60 affects the expression of RPL19 mRNA CTD PMID:19167457 NCBI chr10:83,514,509...83,522,352
Ensembl chr10:83,019,257...83,052,112 		JBrowse link
G Rpl19-ps25 ribosomal protein L19, pseudogene 25 decreases expression EXP fullerene C60 results in decreased expression of RPL19-PS25 mRNA CTD PMID:19167457 NCBI chr  X:70,571,775...70,572,469 JBrowse link
G Rpl28l2 ribosomal protein L28 like 2 decreases expression EXP fullerene C60 results in decreased expression of RPL28L2 mRNA CTD PMID:19167457 NCBI chr  X:151,322,934...151,323,461
Ensembl chr  X:151,322,982...151,323,395 		JBrowse link
G Rpl29-ps23 ribosomal protein L29, pseudogene 23 increases expression EXP fullerene C60 results in increased expression of RPL29-PS23 mRNA CTD PMID:19167457 NCBI chr 2:39,720,319...39,720,958 JBrowse link
G Rpl3 ribosomal protein L3 decreases expression EXP fullerene C60 results in decreased expression of RPL3 mRNA CTD PMID:19167457 NCBI chr 7:111,622,255...111,627,640
Ensembl chr 7:111,621,610...111,636,468 		JBrowse link
G Rpl35 ribosomal protein L35 decreases expression EXP fullerene C60 results in decreased expression of RPL35 mRNA CTD PMID:19167457 NCBI chr 3:22,753,255...22,756,217
Ensembl chr 3:22,753,253...22,756,243 		JBrowse link
G Rpl36 ribosomal protein L36 decreases expression EXP fullerene C60 results in decreased expression of RPL36 mRNA CTD PMID:19167457 NCBI chr 9:1,529,117...1,534,534
Ensembl chr 6:98,809,534...98,809,897
Ensembl chr 5:98,809,534...98,809,897 		JBrowse link
G Rpl37al2 ribosomal protein L37A like 2 increases expression EXP fullerene C60 results in increased expression of RPL37AL2 mRNA CTD PMID:19167457 NCBI chr  X:10,788,445...10,788,843
Ensembl chr  X:10,788,541...10,789,499 		JBrowse link
G Rplp0 ribosomal protein lateral stalk subunit P0 decreases expression EXP fullerene C60 results in decreased expression of RPLP0 mRNA CTD PMID:19167457 NCBI chr12:46,715,121...46,718,390
Ensembl chr12:41,054,179...41,057,632 		JBrowse link
G Rps10l2 ribosomal protein S10-like 2 decreases expression EXP fullerene C60 results in decreased expression of RPS10L2 mRNA CTD PMID:19167457 NCBI chr16:20,703,060...20,703,551
Ensembl chr16:20,703,060...20,703,551 		JBrowse link
G Rps11 ribosomal protein S11 decreases expression EXP fullerene C60 results in decreased expression of RPS11 mRNA CTD PMID:19167457 NCBI chr 1:95,605,690...95,607,798
Ensembl chr 1:95,605,692...95,607,874 		JBrowse link
G Rps15 ribosomal protein S15 increases expression EXP fullerene C60 results in increased expression of RPS15 mRNA CTD PMID:19167457 NCBI chr 7:10,066,572...10,068,167
Ensembl chr 7:9,416,004...9,417,450
Ensembl chr 7:9,416,004...9,417,450 		JBrowse link
G Rps2 ribosomal protein S2 decreases expression EXP fullerene C60 results in decreased expression of RPS2 mRNA CTD PMID:19167457 NCBI chr10:14,251,841...14,253,697
Ensembl chr10:13,747,301...13,749,163 		JBrowse link
G Rps28 ribosomal protein S28 decreases expression EXP fullerene C60 results in decreased expression of RPS28 mRNA CTD PMID:19167457 NCBI chr 7:14,607,801...14,609,170
Ensembl chr 7:14,607,801...14,609,170
Ensembl chr16:14,607,801...14,609,170
Ensembl chr16:14,607,801...14,609,170 		JBrowse link
G Rps6ka4 ribosomal protein S6 kinase A4 increases expression EXP fullerene C60 results in increased expression of RPS6KA4 mRNA CTD PMID:19167457 NCBI chr 1:204,021,805...204,032,781
Ensembl chr 1:204,021,806...204,032,761 		JBrowse link
G Rpsa ribosomal protein SA decreases expression EXP fullerene C60 results in decreased expression of RPSA mRNA CTD PMID:19167457 NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:119,851,225...119,855,247 		JBrowse link
G Rpusd4 RNA pseudouridine synthase D4 decreases expression EXP fullerene C60 results in decreased expression of RPUSD4 mRNA CTD PMID:19167457 NCBI chr 8:33,617,384...33,626,873
Ensembl chr 8:33,617,379...33,626,873 		JBrowse link
G Rrp7a ribosomal RNA processing 7 homolog A increases expression EXP fullerene C60 results in increased expression of RRP7A mRNA CTD PMID:19167457 NCBI chr 7:114,262,929...114,272,817
Ensembl chr 7:114,256,472...114,272,817 		JBrowse link
G Rsph6a radial spoke head 6 homolog A increases expression EXP fullerene C60 results in increased expression of RSPH6A mRNA CTD PMID:19167457 NCBI chr 1:78,700,801...78,720,444
Ensembl chr 1:78,700,814...78,720,431 		JBrowse link
G Rsph9 radial spoke head component 9 decreases expression EXP fullerene C60 results in decreased expression of RSPH9 mRNA CTD PMID:19167457 NCBI chr 9:22,337,681...22,350,515
Ensembl chr 9:14,840,115...14,860,062 		JBrowse link
G Rspo1 R-spondin 1 decreases expression EXP fullerene C60 results in decreased expression of RSPO1 mRNA CTD PMID:19167457 NCBI chr 5:142,536,162...142,557,611
Ensembl chr 5:137,251,659...137,272,933 		JBrowse link
G RT1-A2 RT1 class Ia, locus A2 increases expression ISO fullerene C60 results in increased expression of H2-T23 mRNA CTD PMID:20064541 NCBI chr20:4,872,720...4,876,425 JBrowse link
G RT1-Bb RT1 class II, locus Bb increases expression EXP fullerene C60 results in increased expression of RT1-BB mRNA CTD PMID:19167457 NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,596,559...4,607,597 		JBrowse link
G RT1-CE10 RT1 class I, locus CE10 increases expression EXP fullerene C60 results in increased expression of RT1-CE10 mRNA CTD PMID:19167457 NCBI chr20:3,381,377...3,385,052 JBrowse link
G RT1-CE2 RT1 class I, locus CE2 increases expression EXP fullerene C60 results in increased expression of RT1-CE2 mRNA CTD PMID:19167457 NCBI chr20:3,538,452...3,541,841
Ensembl chr20:3,537,809...3,541,790 		JBrowse link
G RT1-Db1 RT1 class II, locus Db1 increases expression ISO fullerene C60 results in increased expression of H2-EB1 mRNA CTD PMID:20064541 NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,548,666...4,558,258 		JBrowse link
G RT1-DOb RT1 class II, locus DOb increases expression EXP fullerene C60 results in increased expression of RT1-DOB mRNA CTD PMID:19167457 NCBI chr20:4,621,336...4,627,537
Ensembl chr20:4,619,816...4,625,667 		JBrowse link
G RT1-M5 RT1 class Ib, locus M5 decreases expression EXP fullerene C60 results in decreased expression of RT1-M5 mRNA CTD PMID:19167457 NCBI chr20:1,551,751...1,554,015
Ensembl chr20:1,546,511...1,548,775 		JBrowse link
G RT1-S3 RT1 class Ib, locus S3 increases expression EXP fullerene C60 results in increased expression of RT1-S3 mRNA CTD PMID:19167457 NCBI chr20:2,675,463...2,680,229
Ensembl chr20:2,670,709...2,675,411 		JBrowse link
G RT1-T18 RT1 class Ib, locus T18 increases expression EXP fullerene C60 results in increased expression of RT1-T18 mRNA CTD PMID:19167457 NCBI chr20:2,605,261...2,608,909
Ensembl chr20:2,605,265...2,608,909 		JBrowse link
G Rtn4ip1 reticulon 4 interacting protein 1 increases expression EXP fullerene C60 results in increased expression of RTN4IP1 mRNA CTD PMID:19167457 NCBI chr20:47,382,251...47,422,747
Ensembl chr20:47,382,234...47,422,338 		JBrowse link
G Rtn4rl1 reticulon 4 receptor-like 1 increases expression EXP fullerene C60 results in increased expression of RTN4RL1 mRNA CTD PMID:19167457 NCBI chr10:60,541,584...60,615,302
Ensembl chr10:60,043,002...60,116,978 		JBrowse link
G Rtn4rl2 reticulon 4 receptor-like 2 decreases expression EXP fullerene C60 results in decreased expression of RTN4RL2 mRNA CTD PMID:19167457 NCBI chr 3:69,954,557...69,971,108
Ensembl chr 3:69,955,169...69,971,488 		JBrowse link
G Rundc1 RUN domain containing 1 increases expression EXP fullerene C60 results in increased expression of RUNDC1 mRNA CTD PMID:19167457 NCBI chr10:86,361,635...86,375,446
Ensembl chr10:86,361,051...86,370,878 		JBrowse link
G Runx2 RUNX family transcription factor 2 increases expression EXP fullerene C60 results in increased expression of RUNX2 mRNA CTD PMID:19167457 NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167 		JBrowse link
G Rxrb retinoid X receptor beta increases expression EXP fullerene C60 results in increased expression of RXRB mRNA CTD PMID:19167457 NCBI chr20:4,818,707...4,824,968
Ensembl chr20:4,816,815...4,828,773 		JBrowse link
G Ryr3 ryanodine receptor 3 decreases expression EXP fullerene C60 results in decreased expression of RYR3 mRNA CTD PMID:19167457 NCBI chr 3:119,886,129...120,433,465
Ensembl chr 3:99,432,505...99,704,961 		JBrowse link
G S100a9 S100 calcium binding protein A9 increases expression EXP fullerene C60 results in increased expression of S100A9 mRNA CTD PMID:20471445 NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:176,190,361...176,193,230 		JBrowse link
G S100b S100 calcium binding protein B decreases expression EXP fullerene C60 results in decreased expression of S100B mRNA CTD PMID:19167457 NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743 		JBrowse link
G S100z S100 calcium binding protein Z decreases expression EXP fullerene C60 results in decreased expression of S100Z mRNA CTD PMID:19167457 NCBI chr 2:26,737,796...26,753,611
Ensembl chr 2:26,738,776...26,752,390 		JBrowse link
G S1pr4 sphingosine-1-phosphate receptor 4 increases expression EXP fullerene C60 results in increased expression of S1PR4 mRNA CTD PMID:19167457 NCBI chr 7:8,858,528...8,860,804
Ensembl chr 7:8,208,098...8,211,893 		JBrowse link
G Samd12 sterile alpha motif domain containing 12 decreases expression EXP fullerene C60 results in decreased expression of SAMD12 mRNA CTD PMID:19167457 NCBI chr 7:84,768,850...85,064,057
Ensembl chr 7:84,768,254...85,271,766 		JBrowse link
G Samd4b sterile alpha motif domain containing 4B decreases expression EXP fullerene C60 results in decreased expression of SAMD4B mRNA CTD PMID:19167457 NCBI chr 1:83,689,413...83,728,652
Ensembl chr 1:83,689,413...83,713,853 		JBrowse link
G Sap18 Sin3A associated protein 18 decreases expression EXP fullerene C60 results in decreased expression of SAP18 mRNA CTD PMID:19167457 NCBI chr15:36,058,784...36,063,089
Ensembl chr15:31,943,230...31,950,038
Ensembl chr10:31,943,230...31,950,038 		JBrowse link
G Sart3 spliceosome associated factor 3, U4/U6 recycling protein increases expression EXP fullerene C60 results in increased expression of SART3 mRNA CTD PMID:19167457 NCBI chr12:48,519,579...48,547,584
Ensembl chr12:42,859,305...42,887,038 		JBrowse link
G Satb2 SATB homeobox 2 decreases expression EXP fullerene C60 results in decreased expression of SATB2 mRNA CTD PMID:19167457 NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707 		JBrowse link
G Sbno2 strawberry notch homolog 2 increases expression EXP fullerene C60 results in increased expression of SBNO2 mRNA CTD PMID:19167457 NCBI chr 7:10,256,221...10,300,175
Ensembl chr 7:9,605,627...9,649,527 		JBrowse link
G Scd stearoyl-CoA desaturase decreases expression EXP fullerene C60 results in decreased expression of SCD1 mRNA CTD PMID:19167457 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Scd2 stearoyl-Coenzyme A desaturase 2 decreases expression EXP fullerene C60 results in decreased expression of SCD2 mRNA CTD PMID:19167457 NCBI chr 1:253,118,377...253,131,436
Ensembl chr 1:243,169,236...243,182,232 		JBrowse link
G Scgb1a1 secretoglobin family 1A member 1 increases expression EXP fullerene C60 results in increased expression of SCGB1A1 mRNA CTD PMID:19167457 NCBI chr 1:215,406,138...215,409,686
Ensembl chr 1:205,977,060...205,980,610 		JBrowse link
G Sclt1 sodium channel and clathrin linker 1 decreases expression EXP fullerene C60 results in decreased expression of SCLT1 mRNA CTD PMID:19167457 NCBI chr 2:126,533,436...126,691,879
Ensembl chr 2:124,605,658...124,764,065 		JBrowse link
G Scmh1 Scm polycomb group protein homolog 1 decreases expression EXP fullerene C60 results in decreased expression of SCMH1 mRNA CTD PMID:19167457 NCBI chr 5:133,991,167...134,115,893
Ensembl chr 5:133,990,520...134,122,105 		JBrowse link
G Scn10a sodium voltage-gated channel alpha subunit 10 decreases expression EXP fullerene C60 results in decreased expression of SCN10A mRNA CTD PMID:19167457 NCBI chr 8:128,228,424...128,340,749
Ensembl chr 8:119,350,724...119,462,614 		JBrowse link
G Scnn1a sodium channel epithelial 1 subunit alpha increases expression EXP fullerene C60 results in increased expression of SCNN1A mRNA CTD PMID:19167457 NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:158,122,962...158,146,181 		JBrowse link
G Scyl1 SCY1 like pseudokinase 1 increases expression EXP fullerene C60 results in increased expression of SCYL1 mRNA CTD PMID:19167457 NCBI chr 1:212,475,198...212,489,285
Ensembl chr 1:203,045,741...203,059,533 		JBrowse link
G Sdc3 syndecan 3 decreases expression EXP fullerene C60 results in decreased expression of SDC3 mRNA CTD PMID:19167457 NCBI chr 5:148,249,792...148,282,524
Ensembl chr 5:142,965,591...142,996,480 		JBrowse link
G Sdc4 syndecan 4 increases expression EXP fullerene C60 results in increased expression of SDC4 mRNA CTD PMID:19167457 NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:153,154,896...153,173,580 		JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 decreases expression EXP fullerene C60 results in decreased expression of SDF2L1 mRNA CTD PMID:19167457 NCBI chr11:97,376,878...97,379,120
Ensembl chr11:83,872,659...83,874,902 		JBrowse link
G Sec14l1 SEC14-like lipid binding 1 increases expression EXP fullerene C60 results in increased expression of SEC14L1 mRNA CTD PMID:19167457 NCBI chr10:102,818,693...102,865,841
Ensembl chr10:102,319,920...102,367,068 		JBrowse link
G Sec14l2 SEC14-like lipid binding 2 increases expression EXP fullerene C60 results in increased expression of SEC14L2 mRNA CTD PMID:19167457 NCBI chr14:83,197,384...83,222,059
Ensembl chr14:78,973,808...78,993,788 		JBrowse link
G Sec24a SEC24 homolog A, COPII coat complex component decreases expression EXP fullerene C60 results in decreased expression of SEC24A mRNA CTD PMID:19167457 NCBI chr10:36,450,043...36,525,303
Ensembl chr10:35,947,031...36,024,353 		JBrowse link
G Sele selectin E increases expression EXP fullerene C60 results in increased expression of SELE mRNA CTD PMID:19167457 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741 		JBrowse link
G Selenbp1 selenium binding protein 1 increases expression EXP fullerene C60 results in increased expression of SELENBP1 mRNA CTD PMID:19167457 NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:182,493,978...182,504,594 		JBrowse link
G Selenoo selenoprotein O increases expression EXP fullerene C60 results in increased expression of SELENOO mRNA CTD PMID:19167457 NCBI chr 7:120,167,913...120,178,806
Ensembl chr 7:120,167,913...120,178,805 		JBrowse link
G Sema6d semaphorin 6D decreases expression EXP fullerene C60 results in decreased expression of SEMA6D mRNA CTD PMID:19167457 NCBI chr 3:131,801,680...132,394,578
Ensembl chr 3:111,883,872...111,941,094 		JBrowse link
G Sema7a semaphorin 7A (John Milton Hagen blood group) decreases expression EXP fullerene C60 results in decreased expression of SEMA7A mRNA CTD PMID:19167457 NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:58,348,448...58,370,536 		JBrowse link
G Senp8 SUMO peptidase family member, NEDD8 specific decreases expression EXP fullerene C60 results in decreased expression of SENP8 mRNA CTD PMID:19167457 NCBI chr 8:60,135,446...60,148,836
Ensembl chr 8:60,121,714...60,148,928 		JBrowse link
G Septin3 septin 3 decreases expression EXP fullerene C60 results in decreased expression of SEPTIN3 mRNA CTD PMID:19167457 NCBI chr 7:113,783,217...113,811,089
Ensembl chr 7:113,783,095...113,811,087 		JBrowse link
G Serpina1 serpin family A member 1 increases expression EXP fullerene C60 results in increased expression of SERPINA1 mRNA CTD PMID:19167457 NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:122,866,312...122,888,339 		JBrowse link
G Serpina5 serpin family A member 5 decreases expression EXP fullerene C60 results in decreased expression of SERPINA5 mRNA CTD PMID:19167457 NCBI chr 6:128,774,006...128,793,187
Ensembl chr 6:123,023,306...123,028,407 		JBrowse link
G Serpinf2 serpin family F member 2 increases expression EXP fullerene C60 results in increased expression of SERPINF2 mRNA CTD PMID:19167457 NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,272,400...60,281,243 		JBrowse link
G Setd5 SET domain containing 5 increases expression EXP fullerene C60 results in increased expression of SETD5 mRNA CTD PMID:19167457 NCBI chr 4:147,772,955...147,850,669
Ensembl chr 4:146,217,180...146,294,894 		JBrowse link
G Setd6 SET domain containing 6, protein lysine methyltransferase increases expression EXP fullerene C60 results in increased expression of SETD6 mRNA CTD PMID:19167457 NCBI chr19:9,349,011...9,356,515
Ensembl chr19:9,347,458...9,350,453 		JBrowse link
G Sf3b2 splicing factor 3b, subunit 2 increases expression EXP fullerene C60 results in increased expression of SF3B2 mRNA CTD PMID:19167457 NCBI chr 1:211,999,777...212,040,686
Ensembl chr 1:202,570,423...202,590,759 		JBrowse link
G Sgsm2 small G protein signaling modulator 2 increases expression EXP fullerene C60 results in increased expression of SGSM2 mRNA CTD PMID:19167457 NCBI chr10:59,718,180...59,759,822
Ensembl chr10:59,718,183...59,759,447 		JBrowse link
G Sh2b1 SH2B adaptor protein 1 increases expression EXP fullerene C60 results in increased expression of SH2B1 mRNA CTD PMID:19167457 NCBI chr 1:190,479,211...190,492,030
Ensembl chr 1:181,048,623...181,056,579 		JBrowse link
G Sh2d3c SH2 domain containing 3C increases expression EXP fullerene C60 results in increased expression of SH2D3C mRNA CTD PMID:19167457 NCBI chr 3:16,010,622...16,046,491
Ensembl chr 3:16,010,625...16,046,484 		JBrowse link
G Sh3bp2 SH3-domain binding protein 2 increases expression EXP fullerene C60 results in increased expression of SH3BP2 mRNA CTD PMID:19167457 NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251 		JBrowse link
G Sh3gl3 SH3 domain containing GRB2 like 3, endophilin A3 decreases expression EXP fullerene C60 results in decreased expression of SH3GL3 mRNA CTD PMID:19167457 NCBI chr 1:145,533,728...145,664,881
Ensembl chr 1:136,124,499...136,255,584 		JBrowse link
G Sh3pxd2a SH3 and PX domains 2A decreases expression EXP fullerene C60 results in decreased expression of SH3PXD2A mRNA CTD PMID:19167457 NCBI chr 1:256,094,991...256,301,120
Ensembl chr 1:246,160,502...246,360,166 		JBrowse link
G Sh3rf3 SH3 domain containing ring finger 3 decreases expression EXP fullerene C60 results in decreased expression of SH3RF3 mRNA CTD PMID:19167457 NCBI chr20:26,765,278...27,099,261
Ensembl chr20:26,765,015...27,099,257 		JBrowse link
G Sh3tc2 SH3 domain and tetratricopeptide repeats 2 decreases expression EXP fullerene C60 results in decreased expression of SH3TC2 mRNA CTD PMID:19167457 NCBI chr18:57,686,701...57,747,735
Ensembl chr18:55,416,413...55,483,083 		JBrowse link
G Shank3 SH3 and multiple ankyrin repeat domains 3 increases expression EXP fullerene C60 results in increased expression of SHANK3 mRNA CTD PMID:19167457 NCBI chr 7:122,448,323...122,518,623
Ensembl chr 7:120,570,402...120,630,374 		JBrowse link
G Shmt1 serine hydroxymethyltransferase 1 increases expression EXP fullerene C60 results in increased expression of SHMT1 mRNA CTD PMID:19167457 NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,468,700...45,497,820 		JBrowse link
G Shroom3 shroom family member 3 increases expression EXP fullerene C60 results in increased expression of SHROOM3 mRNA CTD PMID:19167457 NCBI chr14:15,099,415...15,396,832
Ensembl chr14:15,099,423...15,396,915 		JBrowse link
G Sik1 salt-inducible kinase 1 decreases expression EXP fullerene C60 results in decreased expression of SIK1 mRNA CTD PMID:19167457 NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,396...9,958,991 		JBrowse link
G Sirt6 sirtuin 6 increases expression EXP fullerene C60 results in increased expression of SIRT6 mRNA CTD PMID:19167457 NCBI chr 7:8,733,056...8,738,543
Ensembl chr 7:8,082,364...8,098,914 		JBrowse link
G Six1 SIX homeobox 1 decreases expression EXP fullerene C60 results in decreased expression of SIX1 mRNA CTD PMID:19167457 NCBI chr 6:97,482,617...97,487,853
Ensembl chr 6:91,746,739...91,751,975 		JBrowse link
G Skp2 S-phase kinase associated protein 2 decreases expression EXP fullerene C60 results in decreased expression of SKP2 mRNA CTD PMID:19167457 NCBI chr 2:59,888,406...59,916,471
Ensembl chr 2:58,161,229...58,189,338 		JBrowse link
G Slc12a6 solute carrier family 12, member 6 decreases expression EXP fullerene C60 results in decreased expression of SLC12A6 mRNA CTD PMID:19167457 NCBI chr 3:119,525,521...119,624,655
Ensembl chr 3:99,071,391...99,170,258 		JBrowse link
G Slc12a7 solute carrier family 12 member 7 affects expression EXP fullerene C60 affects the expression of SLC12A7 mRNA CTD PMID:19167457 NCBI chr 1:31,301,243...31,382,825
Ensembl chr 1:29,472,692...29,554,302 		JBrowse link
G Slc12a8 solute carrier family 12, member 8 increases expression EXP fullerene C60 results in increased expression of SLC12A8 mRNA CTD PMID:19167457 NCBI chr11:80,622,000...80,771,674
Ensembl chr11:67,116,877...67,266,834 		JBrowse link
G Slc14a1 solute carrier family 14 member 1 (Kidd blood group) decreases expression EXP fullerene C60 results in decreased expression of SLC14A1 mRNA CTD PMID:19167457 NCBI chr18:73,840,568...73,883,925
Ensembl chr18:71,565,454...71,595,146 		JBrowse link
G Slc17a1 solute carrier family 17 member 1 decreases expression EXP fullerene C60 results in decreased expression of SLC17A1 mRNA CTD PMID:19167457 NCBI chr17:41,647,332...41,683,078
Ensembl chr17:41,222,049...41,253,304 		JBrowse link
G Slc17a6 solute carrier family 17 member 6 decreases expression EXP fullerene C60 results in decreased expression of SLC17A6 mRNA CTD PMID:19167457 NCBI chr 1:110,348,447...110,388,499
Ensembl chr 1:101,212,489...101,252,542 		JBrowse link
G Slc20a2 solute carrier family 20 member 2 decreases expression EXP fullerene C60 results in decreased expression of SLC20A2 mRNA CTD PMID:19167457 NCBI chr16:76,163,315...76,253,881
Ensembl chr16:69,460,462...69,521,711 		JBrowse link
G Slc22a4 solute carrier family 22 member 4 decreases expression EXP fullerene C60 results in decreased expression of SLC22A4 mRNA CTD PMID:19167457 NCBI chr10:38,634,098...38,687,409
Ensembl chr10:38,133,322...38,179,720 		JBrowse link
G Slc22a7 solute carrier family 22 member 7 decreases expression EXP fullerene C60 results in decreased expression of SLC22A7 mRNA CTD PMID:19167457 NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:14,547,849...14,553,921 		JBrowse link
G Slc24a4 solute carrier family 24 member 4 increases expression EXP fullerene C60 results in increased expression of SLC24A4 mRNA CTD PMID:19167457 NCBI chr 6:127,044,470...127,184,684
Ensembl chr 6:121,280,031...121,414,949 		JBrowse link
G Slc25a1 solute carrier family 25 member 1 increases expression EXP fullerene C60 results in increased expression of SLC25A1 mRNA CTD PMID:19167457 NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781 		JBrowse link
G Slc25a39 solute carrier family 25, member 39 increases expression EXP fullerene C60 results in increased expression of SLC25A39 mRNA CTD PMID:19167457 NCBI chr10:87,862,630...87,867,626
Ensembl chr10:87,362,490...87,367,260 		JBrowse link
G Slc25a42 solute carrier family 25, member 42 increases expression EXP fullerene C60 results in increased expression of SLC25A42 mRNA CTD PMID:19167457 NCBI chr16:19,213,914...19,251,990
Ensembl chr16:19,213,950...19,237,025 		JBrowse link
G Slc26a4 solute carrier family 26 member 4 increases expression EXP fullerene C60 results in increased expression of SLC26A4 mRNA CTD PMID:20471445 NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:48,107,588...48,145,703 		JBrowse link
G Slc27a4 solute carrier family 27 member 4 increases expression EXP fullerene C60 results in increased expression of SLC27A4 mRNA CTD PMID:19167457 NCBI chr 3:33,472,903...33,485,824
Ensembl chr 3:13,075,022...13,087,943 		JBrowse link
G Slc28a3 solute carrier family 28 member 3 decreases expression EXP fullerene C60 results in decreased expression of SLC28A3 mRNA CTD PMID:19167457 NCBI chr17:6,068,034...6,120,421
Ensembl chr17:6,062,549...6,114,038 		JBrowse link
G Slc29a4 solute carrier family 29 member 4 decreases expression EXP fullerene C60 results in decreased expression of SLC29A4 mRNA CTD PMID:19167457 NCBI chr12:16,967,047...16,998,276
Ensembl chr12:11,853,540...11,874,834 		JBrowse link
G Slc2a5 solute carrier family 2 member 5 decreases expression EXP fullerene C60 results in decreased expression of SLC2A5 mRNA CTD PMID:19167457 NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:160,583,234...160,611,106 		JBrowse link
G Slc2a8 solute carrier family 2 member 8 increases expression EXP fullerene C60 results in increased expression of SLC2A8 mRNA CTD PMID:19167457 NCBI chr 3:36,672,589...36,682,206
Ensembl chr 3:16,274,925...16,284,464 		JBrowse link
G Slc31a1 solute carrier family 31 member 1 decreases expression EXP fullerene C60 results in decreased expression of SLC31A1 mRNA CTD PMID:19167457 NCBI chr 5:80,830,574...80,859,810
Ensembl chr 5:75,814,743...75,844,228 		JBrowse link
G Slc31a2 solute carrier family 31 member 2 decreases expression EXP fullerene C60 results in decreased expression of SLC31A2 mRNA CTD PMID:19167457 NCBI chr 5:80,753,589...80,764,126
Ensembl chr 5:75,738,024...75,748,542 		JBrowse link
G Slc35e4 solute carrier family 35, member E4 increases expression EXP fullerene C60 results in increased expression of SLC35E4 mRNA CTD PMID:19167457 NCBI chr14:83,026,914...83,033,778
Ensembl chr14:78,803,323...78,810,241 		JBrowse link
G Slc37a1 solute carrier family 37 member 1 increases expression EXP fullerene C60 results in increased expression of SLC37A1 mRNA CTD PMID:19167457 NCBI chr20:9,361,733...9,435,227
Ensembl chr20:9,378,836...9,433,892 		JBrowse link
G Slc38a10 solute carrier family 38, member 10 increases expression EXP fullerene C60 results in increased expression of SLC38A10 mRNA CTD PMID:19167457 NCBI chr10:105,386,836...105,436,636
Ensembl chr10:105,386,836...105,436,636 		JBrowse link
G Slc39a1 solute carrier family 39 member 1 decreases expression EXP fullerene C60 results in decreased expression of SLC39A1 mRNA CTD PMID:19167457 NCBI chr 2:178,001,052...178,006,689
Ensembl chr 2:175,703,441...175,709,058 		JBrowse link
G Slc39a8 solute carrier family 39 member 8 increases expression EXP fullerene C60 results in increased expression of SLC39A8 mRNA CTD PMID:19167457 NCBI chr 2:226,845,686...226,992,668
Ensembl chr 2:224,256,654...224,319,129 		JBrowse link
G Slc43a1 solute carrier family 43 member 1 increases expression EXP fullerene C60 results in increased expression of SLC43A1 mRNA CTD PMID:19167457 NCBI chr 3:90,327,250...90,353,438
Ensembl chr 3:69,920,649...69,946,768 		JBrowse link
G Slc44a2 solute carrier family 44 member 2 increases expression EXP fullerene C60 results in increased expression of SLC44A2 mRNA CTD PMID:19167457 NCBI chr 8:19,870,867...19,905,345
Ensembl chr 8:19,870,888...19,905,342 		JBrowse link
G Slc45a4 solute carrier family 45, member 4 decreases expression EXP fullerene C60 results in decreased expression of SLC45A4 mRNA CTD PMID:19167457 NCBI chr 7:107,370,826...107,459,163
Ensembl chr 7:105,481,792...105,550,170 		JBrowse link
G Slc47a1 solute carrier family 47 member 1 decreases expression EXP fullerene C60 results in decreased expression of SLC47A1 mRNA CTD PMID:19167457 NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,034,122...46,087,637 		JBrowse link
G Slc48a1 solute carrier family 48 member 1 increases expression EXP fullerene C60 results in increased expression of SLC48A1 mRNA CTD PMID:19167457 NCBI chr 7:128,915,136...128,923,929
Ensembl chr 7:128,915,195...128,923,024 		JBrowse link
G Slc4a1 solute carrier family 4 member 1 (Diego blood group) decreases expression EXP fullerene C60 results in decreased expression of SLC4A1 mRNA CTD PMID:19167457 NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,306,872...87,323,117 		JBrowse link
G Slc6a18 solute carrier family 6 member 18 decreases expression EXP fullerene C60 results in decreased expression of SLC6A18 mRNA CTD PMID:19167457 NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925 		JBrowse link
G Slc6a21 solute carrier family 6 member 21 decreases expression EXP fullerene C60 results in decreased expression of SLC6A21 mRNA CTD PMID:19167457 NCBI chr 1:95,754,257...95,765,854
Ensembl chr 1:95,754,447...95,765,851 		JBrowse link
G Slc6a8 solute carrier family 6 member 8 increases expression EXP fullerene C60 results in increased expression of SLC6A8 mRNA CTD PMID:19167457 NCBI chr  X:156,536,017...156,545,321
Ensembl chr  X:151,384,675...151,393,979 		JBrowse link
G Slc8a1 solute carrier family 8 member A1 decreases expression EXP fullerene C60 results in decreased expression of SLC8A1 mRNA CTD PMID:19167457 NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628 		JBrowse link
G Slc9a8 solute carrier family 9 member A8 decreases expression EXP fullerene C60 results in decreased expression of SLC9A8 mRNA CTD PMID:19167457 NCBI chr 3:176,559,658...176,617,510
Ensembl chr 3:156,148,104...156,198,471 		JBrowse link
G Slco1b2 solute carrier organic anion transporter family member 1B2 affects expression EXP fullerene C60 affects the expression of SLCO1B3 mRNA CTD PMID:19167457 NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:174,551,480...174,619,981 		JBrowse link
G Slco2a1 solute carrier organic anion transporter family, member 2a1 increases expression EXP fullerene C60 results in increased expression of SLCO2A1 mRNA CTD PMID:19167457 NCBI chr 8:103,588,916...103,672,546
Ensembl chr 8:103,588,916...103,672,546 		JBrowse link
G Slitrk1 SLIT and NTRK-like family, member 1 decreases expression EXP fullerene C60 results in decreased expression of SLITRK1 mRNA CTD PMID:19167457 NCBI chr15:92,137,703...92,141,741
Ensembl chr15:85,724,475...85,727,509 		JBrowse link
G Slmap sarcolemma associated protein decreases expression EXP fullerene C60 results in decreased expression of SLMAP mRNA CTD PMID:19167457 NCBI chr16:1,673,964...1,791,902
Ensembl chr16:1,667,208...1,785,149 		JBrowse link
G Sln sarcolipin affects expression EXP fullerene C60 affects the expression of SLN mRNA CTD PMID:19167457 NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:54,243,542...54,247,791 		JBrowse link
G Slpi secretory leukocyte peptidase inhibitor increases expression ISO fullerene C60 results in increased expression of SLPI mRNA CTD PMID:20064541 NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:153,082,369...153,084,453 		JBrowse link
G Smad6 SMAD family member 6 increases expression EXP fullerene C60 results in increased expression of SMAD6 mRNA CTD PMID:19167457 NCBI chr 8:73,345,457...73,414,985
Ensembl chr 8:64,450,114...64,519,763 		JBrowse link
G Smarca4 SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 increases expression EXP fullerene C60 results in increased expression of SMARCA4 mRNA CTD PMID:19167457 NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:20,167,717...20,258,975 		JBrowse link
G Smim38 small integral membrane protein 38 decreases expression EXP fullerene C60 results in decreased expression of SMIM38 mRNA CTD PMID:19167457 NCBI chr 1:200,366,561...200,371,976 JBrowse link
G Smpd2 sphingomyelin phosphodiesterase 2 decreases expression EXP fullerene C60 results in decreased expression of SMPD2 mRNA CTD PMID:19167457 NCBI chr20:46,568,627...46,571,741
Ensembl chr20:44,986,231...44,989,441 		JBrowse link
G Smpdl3a sphingomyelin phosphodiesterase, acid-like 3A decreases expression EXP fullerene C60 results in decreased expression of SMPDL3A mRNA CTD PMID:19167457 NCBI chr20:37,679,004...37,701,979
Ensembl chr20:37,132,592...37,155,567 		JBrowse link
G Smptb polypyrimidine tract-binding protein decreases expression EXP fullerene C60 results in decreased expression of SMPTB mRNA CTD PMID:19167457 NCBI chr  X:16,609,016...16,610,898
Ensembl chr  X:16,606,597...16,610,874 		JBrowse link
G Smtn smoothelin increases expression EXP fullerene C60 results in increased expression of SMTN mRNA CTD PMID:19167457 NCBI chr14:78,398,595...78,420,908
Ensembl chr14:78,397,778...78,420,886 		JBrowse link
G Smtnl1 smoothelin-like 1 decreases expression EXP fullerene C60 results in decreased expression of SMTNL1 mRNA CTD PMID:19167457 NCBI chr 3:69,889,010...69,901,096
Ensembl chr 3:69,889,010...69,901,079 		JBrowse link
G Smug1 single-strand-selective monofunctional uracil-DNA glycosylase 1 decreases expression EXP fullerene C60 results in decreased expression of SMUG1 mRNA CTD PMID:19167457 NCBI chr 7:134,288,565...134,302,179
Ensembl chr 7:134,287,675...134,297,226 		JBrowse link
G Snap25 synaptosome associated protein 25 decreases expression EXP fullerene C60 results in decreased expression of SNAP25 mRNA CTD PMID:19167457 NCBI chr 3:144,494,579...144,576,449
Ensembl chr 3:124,041,898...124,123,760 		JBrowse link
G Snrnp25 small nuclear ribonucleoprotein U11/U12 subunit 25 decreases expression EXP fullerene C60 results in decreased expression of SNRNP25 mRNA CTD PMID:19167457 NCBI chr10:15,420,482...15,423,806
Ensembl chr10:15,420,486...15,423,804 		JBrowse link
G Snrnp48 small nuclear ribonucleoprotein U11/U12 subunit 48 increases expression EXP fullerene C60 results in increased expression of SNRNP48 mRNA CTD PMID:19167457 NCBI chr17:26,596,266...26,616,058
Ensembl chr17:26,596,275...26,616,040 		JBrowse link
G Snrpg small nuclear ribonucleoprotein polypeptide G decreases expression EXP fullerene C60 results in decreased expression of SNRPG mRNA CTD PMID:19167457 NCBI chr 4:120,369,676...120,377,263
Ensembl chr 4:118,812,252...118,819,826
Ensembl chr  X:118,812,252...118,819,826 		JBrowse link
G Snta1 syntrophin, alpha 1 decreases expression EXP fullerene C60 results in decreased expression of SNTA1 mRNA CTD PMID:19167457 NCBI chr 3:163,336,509...163,366,954
Ensembl chr 3:142,876,296...142,906,709 		JBrowse link
G Snx33 sorting nexin 33 increases expression EXP fullerene C60 results in increased expression of SNX33 mRNA CTD PMID:19167457 NCBI chr 8:66,213,133...66,224,926
Ensembl chr 8:57,317,161...57,327,538 		JBrowse link
G Snx8 sorting nexin 8 decreases expression EXP fullerene C60 results in decreased expression of SNX8 mRNA CTD PMID:19167457 NCBI chr12:19,365,746...19,414,333
Ensembl chr12:14,251,859...14,300,432 		JBrowse link
G Sod1 superoxide dismutase 1 increases expression ISO fullerene C60 results in increased expression of SOD1 mRNA CTD PMID:20064541 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249 		JBrowse link
G Sod2 superoxide dismutase 2 decreases expression
increases expression		 EXP fullerene C60 results in decreased expression of SOD2 mRNA
fullerene C60 results in increased expression of SOD2 mRNA		 CTD PMID:19167457 PMID:20471445 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Sox17 SRY-box transcription factor 17 increases expression EXP fullerene C60 results in increased expression of SOX17 mRNA CTD PMID:19167457 NCBI chr 5:19,814,345...19,819,859
Ensembl chr 5:15,016,731...15,022,228 		JBrowse link
G Sox18 SRY-box transcription factor 18 increases expression EXP fullerene C60 results in increased expression of SOX18 mRNA CTD PMID:19167457 NCBI chr 3:189,163,000...189,164,802
Ensembl chr 3:168,785,490...168,787,290 		JBrowse link
G Sox6 SRY-box transcription factor 6 decreases expression EXP fullerene C60 results in decreased expression of SOX6 mRNA CTD PMID:19167457 NCBI chr 1:169,723,306...170,334,846
Ensembl chr 1:169,729,194...170,277,386 		JBrowse link
G Sp5 Sp5 transcription factor increases expression EXP fullerene C60 results in increased expression of SP5 mRNA CTD PMID:19167457 NCBI chr 3:75,682,677...75,685,479
Ensembl chr 3:55,274,931...55,277,733 		JBrowse link
G Sp9 Sp9 transcription factor decreases expression EXP fullerene C60 results in decreased expression of SP9 mRNA CTD PMID:19167457 NCBI chr 3:58,146,826...58,149,357
Ensembl chr 3:58,146,826...58,149,357 		JBrowse link
G Spaca4 sperm acrosome associated 4 decreases expression EXP fullerene C60 results in decreased expression of SPACA4 mRNA CTD PMID:19167457 NCBI chr 1:96,195,514...96,196,187
Ensembl chr 1:96,195,315...96,196,237 		JBrowse link
G Spata20 spermatogenesis associated 20 decreases expression EXP fullerene C60 results in decreased expression of SPATA20 mRNA CTD PMID:19167457 NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368 		JBrowse link
G Spata6l spermatogenesis associated 6-like decreases expression EXP fullerene C60 results in decreased expression of SPATA6L mRNA CTD PMID:19167457 NCBI chr 1:226,630,470...226,682,979
Ensembl chr 1:226,641,518...226,682,884 		JBrowse link
G Spem1 spermatid maturation 1 decreases expression EXP fullerene C60 results in decreased expression of SPEM1 mRNA CTD PMID:19167457 NCBI chr10:54,541,454...54,542,755
Ensembl chr10:54,541,471...54,546,131 		JBrowse link
G Spetex2a Spetex-2A protein affects expression EXP fullerene C60 affects the expression of SPETEX2A mRNA CTD PMID:19167457
G Sphk1 sphingosine kinase 1 increases expression EXP fullerene C60 results in increased expression of SPHK1 mRNA CTD PMID:19167457 NCBI chr10:102,257,413...102,263,086
Ensembl chr10:101,758,711...101,764,240 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression EXP fullerene C60 results in increased expression of SPP1 mRNA CTD PMID:20471445 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162 		JBrowse link
G Spry4 sprouty RTK signaling antagonist 4 decreases expression EXP fullerene C60 results in decreased expression of SPRY4 mRNA CTD PMID:19167457 NCBI chr18:30,687,633...30,702,546
Ensembl chr18:30,436,443...30,453,004 		JBrowse link
G Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 decreases expression EXP fullerene C60 results in decreased expression of SPSB1 mRNA CTD PMID:19167457 NCBI chr 5:165,641,255...165,701,482
Ensembl chr 5:160,358,308...160,418,468 		JBrowse link
G Spta1 spectrin, alpha, erythrocytic 1 decreases expression EXP fullerene C60 results in decreased expression of SPTA1 mRNA CTD PMID:19167457 NCBI chr13:88,735,833...88,811,697
Ensembl chr13:86,203,504...86,279,371 		JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase decreases expression EXP fullerene C60 results in decreased expression of SRC mRNA CTD PMID:19167457 NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476 		JBrowse link
G Srcap Snf2-related CREBBP activator protein decreases expression EXP fullerene C60 results in decreased expression of SRCAP mRNA CTD PMID:19167457 NCBI chr 1:182,123,562...182,172,643
Ensembl chr 1:182,118,416...182,176,610 		JBrowse link
G Srcin1 SRC kinase signaling inhibitor 1 decreases expression EXP fullerene C60 results in decreased expression of SRCIN1 mRNA CTD PMID:19167457 NCBI chr10:82,999,295...83,066,359
Ensembl chr10:82,504,393...82,571,040 		JBrowse link
G Srd5a2 steroid 5 alpha-reductase 2 decreases expression EXP fullerene C60 results in decreased expression of SRD5A2 mRNA CTD PMID:19167457 NCBI chr 6:27,178,089...27,217,588
Ensembl chr 6:21,426,215...21,462,112 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 increases expression EXP fullerene C60 results in increased expression of SREBF1 mRNA CTD PMID:19167457 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650 		JBrowse link
G Srf serum response factor decreases expression EXP fullerene C60 results in decreased expression of SRF mRNA CTD PMID:19167457 NCBI chr 9:21,924,050...21,933,338
Ensembl chr 9:14,426,472...14,435,733 		JBrowse link
G Srgap2 SLIT-ROBO Rho GTPase activating protein 2 decreases expression EXP fullerene C60 results in decreased expression of SRGAP2 mRNA CTD PMID:19167457 NCBI chr13:42,745,956...42,967,091
Ensembl chr13:42,745,947...42,967,058 		JBrowse link
G Srp68 signal recognition particle 68 decreases expression EXP fullerene C60 results in decreased expression of SRP68 mRNA CTD PMID:19167457 NCBI chr10:101,481,213...101,508,035
Ensembl chr10:101,481,212...101,508,035 		JBrowse link
G Srpk1 SRSF protein kinase 1 increases expression EXP fullerene C60 results in increased expression of SRPK1 mRNA CTD PMID:19167457 NCBI chr20:6,645,809...6,682,448
Ensembl chr20:6,645,809...6,682,134 		JBrowse link
G Srrm3 serine/arginine repetitive matrix 3 decreases expression EXP fullerene C60 results in decreased expression of SRRM3 mRNA CTD PMID:19167457 NCBI chr12:20,808,878...20,878,557
Ensembl chr12:20,809,089...20,878,505 		JBrowse link
G Srsf6 serine and arginine rich splicing factor 6 decreases expression EXP fullerene C60 results in decreased expression of SRSF6 mRNA CTD PMID:19167457 NCBI chr 3:172,009,072...172,014,395
Ensembl chr 3:151,589,535...151,594,860 		JBrowse link
G Srsf7 serine and arginine rich splicing factor 7 decreases expression EXP fullerene C60 results in decreased expression of SRSF7 mRNA CTD PMID:19167457 NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:14,811,808...14,818,965 		JBrowse link
G Sstr2 somatostatin receptor 2 decreases expression EXP fullerene C60 results in decreased expression of SSTR2 mRNA CTD PMID:19167457 NCBI chr10:99,163,353...99,170,519
Ensembl chr10:98,664,216...98,674,351 		JBrowse link
G St3gal3 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 increases expression EXP fullerene C60 results in increased expression of ST3GAL3 mRNA CTD PMID:19167457 NCBI chr 5:136,755,780...136,958,081
Ensembl chr 5:131,470,348...131,670,810 		JBrowse link
G St6gal1 ST6 beta-galactoside alpha-2,6-sialyltransferase 1 decreases expression EXP fullerene C60 results in decreased expression of ST6GAL1 mRNA CTD PMID:19167457 NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310 		JBrowse link
G Stac2 SH3 and cysteine rich domain 2 decreases expression EXP fullerene C60 results in decreased expression of STAC2 mRNA CTD PMID:19167457 NCBI chr10:83,032,418...83,048,260
Ensembl chr10:83,032,417...83,048,260 		JBrowse link
G Stard8 StAR-related lipid transfer domain containing 8 increases expression EXP fullerene C60 results in increased expression of STARD8 mRNA CTD PMID:19167457 NCBI chr  X:64,079,079...64,196,052
Ensembl chr  X:64,124,574...64,196,052 		JBrowse link
G Stk11 serine/threonine kinase 11 decreases expression EXP fullerene C60 results in decreased expression of STK11 mRNA CTD PMID:19167457 NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:9,575,269...9,591,315 		JBrowse link
G Stk32a serine/threonine kinase 32A increases expression EXP fullerene C60 results in increased expression of STK32A mRNA CTD PMID:19167457 NCBI chr18:35,258,865...35,374,985
Ensembl chr18:35,259,052...35,369,451 		JBrowse link
G Stmn2 stathmin 2 decreases expression EXP fullerene C60 results in decreased expression of STMN2 mRNA CTD PMID:19167457 NCBI chr 2:95,112,017...95,159,642
Ensembl chr 2:93,204,692...93,252,011 		JBrowse link
G Strn4 striatin 4 increases expression EXP fullerene C60 results in increased expression of STRN4 mRNA CTD PMID:19167457 NCBI chr 1:77,482,267...77,511,862
Ensembl chr 1:77,482,094...77,511,858 		JBrowse link
G Stx5 syntaxin 5 increases expression EXP fullerene C60 results in increased expression of STX5A mRNA CTD PMID:19167457 NCBI chr 1:215,066,532...215,082,685
Ensembl chr 1:205,637,413...205,653,563 		JBrowse link
G Sumo3 small ubiquitin-like modifier 3 decreases expression EXP fullerene C60 results in decreased expression of SUMO3 mRNA CTD PMID:19167457 NCBI chr20:11,010,140...11,020,850
Ensembl chr20:11,007,148...11,020,877
Ensembl chr20:11,007,148...11,020,877 		JBrowse link
G Supt16h SPT16 homolog, facilitates chromatin remodeling subunit increases expression EXP fullerene C60 results in increased expression of SUPT16H mRNA CTD PMID:19167457 NCBI chr15:27,341,196...27,378,314
Ensembl chr15:24,866,489...24,904,846 		JBrowse link
G Susd5 sushi domain containing 5 decreases expression EXP fullerene C60 results in decreased expression of SUSD5 mRNA CTD PMID:19167457 NCBI chr 8:113,996,771...114,036,133
Ensembl chr 8:113,997,362...114,035,861 		JBrowse link
G Sybu syntabulin decreases expression EXP fullerene C60 results in decreased expression of SYBU mRNA CTD PMID:19167457 NCBI chr 7:77,731,662...77,833,413
Ensembl chr 7:75,847,003...75,948,828 		JBrowse link
G Syn1 synapsin I decreases expression EXP fullerene C60 results in decreased expression of SYN1 mRNA CTD PMID:19167457 NCBI chr  X:3,725,745...3,780,940
Ensembl chr  X:1,172,208...1,227,396 		JBrowse link
G Syne1 spectrin repeat containing nuclear envelope protein 1 decreases expression EXP fullerene C60 results in decreased expression of SYNE1 mRNA CTD PMID:19167457 NCBI chr 1:43,917,640...44,388,802
Ensembl chr 1:41,512,030...41,983,322 		JBrowse link
G Syt8 synaptotagmin 8 decreases expression EXP fullerene C60 results in decreased expression of SYT8 mRNA CTD PMID:19167457 NCBI chr 1:207,017,602...207,023,076
Ensembl chr 1:197,590,149...197,593,504 		JBrowse link
G Taar7h trace amine-associated receptor 7h decreases expression EXP fullerene C60 results in decreased expression of TAAR7H mRNA CTD PMID:19167457 NCBI chr 1:23,192,743...23,193,819
Ensembl chr 1:21,387,360...21,388,436
Ensembl chr 1:21,387,360...21,388,436 		JBrowse link
G Tab2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 increases expression EXP fullerene C60 results in increased expression of TAB2 mRNA CTD PMID:19167457 NCBI chr 1:4,195,400...4,245,485
Ensembl chr 1:2,375,490...2,424,756 		JBrowse link
G Tacr1 tachykinin receptor 1 decreases expression EXP fullerene C60 results in decreased expression of TACR1 mRNA CTD PMID:19167457 NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:114,920,844...115,089,733 		JBrowse link
G Taf12 TATA-box binding protein associated factor 12 decreases expression EXP fullerene C60 results in decreased expression of TAF12 mRNA CTD PMID:19167457 NCBI chr 5:149,756,826...149,772,886
Ensembl chr 5:144,472,841...144,488,849 		JBrowse link
G Taf4b TATA-box binding protein associated factor 4b decreases expression EXP fullerene C60 results in decreased expression of TAF4B mRNA CTD PMID:19167457 NCBI chr18:5,952,737...6,086,408
Ensembl chr18:5,952,769...6,068,307 		JBrowse link
G Taf6l TATA-box binding protein associated factor 6 like increases expression EXP fullerene C60 results in increased expression of TAF6L mRNA CTD PMID:19167457 NCBI chr 1:215,101,266...215,113,888
Ensembl chr 1:205,672,149...205,684,655 		JBrowse link
G Tal1 TAL bHLH transcription factor 1, erythroid differentiation factor increases expression EXP fullerene C60 results in increased expression of TAL1 mRNA CTD PMID:19167457 NCBI chr 5:133,823,093...133,837,737
Ensembl chr 5:128,587,701...128,600,976 		JBrowse link
G Tapbp TAP binding protein decreases expression EXP fullerene C60 results in decreased expression of TAPBP mRNA CTD PMID:19167457 NCBI chr20:4,956,937...4,966,191
Ensembl chr20:4,956,937...4,966,181 		JBrowse link
G Tas2r118 taste receptor, type 2, member 118 decreases expression EXP fullerene C60 results in decreased expression of TAS2R16 mRNA CTD PMID:19167457 NCBI chr 4:53,414,815...53,415,714
Ensembl chr 4:52,449,208...52,450,107 		JBrowse link
G Tbata thymus, brain and testes associated decreases expression EXP fullerene C60 results in decreased expression of TBATA mRNA CTD PMID:19167457 NCBI chr20:29,118,055...29,135,124
Ensembl chr20:29,118,070...29,135,109 		JBrowse link
G Tbc1d24 TBC1 domain family, member 24 decreases expression EXP fullerene C60 results in decreased expression of TBC1D24 mRNA CTD PMID:19167457 NCBI chr10:13,711,930...13,740,902
Ensembl chr10:13,209,895...13,236,050 		JBrowse link
G Tbce tubulin folding cofactor E decreases expression EXP fullerene C60 results in decreased expression of TBCE mRNA CTD PMID:19167457 NCBI chr17:55,983,627...56,031,578
Ensembl chr17:51,290,202...51,336,089 		JBrowse link
G Tbkbp1 TBK1 binding protein 1 increases expression EXP fullerene C60 results in increased expression of TBKBP1 mRNA CTD PMID:19167457 NCBI chr10:82,616,978...82,632,169
Ensembl chr10:82,120,564...82,134,352 		JBrowse link
G Tbx1 T-box transcription factor 1 increases expression EXP fullerene C60 results in increased expression of TBX1 mRNA CTD PMID:19167457 NCBI chr11:95,913,610...95,923,392
Ensembl chr11:82,409,275...82,418,380 		JBrowse link
G Tbx2 T-box transcription factor 2 increases expression EXP fullerene C60 results in increased expression of TBX2 mRNA CTD PMID:19167457 NCBI chr10:71,177,082...71,186,275
Ensembl chr10:70,679,518...70,688,529 		JBrowse link
G Tbx4 T-box transcription factor 4 increases expression EXP fullerene C60 results in increased expression of TBX4 mRNA CTD PMID:19167457 NCBI chr10:71,228,145...71,258,222
Ensembl chr10:70,731,163...70,760,825 		JBrowse link
G Tbxa2r thromboxane A2 receptor increases expression EXP fullerene C60 results in increased expression of TBXA2R mRNA CTD PMID:19167457 NCBI chr 7:9,034,077...9,041,489
Ensembl chr 7:8,383,378...8,388,176 		JBrowse link
G Tcea3 transcription elongation factor A3 decreases expression EXP fullerene C60 results in decreased expression of TCEA3 mRNA CTD PMID:19167457 NCBI chr 5:148,476,941...148,509,452
Ensembl chr 5:148,476,941...148,509,448 		JBrowse link
G Tcerg1l transcription elongation regulator 1-like decreases expression EXP fullerene C60 results in decreased expression of TCERG1L mRNA CTD PMID:19167457 NCBI chr 1:202,442,605...202,630,483
Ensembl chr 1:193,012,937...193,200,913 		JBrowse link
G Tcf4 transcription factor 4 decreases expression EXP fullerene C60 results in decreased expression of TCF4 mRNA CTD PMID:19167457 NCBI chr18:65,216,840...65,563,186
Ensembl chr18:62,943,782...63,284,425 		JBrowse link
G Tcn2 transcobalamin 2 increases expression EXP fullerene C60 results in increased expression of TCN2 mRNA CTD PMID:19167457 NCBI chr14:83,036,935...83,052,187
Ensembl chr14:78,813,343...78,828,489 		JBrowse link
G Tcp11 t-complex 11 increases expression EXP fullerene C60 results in increased expression of TCP11 mRNA CTD PMID:19167457 NCBI chr20:6,128,001...6,140,152
Ensembl chr20:6,126,269...6,136,055 		JBrowse link
G Tef TEF transcription factor, PAR bZIP family member increases expression EXP fullerene C60 results in increased expression of TEF mRNA CTD PMID:19167457 NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:113,317,283...113,341,783 		JBrowse link
G Telo2 telomere maintenance 2 increases expression EXP fullerene C60 results in increased expression of TELO2 mRNA CTD PMID:19167457 NCBI chr10:14,624,998...14,640,235
Ensembl chr10:14,120,818...14,135,698 		JBrowse link
G Tenm4 teneurin transmembrane protein 4 decreases expression EXP fullerene C60 results in decreased expression of TENM4 mRNA CTD PMID:19167457 NCBI chr 1:149,895,097...151,263,315
Ensembl chr 1:150,780,381...151,259,144 		JBrowse link
G Tent5b terminal nucleotidyltransferase 5B affects expression EXP fullerene C60 affects the expression of TENT5B mRNA CTD PMID:19167457 NCBI chr 5:145,695,358...145,702,668
Ensembl chr 5:145,695,362...145,706,073
Ensembl chr11:145,695,362...145,706,073 		JBrowse link
G Tes testin LIM domain protein decreases expression EXP fullerene C60 results in decreased expression of TES mRNA CTD PMID:19167457 NCBI chr 4:46,331,257...46,369,782
Ensembl chr 4:45,365,285...45,403,829 		JBrowse link
G Tesc tescalcin increases expression EXP fullerene C60 results in increased expression of TESC mRNA CTD PMID:19167457 NCBI chr12:44,182,741...44,216,574
Ensembl chr12:38,521,861...38,555,824 		JBrowse link
G Tex264 testis expressed 264 increases expression EXP fullerene C60 results in increased expression of TEX264 mRNA CTD PMID:19167457 NCBI chr 8:107,295,806...107,322,858
Ensembl chr 8:107,295,806...107,323,232 		JBrowse link
G Tg thyroglobulin decreases expression EXP fullerene C60 results in decreased expression of TG mRNA CTD PMID:19167457 NCBI chr 7:100,307,349...100,492,246
Ensembl chr 7:98,418,293...98,603,210 		JBrowse link
G Tgfb1i1 transforming growth factor beta 1 induced transcript 1 increases expression EXP fullerene C60 results in increased expression of TGFB1I1 mRNA CTD PMID:19167457 NCBI chr 1:192,258,992...192,265,903
Ensembl chr 1:182,828,544...182,837,080 		JBrowse link
G Tgfbi transforming growth factor, beta induced decreases expression EXP fullerene C60 results in decreased expression of TGFBI mRNA CTD PMID:19167457 NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,955,603...7,985,240 		JBrowse link
G Tgm2 transglutaminase 2 decreases expression EXP fullerene C60 results in decreased expression of TGM2 mRNA CTD PMID:19167457 NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:146,772,687...146,801,981 		JBrowse link
G Thap11 THAP domain containing 11 decreases expression EXP fullerene C60 results in decreased expression of THAP11 mRNA CTD PMID:19167457 NCBI chr19:33,746,977...33,748,794
Ensembl chr19:33,746,854...33,749,540 		JBrowse link
G Thbs4 thrombospondin 4 decreases expression EXP fullerene C60 results in decreased expression of THBS4 mRNA CTD PMID:19167457 NCBI chr 2:25,718,219...25,760,345
Ensembl chr 2:23,983,158...24,026,313 		JBrowse link
G Thsd1 thrombospondin type 1 domain containing 1 increases expression EXP fullerene C60 results in increased expression of THSD1 mRNA CTD PMID:19167457 NCBI chr16:76,473,026...76,507,404
Ensembl chr16:69,771,408...69,801,504 		JBrowse link
G Tie1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1 increases expression EXP fullerene C60 results in increased expression of TIE1 mRNA CTD PMID:19167457 NCBI chr 5:132,000,013...132,019,658
Ensembl chr 5:132,000,015...132,019,592 		JBrowse link
G Tigd3 tigger transposable element derived 3 decreases expression EXP fullerene C60 results in decreased expression of TIGD3 mRNA CTD PMID:19167457 NCBI chr 1:212,607,772...212,612,683
Ensembl chr 1:203,178,460...203,181,272 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression ISO fullerene C60 results in increased expression of TIMP1 mRNA CTD PMID:20064541 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:1,212,972...1,217,664 		JBrowse link
G Timp2 TIMP metallopeptidase inhibitor 2 decreases expression ISO fullerene C60 results in decreased expression of TIMP2 mRNA CTD PMID:31504961 NCBI chr10:104,041,604...104,089,214
Ensembl chr10:103,531,505...103,590,611 		JBrowse link
G Tinf2 TERF1 interacting nuclear factor 2 decreases expression EXP fullerene C60 results in decreased expression of TINF2 mRNA CTD PMID:19167457 NCBI chr15:33,140,611...33,146,930
Ensembl chr15:29,170,652...29,176,984 		JBrowse link
G Tkfc triokinase and FMN cyclase increases expression EXP fullerene C60 results in increased expression of TKFC mRNA CTD PMID:19167457 NCBI chr 1:216,664,446...216,677,815
Ensembl chr 1:207,236,557...207,252,737 		JBrowse link
G Tlnrd1 talin rod domain containing 1 increases expression EXP fullerene C60 results in increased expression of TLNRD1 mRNA CTD PMID:19167457 NCBI chr 1:137,864,340...137,866,359
Ensembl chr 1:137,864,343...137,866,359 		JBrowse link
G Tlr7 toll-like receptor 7 decreases expression EXP fullerene C60 results in decreased expression of TLR7 mRNA CTD PMID:19167457 NCBI chr  X:30,644,324...30,670,796
Ensembl chr  X:27,027,425...27,054,754 		JBrowse link
G Tlx2 T-cell leukemia homeobox 2 decreases expression EXP fullerene C60 results in decreased expression of TLX2 mRNA CTD PMID:19167457 NCBI chr 4:117,131,516...117,133,359
Ensembl chr 4:115,573,799...115,575,642 		JBrowse link
G Tm4sf5 transmembrane 4 L six family member 5 increases expression EXP fullerene C60 results in increased expression of TM4SF5 mRNA CTD PMID:19167457 NCBI chr10:55,219,384...55,225,742
Ensembl chr10:55,219,384...55,225,742 		JBrowse link
G Tmc2 transmembrane channel-like 2 decreases expression EXP fullerene C60 results in decreased expression of TMC2 mRNA CTD PMID:19167457 NCBI chr 3:117,396,378...117,464,336
Ensembl chr 3:117,396,378...117,464,336 		JBrowse link
G Tmc5 transmembrane channel-like 5 decreases expression EXP fullerene C60 results in decreased expression of TMC5 mRNA CTD PMID:19167457 NCBI chr 1:182,349,102...182,433,679
Ensembl chr 1:172,914,457...172,999,474 		JBrowse link
G Tmcc2 transmembrane and coiled-coil domain family 2 increases expression EXP fullerene C60 results in increased expression of TMCC2 mRNA CTD PMID:19167457 NCBI chr13:43,794,029...43,831,716
Ensembl chr13:43,794,029...43,831,716 		JBrowse link
G Tmed5 transmembrane p24 trafficking protein 5 decreases expression EXP fullerene C60 results in decreased expression of TMED5 mRNA CTD PMID:19167457 NCBI chr14:1,752,857...1,763,990
Ensembl chr14:1,607,819...1,628,426 		JBrowse link
G Tmed9 transmembrane p24 trafficking protein 9 decreases expression EXP fullerene C60 results in decreased expression of TMED9 mRNA CTD PMID:19167457 NCBI chr17:9,034,797...9,039,311
Ensembl chr17:9,029,646...9,034,176 		JBrowse link
G Tmem147 transmembrane protein 147 decreases expression EXP fullerene C60 results in decreased expression of TMEM147 mRNA CTD PMID:19167457 NCBI chr 1:85,977,028...85,978,848
Ensembl chr 1:85,977,025...85,978,868 		JBrowse link
G Tmem151b transmembrane protein 151B decreases expression EXP fullerene C60 results in decreased expression of TMEM151B mRNA CTD PMID:19167457 NCBI chr 9:15,456,446...15,464,289
Ensembl chr 9:15,455,801...15,464,302 		JBrowse link
G Tmem213 transmembrane protein 213 decreases expression EXP fullerene C60 results in decreased expression of TMEM213 mRNA CTD PMID:19167457 NCBI chr 4:66,825,040...66,831,070 JBrowse link
G Tmem214 transmembrane protein 214 decreases expression EXP fullerene C60 results in decreased expression of TMEM214 mRNA CTD PMID:19167457 NCBI chr 6:25,501,575...25,510,444
Ensembl chr 6:25,502,698...25,510,444 		JBrowse link
G Tmem259 transmembrane protein 259 increases expression EXP fullerene C60 results in increased expression of TMEM259 mRNA CTD PMID:19167457 NCBI chr 7:10,374,804...10,381,566
Ensembl chr 7:9,722,485...9,730,932 		JBrowse link
G Tmem273 transmembrane protein 273 decreases expression EXP fullerene C60 results in decreased expression of TMEM273 mRNA CTD PMID:19167457 NCBI chr16:8,055,930...8,088,280
Ensembl chr16:8,049,669...8,081,981 		JBrowse link
G Tmem30b transmembrane protein 30B decreases expression EXP fullerene C60 results in decreased expression of TMEM30B mRNA CTD PMID:19167457 NCBI chr 6:97,987,471...97,990,546
Ensembl chr 6:92,249,790...92,254,842 		JBrowse link
G Tmem43 transmembrane protein 43 decreases expression EXP fullerene C60 results in decreased expression of TMEM43 mRNA CTD PMID:19167457 NCBI chr 4:125,534,844...125,549,986
Ensembl chr 4:123,977,625...123,992,825 		JBrowse link
G Tmem74 transmembrane protein 74 decreases expression EXP fullerene C60 results in decreased expression of TMEM74 mRNA CTD PMID:19167457 NCBI chr 7:74,929,290...74,937,929
Ensembl chr 7:74,931,694...74,937,934 		JBrowse link
G Tmem8b transmembrane protein 8B affects expression EXP fullerene C60 affects the expression of TMEM8B mRNA CTD PMID:19167457 NCBI chr 5:62,715,238...62,744,187
Ensembl chr 5:57,919,804...57,946,772 		JBrowse link
G Tmod4 tropomodulin 4 increases expression EXP fullerene C60 results in increased expression of TMOD4 mRNA CTD PMID:19167457 NCBI chr 2:185,384,547...185,389,549
Ensembl chr 2:182,695,709...182,700,540 		JBrowse link
G Tmprss3 transmembrane serine protease 3 decreases expression EXP fullerene C60 results in decreased expression of TMPRSS3 mRNA CTD PMID:19167457 NCBI chr20:9,254,102...9,273,808
Ensembl chr20:9,254,109...9,274,363 		JBrowse link
G Tmtc1 transmembrane O-mannosyltransferase targeting cadherins 1 affects expression EXP fullerene C60 affects the expression of TMTC1 mRNA CTD PMID:19167457 NCBI chr 4:181,142,937...181,357,979
Ensembl chr 4:181,146,251...181,359,289 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases secretion		 ISO fullerene C60 promotes the reaction [ALB protein modified form results in increased expression of TNF protein]
fullerene C60 results in increased secretion of TNF protein		 CTD PMID:19376187 PMID:20064541 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfsf4 TNF superfamily member 4 increases expression EXP fullerene C60 results in increased expression of TNFSF4 mRNA CTD PMID:20471445 NCBI chr13:76,256,654...76,280,133
Ensembl chr13:73,723,329...73,746,788 		JBrowse link
G Tnip1 TNFAIP3 interacting protein 1 increases expression EXP fullerene C60 results in increased expression of TNIP1 mRNA CTD PMID:19167457 NCBI chr10:39,537,759...39,585,038
Ensembl chr10:39,037,058...39,077,625 		JBrowse link
G Tnnc1 troponin C1, slow skeletal and cardiac type decreases expression EXP fullerene C60 results in decreased expression of TNNC1 mRNA CTD PMID:19167457 NCBI chr16:6,408,607...6,412,070
Ensembl chr16:6,402,171...6,405,634 		JBrowse link
G Tns1 tensin 1 increases expression EXP fullerene C60 results in increased expression of TNS1 mRNA CTD PMID:19167457 NCBI chr 9:82,941,068...83,152,007
Ensembl chr 9:75,495,814...75,703,225 		JBrowse link
G Tollip toll interacting protein decreases expression EXP fullerene C60 results in decreased expression of TOLLIP mRNA CTD PMID:19167457 NCBI chr 1:206,391,120...206,413,809
Ensembl chr 1:196,950,771...196,983,625 		JBrowse link
G Tom1 target of myb1 membrane trafficking protein increases expression EXP fullerene C60 results in increased expression of TOM1 mRNA CTD PMID:19167457 NCBI chr19:13,411,227...13,446,129
Ensembl chr19:13,405,501...13,440,384 		JBrowse link
G Tp53 tumor protein p53 decreases expression
multiple interactions		 EXP
ISO		 fullerene C60 results in decreased expression of TP53 mRNA
fullerene C60 analog results in increased phosphorylation of and results in increased expression of TP53 protein		 CTD PMID:19167457 PMID:20045429 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Tp53i11 tumor protein p53 inducible protein 11 increases expression EXP fullerene C60 results in increased expression of TP53I11 mRNA CTD PMID:19167457 NCBI chr 3:79,144,824...79,160,056
Ensembl chr 3:79,144,895...79,160,050 		JBrowse link
G Tp53inp2 tumor protein p53 inducible nuclear protein 2 decreases expression EXP fullerene C60 results in decreased expression of TP53INP2 mRNA CTD PMID:19167457 NCBI chr 3:143,881,427...143,890,104
Ensembl chr 3:143,882,021...143,890,097 		JBrowse link
G Tpcn1 two pore segment channel 1 increases expression EXP fullerene C60 results in increased expression of TPCN1 mRNA CTD PMID:19167457 NCBI chr12:41,633,399...41,690,200
Ensembl chr12:35,972,846...36,029,626 		JBrowse link
G Tpd52l1 TPD52 like 1 increases expression EXP fullerene C60 results in increased expression of TPD52L1 mRNA CTD PMID:19167457 NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:26,172,170...26,291,109 		JBrowse link
G Tpd52l3 TPD52 like 3 decreases expression EXP fullerene C60 results in decreased expression of TPD52L3 mRNA CTD PMID:19167457 NCBI chr 1:227,781,173...227,785,040
Ensembl chr 1:227,773,724...227,784,467 		JBrowse link
G Tpo thyroid peroxidase decreases expression EXP fullerene C60 results in decreased expression of TPO mRNA CTD PMID:19167457 NCBI chr 6:52,425,998...52,495,793
Ensembl chr 6:46,698,414...46,768,199 		JBrowse link
G Tpst2 tyrosylprotein sulfotransferase 2 decreases expression EXP fullerene C60 results in decreased expression of TPST2 mRNA CTD PMID:19167457 NCBI chr12:44,321,875...44,363,892
Ensembl chr12:44,321,875...44,362,329 		JBrowse link
G Tra2b transformer 2 beta decreases expression EXP fullerene C60 results in decreased expression of TRA2B mRNA CTD PMID:19167457 NCBI chr11:92,293,403...92,311,651
Ensembl chr11:78,788,884...78,807,249 		JBrowse link
G Traf6 TNF receptor associated factor 6 increases expression EXP fullerene C60 results in increased expression of TRAF6 mRNA CTD PMID:19167457 NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:87,963,514...87,983,507 		JBrowse link
G Trafd1 TRAF type zinc finger domain containing 1 increases expression EXP fullerene C60 results in increased expression of TRAFD1 mRNA CTD PMID:19167457 NCBI chr12:40,826,251...40,840,169
Ensembl chr12:35,165,606...35,179,525 		JBrowse link
G Trappc10 trafficking protein particle complex subunit 10 increases expression EXP fullerene C60 results in increased expression of TRAPPC10 mRNA CTD PMID:19167457 NCBI chr20:10,438,737...10,499,074
Ensembl chr20:10,438,737...10,499,074 		JBrowse link
G Trappc2l trafficking protein particle complex subunit 2L decreases expression EXP fullerene C60 results in decreased expression of TRAPPC2L mRNA CTD PMID:19167457 NCBI chr19:50,662,507...50,666,193
Ensembl chr19:50,662,507...50,666,192 		JBrowse link
G Treml1 triggering receptor expressed on myeloid cells-like 1 decreases expression EXP fullerene C60 results in decreased expression of TREML1 mRNA CTD PMID:19167457 NCBI chr 9:20,133,193...20,139,933
Ensembl chr 9:12,635,590...12,642,347 		JBrowse link
G Trib1 tribbles pseudokinase 1 increases expression EXP fullerene C60 results in increased expression of TRIB1 mRNA CTD PMID:19167457 NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:91,206,579...91,214,731 		JBrowse link
G Trim11 tripartite motif-containing 11 increases expression EXP fullerene C60 results in increased expression of TRIM11 mRNA CTD PMID:19167457 NCBI chr10:44,255,019...44,270,711
Ensembl chr10:43,758,354...43,771,138 		JBrowse link
G Trim14 tripartite motif-containing 14 decreases expression EXP fullerene C60 results in decreased expression of TRIM14 mRNA CTD PMID:19167457 NCBI chr 5:65,596,149...65,620,434
Ensembl chr 5:60,800,032...60,824,858 		JBrowse link
G Trim16 tripartite motif-containing 16 decreases expression EXP fullerene C60 results in decreased expression of TRIM16 mRNA CTD PMID:19167457 NCBI chr10:47,985,235...48,008,242
Ensembl chr10:47,486,297...47,551,907 		JBrowse link
G Trim17 tripartite motif-containing 17 decreases expression EXP fullerene C60 results in decreased expression of TRIM17 mRNA CTD PMID:19167457 NCBI chr10:43,743,111...43,750,929
Ensembl chr10:43,740,604...43,750,919 		JBrowse link
G Trim23 tripartite motif-containing 23 decreases expression EXP fullerene C60 results in decreased expression of TRIM23 mRNA CTD PMID:19167457 NCBI chr 2:37,036,193...37,069,024
Ensembl chr 2:35,302,409...35,335,743 		JBrowse link
G Trim28 tripartite motif-containing 28 increases expression EXP fullerene C60 results in increased expression of TRIM28 mRNA CTD PMID:19167457 NCBI chr 1:82,724,842...82,731,566
Ensembl chr 1:73,652,709...73,659,380 		JBrowse link
G Trim54 tripartite motif-containing 54 decreases expression EXP fullerene C60 results in decreased expression of TRIM54 mRNA CTD PMID:19167457 NCBI chr 6:25,239,340...25,258,511
Ensembl chr 6:25,239,340...25,258,511 		JBrowse link
G Trio trio Rho guanine nucleotide exchange factor increases expression EXP fullerene C60 results in increased expression of TRIO mRNA CTD PMID:19167457 NCBI chr 2:80,235,485...80,531,824
Ensembl chr 2:78,505,070...78,803,135 		JBrowse link
G Trmt1 tRNA methyltransferase 1 increases expression EXP fullerene C60 results in increased expression of TRMT1 mRNA CTD PMID:19167457 NCBI chr19:40,361,583...40,374,971
Ensembl chr19:23,456,756...23,466,956 		JBrowse link
G Trmt10a tRNA methyltransferase 10A increases expression EXP fullerene C60 results in increased expression of TRMT10A mRNA CTD PMID:19167457 NCBI chr 2:226,669,445...226,684,166
Ensembl chr 2:226,669,832...226,684,151 		JBrowse link
G Trpc4ap transient receptor potential cation channel, subfamily C, member 4 associated protein increases expression EXP fullerene C60 results in increased expression of TRPC4AP mRNA CTD PMID:19167457 NCBI chr 3:164,582,146...164,653,123
Ensembl chr 3:144,122,003...144,192,986 		JBrowse link
G Trpm4 transient receptor potential cation channel, subfamily M, member 4 increases expression EXP fullerene C60 results in increased expression of TRPM4 mRNA CTD PMID:19167457 NCBI chr 1:104,918,462...104,949,453
Ensembl chr 1:95,782,000...95,812,532 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 affects expression EXP fullerene C60 affects the expression of TSC22D3 mRNA CTD PMID:19167457 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:104,217,925...104,276,861 		JBrowse link
G Tshz1 teashirt zinc finger homeobox 1 decreases expression EXP fullerene C60 results in decreased expression of TSHZ1 mRNA CTD PMID:19167457 NCBI chr18:77,376,399...77,452,815
Ensembl chr18:77,377,394...77,453,509 		JBrowse link
G Tspan12 tetraspanin 12 decreases expression EXP fullerene C60 results in decreased expression of TSPAN12 mRNA CTD PMID:19167457 NCBI chr 4:51,279,562...51,355,030
Ensembl chr 4:50,313,772...50,389,246 		JBrowse link
G Tspan4 tetraspanin 4 increases expression EXP fullerene C60 results in increased expression of TSPAN4 mRNA CTD PMID:19167457 NCBI chr 1:206,001,731...206,021,414
Ensembl chr 1:196,572,228...196,617,448 		JBrowse link
G Tspoap1 TSPO associated protein 1 increases expression EXP fullerene C60 results in increased expression of TSPOAP1 mRNA CTD PMID:19167457 NCBI chr10:73,053,414...73,083,640
Ensembl chr10:72,560,980...72,586,412 		JBrowse link
G Ttbk2 tau tubulin kinase 2 decreases expression EXP fullerene C60 results in decreased expression of TTBK2 mRNA CTD PMID:19167457 NCBI chr 3:107,691,123...107,802,911
Ensembl chr 3:107,697,340...107,803,223 		JBrowse link
G Ttc22 tetratricopeptide repeat domain 22 increases expression EXP fullerene C60 results in increased expression of TTC22 mRNA CTD PMID:19167457 NCBI chr 5:121,401,973...121,423,130
Ensembl chr 5:121,406,326...121,423,130 		JBrowse link
G Ttc34 tetratricopeptide repeat domain 34 decreases expression EXP fullerene C60 results in decreased expression of TTC34 mRNA CTD PMID:19167457 NCBI chr 5:170,693,410...170,711,215
Ensembl chr 5:165,411,058...165,428,857 		JBrowse link
G Ttll7 tubulin tyrosine ligase like 7 decreases expression EXP fullerene C60 results in decreased expression of TTLL7 mRNA CTD PMID:19167457 NCBI chr 2:235,765,786...235,889,047
Ensembl chr 2:235,765,835...235,885,047 		JBrowse link
G Ttyh2 tweety family member 2 decreases expression EXP fullerene C60 results in decreased expression of TTYH2 mRNA CTD PMID:19167457 NCBI chr10:100,208,129...100,252,505
Ensembl chr10:99,709,007...99,753,444 		JBrowse link
G Txn1 thioredoxin 1 decreases expression EXP fullerene C60 results in decreased expression of TXN1 mRNA CTD PMID:19167457 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629 		JBrowse link
G Txndc11 thioredoxin domain containing 11 increases expression EXP fullerene C60 results in increased expression of TXNDC11 mRNA CTD PMID:19167457 NCBI chr10:5,022,464...5,079,958
Ensembl chr10:4,515,478...4,572,989 		JBrowse link
G Txnip thioredoxin interacting protein decreases expression EXP fullerene C60 results in decreased expression of TXNIP mRNA CTD PMID:19167457 NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886 		JBrowse link
G U2surp U2 snRNP-associated SURP domain containing decreases expression EXP fullerene C60 results in decreased expression of U2SURP mRNA CTD PMID:19167457 NCBI chr 8:104,898,580...104,963,642
Ensembl chr 8:96,022,957...96,075,691 		JBrowse link
G Uba5 ubiquitin-like modifier activating enzyme 5 decreases expression EXP fullerene C60 results in decreased expression of UBA5 mRNA CTD PMID:19167457 NCBI chr 8:113,544,037...113,559,711
Ensembl chr 8:104,665,046...104,680,894 		JBrowse link
G Ubald2 UBA-like domain containing 2 decreases expression EXP fullerene C60 results in decreased expression of UBALD2 mRNA CTD PMID:19167457 NCBI chr10:101,662,507...101,667,089
Ensembl chr10:101,658,127...101,667,061 		JBrowse link
G Ube2o ubiquitin-conjugating enzyme E2O increases expression EXP fullerene C60 results in increased expression of UBE2O mRNA CTD PMID:19167457 NCBI chr10:101,765,572...101,812,736
Ensembl chr10:101,766,005...101,812,899 		JBrowse link
G Ubqln2 ubiquilin 2 decreases expression EXP fullerene C60 results in decreased expression of UBQLN2 mRNA CTD PMID:19167457 NCBI chr  X:21,228,809...21,232,228
Ensembl chr  X:17,853,114...17,856,505 		JBrowse link
G Ubqln4 ubiquilin 4 increases expression EXP fullerene C60 results in increased expression of UBQLN4 mRNA CTD PMID:19167457 NCBI chr 2:176,310,524...176,325,724
Ensembl chr 2:174,012,777...174,028,059 		JBrowse link
G Ubtf upstream binding transcription factor increases expression EXP fullerene C60 results in increased expression of UBTF mRNA CTD PMID:19167457 NCBI chr10:87,758,346...87,775,377
Ensembl chr10:87,258,217...87,272,969 		JBrowse link
G Ubxn10 UBX domain protein 10 decreases expression EXP fullerene C60 results in decreased expression of UBXN10 mRNA CTD PMID:19167457 NCBI chr 5:150,953,772...150,959,608
Ensembl chr 5:150,950,731...150,959,744 		JBrowse link
G Uhrf1 ubiquitin-like with PHD and ring finger domains 1 decreases expression EXP fullerene C60 results in decreased expression of UHRF1 mRNA CTD PMID:19167457 NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,134,909...1,154,631 		JBrowse link
G Ulk1 unc-51 like autophagy activating kinase 1 increases expression EXP fullerene C60 results in increased expression of ULK1 mRNA CTD PMID:19167457 NCBI chr12:51,511,492...51,537,746
Ensembl chr12:45,851,710...45,877,966 		JBrowse link
G Unc45b unc-45 myosin chaperone B increases expression EXP fullerene C60 results in increased expression of UNC45B mRNA CTD PMID:19167457 NCBI chr10:68,343,011...68,370,683
Ensembl chr10:67,845,462...67,873,389 		JBrowse link
G Unc5d unc-5 netrin receptor D decreases expression EXP fullerene C60 results in decreased expression of UNC5D mRNA CTD PMID:19167457 NCBI chr16:62,860,119...63,406,932
Ensembl chr16:62,860,174...63,401,143 		JBrowse link
G Upb1 beta-ureidopropionase 1 decreases expression EXP fullerene C60 results in decreased expression of UPB1 mRNA CTD PMID:19167457 NCBI chr20:13,216,693...13,243,016
Ensembl chr20:13,217,258...13,243,590 		JBrowse link
G Upk3a uroplakin 3A decreases expression EXP fullerene C60 results in decreased expression of UPK3A mRNA CTD PMID:19167457 NCBI chr 7:116,128,981...116,139,950
Ensembl chr 7:116,134,874...116,139,948 		JBrowse link
G Usf2 upstream transcription factor 2, c-fos interacting increases expression EXP fullerene C60 results in increased expression of USF2 mRNA CTD PMID:19167457 NCBI chr 1:86,174,703...86,185,942
Ensembl chr 1:86,174,703...86,185,617 		JBrowse link
G Usp2 ubiquitin specific peptidase 2 affects expression EXP fullerene C60 affects the expression of USP2 mRNA CTD PMID:19167457 NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331 		JBrowse link
G Usp32 ubiquitin specific peptidase 32 increases expression EXP fullerene C60 results in increased expression of USP32 mRNA CTD PMID:19167457 NCBI chr10:70,353,310...70,538,008
Ensembl chr10:69,855,885...70,029,137 		JBrowse link
G Usp5 ubiquitin specific peptidase 5 increases expression EXP fullerene C60 results in increased expression of USP5 mRNA CTD PMID:19167457 NCBI chr 4:159,305,927...159,321,345
Ensembl chr 4:157,619,643...157,634,711 		JBrowse link
G Uts2r urotensin 2 receptor decreases expression EXP fullerene C60 results in decreased expression of UTS2R mRNA CTD PMID:19167457 NCBI chr10:106,936,398...106,937,558
Ensembl chr10:106,438,092...106,439,252 		JBrowse link
G Vamp2 vesicle-associated membrane protein 2 increases expression EXP fullerene C60 results in increased expression of VAMP2 mRNA CTD PMID:19167457 NCBI chr10:54,292,423...54,296,657
Ensembl chr10:53,793,923...53,797,809 		JBrowse link
G Vangl1 VANGL planar cell polarity protein 1 decreases expression EXP fullerene C60 results in decreased expression of VANGL1 mRNA CTD PMID:19167457 NCBI chr 2:189,586,681...189,637,609
Ensembl chr 2:189,589,229...189,637,619 		JBrowse link
G Vangl2 VANGL planar cell polarity protein 2 decreases expression EXP fullerene C60 results in decreased expression of VANGL2 mRNA CTD PMID:19167457 NCBI chr13:86,995,124...87,021,770
Ensembl chr13:84,465,527...84,489,378 		JBrowse link
G Vars1 valyl-tRNA synthetase 1 increases expression EXP fullerene C60 results in increased expression of VARS1 mRNA CTD PMID:19167457 NCBI chr20:3,810,427...3,825,193
Ensembl chr20:3,805,776...3,820,298 		JBrowse link
G Vdac1 voltage-dependent anion channel 1 decreases expression EXP fullerene C60 results in decreased expression of VDAC1 mRNA CTD PMID:19167457 NCBI chr10:37,029,377...37,060,542
Ensembl chr10:36,532,244...36,559,640 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression EXP fullerene C60 results in increased expression of VEGFA mRNA CTD PMID:19167457 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
G Vegfb vascular endothelial growth factor B increases expression EXP fullerene C60 results in increased expression of VEGFB mRNA CTD PMID:19167457 NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:204,172,225...204,177,944 		JBrowse link
G Veph1 ventricular zone expressed PH domain-containing 1 decreases expression EXP fullerene C60 results in decreased expression of VEPH1 mRNA CTD PMID:19167457 NCBI chr 2:150,291,379...150,537,491
Ensembl chr 2:150,296,573...150,537,266 		JBrowse link
G Vgll2 vestigial-like family member 2 decreases expression EXP fullerene C60 results in decreased expression of VGLL2 mRNA CTD PMID:19167457 NCBI chr20:31,952,214...31,958,100
Ensembl chr20:31,409,552...31,415,408 		JBrowse link
G Vill villin-like increases expression EXP fullerene C60 results in increased expression of VILL mRNA CTD PMID:19167457 NCBI chr 8:118,776,718...118,794,983
Ensembl chr 8:118,776,742...118,794,983 		JBrowse link
G Vkorc1 vitamin K epoxide reductase complex, subunit 1 decreases expression EXP fullerene C60 results in decreased expression of VKORC1 mRNA CTD PMID:19167457 NCBI chr 1:191,932,969...191,935,490
Ensembl chr 1:182,500,844...182,505,008 		JBrowse link
G Vmac vimentin-type intermediate filament associated coiled-coil protein decreases expression EXP fullerene C60 results in decreased expression of VMAC mRNA CTD PMID:19167457 NCBI chr 9:1,546,747...1,550,417
Ensembl chr 9:1,546,747...1,549,771 		JBrowse link
G Vom2r60 vomeronasal 2 receptor, 60 decreases expression EXP fullerene C60 results in decreased expression of VOM2R60 mRNA CTD PMID:19167457 NCBI chr12:7,688,051...7,794,445
Ensembl chr12:2,890,226...3,077,368 		JBrowse link
G Vom2r73 vomeronasal 2 receptor, 73 decreases expression EXP fullerene C60 results in decreased expression of VOM2R73 mRNA CTD PMID:19167457 NCBI chr14:949,133...959,911 JBrowse link
G Vopp1 VOPP1 WW domain binding protein decreases expression EXP fullerene C60 results in decreased expression of VOPP1 mRNA CTD PMID:19167457 NCBI chr 4:88,692,784...88,762,903
Ensembl chr 4:87,363,477...87,450,375 		JBrowse link
G Vps11 VPS11 core subunit of CORVET and HOPS complexes increases expression EXP fullerene C60 results in increased expression of VPS11 mRNA CTD PMID:19167457 NCBI chr 8:53,580,939...53,595,378
Ensembl chr 8:44,684,127...44,698,568 		JBrowse link
G Vps25 vacuolar protein sorting 25 homolog decreases expression EXP fullerene C60 results in decreased expression of VPS25 mRNA CTD PMID:19167457 NCBI chr10:86,696,330...86,701,871
Ensembl chr10:86,188,812...86,231,829 		JBrowse link
G Vsig2 V-set and immunoglobulin domain containing 2 decreases expression EXP fullerene C60 results in decreased expression of VSIG2 mRNA CTD PMID:19167457 NCBI chr 8:45,438,865...45,443,908
Ensembl chr 8:37,250,107...37,255,150 		JBrowse link
G Vwa5b2 von Willebrand factor A domain containing 5B2 decreases expression EXP fullerene C60 results in decreased expression of VWA5B2 mRNA CTD PMID:19167457 NCBI chr11:80,306,067...80,323,220
Ensembl chr11:80,306,350...80,323,220 		JBrowse link
G Washc4 WASH complex subunit 4 increases expression EXP fullerene C60 results in increased expression of WASHC4 mRNA CTD PMID:19167457 NCBI chr 7:22,075,546...22,127,847
Ensembl chr 7:20,187,922...20,240,226 		JBrowse link
G Wdr19 WD repeat domain 19 decreases expression EXP fullerene C60 results in decreased expression of WDR19 mRNA CTD PMID:19167457 NCBI chr14:43,396,130...43,460,012
Ensembl chr14:43,042,478...43,106,288 		JBrowse link
G Wdr6 WD repeat domain 6 increases expression EXP fullerene C60 results in increased expression of WDR6 mRNA CTD PMID:19167457 NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:109,268,079...109,274,499 		JBrowse link
G Wdr86 WD repeat domain 86 decreases expression EXP fullerene C60 results in decreased expression of WDR86 mRNA CTD PMID:19167457 NCBI chr 4:10,423,496...10,443,473
Ensembl chr 4:10,424,008...10,441,465 		JBrowse link
G Whrn whirlin increases expression EXP fullerene C60 results in increased expression of WHRN mRNA CTD PMID:19167457 NCBI chr 5:81,843,820...81,933,400
Ensembl chr 5:76,828,301...76,912,223 		JBrowse link
G Wnk4 WNK lysine deficient protein kinase 4 increases expression EXP fullerene C60 results in increased expression of WNK4 mRNA CTD PMID:19167457 NCBI chr10:86,702,828...86,719,917
Ensembl chr10:86,188,812...86,231,829 		JBrowse link
G Wnt3 Wnt family member 3 decreases expression EXP fullerene C60 results in decreased expression of WNT3 mRNA CTD PMID:19167457 NCBI chr10:89,180,224...89,224,195
Ensembl chr10:88,680,248...88,724,099 		JBrowse link
G Wnt5b Wnt family member 5B increases expression EXP fullerene C60 results in increased expression of WNT5B mRNA CTD PMID:19167457 NCBI chr 4:154,281,852...154,406,081
Ensembl chr 4:152,609,569...152,733,407 		JBrowse link
G Wnt7a Wnt family member 7A increases expression EXP fullerene C60 results in increased expression of WNT7A mRNA CTD PMID:19167457 NCBI chr 4:125,420,276...125,466,149
Ensembl chr 4:123,863,108...123,908,981 		JBrowse link
G Wscd1 WSC domain containing 1 increases expression EXP fullerene C60 results in increased expression of WSCD1 mRNA CTD PMID:19167457 NCBI chr10:56,884,404...56,924,013
Ensembl chr10:56,395,874...56,424,677 		JBrowse link
G Xdh xanthine dehydrogenase increases expression EXP fullerene C60 results in increased expression of XDH mRNA CTD PMID:19167457 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268 		JBrowse link
G Xkr4 XK related 4 increases expression EXP fullerene C60 results in increased expression of XKR4 mRNA CTD PMID:19167457 NCBI chr 5:15,896,818...16,297,733
Ensembl chr 5:15,895,863...16,282,962 		JBrowse link
G Xpr1 xenotropic and polytropic retrovirus receptor 1 decreases expression EXP fullerene C60 results in decreased expression of XPR1 mRNA CTD PMID:19167457 NCBI chr13:69,991,517...70,136,249
Ensembl chr13:67,446,380...67,585,946 		JBrowse link
G Xrn1 5'-3' exoribonuclease 1 increases expression EXP fullerene C60 results in increased expression of XRN1 mRNA CTD PMID:19167457 NCBI chr 8:96,527,871...96,637,385
Ensembl chr 8:96,528,195...96,632,739 		JBrowse link
G Xylb xylulokinase affects expression EXP fullerene C60 affects the expression of XYLB mRNA CTD PMID:19167457 NCBI chr 8:119,093,466...119,128,858
Ensembl chr 8:119,096,029...119,128,848 		JBrowse link
G Yes1 YES proto-oncogene 1, Src family tyrosine kinase decreases expression EXP fullerene C60 results in decreased expression of YES1 mRNA CTD PMID:19167457 NCBI chr 9:120,646,657...120,753,880
Ensembl chr 9:113,200,256...113,299,837 		JBrowse link
G Yipf3 Yip1 domain family, member 3 decreases expression EXP fullerene C60 results in decreased expression of YIPF3 mRNA CTD PMID:19167457 NCBI chr 9:14,730,289...14,735,644
Ensembl chr 9:14,730,284...14,735,641 		JBrowse link
G Ypel4 yippee-like 4 increases expression EXP fullerene C60 results in increased expression of YPEL4 mRNA CTD PMID:19167457 NCBI chr 3:69,815,373...69,820,708
Ensembl chr 3:69,816,175...69,820,707 		JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 affects expression EXP fullerene C60 affects the expression of ZBTB16 mRNA CTD PMID:19167457 NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:48,994,566...49,177,011 		JBrowse link
G Zbtb20 zinc finger and BTB domain containing 20 increases expression EXP fullerene C60 results in increased expression of ZBTB20 mRNA CTD PMID:19167457 NCBI chr11:70,558,010...71,297,039
Ensembl chr11:57,072,880...57,510,210 		JBrowse link
G Zbtb21 zinc finger and BTB domain containing 21 increases expression EXP fullerene C60 results in increased expression of ZBTB21 mRNA CTD PMID:19167457 NCBI chr11:50,781,697...50,796,399
Ensembl chr11:37,312,378...37,326,996 		JBrowse link
G Zbtb38 zinc finger and BTB domain containing 38 decreases expression EXP fullerene C60 results in decreased expression of ZBTB38 mRNA CTD PMID:19167457 NCBI chr 8:106,124,181...106,231,215
Ensembl chr 8:97,280,993...97,485,625 		JBrowse link
G Zbtb39 zinc finger and BTB domain containing 39 decreases expression EXP fullerene C60 results in decreased expression of ZBTB39 mRNA CTD PMID:19167457 NCBI chr 7:63,576,998...63,584,549
Ensembl chr 7:63,576,917...63,589,210 		JBrowse link
G Zbtb43 zinc finger and BTB domain containing 43 increases expression EXP fullerene C60 results in increased expression of ZBTB43 mRNA CTD PMID:19167457 NCBI chr 3:16,744,535...16,763,854
Ensembl chr 3:16,744,535...16,763,909 		JBrowse link
G Zbtb47 zinc finger and BTB domain containing 47 increases expression EXP fullerene C60 results in increased expression of ZBTB47 mRNA CTD PMID:19167457 NCBI chr 8:121,420,758...121,434,365
Ensembl chr 8:121,423,696...121,433,225 		JBrowse link
G Zbtb49 zinc finger and BTB domain containing 49 increases expression EXP fullerene C60 results in increased expression of ZBTB49 mRNA CTD PMID:19167457 NCBI chr14:72,590,692...72,612,404
Ensembl chr14:72,590,708...72,612,404 		JBrowse link
G Zc3hav1l ZC3HAV1 like decreases expression EXP fullerene C60 results in decreased expression of ZC3HAV1L mRNA CTD PMID:19167457 NCBI chr 4:66,994,192...67,003,207
Ensembl chr 4:66,994,199...67,001,620 		JBrowse link
G Zcchc24 zinc finger CCHC-type containing 24 decreases expression EXP fullerene C60 results in decreased expression of ZCCHC24 mRNA CTD PMID:19167457 NCBI chr16:1,274,544...1,326,664
Ensembl chr16:1,274,548...1,326,696 		JBrowse link
G Zfp13 zinc finger protein 13 increases expression EXP fullerene C60 results in increased expression of ZFP13 mRNA CTD PMID:19167457 NCBI chr10:13,119,707...13,128,284
Ensembl chr10:12,615,190...12,623,615 		JBrowse link
G Zfp136 zinc finger protein 136 decreases expression EXP fullerene C60 results in decreased expression of ZFP136 mRNA CTD PMID:19167457 NCBI chr18:609,472...618,190
Ensembl chr18:474,716...615,539 		JBrowse link
G Zfp142 zinc finger protein 142 increases expression EXP fullerene C60 results in increased expression of ZFP142 mRNA CTD PMID:19167457 NCBI chr 9:76,141,053...76,164,784
Ensembl chr 9:76,142,227...76,164,856 		JBrowse link
G Zfp219 zinc finger protein 219 increases expression EXP fullerene C60 results in increased expression of ZFP219 mRNA CTD PMID:19167457 NCBI chr15:27,169,335...27,183,555
Ensembl chr15:24,695,837...24,710,030 		JBrowse link
G Zfp266 zinc finger protein 266 decreases expression EXP fullerene C60 results in decreased expression of ZFP266 mRNA CTD PMID:19167457 NCBI chr 8:27,307,015...27,338,624
Ensembl chr 8:19,030,768...19,060,937 		JBrowse link
G Zfp275 zinc finger protein 275 decreases expression EXP fullerene C60 results in decreased expression of ZFP275 mRNA CTD PMID:19167457 NCBI chr  X:151,057,530...151,074,392
Ensembl chr  X:151,057,573...151,074,276 		JBrowse link
G Zfp282 zinc finger protein 282 decreases expression EXP fullerene C60 results in decreased expression of ZFP282 mRNA CTD PMID:19167457 NCBI chr 4:76,884,996...76,910,250
Ensembl chr 4:76,884,924...76,911,370 		JBrowse link
G Zfp36 zinc finger protein 36 decreases expression
increases expression		 EXP fullerene C60 results in decreased expression of ZFP36 mRNA
fullerene C60 results in increased expression of ZFP36 mRNA		 CTD PMID:19167457 NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564 		JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 increases expression EXP fullerene C60 results in increased expression of ZFP36L2 mRNA CTD PMID:19167457 NCBI chr 6:16,242,622...16,246,662
Ensembl chr 6:10,490,032...10,494,064 		JBrowse link
G Zfp574 zinc finger protein 574 increases expression EXP fullerene C60 results in increased expression of ZFP574 mRNA CTD PMID:19167457 NCBI chr 1:80,667,984...80,678,257
Ensembl chr 1:80,664,259...80,679,427 		JBrowse link
G Zfp575 zinc finger protein 575 decreases expression EXP fullerene C60 results in decreased expression of ZFP575 mRNA CTD PMID:19167457 NCBI chr 1:80,175,016...80,177,176
Ensembl chr 1:80,175,016...80,177,123 		JBrowse link
G Zfp609 zinc finger protein 609 decreases expression EXP fullerene C60 results in decreased expression of ZFP609 mRNA CTD PMID:19167457 NCBI chr 8:66,214,553...66,349,319
Ensembl chr 8:66,214,555...66,317,977 		JBrowse link
G Zfp629 zinc finger protein 629 decreases expression EXP fullerene C60 results in decreased expression of ZFP629 mRNA CTD PMID:19167457 NCBI chr 1:182,217,499...182,258,585
Ensembl chr 1:182,210,935...182,230,016 		JBrowse link
G Zfp703 zinc finger protein 703 increases expression EXP fullerene C60 results in increased expression of ZFP703 mRNA CTD PMID:19167457 NCBI chr16:65,076,507...65,080,677
Ensembl chr16:65,076,507...65,080,677 		JBrowse link
G Zfp775 zinc finger protein 775 increases expression EXP fullerene C60 results in increased expression of ZFP775 mRNA CTD PMID:19167457 NCBI chr 4:77,557,037...77,575,296
Ensembl chr 4:77,548,847...77,575,296 		JBrowse link
G Zfp866 zinc finger protein 866 increases expression EXP fullerene C60 results in increased expression of CXCL5 mRNA CTD PMID:20471445 NCBI chr16:19,653,966...19,675,968
Ensembl chr16:19,668,258...19,675,932 		JBrowse link
G Zfp870 zinc finger protein 870 decreases expression EXP fullerene C60 results in decreased expression of ZFP870 mRNA CTD PMID:19167457 NCBI chr 7:11,990,146...12,003,813
Ensembl chr 7:11,990,148...12,003,813 		JBrowse link
G Zfp91 zinc finger protein 91 decreases expression EXP fullerene C60 results in decreased expression of ZFP91 mRNA CTD PMID:19167457 NCBI chr 1:219,316,002...219,353,654
Ensembl chr 1:209,891,344...209,927,762 		JBrowse link
G Zfpm1 zinc finger protein, multitype 1 decreases expression EXP fullerene C60 results in decreased expression of ZFPM1 mRNA CTD PMID:19167457 NCBI chr19:67,242,922...67,299,149
Ensembl chr19:50,334,682...50,390,591 		JBrowse link
G Zfyve9 zinc finger FYVE-type containing 9 increases expression EXP fullerene C60 results in increased expression of ZFYVE9 mRNA CTD PMID:19167457 NCBI chr 5:128,599,379...128,758,394
Ensembl chr 5:123,370,677...123,529,699 		JBrowse link
G Zhx2 zinc fingers and homeoboxes 2 decreases expression EXP fullerene C60 results in decreased expression of ZHX2 mRNA CTD PMID:19167457 NCBI chr 7:89,226,358...89,374,266
Ensembl chr 7:89,226,463...89,374,378 		JBrowse link
G Zmiz2 zinc finger, MIZ-type containing 2 increases expression EXP fullerene C60 results in increased expression of ZMIZ2 mRNA CTD PMID:19167457 NCBI chr14:85,465,323...85,481,860
Ensembl chr14:81,251,417...81,267,936 		JBrowse link
G Zmym3 zinc finger MYM-type containing 3 increases expression EXP fullerene C60 results in increased expression of ZMYM3 mRNA CTD PMID:19167457 NCBI chr  X:66,528,585...66,544,234
Ensembl chr  X:66,528,585...66,544,782 		JBrowse link
G Zp2 zona pellucida glycoprotein 2 increases expression EXP fullerene C60 results in increased expression of ZP2 mRNA CTD PMID:19167457 NCBI chr 1:183,944,840...183,956,619
Ensembl chr 1:174,513,511...174,525,288 		JBrowse link
G Zxdc ZXD family zinc finger C decreases expression EXP fullerene C60 results in decreased expression of ZXDC mRNA CTD PMID:19167457 NCBI chr 4:124,439,560...124,471,694
Ensembl chr 4:122,882,336...122,916,496 		JBrowse link
cantharidic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Casp3 caspase 3 multiple interactions
increases cleavage		 ISO SB 203580 inhibits the reaction [cantharidic acid results in increased cleavage of CASP3 protein] CTD PMID:29159945 PMID:29345422 PMID:31916385 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp8 caspase 8 increases cleavage
multiple interactions		 ISO cantharidic acid results in increased cleavage of CASP8 protein
SB 203580 inhibits the reaction [cantharidic acid results in increased cleavage of CASP8 protein]		 CTD PMID:29159945 PMID:29345422 PMID:31916385 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Casp9 caspase 9 increases cleavage
multiple interactions		 ISO cantharidic acid results in increased cleavage of CASP9 protein
SB 203580 inhibits the reaction [cantharidic acid results in increased cleavage of CASP9 protein]		 CTD PMID:29159945 PMID:29345422 PMID:31916385 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
decreases phosphorylation
increases phosphorylation		 ISO U 0126 inhibits the reaction [cantharidic acid results in increased phosphorylation of MAPK1 protein]
cantharidic acid results in decreased phosphorylation of MAPK1 protein		 CTD PMID:29159945 PMID:29345422 PMID:31916385 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
decreases phosphorylation
increases phosphorylation		 ISO U 0126 inhibits the reaction [cantharidic acid results in increased phosphorylation of MAPK3 protein]
cantharidic acid results in decreased phosphorylation of MAPK3 protein		 CTD PMID:29159945 PMID:29345422 PMID:31916385 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation ISO cantharidic acid results in increased phosphorylation of MAPK8 protein CTD PMID:29345422 PMID:31916385 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 increases phosphorylation ISO cantharidic acid results in increased phosphorylation of MAPK9 protein CTD PMID:29345422 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO cantharidic acid results in increased cleavage of PARP1 protein CTD PMID:29159945 PMID:29345422 PMID:31916385 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
carbocyclic thromboxane A2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Tnfrsf11b TNF receptor superfamily member 11B decreases expression ISO thromboxane A2, carbocyclic results in decreased expression of TNFRSF11B mRNA CTD PMID:18264100 NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538 		JBrowse link
G Tnfsf11 TNF superfamily member 11 increases expression ISO thromboxane A2, carbocyclic results in increased expression of TNFSF11 mRNA CTD PMID:18264100 NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445 		JBrowse link
chlorendic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C6 complement C6 decreases expression EXP chlorendic acid results in decreased expression of C6 mRNA CTD PMID:22584684 NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:53,851,985...53,921,275 		JBrowse link
G Ccnb1 cyclin B1 increases expression EXP chlorendic acid results in increased expression of CCNB1 mRNA CTD PMID:22584684 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172 		JBrowse link
G Ccnd1 cyclin D1 increases expression EXP chlorendic acid results in increased expression of CCND1 mRNA CTD PMID:22584684 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression EXP chlorendic acid results in increased expression of CDK1 mRNA CTD PMID:22584684 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 increases expression EXP chlorendic acid results in increased expression of CDKN3 mRNA CTD PMID:22584684 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:20,022,664...20,033,945 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 increases secretion
increases expression		 ISO chlorendic acid results in increased secretion of ENPP2 protein
chlorendic acid results in increased expression of ENPP2 mRNA		 CTD PMID:22952646 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:86,202,350...86,324,827 		JBrowse link
G Gjb1 gap junction protein, beta 1 multiple interactions EXP [Diethylnitrosamine co-treated with chlorendic acid] results in decreased expression of GJB1 protein; [Ethylnitrosourea co-treated with chlorendic acid] results in decreased expression of GJB1 protein CTD PMID:1973356 NCBI chr  X:70,541,845...70,549,776
Ensembl chr  X:66,501,820...66,509,925 		JBrowse link
G Kif11 kinesin family member 11 increases expression EXP chlorendic acid results in increased expression of KIF11 mRNA CTD PMID:22584684 NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:235,124,316...235,176,766 		JBrowse link
G Mir193a microRNA 193a decreases expression EXP chlorendic acid results in decreased expression of MIR193A mRNA CTD PMID:22584684 NCBI chr10:65,170,306...65,170,417
Ensembl chr10:64,672,343...64,672,454 		JBrowse link
G Mir200a microRNA 200a increases expression EXP chlorendic acid results in increased expression of MIR200A mRNA CTD PMID:22584684 NCBI chr 5:171,930,717...171,930,805 JBrowse link
G Mir200b microRNA 200b increases expression EXP chlorendic acid results in increased expression of MIR200B mRNA CTD PMID:22584684 NCBI chr 5:171,931,495...171,931,589
Ensembl chr 5:166,649,272...166,649,366 		JBrowse link
G Mir203-2 microRNA 203-2 decreases expression EXP chlorendic acid results in decreased expression of MIR203 mRNA CTD PMID:22584684 NCBI chr 6:131,199,542...131,199,656
Ensembl chr 6:131,199,542...131,199,656 		JBrowse link
G Mir20a microRNA 20a decreases expression EXP chlorendic acid results in decreased expression of MIR20A mRNA CTD PMID:22584684 NCBI chr15:98,588,303...98,588,387
Ensembl chr15:92,181,084...92,181,168 		JBrowse link
G Mir28 microRNA 28 increases expression EXP chlorendic acid results in increased expression of MIR28 mRNA CTD PMID:22584684 NCBI chr11:89,480,252...89,480,337
Ensembl chr11:75,975,523...75,975,608 		JBrowse link
G Mir34a microRNA 34a increases expression EXP chlorendic acid results in increased expression of MIR34A mRNA CTD PMID:22584684 NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:160,533,002...160,533,103 		JBrowse link
G Mir429 microRNA 429 increases expression EXP chlorendic acid results in increased expression of MIR429 mRNA CTD PMID:22584684 NCBI chr 5:171,929,682...171,929,766
Ensembl chr 5:166,647,459...166,647,543 		JBrowse link
G Mir497 microRNA 497 decreases expression EXP chlorendic acid results in decreased expression of MIR497 mRNA CTD PMID:22584684 NCBI chr10:55,450,171...55,450,239
Ensembl chr10:54,951,505...54,951,584 		JBrowse link
G Mir96 microRNA 96 decreases expression EXP chlorendic acid results in decreased expression of MIR96 mRNA CTD PMID:22584684 NCBI chr 4:59,755,841...59,755,946
Ensembl chr 4:58,788,411...58,788,516 		JBrowse link
G Nampt nicotinamide phosphoribosyltransferase decreases expression EXP chlorendic acid results in decreased expression of NAMPT mRNA CTD PMID:22584684 NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:49,424,332...49,462,100 		JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator increases expression EXP chlorendic acid results in increased expression of NUPR1 mRNA CTD PMID:22584684 NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:181,213,368...181,215,281 		JBrowse link
G Ppp3ca protein phosphatase 3 catalytic subunit alpha multiple interactions ISO chlorendic acid results in increased cleavage of and results in increased activity of PPP3CA protein CTD PMID:22952646 NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:225,165,766...225,438,974 		JBrowse link
G Stmn1 stathmin 1 increases expression EXP chlorendic acid results in increased expression of STMN1 mRNA CTD PMID:22584684 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:146,681,436...146,687,154 		JBrowse link
G Tnf tumor necrosis factor increases expression ISO chlorendic acid results in increased expression of TNF mRNA CTD PMID:22952646 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Top2a DNA topoisomerase II alpha increases expression EXP chlorendic acid results in increased expression of TOP2A mRNA CTD PMID:22584684 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874 		JBrowse link
G Tp53inp1 tumor protein p53 inducible nuclear protein 1 increases expression EXP chlorendic acid results in increased expression of TP53INP1 mRNA CTD PMID:22584684 NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:24,260,568...24,267,968 		JBrowse link
G Wee1 WEE1 G2 checkpoint kinase increases expression EXP chlorendic acid results in increased expression of WEE1 mRNA CTD PMID:22584684 NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:164,174,779...164,197,688 		JBrowse link
cytisine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions ISO
EXP		 cytisine results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]
cytisine affects binding to Chrna2 protein; cytisine inhibits the reaction [epibatidine affects binding to Chrna2 protein] in rat retina		 CTD
RGD		 PMID:9454827 PMID:16129735 RGD:2303195 NCBI chr15:44,517,862...44,534,144
Ensembl chr15:40,342,317...40,358,601 		JBrowse link
G Chrna3 cholinergic receptor nicotinic alpha 3 subunit multiple interactions ISO
EXP		 cytisine results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]
cytisine affects binding [Epibatidine binds to Chrna3 protein]
cytisine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]		 CTD
RGD		 PMID:9454827 PMID:11600638 PMID:16129735 RGD:2303195 NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:55,401,702...55,415,165 		JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions
affects expression
affects binding		 ISO
EXP		 cytisine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; cytisine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; cytisine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; cytisine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]; Nicotine inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]; pozanicline inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]
cytisine affects binding to Chrna4 protein; cytisine inhibits the reaction [epibatidine affects binding to Chrna4 protein] in rat retina
cytisine affects binding to Chrna4 protein; cytisine competes with [Epibatidine binds to Chrna4 protein]
cytisine inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]
cytisine affects the expression of CHRNA4 protein		 CTD
RGD		 PMID:7756618 PMID:9336329 PMID:9454827 PMID:14645658 PMID:20331614 More... RGD:2303195, RGD:2303194 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:168,136,266...168,156,957 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit multiple interactions ISO
EXP		 cytisine inhibits the reaction [Bungarotoxins binds to CHRNA7 protein]
cytisine inhibits the reaction [iodo-alpha-bungarotoxin binds to CHRNA7 protein]		 CTD PMID:10216184 PMID:19448648 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:116,714,711...116,837,240 		JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit affects binding
multiple interactions
affects expression		 ISO
EXP		 cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]
cytisine affects binding to Chrnb2 protein; cytisine inhibits the reaction [epibatidine affects binding to Chrnb2 protein] in rat retina
cytisine affects binding to Chrnb2 protein; cytisine competes with [Epibatidine binds to Chrnb2 protein]
cytisine affects the expression of CHRNB2 protein
cytisine inhibits the reaction [Nicotine results in increased expression of CHRNB2 protein]
cytisine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; cytisine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; cytisine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Nicotine inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]; pozanicline inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]		 CTD
RGD		 PMID:7756618 PMID:9336329 PMID:14645658 PMID:20331614 PMID:16129735 More... RGD:2303195, RGD:2303194 NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:175,181,402...175,189,619 		JBrowse link
G Chrnb3 cholinergic receptor nicotinic beta 3 subunit multiple interactions EXP cytisine affects binding to Chrnb3 protein; cytisine inhibits the reaction [epibatidine affects binding to Chrnb3 protein] in rat retina RGD PMID:16129735 RGD:2303195 NCBI chr16:71,411,847...71,454,225
Ensembl chr16:64,714,169...64,751,360 		JBrowse link
G Chrnb4 cholinergic receptor nicotinic beta 4 subunit multiple interactions ISO
EXP		 cytisine results in increased activity of [CHRNB4 protein binds to CHRNA2 protein]; cytisine results in increased activity of [CHRNB4 protein binds to CHRNA3 protein]; cytisine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]
cytisine results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]		 CTD PMID:9454827 PMID:11600638 NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:55,418,313...55,437,027 		JBrowse link
G Ifng interferon gamma decreases secretion ISO cytisine analog results in decreased secretion of IFNG protein CTD PMID:17630191 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Tbx21 T-box transcription factor 21 decreases expression ISO cytisine analog results in decreased expression of TBX21 mRNA CTD PMID:17630191 NCBI chr10:82,578,751...82,595,253
Ensembl chr10:82,082,322...82,098,831 		JBrowse link
G Tnf tumor necrosis factor decreases secretion ISO cytisine analog results in decreased secretion of TNF protein CTD PMID:17630191 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
HU-308 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Arg1 arginase 1 multiple interactions EXP HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of ARG1 mRNA] CTD PMID:29560022 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:20,475,968...20,488,422 		JBrowse link
G Atg5 autophagy related 5 multiple interactions ISO ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]] CTD PMID:27611972 NCBI chr20:49,380,835...49,471,826
Ensembl chr20:47,798,290...47,889,209 		JBrowse link
G Becn1 beclin 1 multiple interactions ISO [HU 308 co-treated with Dextran Sulfate] affects the expression of BECN1 protein; HU 308 inhibits the reaction [Glucose results in decreased expression of BECN1 protein]; HU 308 inhibits the reaction [Streptozocin results in decreased expression of BECN1 protein]; HU 308 promotes the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein] CTD PMID:27611972 PMID:30459625 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742 		JBrowse link
G Casp1 caspase 1 multiple interactions ISO 3-methyladenine affects the reaction [[HU 308 co-treated with Dextran Sulfate] affects the cleavage of CASP1 protein]; [HU 308 co-treated with Dextran Sulfate] affects the cleavage of CASP1 protein; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; dorsomorphin inhibits the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein] CTD PMID:27611972 NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO HU 308 inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; HU 308 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] CTD PMID:34537380 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Cd68 Cd68 molecule multiple interactions EXP HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein] CTD PMID:29560022 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,381,815...54,383,697 		JBrowse link
G Chi3l3 chitinase 3-like 3 multiple interactions EXP HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CHI3L3 mRNA] CTD PMID:29560022 NCBI chr 2:193,808,135...193,825,511
Ensembl chr 2:193,812,431...193,825,513 		JBrowse link
G Cnr2 cannabinoid receptor 2 multiple interactions EXP
ISO		 HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 mRNA]; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 protein]
[HU 308 co-treated with lipopolysaccharide, E. coli O26-B6] results in increased expression of CNR2 mRNA; HU 308 binds to and results in increased activity of CNR2 protein		 CTD PMID:27194477 PMID:29560022 PMID:30232034 PMID:34537380 NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:148,125,604...148,151,548 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions ISO HU 308 inhibits the reaction [TNF protein results in increased expression of CSF2 mRNA] CTD PMID:34537380 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,386,945...38,389,199 		JBrowse link
G Il10 interleukin 10 multiple interactions ISO
EXP		 HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 protein]
HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 mRNA]		 CTD PMID:29560022 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP
ISO		 HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B mRNA]
HU 308 inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; HU 308 inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; HU 308 inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; HU 308 inhibits the reaction [IL1B protein results in increased expression of MMP3 mRNA]
3-methyladenine affects the reaction [[HU 308 co-treated with Dextran Sulfate] affects the expression of IL1B protein]; [HU 308 co-treated with Dextran Sulfate] affects the expression of IL1B protein; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]]; dorsomorphin inhibits the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]]; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B protein]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]		 CTD PMID:27611972 PMID:29560022 PMID:34537380 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions EXP
ISO		 HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 mRNA]
HU 308 inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]
HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 protein]		 CTD PMID:29560022 PMID:34537380 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions ISO HU 308 inhibits the reaction [IL1B protein results in increased expression of MMP1 mRNA]; HU 308 inhibits the reaction [TNF protein results in increased expression of MMP1 mRNA] CTD PMID:34537380 NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097 		JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions ISO HU 308 inhibits the reaction [IL1B protein results in increased expression of MMP3 mRNA] CTD PMID:34537380 NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961 		JBrowse link
G Mrc1 mannose receptor, C type 1 multiple interactions EXP HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of MRC1 protein] CTD PMID:29560022 NCBI chr17:82,157,725...82,239,411
Ensembl chr17:77,249,187...77,330,857 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions EXP
ISO		 HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]
HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]; HU 308 inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]		 CTD PMID:29560022 PMID:30459625 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions EXP
ISO		 HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein] CTD PMID:29560022 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions ISO [HU 308 co-treated with Dextran Sulfate] affects the expression of NLRP3 protein CTD PMID:27611972 NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO
EXP		 HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein] CTD PMID:29560022 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 multiple interactions EXP HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of PIK3R1 protein] CTD PMID:29560022 NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase B1 multiple interactions ISO HU 308 inhibits the reaction [Glucose results in increased phosphorylation of RPS6KB1 protein] CTD PMID:30459625 NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions ISO [HU 308 co-treated with Dextran Sulfate] affects the expression of SQSTM1 protein; HU 308 inhibits the reaction [Glucose results in increased expression of SQSTM1 protein]; HU 308 inhibits the reaction [Streptozocin results in increased expression of SQSTM1 protein]; HU 308 promotes the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in decreased expression of SQSTM1 protein] CTD PMID:27611972 PMID:30459625 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP
ISO		 HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of TGFB1 mRNA]
HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of TGFB1 protein]		 CTD PMID:29560022 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP
ISO		 HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of TNF mRNA]
HU 308 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; HU 308 inhibits the reaction [TNF protein results in increased expression of CSF2 mRNA]; HU 308 inhibits the reaction [TNF protein results in increased expression of MMP1 mRNA]
HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of TNF protein]		 CTD PMID:29560022 PMID:34537380 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
KT 5720 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca1 ATP binding cassette subfamily A member 1 multiple interactions ISO KT 5720 inhibits the reaction [Capsaicin results in increased expression of ABCA1 protein] CTD PMID:21908651 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases activity ISO KT 5720 results in decreased activity of ABCB1 protein CTD PMID:15725475 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions ISO
EXP		 KT 5720 inhibits the reaction [Bucladesine affects the localization of ABCC2 protein]; KT 5720 inhibits the reaction [Bucladesine results in increased expression of ABCC2 mRNA]; KT 5720 inhibits the reaction [Bucladesine results in increased expression of ABCC2 protein]
KT 5720 inhibits the reaction [Bucladesine affects the localization of ABCC2 protein]; KT 5720 inhibits the reaction [Taurolithocholic Acid results in decreased activity of and affects the localization of ABCC2 protein]		 CTD PMID:26049102 PMID:29052767 PMID:31300867 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Adra1a adrenoceptor alpha 1A multiple interactions ISO KT 5720 inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in decreased transport of Potassium] CTD PMID:15365637 NCBI chr15:45,005,648...45,111,416
Ensembl chr15:40,832,534...40,927,500 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions EXP KT 5720 inhibits the reaction [Taurolithocholic Acid results in increased phosphorylation of AKT1 protein] CTD PMID:31300867 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G App amyloid beta precursor protein multiple interactions ISO KT 5720 inhibits the reaction [cilostazol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]] CTD PMID:24254769 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Atf2 activating transcription factor 2 multiple interactions ISO KT 5720 inhibits the reaction [Bucladesine results in increased expression of ATF2 protein modified form] CTD PMID:26049102 NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:58,718,332...58,795,236 		JBrowse link
G Calca calcitonin-related polypeptide alpha multiple interactions EXP KT 5720 inhibits the reaction [NPPA protein results in increased secretion of CALCA protein] CTD PMID:17522345 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105 		JBrowse link
G Cartpt CART prepropeptide multiple interactions EXP KT 5720 inhibits the reaction [CARTPT protein results in increased phosphorylation of GRIN1 protein] CTD PMID:19632277 NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP		 KT 5720 inhibits the reaction [cilostazol results in increased activity of CASP3 protein]; KT 5720 inhibits the reaction [Colforsin results in increased activity of CASP3 protein]
KT 5720 inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP3 protein]
KT 5720 inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]		 CTD PMID:20131233 PMID:21873648 PMID:32115946 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1 multiple interactions ISO KT 5720 affects the reaction [muscarinic toxin 7 binds to CHRM1 protein]; KT 5720 promotes the reaction [Acetylcholine binds to CHRM1 protein]; KT 5720 promotes the reaction [N-Methylscopolamine binds to CHRM1 protein]; Staurosporine affects the reaction [KT 5720 promotes the reaction [N-Methylscopolamine binds to CHRM1 protein]] CTD PMID:10860942 PMID:16439611 NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:205,567,220...205,582,356 		JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 multiple interactions ISO KT 5720 promotes the reaction [N-Methylscopolamine binds to CHRM2 protein] CTD PMID:10860942 NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,014,144...65,149,103 		JBrowse link
G Chrm3 cholinergic receptor, muscarinic 3 affects binding EXP KT 5720 binds to CHRM3 protein CTD PMID:12435818 NCBI chr17:64,696,549...65,158,622
Ensembl chr17:60,005,202...60,467,278 		JBrowse link
G Cidec cell death-inducing DFFA-like effector c multiple interactions ISO KT 5720 inhibits the reaction [Isoproterenol results in increased expression of CIDEC protein] CTD PMID:21097823 NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:146,569,289...146,582,173 		JBrowse link
G Csnk2a1 casein kinase 2 alpha 1 multiple interactions ISO KT 5720 inhibits the reaction [cilostazol results in increased phosphorylation of CSNK2A1 protein] CTD PMID:24254769 NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:140,709,991...140,756,696 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions ISO KT 5720 inhibits the reaction [cilostazol affects the expression of EP300 protein] CTD PMID:24254769 NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088 		JBrowse link
G Fgf1 fibroblast growth factor 1 multiple interactions EXP KT 5720 inhibits the reaction [Norepinephrine inhibits the reaction [Carbachol results in increased expression of FGF1 protein]] CTD PMID:15264218 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357 		JBrowse link
G Gper1 G protein-coupled estrogen receptor 1 multiple interactions EXP KT 5720 inhibits the reaction [[1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone binds to and results in increased activity of GPER1 protein] which results in increased expression of SLC1A2 protein] CTD PMID:22645130 NCBI chr12:20,331,073...20,336,527
Ensembl chr12:15,217,442...15,221,889 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions EXP KT 5720 inhibits the reaction [CARTPT protein results in increased phosphorylation of GRIN1 protein] CTD PMID:19632277 NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 multiple interactions ISO KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA1 mRNA] CTD PMID:26049102 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:23,703,477...23,720,121 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 multiple interactions ISO KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA2 mRNA] CTD PMID:26049102 NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798 		JBrowse link
G Gsta4 glutathione S-transferase alpha 4 multiple interactions ISO KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA4 mRNA] CTD PMID:26049102 NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:79,066,934...79,084,182 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP
ISO		 KT 5720 inhibits the reaction [Nitroprusside results in increased expression of HMOX1 protein]
Dinoprostone inhibits the reaction [KT 5720 promotes the reaction [Lipopolysaccharides results in increased activity of HMOX1 protein]]; KT 5720 inhibits the reaction [Dinoprostone inhibits the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]]; KT 5720 promotes the reaction [Lipopolysaccharides results in increased activity of HMOX1 protein]; KT 5720 promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]		 CTD PMID:16439612 PMID:24003391 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO KT 5720 inhibits the reaction [Dipyridamole promotes the reaction [IL1B protein results in increased abundance of Cyclic AMP]] CTD PMID:8904084 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Itgam integrin subunit alpha M multiple interactions ISO KT 5720 inhibits the reaction [2-(2-fluorobenzamido)benzoate ethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]] CTD PMID:21457779 NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO KT 5720 inhibits the reaction [Bucladesine results in increased expression of JUN protein modified form]; KT 5720 inhibits the reaction [Bucladesine results in increased expression of JUN protein] CTD PMID:26049102 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656 		JBrowse link
G Lrp1 LDL receptor related protein 1 multiple interactions ISO KT 5720 inhibits the reaction [Capsaicin results in decreased expression of LRP1 protein] CTD PMID:21908651 NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]]; KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]]; KT 5720 promotes the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein] CTD PMID:11675405 PMID:39197814 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]]; KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK3 protein]]; KT 5720 promotes the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein] CTD PMID:11675405 PMID:39197814 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Nos1 nitric oxide synthase 1 multiple interactions EXP KT 5720 inhibits the reaction [Mevinphos results in increased expression of NOS1 protein] CTD PMID:17438462 NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945 		JBrowse link
G Nppa natriuretic peptide A multiple interactions EXP KT 5720 inhibits the reaction [NPPA protein results in increased secretion of CALCA protein] CTD PMID:17522345 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351 		JBrowse link
G Nucb2 nucleobindin 2 multiple interactions EXP KT 5720 inhibits the reaction [NUCB2 protein results in increased import of Calcium] CTD PMID:17627999 NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:170,750,877...170,787,353 		JBrowse link
G Pla2g6 phospholipase A2 group VI multiple interactions EXP KT 5720 inhibits the reaction [UCN protein results in decreased expression of PLA2G6 protein] CTD PMID:17885217 NCBI chr 7:112,731,803...112,771,978
Ensembl chr 7:110,851,378...110,891,114 		JBrowse link
G Prkaca protein kinase cAMP-activated catalytic subunit alpha multiple interactions EXP KT 5720 inhibits the reaction [Bucladesine results in increased activity of PRKACA protein]; KT 5720 inhibits the reaction [Taurolithocholic Acid results in increased activity of PRKACA protein] CTD PMID:31300867 NCBI chr19:41,059,843...41,083,189
Ensembl chr19:24,155,090...24,178,430 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO [KT 5720 co-treated with Dinoprostone] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; KT 5720 affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] CTD PMID:24003391 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO KT 5720 inhibits the reaction [cilostazol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]]; KT 5720 inhibits the reaction [cilostazol results in increased phosphorylation of SIRT1 protein] CTD PMID:24254769 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Slc1a2 solute carrier family 1 member 2 multiple interactions EXP KT 5720 inhibits the reaction [[1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone binds to and results in increased activity of GPER1 protein] which results in increased expression of SLC1A2 protein] CTD PMID:22645130 NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:89,005,129...89,126,498 		JBrowse link
G Smad3 SMAD family member 3 multiple interactions ISO KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]]; KT 5720 promotes the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] CTD PMID:39197814 NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960 		JBrowse link
G Socs3 suppressor of cytokine signaling 3 multiple interactions ISO KT 5720 inhibits the reaction [isoeugenol results in increased expression of SOCS3 mRNA] CTD PMID:21969073 NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]]; KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]]; KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]]; KT 5720 promotes the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]; KT 5720 promotes the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]; KT 5720 promotes the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] CTD PMID:39197814 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Th tyrosine hydroxylase decreases expression
multiple interactions		 EXP KT 5720 results in decreased expression of TH mRNA
KT 5720 inhibits the reaction [Colforsin results in increased expression of TH mRNA]; KT 5720 inhibits the reaction [HU 211 results in decreased expression of TH mRNA]		 CTD PMID:18992715 NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of TNF mRNA]]; KT 5720 inhibits the reaction [Terbutaline results in decreased expression of TNF mRNA] CTD PMID:11675405 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfsf11 TNF superfamily member 11 multiple interactions EXP KT 5720 inhibits the reaction [modafinil results in increased expression of TNFSF11 mRNA] CTD PMID:29649498 NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445 		JBrowse link
G Ucn urocortin multiple interactions EXP KT 5720 inhibits the reaction [UCN protein results in decreased expression of PLA2G6 protein] CTD PMID:17885217 NCBI chr 6:30,958,086...30,958,916
Ensembl chr 6:25,238,120...25,238,950 		JBrowse link
G Zfp36 zinc finger protein 36 multiple interactions ISO KT 5720 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein] CTD PMID:21969073 NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564 		JBrowse link
lactiflorin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Edn1 endothelin 1 multiple interactions EXP lactiflorin promotes the reaction [ITGA6 protein results in increased expression of EDN1 protein] CTD PMID:36731809 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885 		JBrowse link
G Itga6 integrin subunit alpha 6 multiple interactions EXP lactiflorin promotes the reaction [ITGA6 protein results in increased expression of EDN1 protein] CTD PMID:36731809 NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:56,617,268...56,689,428 		JBrowse link
ledipasvir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcg2 ATP binding cassette subfamily G member 2 affects binding ISO ledipasvir binds to ABCG2 protein CTD PMID:33954893 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409 		JBrowse link
G Klrc1 killer cell lectin like receptor C1 decreases expression ISO ledipasvir co-treated with sofosbuvir decreases expression of NCR1 protein in natural killer cells RGD PMID:31218578 RGD:40400920 NCBI chr 4:164,828,163...164,838,446
Ensembl chr 4:163,147,189...163,152,425 		JBrowse link
G Ncr1 natural cytotoxicity triggering receptor 1 affects expression ISO ledipasvir co-treated sofosbuvir with affects expression of NCR1 protein in natural killer cells RGD PMID:31218578 RGD:40400920 NCBI chr 1:78,657,409...78,665,255
Ensembl chr 1:69,616,601...69,660,558 		JBrowse link
LY 379268 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bad BCL2-associated agonist of cell death multiple interactions
increases phosphorylation		 EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 results in increased phosphorylation of BAD protein]; U 0126 inhibits the reaction [LY 379268 results in increased phosphorylation of BAD protein] CTD PMID:17293559 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823 		JBrowse link
G Bcl2l1 Bcl2-like 1 increases expression
multiple interactions		 EXP LY 379268 results in increased expression of BCL2L1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 results in increased expression of BCL2L1 protein]		 CTD PMID:17293559 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; U 0126 inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]] CTD PMID:17293559 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 increases phosphorylation EXP LY 379268 results in increased phosphorylation of MAP3K5 protein CTD PMID:17293559 NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation		 EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 results in increased phosphorylation of MAPK1 protein]; LY 341495 inhibits the reaction [LY 379268 results in increased phosphorylation of MAPK1 protein]; Pertussis Toxin inhibits the reaction [LY 379268 results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [LY 379268 results in increased phosphorylation of MAPK1 protein] CTD PMID:17293559 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation
multiple interactions		 EXP LY 379268 results in increased phosphorylation of MAPK3 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 results in increased phosphorylation of MAPK3 protein]; LY 341495 inhibits the reaction [LY 379268 results in increased phosphorylation of MAPK3 protein]; Pertussis Toxin inhibits the reaction [LY 379268 results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [LY 379268 results in increased phosphorylation of MAPK3 protein]		 CTD PMID:17293559 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions EXP LY 379268 inhibits the reaction [bisphenol A results in decreased expression of NR3C1 mRNA] CTD PMID:25812946 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375 		JBrowse link
prostaglandin G2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1c1 aldo-keto reductase family 1, member C1 increases metabolic processing ISO AKR1C1 protein results in increased metabolism of prostaglandin G2 CTD PMID:8573067 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases abundance		 ISO [PTGS2 protein results in increased abundance of prostaglandin G2] inhibits the reaction [Sodium Salicylate inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid]]; [PTGS2 protein results in increased abundance of prostaglandin G2] inhibits the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein] CTD PMID:12538810 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
prostaglandin H2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gstm2 glutathione S-transferase mu 2 affects metabolic processing ISO GSTM2 protein affects the metabolism of Prostaglandin H2 CTD PMID:10905636 NCBI chr 2:198,312,179...198,316,962
Ensembl chr 2:195,544,426...195,628,961 		JBrowse link
G Gstm5 glutathione S-transferase, mu 5 affects metabolic processing ISO GSTM3 protein affects the metabolism of Prostaglandin H2 CTD PMID:10905636 NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:195,531,495...195,534,553 		JBrowse link
G Ptgds prostaglandin D2 synthase increases metabolic processing EXP PTGDS protein results in increased metabolism of Prostaglandin H2 CTD PMID:22043816 NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:8,281,899...8,284,833 		JBrowse link
rebaudioside A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace angiotensin I converting enzyme decreases expression ISO rebaudioside A results in decreased expression of ACE mRNA CTD PMID:31655124 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131 		JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA] CTD PMID:25554529 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] CTD PMID:30883860 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression ISO rebaudioside A results in increased expression of AGTR1 mRNA CTD PMID:31655124 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase increases expression ISO rebaudioside A results in increased expression of ALOX5 mRNA CTD PMID:31655124 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator decreases expression ISO rebaudioside A results in decreased expression of BAX mRNA CTD PMID:31655124 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression ISO rebaudioside A results in increased expression of CALCA mRNA CTD PMID:31655124 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105 		JBrowse link
G Cat catalase multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA] CTD PMID:25554529 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Cav1 caveolin 1 decreases expression ISO rebaudioside A results in decreased expression of CAV1 mRNA CTD PMID:31655124 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO rebaudioside A results in decreased expression of CCL2 mRNA CTD PMID:31655124 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator decreases expression ISO rebaudioside A results in decreased expression of CFLAR mRNA CTD PMID:31655124 NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA] CTD PMID:25554529 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055 		JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA] CTD PMID:25554529 NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428 		JBrowse link
G Edn1 endothelin 1 decreases expression ISO rebaudioside A results in decreased expression of EDN1 mRNA CTD PMID:31655124 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885 		JBrowse link
G Ednra endothelin receptor type A increases expression ISO rebaudioside A results in increased expression of EDNRA mRNA CTD PMID:31655124 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049 		JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO rebaudioside A results in decreased expression of F2R mRNA CTD PMID:31655124 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870 		JBrowse link
G Faslg Fas ligand increases expression ISO rebaudioside A results in increased expression of FASLG mRNA CTD PMID:31655124 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression ISO rebaudioside A results in increased expression of FGF1 mRNA CTD PMID:31655124 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 decreases expression ISO rebaudioside A results in decreased expression of FLT1 mRNA CTD PMID:31655124 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626 		JBrowse link
G Foxo1 forkhead box O1 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA] CTD PMID:25554529 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:136,312,168...136,387,790 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA] CTD PMID:25554529 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804 		JBrowse link
G Il10 interleukin 10 multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in increased expression of IL10 protein] CTD PMID:30883860 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il6 interleukin 6 multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in increased expression of IL6 protein] CTD PMID:30883860 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Insr insulin receptor multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA] CTD PMID:25554529 NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883 		JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA] CTD PMID:25554529 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122 		JBrowse link
G Irs2 insulin receptor substrate 2 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA] CTD PMID:25554529 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:78,485,045...78,512,482 		JBrowse link
G Itgav integrin subunit alpha V decreases expression ISO rebaudioside A results in decreased expression of ITGAV mRNA CTD PMID:31655124 NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:68,838,189...68,926,639 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression ISO rebaudioside A results in decreased expression of KIT mRNA CTD PMID:31655124 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652 		JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580 		JBrowse link
G Lep leptin multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA]; rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262 		JBrowse link
G Lipc lipase C, hepatic type multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA] CTD PMID:25554529 NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464 		JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in increased expression of MMP13 protein] CTD PMID:30883860 NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in increased activity of MMP2 protein] CTD PMID:30883860 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870 		JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression
multiple interactions		 ISO
EXP		 rebaudioside A results in increased expression of MMP9 mRNA
rebaudioside A inhibits the reaction [Thioacetamide results in increased activity of MMP9 protein]		 CTD PMID:30883860 PMID:31655124 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA] CTD PMID:25554529 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein] CTD PMID:30883860 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA] CTD PMID:25554529 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA] CTD PMID:25554529 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA] CTD PMID:25554529 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191 		JBrowse link
G Pf4 platelet factor 4 increases expression ISO rebaudioside A results in increased expression of PF4 mRNA CTD PMID:31655124 NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA] CTD PMID:25554529 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Ppard peroxisome proliferator-activated receptor delta multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA] CTD PMID:25554529 NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA] CTD PMID:25554529 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO rebaudioside A results in decreased expression of PTGS2 mRNA CTD PMID:31655124 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in increased expression of RELA protein] CTD PMID:30883860 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Scd stearoyl-CoA desaturase multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA] CTD PMID:25554529 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Sele selectin E decreases expression ISO rebaudioside A results in decreased expression of SELE mRNA CTD PMID:31655124 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA] CTD PMID:25554529 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Slc27a1 solute carrier family 27 member 1 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA] CTD PMID:25554529 NCBI chr16:18,311,859...18,337,024
Ensembl chr16:18,278,984...18,296,063 		JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA] CTD PMID:25554529 NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933 		JBrowse link
G Smad7 SMAD family member 7 multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in decreased expression of SMAD7 protein] CTD PMID:30883860 NCBI chr18:71,263,508...71,291,849
Ensembl chr18:68,988,429...69,016,765 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in increased expression of TGFB1 protein] CTD PMID:30883860 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP rebaudioside A inhibits the reaction [Thioacetamide results in increased expression of TNF protein] CTD PMID:30883860 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfsf10 TNF superfamily member 10 decreases expression ISO rebaudioside A results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135 		JBrowse link
SR 144528 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acta2 actin alpha 2, smooth muscle multiple interactions ISO SR 144528 inhibits the reaction [celastrol inhibits the reaction [Folic Acid results in increased expression of ACTA2 protein]] CTD PMID:29789558 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in decreased phosphorylation of AKT1 protein]; SR 144528 inhibits the reaction [Dronabinol results in increased phosphorylation of AKT1 protein]; SR 144528 inhibits the reaction [methanandamide results in increased phosphorylation of AKT1 protein] CTD PMID:12834810 PMID:30733293 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Atf4 activating transcription factor 4 multiple interactions ISO [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of ATF4 mRNA] CTD PMID:31054322 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446 		JBrowse link
G Atf6 activating transcription factor 6 multiple interactions ISO [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of ATF6 mRNA] CTD PMID:31054322 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:82,930,034...83,107,177 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased activity of CASP3 protein] CTD PMID:16818634 PMID:16818650 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]]; SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]] CTD PMID:10218491 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in decreased expression of CDK1 protein] CTD PMID:16818634 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408 		JBrowse link
G Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased expression of CNP protein] CTD PMID:32956517 NCBI chr10:86,011,504...86,018,063
Ensembl chr10:85,511,160...85,517,720 		JBrowse link
G Cnr1 cannabinoid receptor 1 multiple interactions ISO SR 144528 inhibits the reaction [[anandamide binds to and results in increased activity of CNR1 protein] inhibits the reaction [Lipopolysaccharides results in increased transport of Nitric Oxide]] CTD PMID:11891798 NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099 		JBrowse link
G Cnr2 cannabinoid receptor 2 affects binding
multiple interactions		 ISO
EXP		 SR 144528 binds to CNR2 protein
SR 144528 binds to and results in decreased activity of CNR2 protein
[SR 144528 binds to and results in decreased activity of CNR2 protein] which results in decreased susceptibility to (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone; [SR 144528 binds to and results in decreased activity of CNR2 protein] which results in decreased susceptibility to palmidrol analog; SR 144528 binds to and results in decreased activity of CNR2 protein; SR 144528 inhibits the reaction [[3-(1,1-dimethyl-heptyl)-1-9-dihydroxy-benzo(c)chromen-6-one binds to and results in increased activity of CNR2 protein] which results in decreased susceptibility to Paclitaxel]; SR 144528 inhibits the reaction [[AM 1241 binds to and results in increased activity of CNR2 protein] which results in decreased susceptibility to Paclitaxel]; SR 144528 inhibits the reaction [CNR2 protein affects the susceptibility to Dronabinol]
[SR 144528 binds to and results in increased activity of CNR2 protein] inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CXCL8 protein]; SR 144528 binds to and results in decreased activity of CNR2 protein; SR 144528 inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]]; SR 144528 inhibits the reaction [[virodhamine binds to and results in increased activity of CNR2 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]]; SR 144528 inhibits the reaction [CNR2 protein affects the reaction [glyceryl 2-arachidonate results in increased transport of Calcium]]; SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]]; SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]]; SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CXCL8 mRNA]]; SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CXCL8 protein]]; SR 144528 inhibits the reaction [Dronabinol inhibits the reaction [ERBB2 protein binds to CNR2 protein]]		 CTD PMID:10218491 PMID:10617657 PMID:10688601 PMID:12509806 PMID:15115777 More... NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:148,125,604...148,151,548 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions ISO [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of DDIT3 mRNA] CTD PMID:31054322 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol inhibits the reaction [ERBB2 protein binds to CNR2 protein]]; SR 144528 inhibits the reaction [Dronabinol inhibits the reaction [ERBB2 protein binds to ERBB2 protein]]; SR 144528 inhibits the reaction [Dronabinol results in decreased expression of and affects the phosphorylation of ERBB2 protein] CTD PMID:30733293 NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078 		JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO SR 144528 inhibits the reaction [celastrol inhibits the reaction [Folic Acid results in increased expression of FN1 protein]] CTD PMID:29789558 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678 		JBrowse link
G Gata3 GATA binding protein 3 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased expression of GATA3 mRNA] CTD PMID:14741435 NCBI chr17:73,544,234...73,575,670
Ensembl chr17:68,643,873...68,665,391 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions ISO [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of HSPA5 mRNA] CTD PMID:31054322 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891 		JBrowse link
G Ifng interferon gamma multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in decreased expression of IFNG mRNA]; SR 144528 inhibits the reaction [Dronabinol results in decreased expression of IFNG protein] CTD PMID:12446015 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Il10 interleukin 10 multiple interactions ISO SR 144528 inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]] CTD PMID:15821753 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO SR 144528 inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Lipopolysaccharides results in increased secretion of IL12B protein]] CTD PMID:15821753 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [Rimonabant co-treated with SR 144528] inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; SR 144528 inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]] CTD PMID:15748152 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il2 interleukin 2 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in decreased expression of IL2 mRNA] CTD PMID:12446015 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566 		JBrowse link
G Il4 interleukin 4 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased expression of IL4 mRNA]; SR 144528 inhibits the reaction [Dronabinol results in increased expression of IL4 protein] CTD PMID:12446015 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750 		JBrowse link
G Il5 interleukin 5 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased expression of IL5 mRNA] CTD PMID:12446015 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213 		JBrowse link
G Irf1 interferon regulatory factor 1 multiple interactions ISO SR 144528 inhibits the reaction [caryophyllene inhibits the reaction [TNF protein results in increased expression of IRF1 protein]] CTD PMID:28624443 NCBI chr10:38,417,935...38,424,946
Ensembl chr10:37,916,670...37,924,166 		JBrowse link
G Mag myelin-associated glycoprotein multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased expression of MAG protein] CTD PMID:32956517 NCBI chr 1:95,275,728...95,291,133
Ensembl chr 1:86,148,228...86,163,656 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in decreased phosphorylation of MAPK1 protein]; SR 144528 inhibits the reaction [Dronabinol results in increased phosphorylation of MAPK1 protein]; SR 144528 inhibits the reaction [methanandamide results in increased phosphorylation of MAPK1 protein] CTD PMID:12834810 PMID:30733293 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in decreased phosphorylation of MAPK3 protein]; SR 144528 inhibits the reaction [Dronabinol results in increased phosphorylation of MAPK3 protein]; SR 144528 inhibits the reaction [methanandamide results in increased phosphorylation of MAPK3 protein] CTD PMID:12834810 PMID:30733293 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased phosphorylation of MAPK8 protein] CTD PMID:24184660 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased phosphorylation of MAPK9 protein] CTD PMID:24184660 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178 		JBrowse link
G Mbp myelin basic protein multiple interactions EXP SR 144528 inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased expression of MBP protein] CTD PMID:17880390 NCBI chr18:78,130,652...78,241,174
Ensembl chr18:75,855,878...75,966,404 		JBrowse link
G Mog myelin oligodendrocyte glycoprotein multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased expression of MOG protein] CTD PMID:32956517 NCBI chr20:1,514,110...1,528,716
Ensembl chr20:1,513,239...1,523,474 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO [Rimonabant co-treated with SR 144528] inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] CTD PMID:15748152 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased expression of NUPR1 mRNA] CTD PMID:16818650 NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:181,213,368...181,215,281 		JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased localization of RAF1 protein]; SR 144528 inhibits the reaction [methanandamide results in increased localization of RAF1 protein] CTD PMID:12834810 NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO SR 144528 inhibits the reaction [Dronabinol results in increased expression of TGFB1 protein] CTD PMID:11779138 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO SR 144528 inhibits the reaction [caryophyllene inhibits the reaction [TNF protein results in increased expression of IRF1 protein]]; SR 144528 inhibits the reaction [caryophyllene inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]] CTD PMID:28624443 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO SR 144528 inhibits the reaction [caryophyllene inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]] CTD PMID:28624443 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO SR 144528 inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased expression of and results in decreased secretion of VEGFA protein] CTD PMID:15313899 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
G Xbp1 X-box binding protein 1 multiple interactions ISO [Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of XBP1 mRNA alternative form] CTD PMID:31054322 NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693 		JBrowse link
steviol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acaca acetyl-CoA carboxylase alpha multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACACA mRNA] CTD PMID:25554529 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457 		JBrowse link
G Ace angiotensin I converting enzyme decreases expression ISO steviol results in decreased expression of ACE mRNA CTD PMID:31655124 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131 		JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA] CTD PMID:25554529 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression ISO steviol results in increased expression of AGTR1 mRNA CTD PMID:31655124 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions ISO steviol binds to and results in increased activity of AHR protein CTD PMID:28887089 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase increases expression ISO steviol results in increased expression of ALOX5 mRNA CTD PMID:31655124 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator decreases expression ISO steviol results in decreased expression of BAX mRNA CTD PMID:31655124 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression ISO steviol results in increased expression of CALCA mRNA CTD PMID:31655124 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105 		JBrowse link
G Cat catalase multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA] CTD PMID:25554529 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO steviol results in decreased expression of CCL2 mRNA CTD PMID:31655124 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator decreases expression ISO steviol results in decreased expression of CFLAR mRNA CTD PMID:31655124 NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA] CTD PMID:25554529 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression ISO steviol results in increased expression of CYP1A1 mRNA; steviol results in increased expression of CYP1A1 protein CTD PMID:28887089 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression ISO steviol results in increased expression of CYP1A2 mRNA; steviol results in increased expression of CYP1A2 protein CTD PMID:28887089 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression ISO steviol results in increased expression of CYP1B1 mRNA CTD PMID:28887089 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression ISO steviol results in increased expression of CYP2B6 mRNA CTD PMID:28887089 NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
multiple interactions		 ISO steviol results in increased expression of CYP3A4 mRNA; steviol results in increased expression of CYP3A4 protein
steviol binds to and results in decreased activity of CYP3A4 protein		 CTD PMID:28887089 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA] CTD PMID:25554529 NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428 		JBrowse link
G Edn1 endothelin 1 decreases expression ISO steviol results in decreased expression of EDN1 mRNA CTD PMID:31655124 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885 		JBrowse link
G Ednra endothelin receptor type A increases expression ISO steviol results in increased expression of EDNRA mRNA CTD PMID:31655124 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049 		JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO steviol results in decreased expression of F2R mRNA CTD PMID:31655124 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870 		JBrowse link
G Faslg Fas ligand increases expression ISO steviol results in increased expression of FASLG mRNA CTD PMID:31655124 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215 		JBrowse link
G Fasn fatty acid synthase multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FASN mRNA] CTD PMID:25554529 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression ISO steviol results in increased expression of FGF1 mRNA CTD PMID:31655124 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 decreases expression ISO steviol results in decreased expression of FLT1 mRNA CTD PMID:31655124 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626 		JBrowse link
G Foxo1 forkhead box O1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA] CTD PMID:25554529 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:136,312,168...136,387,790 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA] CTD PMID:25554529 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804 		JBrowse link
G Gpam glycerol-3-phosphate acyltransferase, mitochondrial multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of GPAM mRNA] CTD PMID:25554529 NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:254,106,331...254,142,639 		JBrowse link
G Insr insulin receptor multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA] CTD PMID:25554529 NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883 		JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA] CTD PMID:25554529 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122 		JBrowse link
G Irs2 insulin receptor substrate 2 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA] CTD PMID:25554529 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:78,485,045...78,512,482 		JBrowse link
G Itgav integrin subunit alpha V decreases expression ISO steviol results in decreased expression of ITGAV mRNA CTD PMID:31655124 NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:68,838,189...68,926,639 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression ISO steviol results in decreased expression of KIT mRNA CTD PMID:31655124 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652 		JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACACA mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FASN mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of GPAM mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PLIN2 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PRKAA1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580 		JBrowse link
G Lep leptin multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACACA mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FASN mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of GPAM mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PLIN2 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PRKAA1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA]; steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262 		JBrowse link
G Lipc lipase C, hepatic type multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA] CTD PMID:25554529 NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464 		JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression ISO steviol results in increased expression of MMP9 mRNA CTD PMID:31655124 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA] CTD PMID:25554529 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA] CTD PMID:25554529 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA] CTD PMID:25554529 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO steviol binds to and results in increased activity of NR1I2 protein CTD PMID:28887089 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA] CTD PMID:25554529 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191 		JBrowse link
G Pf4 platelet factor 4 increases expression ISO steviol results in increased expression of PF4 mRNA CTD PMID:31655124 NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365 		JBrowse link
G Plin2 perilipin 2 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PLIN2 mRNA] CTD PMID:25554529 NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:101,154,411...101,242,319 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA] CTD PMID:25554529 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Ppard peroxisome proliferator-activated receptor delta multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA] CTD PMID:25554529 NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA] CTD PMID:25554529 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656 		JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PRKAA1 mRNA] CTD PMID:25554529 NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:54,240,137...54,275,978 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO steviol results in decreased expression of PTGS2 mRNA CTD PMID:31655124 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Scd stearoyl-CoA desaturase multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA] CTD PMID:25554529 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Sele selectin E decreases expression ISO steviol results in decreased expression of SELE mRNA CTD PMID:31655124 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA] CTD PMID:25554529 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Slc27a1 solute carrier family 27 member 1 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA] CTD PMID:25554529 NCBI chr16:18,311,859...18,337,024
Ensembl chr16:18,278,984...18,296,063 		JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA] CTD PMID:25554529 NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Tnfsf10 TNF superfamily member 10 decreases expression ISO steviol results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135 		JBrowse link
stevioside term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace angiotensin I converting enzyme decreases expression ISO stevioside results in decreased expression of ACE mRNA CTD PMID:31655124 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131 		JBrowse link
G Ache acetylcholinesterase multiple interactions EXP stevioside inhibits the reaction [Scopolamine results in increased activity of ACHE protein] CTD PMID:20871768 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA] CTD PMID:25554529 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant decreases secretion EXP stevioside results in decreased secretion of ACP5 protein CTD PMID:21089163 NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:20,663,985...20,667,929 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression ISO stevioside results in increased expression of AGTR1 mRNA CTD PMID:31655124 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase increases expression ISO stevioside results in increased expression of ALOX5 mRNA CTD PMID:31655124 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator decreases expression ISO stevioside results in decreased expression of BAX mRNA CTD PMID:31655124 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression ISO stevioside results in increased expression of CALCA mRNA CTD PMID:31655124 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105 		JBrowse link
G Cat catalase multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA] CTD PMID:25554529 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO stevioside results in decreased expression of CCL2 mRNA CTD PMID:31655124 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator decreases expression ISO stevioside results in decreased expression of CFLAR mRNA CTD PMID:31655124 NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA] CTD PMID:25554529 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression ISO stevioside results in increased expression of CYP1A1 mRNA CTD PMID:28887089 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression ISO stevioside results in increased expression of CYP1A2 mRNA; stevioside results in increased expression of CYP1A2 protein CTD PMID:28887089 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression ISO stevioside results in increased expression of CYP1B1 mRNA CTD PMID:28887089 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions
increases expression		 ISO stevioside binds to and results in decreased activity of CYP3A4 protein
stevioside results in increased expression of CYP3A4 mRNA; stevioside results in increased expression of CYP3A4 protein		 CTD PMID:28887089 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA] CTD PMID:25554529 NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428 		JBrowse link
G Edn1 endothelin 1 decreases expression ISO stevioside results in decreased expression of EDN1 mRNA CTD PMID:31655124 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885 		JBrowse link
G Ednra endothelin receptor type A increases expression ISO stevioside results in increased expression of EDNRA mRNA CTD PMID:31655124 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049 		JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO stevioside results in decreased expression of F2R mRNA CTD PMID:31655124 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870 		JBrowse link
G Faslg Fas ligand increases expression ISO stevioside results in increased expression of FASLG mRNA CTD PMID:31655124 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression ISO stevioside results in increased expression of FGF1 mRNA CTD PMID:31655124 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 decreases expression ISO stevioside results in decreased expression of FLT1 mRNA CTD PMID:31655124 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626 		JBrowse link
G Foxo1 forkhead box O1 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA] CTD PMID:25554529 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:136,312,168...136,387,790 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA] CTD PMID:25554529 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804 		JBrowse link
G Insr insulin receptor multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA] CTD PMID:25554529 NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883 		JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA] CTD PMID:25554529 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122 		JBrowse link
G Irs2 insulin receptor substrate 2 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA] CTD PMID:25554529 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:78,485,045...78,512,482 		JBrowse link
G Itgav integrin subunit alpha V decreases expression ISO stevioside results in decreased expression of ITGAV mRNA CTD PMID:31655124 NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:68,838,189...68,926,639 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression ISO stevioside results in decreased expression of KIT mRNA CTD PMID:31655124 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652 		JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PLIN2 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580 		JBrowse link
G Lep leptin multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of ACOX1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CAT mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of CPT1A mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of FOXO1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of G6PC1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of INSR mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of IRS2 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PLIN2 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA]; stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262 		JBrowse link
G Lipc lipase C, hepatic type multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of LIPC mRNA] CTD PMID:25554529 NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464 		JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression ISO stevioside results in increased expression of MMP9 mRNA CTD PMID:31655124 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of MTOR mRNA] CTD PMID:25554529 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKB1 mRNA] CTD PMID:25554529 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of NFKBIA mRNA] CTD PMID:25554529 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PCK1 mRNA] CTD PMID:25554529 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191 		JBrowse link
G Pf4 platelet factor 4 increases expression ISO stevioside results in increased expression of PF4 mRNA CTD PMID:31655124 NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365 		JBrowse link
G Plin2 perilipin 2 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PLIN2 mRNA] CTD PMID:25554529 NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:101,154,411...101,242,319 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARA mRNA] CTD PMID:25554529 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Ppard peroxisome proliferator-activated receptor delta multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA] CTD PMID:25554529 NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARGC1A mRNA] CTD PMID:25554529 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO stevioside results in decreased expression of PTGS2 mRNA CTD PMID:31655124 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Scd stearoyl-CoA desaturase multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SCD1 mRNA] CTD PMID:25554529 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Sele selectin E decreases expression ISO stevioside results in decreased expression of SELE mRNA CTD PMID:31655124 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SIRT1 mRNA] CTD PMID:25554529 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Slc27a1 solute carrier family 27 member 1 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC27A1 mRNA] CTD PMID:25554529 NCBI chr16:18,311,859...18,337,024
Ensembl chr16:18,278,984...18,296,063 		JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SLC2A2 mRNA] CTD PMID:25554529 NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of SOD2 mRNA] CTD PMID:25554529 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Tnfsf10 TNF superfamily member 10 decreases expression ISO stevioside results in decreased expression of TNFSF10 mRNA CTD PMID:31655124 NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135 		JBrowse link
trabectedin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases expression		 ISO
EXP		 [ABCB1A protein mutant form co-treated with ABCB1B protein mutant form] results in increased susceptibility to trabectedin
trabectedin results in increased expression of ABCB1A mRNA		 CTD PMID:12154027 PMID:19238326 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B multiple interactions
increases expression		 ISO
EXP		 [ABCB1A protein mutant form co-treated with ABCB1B protein mutant form] results in increased susceptibility to trabectedin
trabectedin results in increased expression of ABCB1B mRNA		 CTD PMID:12154027 PMID:19238326 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:25,242,798...25,325,199 		JBrowse link
G Aco1 aconitase 1 increases expression ISO Trabectedin results in increased expression of ACO1 mRNA; Trabectedin results in increased expression of ACO1 protein CTD PMID:36396105 NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:55,259,827...55,316,391 		JBrowse link
G Car3 carbonic anhydrase 3 decreases expression EXP trabectedin results in decreased expression of CAR3 mRNA CTD PMID:12154027 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280 		JBrowse link
G Ccna2 cyclin A2 decreases expression ISO trabectedin results in decreased expression of CCNA2 mRNA CTD PMID:15961672 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577 		JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO trabectedin results in decreased expression of CCNB1 mRNA CTD PMID:15961672 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172 		JBrowse link
G Ccnb2 cyclin B2 decreases expression ISO trabectedin results in decreased expression of CCNB2 mRNA CTD PMID:15961672 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:71,087,595...71,100,874 		JBrowse link
G Ccnd1 cyclin D1 increases expression EXP trabectedin results in increased expression of CCND1 mRNA CTD PMID:12154027 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Ccne1 cyclin E1 increases expression ISO trabectedin results in increased expression of CCNE1 mRNA CTD PMID:15961672 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression EXP trabectedin results in increased expression of CDK1 mRNA CTD PMID:12154027 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases expression EXP trabectedin results in decreased expression of CYP1A2 mRNA CTD PMID:12154027 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases activity EXP trabectedin results in decreased activity of CYP2E1 protein CTD PMID:12154027 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases activity EXP trabectedin results in decreased activity of CYP3A2 protein CTD PMID:12154027 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 multiple interactions EXP Trabectedin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:12504080 NCBI chr12:14,369,950...14,398,803
Ensembl chr12:9,254,475...9,285,030
Ensembl chr12:9,254,475...9,285,030 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 decreases expression EXP trabectedin results in decreased expression of CYP3A13 mRNA CTD PMID:12154027 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422 		JBrowse link
G Dhfr dihydrofolate reductase decreases expression ISO trabectedin results in decreased expression of DHFR mRNA CTD PMID:15961672 NCBI chr 2:25,320,895...25,346,004
Ensembl chr 2:23,586,031...23,613,713 		JBrowse link
G E2f1 E2F transcription factor 1 increases expression ISO trabectedin results in increased expression of E2F1 mRNA CTD PMID:15961672 NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361 		JBrowse link
G Gpx4 glutathione peroxidase 4 decreases expression ISO Trabectedin results in decreased expression of GPX4 mRNA; Trabectedin results in decreased expression of GPX4 protein CTD PMID:36396105 NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:9,650,185...9,652,982 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases expression ISO Trabectedin results in increased expression of HIF1A mRNA; Trabectedin results in increased expression of HIF1A protein CTD PMID:36396105 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 increases expression ISO Trabectedin results in increased expression of KEAP1 protein CTD PMID:36396105 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862 		JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression EXP trabectedin results in increased expression of MKI67 protein CTD PMID:12154027 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions
decreases response to substance		 ISO everolimus inhibits the reaction [MTOR results in decreased susceptibility to trabectedin] CTD PMID:21622721 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 decreases expression ISO Trabectedin results in decreased expression of NFE2L2 protein CTD PMID:36396105 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nfya nuclear transcription factor Y subunit alpha multiple interactions ISO trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein] CTD PMID:15961672 NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898 		JBrowse link
G Nfyb nuclear transcription factor Y subunit beta multiple interactions ISO trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein] CTD PMID:15961672 NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565 		JBrowse link
G Nfyc nuclear transcription factor Y subunit gamma multiple interactions ISO trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein] CTD PMID:15961672 NCBI chr 5:134,336,802...134,405,372
Ensembl chr 5:134,336,808...134,405,377 		JBrowse link
G Tfrc transferrin receptor increases expression ISO Trabectedin results in increased expression of TFRC mRNA; Trabectedin results in increased expression of TFRC protein CTD PMID:36396105 NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257 		JBrowse link
G Tk1 thymidine kinase 1 decreases expression ISO trabectedin results in decreased expression of TK1 mRNA CTD PMID:15961672 NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920 		JBrowse link
triethylenediamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions EXP triethylenediamine inhibits the reaction [Gallic Acid results in increased activity of MGST1 protein] CTD PMID:19111564 NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:171,029,630...171,044,892 		JBrowse link
varenicline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Apoe apolipoprotein E affects response to substance ISO APOE protein affects the susceptibility to Varenicline CTD PMID:28202387 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932 		JBrowse link
G Cd36 CD36 molecule multiple interactions
increases expression		 ISO methyllycaconitine inhibits the reaction [Varenicline results in increased expression of CD36 mRNA]; methyllycaconitine inhibits the reaction [Varenicline results in increased expression of CD36 protein]
Varenicline results in increased expression of CD36 mRNA; Varenicline results in increased expression of CD36 protein		 CTD PMID:28202387 NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903 		JBrowse link
G Cdh5 cadherin 5 decreases expression
multiple interactions		 ISO Varenicline results in decreased expression of CDH5
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Varenicline results in decreased expression of CDH5]; methyllycaconitine inhibits the reaction [Varenicline results in decreased expression of CDH5]; pyrazolanthrone inhibits the reaction [Varenicline results in decreased expression of CDH5]; SB 203580 inhibits the reaction [Varenicline results in decreased expression of CDH5]		 CTD PMID:28842382 NCBI chr19:821,875...860,931
Ensembl chr19:815,411...854,368 		JBrowse link
G Chrna3 cholinergic receptor nicotinic alpha 3 subunit multiple interactions EXP Varenicline binds to and results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]; Varenicline binds to and results in increased activity of [CHRNA3 protein binds to CHRNB4 protein] CTD PMID:16766716 NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:55,401,702...55,415,165 		JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions ISO
EXP		 Varenicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]
varenicline binds to Chrna4 protein; varenicline inhibits [alpha-conotoxin MII binds to Chrna4 protein] in rat brain striatal sections
Varenicline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]		 CTD
RGD		 PMID:16766716 PMID:20100906 PMID:20207347 PMID:20331614 PMID:20373480 More... RGD:8549526 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:168,136,266...168,156,957 		JBrowse link
G Chrna6 cholinergic receptor nicotinic alpha 6 subunit multiple interactions
affects binding		 EXP Varenicline binds to and results in increased activity of CHRNA6 protein
Varenicline inhibits the reaction [alpha-Conotoxin MII binds to Chrna6]; Varenicline inhibits the reaction [epibatidine binds to Chrna6].
Varenicline binds to Chrna6 protein		 CTD
RGD		 PMID:16766716 PMID:22550286 PMID:22550286 RGD:8549526, RGD:8549526 NCBI chr16:71,400,615...71,407,315
Ensembl chr16:64,697,741...64,704,441 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit multiple interactions EXP Varenicline binds to and results in increased activity of [CHRNA7 protein binds to CHRNA7 protein] CTD PMID:16766716 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:116,714,711...116,837,240 		JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit multiple interactions ISO
EXP		 Varenicline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]
Varenicline binds to and results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]; Varenicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]		 CTD PMID:16766716 PMID:20100906 PMID:20207347 PMID:20331614 PMID:20373480 More... NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:175,181,402...175,189,619 		JBrowse link
G Chrnb4 cholinergic receptor nicotinic beta 4 subunit multiple interactions EXP Varenicline binds to and results in increased activity of [CHRNA3 protein binds to CHRNB4 protein] CTD PMID:16766716 NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:55,418,313...55,437,027 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases activity ISO Varenicline results in decreased activity of CYP1A1 protein CTD PMID:33814510 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity ISO Varenicline results in decreased activity of CYP1B1 protein CTD PMID:33814510 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation
multiple interactions
decreases activity		 ISO Varenicline results in increased phosphorylation of MAPK1 protein
methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of MAPK1 protein]
Varenicline results in decreased activity of MAPK1 protein		 CTD PMID:28202387 PMID:28842382 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation
decreases activity
multiple interactions		 ISO Varenicline results in increased phosphorylation of MAPK3 protein
Varenicline results in decreased activity of MAPK3 protein
methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of MAPK3 protein]		 CTD PMID:28202387 PMID:28842382 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Olr1 oxidized low density lipoprotein receptor 1 increases expression
multiple interactions		 ISO Varenicline results in increased expression of OLR1 mRNA; Varenicline results in increased expression of OLR1 protein
methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 mRNA]; methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 protein]		 CTD PMID:28202387 NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:162,926,439...162,948,523 		JBrowse link
G Pon1 paraoxonase 1 decreases activity ISO Varenicline results in decreased activity of PON1 protein CTD PMID:31581362 NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases phosphorylation
multiple interactions		 ISO Varenicline results in increased phosphorylation of RELA protein
methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of RELA protein]		 CTD PMID:28202387 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 affects response to substance ISO SLC22A2 gene SNP affects the susceptibility to Varenicline CTD PMID:25143296 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19909
    chemical entity 19907
      molecular entity 19906
        polyatomic entity 19857
          molecule 19750
            cyclic compound 19545
              polycyclic compound 18849
                bridged compound 1798
                  (+)-alpha-santalene + 0
                  (+)-endo-beta-bergamotene + 0
                  (+)-exo-beta-bergamotene 0
                  (+)-sativene 0
                  (+)-vulgraon B 0
                  (-)-(4S,5S,7S,10R,20S)-7,12,18-trihydroxyabieta-8,11,13-trien-20-aldehyde 7,18,20-acetal 0
                  (-)-(4S,5S,8R,10R,20S)-8,18-dihydroxy-12-oxo-abieta-9(11),13-dien-20-aldehyde 8,18,20-acetal 0
                  (-)-14,15-dihydroxysativene 0
                  (-)-15-hydroxysativene 0
                  (-)-beta-santalene 0
                  (-)-isosativene 0
                  (-)-sativene 0
                  (16R)-deshydroxymethyl-stemmadenine 0
                  (16S)-deshydroxymethyl-stemmadenine 0
                  (1S,7R,8R,14S)-15,17-diazatetracyclo[12.2.2.1(3,7).1(8,12)]icosa-3(20),12(19)-diene-6,9-dione 0
                  (3beta,16alpha)-13,28-epoxyoleanane-3,16,30-triol + 0
                  (3beta,16alpha)-13,28-epoxyoleanane-3,16-diol + 0
                  (3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside 0
                  (4aR,10bS)-noroxomaritidine 0
                  (4aS,10bR)-noroxomaritidine 0
                  (5R)-hydroxy-beta-trans-bergamotene 0
                  (E)-endo-beta-bergamoten-12-oic acid 0
                  1,2-diacetyltrichagmalin C 0
                  1,3,6,8-tetraazatricyclo[6.2.1.1(3,6)]dodecane 0
                  1,30-diacetyltrichagmalin F 0
                  1,7,8,9,10,10-hexachloro-4-methyl-4-azatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5-dione 0
                  15-acetoxyorbiculin G 0
                  15-acetyltrichagmalin C 0
                  15-acetyltrichagmalin E 0
                  16beta,17-dihydroxy-ent-kaurane-19-oic acid 0
                  17-O-acetylnorajmaline 0
                  18-hydroxycarbocyclic thromboxane A2 0
                  19-hydroxycarbocyclic thromboxane A2 0
                  19-hydroxyprostaglandin H1 0
                  19-hydroxyprostaglandin H2 0
                  1S,6R-di(2-)methylbutanoyloxy-4S-hydroxy-8S-benzoyloxy-9R-(3-)furancarbonyloxy-13-acetyloxy-beta-dihydroagarofuran 0
                  1alpha-acetoxy-2alpha-hydroxy-6beta,9beta,15-tribenzoyloxy-beta-dihydroagarofuran 0
                  2-O-deacetyleuonine 0
                  2-methylisoborneol 0
                  25-O-methoxycimigenol 3-O-alpha-L-arabinopyranoside 0
                  2alpha-acetoxy-1alpha-hydroxy-6beta,9beta,15-tribenzoyloxy-beta-dihydroagarofuran 0
                  3,6-anhydro-alpha-L-galactopyranose 0
                  3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide + 0
                  30-acetyltrichagmalin F 0
                  4'-O-demethylsordarin 0
                  5-oxo-1,2-campholide + 0
                  6'-O-acetylpaeoniflorin 0
                  6'-O-galloylalbiflorin 0
                  7-epiclusianone 0
                  8,5'-cyclo-2'-deoxyadenosine 1
                  8,5'-cyclo-2'-deoxyadenosine monophosphate 0
                  8,5'-cyclo-2'-deoxyguanosine 0
                  8,5'-cyclo-2'-deoxyguanosine monophosphate 0
                  8-acetoxyheterophyllisine 0
                  8-hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid 0
                  9-\{2,5-anhydro-4-[(phosphonooxy)methyl]-alpha-L-lyxofuranosyl\}-9H-purin-6-amine 0
                  BE-24566B 0
                  Camoensine 0
                  Euphorbia diterpenoid 1 0
                  Euphorbia diterpenoid 2 0
                  FR177391 0
                  HU-308 24
                  IWR-1-endo 0
                  IWR-1-exo 0
                  K-252a + 45
                  LY 379268 7
                  LY404039 0
                  N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide + 0
                  N-deethylaconine 0
                  NPD6433 0
                  SR 144528 38
                  TTT-3002 0
                  \{[(1r,7r)-4-(4-acetamidophenyl)-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-1-yl]carbamoyloxy\}acetic acid 0
                  aconine 0
                  albiflorin + 8
                  alpha-benzoyloxypaeoniflorin 0
                  alpha-bergamotene + 0
                  alpha-bergamotenoic acid 0
                  alpha-copaene 0
                  alpha-longipinene + 0
                  alpha-santalenoic acid 0
                  amataine 0
                  anisatin 0
                  ardisianoside A 0
                  ardisianoside B 0
                  ardisianoside C 0
                  ardisianoside D 0
                  ardisianoside E 0
                  aspergillide A 0
                  aspergillide B 0
                  aspergillide C 0
                  benzoylaconine 2
                  benzoylhypaconine 3
                  benzoylmesaconine 2
                  beta-benzoyloxypaeoniflorin 0
                  beta-copaene 0
                  beta-longipinene 0
                  beta-ylangene 0
                  betaenone A + 0
                  bicozamycin 0
                  bicyclo[2.2.2]octane-2,6-dione 0
                  butropium + 0
                  camphenilone 0
                  cantharidic acid 8
                  capilliposide B 0
                  carbocyclic thromboxane A2 + 2
                  catharanthine 0
                  cedr-8(15)-en-9-ol 0
                  cedr-8-ene 0
                  chaetoxanthone A 0
                  chaetoxanthone B 0
                  chasmanine 0
                  chlorendic acid 26
                  cimifoetiside A 0
                  cimifoetiside B 0
                  corianin 0
                  coriatin 0
                  crassicauline A 0
                  curvularol 0
                  cytisine 10
                  deoxyaconitine 0
                  desacetylpyramidaglain D 0
                  dihydroagarofuran + 0
                  dilopholide 0
                  eurysterol A sulfonic acid 0
                  eurysterol B sulfonic acid 0
                  foresaconitine 0
                  foresticine 0
                  futoenone 0
                  gaudichaudiic acid F 0
                  gaudichaudiic acid G 0
                  gaudichaudiic acid H 0
                  gaudichaudiic acid I 0
                  gilvusmycin 0
                  gnidilatimonoein 0
                  guttiferone F 0
                  hesseltin A 0
                  hispidospermidin 0
                  hokbusine A 0
                  hypaconine 0
                  hyperinol A 0
                  hyperinol B 0
                  inflexin 0
                  integrastatin A 0
                  integrastatin B 0
                  isobornyl formate 0
                  isotalatizidine 0
                  kadsurenin C 0
                  kadsurenin K 0
                  kadsurenin L 0
                  karakoline 0
                  komaroviquinone 0
                  lactiflorin 2
                  ledipasvir + 3
                  lurasidone 0
                  lycojapodine A 0
                  maoecrystal Z 0
                  maytenfolone A 0
                  megathyrin A 0
                  mesaconine 0
                  minheryin G 0
                  mustakone 0
                  myrtenic acid 0
                  neojiangyouaconitine 0
                  neoline 0
                  norajmaline + 0
                  norbornane + 0
                  norbornene 0
                  norcamphor + 0
                  ochrocarpinone A 0
                  ochrocarpinone B 0
                  ochrocarpinone C 0
                  orbiculin A 0
                  orbiculin D 0
                  orbiculin E 0
                  orbiculin F 0
                  orbiculin G + 0
                  orbiculin H 0
                  orbiculin I 0
                  oxonitine 0
                  oxypaeoniflorin 0
                  paeoniflorigenone 0
                  paeoniflorin sulfonate 0
                  pinocarvone 0
                  polycyclic cage + 1610
                  prostaglandin G2 2-glyceryl ester 0
                  prostaglandin H1 + 0
                  prostaglandin H2 2-glyceryl ester 0
                  prostaglandins G + 2
                  prostaglandins H + 3
                  quassimarin 0
                  regelidine 0
                  rostratin A 0
                  rostratin B 0
                  rostratin C 0
                  rostratin D 0
                  rotundifolioside A 0
                  rotundifolioside H 0
                  rotundifolioside I 0
                  rotundifolioside J 0
                  rubusoside + 63
                  saikogenin E + 0
                  saikosaponin C 0
                  salvileucalin B 0
                  samaderine B 0
                  samaderine C 0
                  senbusine A 0
                  somaliensene A 0
                  sordaricin 0
                  stemphyloxin II 0
                  steviol + 70
                  steviol glycoside + 63
                  steviolbioside 0
                  steviolmonoside + 0
                  stevioside + 52
                  streptolydigin 0
                  tandospirone 0
                  tarocin B 0
                  trabectedin 28
                  trichagmalin A 0
                  trichagmalin B 0
                  trichagmalin C + 0
                  trichagmalin D 0
                  trichagmalin E + 0
                  trichagmalin F + 0
                  trichanolide 0
                  triethylenediamine 1
                  triptofordin C 2 0
                  varenicline 17
                  viguilenin 0
                  xibornol 0
                  xylocarpin J 0
                  yunaconitine 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19909
    subatomic particle 19907
      composite particle 19907
        hadron 19907
          baryon 19907
            nucleon 19907
              atomic nucleus 19907
                atom 19907
                  group 19859
                    polyatomic entity 19857
                      molecule 19750
                        cyclic compound 19545
                          polycyclic compound 18849
                            bridged compound 1798
                              (+)-alpha-santalene + 0
                              (+)-endo-beta-bergamotene + 0
                              (+)-exo-beta-bergamotene 0
                              (+)-sativene 0
                              (+)-vulgraon B 0
                              (-)-(4S,5S,7S,10R,20S)-7,12,18-trihydroxyabieta-8,11,13-trien-20-aldehyde 7,18,20-acetal 0
                              (-)-(4S,5S,8R,10R,20S)-8,18-dihydroxy-12-oxo-abieta-9(11),13-dien-20-aldehyde 8,18,20-acetal 0
                              (-)-14,15-dihydroxysativene 0
                              (-)-15-hydroxysativene 0
                              (-)-beta-santalene 0
                              (-)-isosativene 0
                              (-)-sativene 0
                              (16R)-deshydroxymethyl-stemmadenine 0
                              (16S)-deshydroxymethyl-stemmadenine 0
                              (1S,7R,8R,14S)-15,17-diazatetracyclo[12.2.2.1(3,7).1(8,12)]icosa-3(20),12(19)-diene-6,9-dione 0
                              (3beta,16alpha)-13,28-epoxyoleanane-3,16,30-triol + 0
                              (3beta,16alpha)-13,28-epoxyoleanane-3,16-diol + 0
                              (3beta,16alpha)-16-hydroxy-13,28-epoxyoleanan-3-yl alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-arabinopyranoside 0
                              (4aR,10bS)-noroxomaritidine 0
                              (4aS,10bR)-noroxomaritidine 0
                              (5R)-hydroxy-beta-trans-bergamotene 0
                              (E)-endo-beta-bergamoten-12-oic acid 0
                              1,2-diacetyltrichagmalin C 0
                              1,3,6,8-tetraazatricyclo[6.2.1.1(3,6)]dodecane 0
                              1,30-diacetyltrichagmalin F 0
                              1,7,8,9,10,10-hexachloro-4-methyl-4-azatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5-dione 0
                              15-acetoxyorbiculin G 0
                              15-acetyltrichagmalin C 0
                              15-acetyltrichagmalin E 0
                              16beta,17-dihydroxy-ent-kaurane-19-oic acid 0
                              17-O-acetylnorajmaline 0
                              18-hydroxycarbocyclic thromboxane A2 0
                              19-hydroxycarbocyclic thromboxane A2 0
                              19-hydroxyprostaglandin H1 0
                              19-hydroxyprostaglandin H2 0
                              1S,6R-di(2-)methylbutanoyloxy-4S-hydroxy-8S-benzoyloxy-9R-(3-)furancarbonyloxy-13-acetyloxy-beta-dihydroagarofuran 0
                              1alpha-acetoxy-2alpha-hydroxy-6beta,9beta,15-tribenzoyloxy-beta-dihydroagarofuran 0
                              2-O-deacetyleuonine 0
                              2-methylisoborneol 0
                              25-O-methoxycimigenol 3-O-alpha-L-arabinopyranoside 0
                              2alpha-acetoxy-1alpha-hydroxy-6beta,9beta,15-tribenzoyloxy-beta-dihydroagarofuran 0
                              3,6-anhydro-alpha-L-galactopyranose 0
                              3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide + 0
                              30-acetyltrichagmalin F 0
                              4'-O-demethylsordarin 0
                              5-oxo-1,2-campholide + 0
                              6'-O-acetylpaeoniflorin 0
                              6'-O-galloylalbiflorin 0
                              7-epiclusianone 0
                              8,5'-cyclo-2'-deoxyadenosine 1
                              8,5'-cyclo-2'-deoxyadenosine monophosphate 0
                              8,5'-cyclo-2'-deoxyguanosine 0
                              8,5'-cyclo-2'-deoxyguanosine monophosphate 0
                              8-acetoxyheterophyllisine 0
                              8-hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid 0
                              9-\{2,5-anhydro-4-[(phosphonooxy)methyl]-alpha-L-lyxofuranosyl\}-9H-purin-6-amine 0
                              BE-24566B 0
                              Camoensine 0
                              Euphorbia diterpenoid 1 0
                              Euphorbia diterpenoid 2 0
                              FR177391 0
                              HU-308 24
                              IWR-1-endo 0
                              IWR-1-exo 0
                              K-252a + 45
                              LY 379268 7
                              LY404039 0
                              N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide + 0
                              N-deethylaconine 0
                              NPD6433 0
                              SR 144528 38
                              TTT-3002 0
                              \{[(1r,7r)-4-(4-acetamidophenyl)-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-1-yl]carbamoyloxy\}acetic acid 0
                              aconine 0
                              albiflorin + 8
                              alpha-benzoyloxypaeoniflorin 0
                              alpha-bergamotene + 0
                              alpha-bergamotenoic acid 0
                              alpha-copaene 0
                              alpha-longipinene + 0
                              alpha-santalenoic acid 0
                              amataine 0
                              anisatin 0
                              ardisianoside A 0
                              ardisianoside B 0
                              ardisianoside C 0
                              ardisianoside D 0
                              ardisianoside E 0
                              aspergillide A 0
                              aspergillide B 0
                              aspergillide C 0
                              benzoylaconine 2
                              benzoylhypaconine 3
                              benzoylmesaconine 2
                              beta-benzoyloxypaeoniflorin 0
                              beta-copaene 0
                              beta-longipinene 0
                              beta-ylangene 0
                              betaenone A + 0
                              bicozamycin 0
                              bicyclo[2.2.2]octane-2,6-dione 0
                              butropium + 0
                              camphenilone 0
                              cantharidic acid 8
                              capilliposide B 0
                              carbocyclic thromboxane A2 + 2
                              catharanthine 0
                              cedr-8(15)-en-9-ol 0
                              cedr-8-ene 0
                              chaetoxanthone A 0
                              chaetoxanthone B 0
                              chasmanine 0
                              chlorendic acid 26
                              cimifoetiside A 0
                              cimifoetiside B 0
                              corianin 0
                              coriatin 0
                              crassicauline A 0
                              curvularol 0
                              cytisine 10
                              deoxyaconitine 0
                              desacetylpyramidaglain D 0
                              dihydroagarofuran + 0
                              dilopholide 0
                              eurysterol A sulfonic acid 0
                              eurysterol B sulfonic acid 0
                              foresaconitine 0
                              foresticine 0
                              futoenone 0
                              gaudichaudiic acid F 0
                              gaudichaudiic acid G 0
                              gaudichaudiic acid H 0
                              gaudichaudiic acid I 0
                              gilvusmycin 0
                              gnidilatimonoein 0
                              guttiferone F 0
                              hesseltin A 0
                              hispidospermidin 0
                              hokbusine A 0
                              hypaconine 0
                              hyperinol A 0
                              hyperinol B 0
                              inflexin 0
                              integrastatin A 0
                              integrastatin B 0
                              isobornyl formate 0
                              isotalatizidine 0
                              kadsurenin C 0
                              kadsurenin K 0
                              kadsurenin L 0
                              karakoline 0
                              komaroviquinone 0
                              lactiflorin 2
                              ledipasvir + 3
                              lurasidone 0
                              lycojapodine A 0
                              maoecrystal Z 0
                              maytenfolone A 0
                              megathyrin A 0
                              mesaconine 0
                              minheryin G 0
                              mustakone 0
                              myrtenic acid 0
                              neojiangyouaconitine 0
                              neoline 0
                              norajmaline + 0
                              norbornane + 0
                              norbornene 0
                              norcamphor + 0
                              ochrocarpinone A 0
                              ochrocarpinone B 0
                              ochrocarpinone C 0
                              orbiculin A 0
                              orbiculin D 0
                              orbiculin E 0
                              orbiculin F 0
                              orbiculin G + 0
                              orbiculin H 0
                              orbiculin I 0
                              oxonitine 0
                              oxypaeoniflorin 0
                              paeoniflorigenone 0
                              paeoniflorin sulfonate 0
                              pinocarvone 0
                              polycyclic cage + 1610
                              prostaglandin G2 2-glyceryl ester 0
                              prostaglandin H1 + 0
                              prostaglandin H2 2-glyceryl ester 0
                              prostaglandins G + 2
                              prostaglandins H + 3
                              quassimarin 0
                              regelidine 0
                              rostratin A 0
                              rostratin B 0
                              rostratin C 0
                              rostratin D 0
                              rotundifolioside A 0
                              rotundifolioside H 0
                              rotundifolioside I 0
                              rotundifolioside J 0
                              rubusoside + 63
                              saikogenin E + 0
                              saikosaponin C 0
                              salvileucalin B 0
                              samaderine B 0
                              samaderine C 0
                              senbusine A 0
                              somaliensene A 0
                              sordaricin 0
                              stemphyloxin II 0
                              steviol + 70
                              steviol glycoside + 63
                              steviolbioside 0
                              steviolmonoside + 0
                              stevioside + 52
                              streptolydigin 0
                              tandospirone 0
                              tarocin B 0
                              trabectedin 28
                              trichagmalin A 0
                              trichagmalin B 0
                              trichagmalin C + 0
                              trichagmalin D 0
                              trichagmalin E + 0
                              trichagmalin F + 0
                              trichanolide 0
                              triethylenediamine 1
                              triptofordin C 2 0
                              varenicline 17
                              viguilenin 0
                              xibornol 0
                              xylocarpin J 0
                              yunaconitine 0
paths to the root